<?xml version='1.0' encoding='utf-8'?>
<graphml xmlns="http://graphml.graphdrawing.org/xmlns" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://graphml.graphdrawing.org/xmlns http://graphml.graphdrawing.org/xmlns/1.0/graphml.xsd"><key id="d9" for="edge" attr.name="context" attr.type="string"/>
<key id="d8" for="edge" attr.name="type" attr.type="string"/>
<key id="d7" for="node" attr.name="canonical_name" attr.type="string"/>
<key id="d6" for="node" attr.name="name" attr.type="string"/>
<key id="d5" for="node" attr.name="entity_type" attr.type="string"/>
<key id="d4" for="node" attr.name="paper_id" attr.type="string"/>
<key id="d3" for="node" attr.name="statement" attr.type="string"/>
<key id="d2" for="node" attr.name="year" attr.type="long"/>
<key id="d1" for="node" attr.name="content" attr.type="string"/>
<key id="d0" for="node" attr.name="type" attr.type="string"/>
<graph edgedefault="directed"><node id="PDF_35_2018">
  <data key="d0">Paper</data>
  <data key="d1">Focus Article
Regulation of germ cell
development by intercellular
signaling in the mammalian
ovarian follicle
Hugh J. Clarke *
Prior to ovulation, the mammalian oocyte undergoes a process of differentiation
within the ovarian follicle that confers on it the ability to give rise to an embryo.
Differentiation comprises two phases-growth, during which the oocyte
increases more than 100-fold in volume as it accumulates macromolecules and
organelles that will sustain early embryogenesis; and meiotic</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_35_2018_Hypothesis_6607342765796793125">
  <data key="d0">Hypothesis</data>
  <data key="d1">Oocyte growth per se does not trigger granulosa cell proliferation, although factors produced by growing oocytes might play a role.</data>
  <data key="d3">Oocyte growth per se does not trigger granulosa cell proliferation, although factors produced by growing oocytes might play a role.</data>
  <data key="d4">PDF_35_2018</data>
</node>
<node id="PDF_35_2018_Method_-4022510037365219681">
  <data key="d0">Method</data>
  <data key="d1">using a Vasa-driven Cre.</data>
  <data key="d3">using a Vasa-driven Cre.</data>
  <data key="d4">PDF_35_2018</data>
</node>
<node id="PDF_35_2018_Result_6372364759180780684">
  <data key="d0">Result</data>
  <data key="d1">KITL produced by the granulosa cells in the primordial follicle triggers growth of the enclosed oocyte.</data>
  <data key="d3">KITL produced by the granulosa cells in the primordial follicle triggers growth of the enclosed oocyte.</data>
  <data key="d4">PDF_35_2018</data>
</node>
<node id="Protein_KITL">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">KITL</data>
  <data key="d7">KITL</data>
</node>
<node id="PDF_35_2018_Result_2505657037585826409">
  <data key="d0">Result</data>
  <data key="d1">PI3-kinase signaling promotes oocyte growth directly</data>
  <data key="d3">PI3-kinase signaling promotes oocyte growth directly</data>
  <data key="d4">PDF_35_2018</data>
</node>
<node id="PDF_35_2018_Conclusion_168680280078598681">
  <data key="d0">Conclusion</data>
  <data key="d1">Oocyte differentiation thus depends on continuous signaling interactions with the somatic cells of the follicle.</data>
  <data key="d3">Oocyte differentiation thus depends on continuous signaling interactions with the somatic cells of the follicle.</data>
  <data key="d4">PDF_35_2018</data>
</node>
<node id="PDF_06_2021">
  <data key="d0">Paper</data>
  <data key="d1">Here is the complete text from the scientific PDF, as requested.

Developmental Cell
Article
Meiotic Cells Counteract Programmed
Retrotransposon Activation via RNA-Binding
Translational Repressor Assemblies
Raphaelle Laureau, 1 Annie Dyatel,¹ Gizem Dursuk, 1 Samantha Brown,¹ Hannah Adeoye, 1 Jia-Xing Yue, 2
Matteo De Chiara, Anthony Harris, Elçin Ünal, 3 Gianni Liti, 2 lan R. Adams, and Luke E. Berchowitz1,5,*
1Department of Genetics and Development, Hammer Health Sciences Center, Columbia Unive</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_06_2021_Conclusion_-3571697265012646536">
  <data key="d0">Conclusion</data>
  <data key="d1">Our findings inform how genes that are evolving from retrotransposons can build upon existing regulatory networks during domestication.</data>
  <data key="d3">Our findings inform how genes that are evolving from retrotransposons can build upon existing regulatory networks during domestication.</data>
  <data key="d4">PDF_06_2021</data>
</node>
<node id="PDF_06_2021_Result_-8293907984342820785">
  <data key="d0">Result</data>
  <data key="d1">We show that budding yeast Ty3/Gypsy co-opts binding sites of the essential meiotic transcription factor Ndt80 upstream of the integration site, thereby tightly linking its transcriptional activation to meiotic progression.</data>
  <data key="d3">We show that budding yeast Ty3/Gypsy co-opts binding sites of the essential meiotic transcription factor Ndt80 upstream of the integration site, thereby tightly linking its transcriptional activation to meiotic progression.</data>
  <data key="d4">PDF_06_2021</data>
</node>
<node id="Protein_NDT80">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">NDT80</data>
  <data key="d7">Ndt80</data>
</node>
<node id="Gene_TY3/GYPSY">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">TY3/GYPSY</data>
  <data key="d7">Ty3/Gypsy</data>
</node>
<node id="PDF_06_2021_Result_6580076833441545751">
  <data key="d0">Result</data>
  <data key="d1">We also elucidate how yeast cells thwart Ty3/Gypsy proliferation by blocking translation of the retrotransposon mRNA using amyloid-like assemblies of the RNA-binding protein Rim4.</data>
  <data key="d3">We also elucidate how yeast cells thwart Ty3/Gypsy proliferation by blocking translation of the retrotransposon mRNA using amyloid-like assemblies of the RNA-binding protein Rim4.</data>
  <data key="d4">PDF_06_2021</data>
</node>
<node id="Protein_RIM4">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">RIM4</data>
  <data key="d7">Rim4</data>
</node>
<node id="PDF_06_2021_Result_1886473363624640680">
  <data key="d0">Result</data>
  <data key="d1">We show that mammals utilize equivalent master meiotic regulators (Stra8, Mybl1, Dazl) to regulate Ty3/Gypsy-derived genes in developing gametes.</data>
  <data key="d3">We show that mammals utilize equivalent master meiotic regulators (Stra8, Mybl1, Dazl) to regulate Ty3/Gypsy-derived genes in developing gametes.</data>
  <data key="d4">PDF_06_2021</data>
</node>
<node id="Gene_STRA8">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">STRA8</data>
  <data key="d7">STRA8</data>
</node>
<node id="Gene_MYBL1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">MYBL1</data>
  <data key="d7">Mybl1</data>
</node>
<node id="Gene_DAZL">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">DAZL</data>
  <data key="d7">Dazl</data>
</node>
<node id="PDF_49_2017">
  <data key="d0">Paper</data>
  <data key="d1">QuPath is new bioimage analysis software designed to meet the growing need for a user-friendly,
extensible, open-source solution for digital pathology and whole slide image analysis. In addition to
offering a comprehensive panel of tumor identification and high-throughput biomarker evaluation
tools, QuPath provides researchers with powerful batch-processing and scripting functionality, and an
extensible platform with which to develop and share new algorithms to analyze complex tissue images.
Fur</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_49_2017_Result_-996224747342952721">
  <data key="d0">Result</data>
  <data key="d1">a statistically significant association between disease-specific survival and positive cell density scores was demonstrated for both CD3 and CD8</data>
  <data key="d3">a statistically significant association between disease-specific survival and positive cell density scores was demonstrated for both CD3 and CD8</data>
  <data key="d4">PDF_49_2017</data>
</node>
<node id="Protein_CD3">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">CD3</data>
  <data key="d7">CD3</data>
</node>
<node id="Protein_CD8">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">CD8</data>
  <data key="d7">CD8</data>
</node>
<node id="PDF_49_2017_Result_5555692958255038668">
  <data key="d0">Result</data>
  <data key="d1">aberrant p53 expression is associated with significantly poorer unadjusted disease-specific survival when compared with intermediate, 'wild-type' expression</data>
  <data key="d3">aberrant p53 expression is associated with significantly poorer unadjusted disease-specific survival when compared with intermediate, 'wild-type' expression</data>
  <data key="d4">PDF_49_2017</data>
</node>
<node id="Protein_TP53">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">TP53</data>
  <data key="d7">TP53</data>
</node>
<node id="Gene_TP53">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">TP53</data>
  <data key="d7">TP53</data>
</node>
<node id="PDF_49_2017_Result_-4649153068088334797">
  <data key="d0">Result</data>
  <data key="d1">higher PD-L1 expression to be significantly associated with improved disease-specific survival in unadjusted analysis</data>
  <data key="d3">higher PD-L1 expression to be significantly associated with improved disease-specific survival in unadjusted analysis</data>
  <data key="d4">PDF_49_2017</data>
</node>
<node id="Protein_PD-L1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">PD-L1</data>
  <data key="d7">PD-L1</data>
</node>
<node id="PDF_49_2017_Result_-891350384711302256">
  <data key="d0">Result</data>
  <data key="d1">lower disease-specific survival among patients with a high tumor stromal percentage in unadjusted analysis</data>
  <data key="d3">lower disease-specific survival among patients with a high tumor stromal percentage in unadjusted analysis</data>
  <data key="d4">PDF_49_2017</data>
</node>
<node id="PDF_04_2013">
  <data key="d0">Paper</data>
  <data key="d1">Here is the extracted text from the scientific PDF you provided. 

**Genesis and Regulatory Wiring of Retroelement-Derived
Domesticated Genes: A Phylogenomic Perspective**

Janez Kokošar and Dušan Kordiš*
Department of Molecular and Biomedical Sciences, Josef Stefan Institute, Ljubljana, Slovenia
*Corresponding author: E-mail: dusan.kordis@ijs.si.
Associate editor: Jianzhi Zhang

**Abstract**
Molecular domestications of transposable elements have occurred repeatedly during the evolution of eukar</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_04_2013_Hypothesis_-552669748670766290">
  <data key="d0">Hypothesis</data>
  <data key="d1">RDDGs originated from retroelement remains</data>
  <data key="d3">RDDGs originated from retroelement remains</data>
  <data key="d4">PDF_04_2013</data>
</node>
<node id="PDF_04_2013_Method_2235178835756339331">
  <data key="d0">Method</data>
  <data key="d1">phylogenomic analysis, using whole-genome information from more than 90 chordate genomes</data>
  <data key="d3">phylogenomic analysis, using whole-genome information from more than 90 chordate genomes</data>
  <data key="d4">PDF_04_2013</data>
</node>
<node id="PDF_04_2013_Method_-7138270917738499825">
  <data key="d0">Method</data>
  <data key="d1">comparative genomic and phylogenomic analyses</data>
  <data key="d3">comparative genomic and phylogenomic analyses</data>
  <data key="d4">PDF_04_2013</data>
</node>
<node id="PDF_04_2013_Method_-8868282894336236895">
  <data key="d0">Method</data>
  <data key="d1">Bayesian phylogenetics and conserved synteny</data>
  <data key="d3">Bayesian phylogenetics and conserved synteny</data>
  <data key="d4">PDF_04_2013</data>
</node>
<node id="PDF_04_2013_Result_-7584703077616507795">
  <data key="d0">Result</data>
  <data key="d1">RDDGs originated from Metaviridae remains</data>
  <data key="d3">RDDGs originated from Metaviridae remains</data>
  <data key="d4">PDF_04_2013</data>
</node>
<node id="PDF_04_2013_Result_8531639358069998615">
  <data key="d0">Result</data>
  <data key="d1">major diversification occurred in the ancestor of placental mammals</data>
  <data key="d3">major diversification occurred in the ancestor of placental mammals</data>
  <data key="d4">PDF_04_2013</data>
</node>
<node id="PDF_04_2013_Result_-1132446246714849278">
  <data key="d0">Result</data>
  <data key="d1">RDDGs are present in all three placental superorders</data>
  <data key="d3">RDDGs are present in all three placental superorders</data>
  <data key="d4">PDF_04_2013</data>
</node>
<node id="PDF_04_2013_Result_444563630561013278">
  <data key="d0">Result</data>
  <data key="d1">Analysis of active Metaviridae lineages in amniotes, demonstrated that RDDGs originated from retroelement remains</data>
  <data key="d3">Analysis of active Metaviridae lineages in amniotes, demonstrated that RDDGs originated from retroelement remains</data>
  <data key="d4">PDF_04_2013</data>
</node>
<node id="PDF_04_2013_Conclusion_-5562496876107181190">
  <data key="d0">Conclusion</data>
  <data key="d1">the origin of placental mammal-specific innovations and adaptations, such as placenta and newly evolved brain functions, was most probably connected to the regulatory wiring of DGs and their rapid fixation in the ancestor of placental mammals</data>
  <data key="d3">the origin of placental mammal-specific innovations and adaptations, such as placenta and newly evolved brain functions, was most probably connected to the regulatory wiring of DGs and their rapid fixation in the ancestor of placental mammals</data>
  <data key="d4">PDF_04_2013</data>
</node>
<node id="PDF_18_2013">
  <data key="d0">Paper</data>
  <data key="d1">npg
2013 Nature America, Inc. All rights reserved.
COMMENTARY
OPEN
The Genotype-Tissue Expression (GTEX)
project
The GTEx Consortium*
Genome-wide association studies have identified thousands of loci for common diseases, but, for the majority
of these, the mechanisms underlying disease susceptibility remain unknown. Most associated variants are not
correlated with protein-coding changes, suggesting that polymorphisms in regulatory regions probably contribute to
many disease phenotypes. Here we d</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_18_2013_Hypothesis_1698064238978234472">
  <data key="d0">Hypothesis</data>
  <data key="d1">Polymorphisms in regulatory regions probably contribute to many disease phenotypes.</data>
  <data key="d3">Polymorphisms in regulatory regions probably contribute to many disease phenotypes.</data>
  <data key="d4">PDF_18_2013</data>
</node>
<node id="Disease_DISEASE">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">DISEASE</data>
  <data key="d7">Disease</data>
</node>
<node id="PDF_18_2013_Method_7340696956969420060">
  <data key="d0">Method</data>
  <data key="d1">Expression quantitative trait locus (eQTL) mapping</data>
  <data key="d3">Expression quantitative trait locus (eQTL) mapping</data>
  <data key="d4">PDF_18_2013</data>
</node>
<node id="PDF_18_2013_Method_-1981325593318475646">
  <data key="d0">Method</data>
  <data key="d1">massively parallel sequencing of RNA</data>
  <data key="d3">massively parallel sequencing of RNA</data>
  <data key="d4">PDF_18_2013</data>
</node>
<node id="PDF_18_2013_Method_10165599989779262">
  <data key="d0">Method</data>
  <data key="d1">gene expression array</data>
  <data key="d3">gene expression array</data>
  <data key="d4">PDF_18_2013</data>
</node>
<node id="PDF_18_2013_Method_1833730253347585872">
  <data key="d0">Method</data>
  <data key="d1">DNA genotyping using the Illumina HumanOmni5M-Quad BeadChip to collect whole-genome SNP and CNV information</data>
  <data key="d3">DNA genotyping using the Illumina HumanOmni5M-Quad BeadChip to collect whole-genome SNP and CNV information</data>
  <data key="d4">PDF_18_2013</data>
</node>
<node id="PDF_18_2013_Method_7975679540487905188">
  <data key="d0">Method</data>
  <data key="d1">Illumina Infinium HumanExome BeadChip to obtain high-quality SNP calls in coding regions</data>
  <data key="d3">Illumina Infinium HumanExome BeadChip to obtain high-quality SNP calls in coding regions</data>
  <data key="d4">PDF_18_2013</data>
</node>
<node id="PDF_18_2013_Method_3696440658537175570">
  <data key="d0">Method</data>
  <data key="d1">RNA sequencing (RNA-seq) using a 76-base, paired-end Illumina TruSeq RNA protocol</data>
  <data key="d3">RNA sequencing (RNA-seq) using a 76-base, paired-end Illumina TruSeq RNA protocol</data>
  <data key="d4">PDF_18_2013</data>
</node>
<node id="PDF_18_2013_Method_2515045453521819794">
  <data key="d0">Method</data>
  <data key="d1">Establishment of Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines and primary fibroblast cell lines</data>
  <data key="d3">Establishment of Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines and primary fibroblast cell lines</data>
  <data key="d4">PDF_18_2013</data>
</node>
<node id="PDF_18_2013_Result_-9161646209441668556">
  <data key="d0">Result</data>
  <data key="d1">eQTLs are common in humans</data>
  <data key="d3">eQTLs are common in humans</data>
  <data key="d4">PDF_18_2013</data>
</node>
<node id="PDF_18_2013_Conclusion_-1276811915882357539">
  <data key="d0">Conclusion</data>
  <data key="d1">A large-scale GTEx resource will be a powerful tool in unraveling the complex patterns of genetic variation and gene regulation across diverse human tissue types.</data>
  <data key="d3">A large-scale GTEx resource will be a powerful tool in unraveling the complex patterns of genetic variation and gene regulation across diverse human tissue types.</data>
  <data key="d4">PDF_18_2013</data>
</node>
<node id="PDF_18_2013_Conclusion_-520697566531489822">
  <data key="d0">Conclusion</data>
  <data key="d1">The GTEx project will aid in the interpretation of GWAS findings for translational research by providing data and resources on eQTLs in a wide range of tissues of relevance to many diseases.</data>
  <data key="d3">The GTEx project will aid in the interpretation of GWAS findings for translational research by providing data and resources on eQTLs in a wide range of tissues of relevance to many diseases.</data>
  <data key="d4">PDF_18_2013</data>
</node>
<node id="PDF_18_2013_Conclusion_-5162339154313744163">
  <data key="d0">Conclusion</data>
  <data key="d1">The value of a large GTEx resource goes well beyond GWAS follow-up, by providing a deeper understanding of the functional elements of the genome and their underlying biological mechanisms.</data>
  <data key="d3">The value of a large GTEx resource goes well beyond GWAS follow-up, by providing a deeper understanding of the functional elements of the genome and their underlying biological mechanisms.</data>
  <data key="d4">PDF_18_2013</data>
</node>
<node id="PDF_39_2016">
  <data key="d0">Paper</data>
  <data key="d1">Here is the full text, as requested:

Article
Cell Reports
MOAP-1 Mediates Fas-Induced Apoptosis in Liver by
Facilitating tBid Recruitment to Mitochondria
Chong Teik Tan, Qi-Ling Zhou,
+ Fas activation
X MOAP-1 Knockout
Intact mitochondria
Survival
Yu-Chin Su, ..., Kanaga Sabapathy,
Chun-Dong Yu, Victor C. Yu
Correspondence
phayuv@nus.edu.sg
In Brief
Activation of Fas apoptotic signaling
triggers acute liver injury. Tan et al. show
that deletion of the MOAP-1 gene
protects mice from this injury.</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_39_2016_Result_-318989661465928678">
  <data key="d0">Result</data>
  <data key="d1">MOAP-1-deficient mice are markedly resistant to Fas-induced hepatocellular apoptosis and lethality.</data>
  <data key="d3">MOAP-1-deficient mice are markedly resistant to Fas-induced hepatocellular apoptosis and lethality.</data>
  <data key="d4">PDF_39_2016</data>
</node>
<node id="Protein_MOAP-1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">MOAP-1</data>
  <data key="d7">MOAP-1</data>
</node>
<node id="Protein_FAS">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">FAS</data>
  <data key="d7">Fas</data>
</node>
<node id="Process_APOPTOSIS">
  <data key="d0">Entity</data>
  <data key="d5">Process</data>
  <data key="d6">APOPTOSIS</data>
  <data key="d7">Apoptosis</data>
</node>
<node id="PDF_39_2016_Result_2154384502965408521">
  <data key="d0">Result</data>
  <data key="d1">tBid is unable to associate with MTCH2 and fails to accumulate at mitochondria in the absence of MOAP-1.</data>
  <data key="d3">tBid is unable to associate with MTCH2 and fails to accumulate at mitochondria in the absence of MOAP-1.</data>
  <data key="d4">PDF_39_2016</data>
</node>
<node id="Protein_TBID">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">TBID</data>
  <data key="d7">tBid</data>
</node>
<node id="Protein_MTCH2">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">MTCH2</data>
  <data key="d7">MTCH2</data>
</node>
<node id="Process_MITOCHONDRIA">
  <data key="d0">Entity</data>
  <data key="d5">Process</data>
  <data key="d6">MITOCHONDRIA</data>
  <data key="d7">Mitochondria</data>
</node>
<node id="PDF_39_2016_Result_-667261254184653789">
  <data key="d0">Result</data>
  <data key="d1">MOAP-1 associates with MTCH2, but not tBid.</data>
  <data key="d3">MOAP-1 associates with MTCH2, but not tBid.</data>
  <data key="d4">PDF_39_2016</data>
</node>
<node id="PDF_39_2016_Result_-2160432020041116881">
  <data key="d0">Result</data>
  <data key="d1">Re-expression of MOAP-1, but not the MOAP-1 mutant defective in binding MTCH, restores the binding of tBid to MTCH2 and hepatocellular apoptosis upon Fas activation.</data>
  <data key="d3">Re-expression of MOAP-1, but not the MOAP-1 mutant defective in binding MTCH, restores the binding of tBid to MTCH2 and hepatocellular apoptosis upon Fas activation.</data>
  <data key="d4">PDF_39_2016</data>
</node>
<node id="Gene_MTCH2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">MTCH2</data>
  <data key="d7">MTCH2</data>
</node>
<node id="PDF_39_2016_Conclusion_-6214686346960481988">
  <data key="d0">Conclusion</data>
  <data key="d1">MOAP-1 serves as a critical component of the Fas signaling in liver by promoting the mitochondrial receptor function of MTCH2 for tBid.</data>
  <data key="d3">MOAP-1 serves as a critical component of the Fas signaling in liver by promoting the mitochondrial receptor function of MTCH2 for tBid.</data>
  <data key="d4">PDF_39_2016</data>
</node>
<node id="PDF_58_2023">
  <data key="d0">Paper</data>
  <data key="d1">Here is the full text of the article extracted from the PDF:

Article
THE
EMBO
SOURCE
DATA
TRANSPARENT
PROCESS
OPEN
ACCESS
JOURNAL
Assembly and function of the amyloid-like
translational repressor Rim4 is coupled with
nutrient conditions
ID
Diana SM Ottoz¹, Lauren C Tang², Annie E Dyatel¹, Marko Jovanovic² &amp; Luke E Berchowitz 1,3,* D
Abstract
Amyloid-like protein assemblies have been associated with toxic
phenotypes because of their repetitive and stable structure. How-
ever, evidence that cells</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_58_2023_Hypothesis_4931475269163258933">
  <data key="d0">Hypothesis</data>
  <data key="d1">Rim4 assembly stimulates RRM-mediated binding of its target RNAs, a requisite for its function as a translational repressor.</data>
  <data key="d3">Rim4 assembly stimulates RRM-mediated binding of its target RNAs, a requisite for its function as a translational repressor.</data>
  <data key="d4">PDF_58_2023</data>
</node>
<node id="Compound_RNA">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">RNA</data>
  <data key="d7">RNA</data>
</node>
<node id="PDF_58_2023_Method_4078968727892392345">
  <data key="d0">Method</data>
  <data key="d1">semi-denaturing detergent agarose gel electrophoresis (SDD-AGE), a technique that allows for the resolution of SDS-resistant aggregates</data>
  <data key="d3">semi-denaturing detergent agarose gel electrophoresis (SDD-AGE), a technique that allows for the resolution of SDS-resistant aggregates</data>
  <data key="d4">PDF_58_2023</data>
</node>
<node id="PDF_58_2023_Method_2813433265140845269">
  <data key="d0">Method</data>
  <data key="d1">flow cytometry</data>
  <data key="d3">flow cytometry</data>
  <data key="d4">PDF_58_2023</data>
</node>
<node id="PDF_58_2023_Method_6495057347155501077">
  <data key="d0">Method</data>
  <data key="d1">RNA-immunopurification (RNA-IP) followed by qPCR</data>
  <data key="d3">RNA-immunopurification (RNA-IP) followed by qPCR</data>
  <data key="d4">PDF_58_2023</data>
</node>
<node id="PDF_58_2023_Result_3345746782032400808">
  <data key="d0">Result</data>
  <data key="d1">assembled Rim4 binds RNA more efficiently than its monomeric form, a requirement for effective translational repression</data>
  <data key="d3">assembled Rim4 binds RNA more efficiently than its monomeric form, a requirement for effective translational repression</data>
  <data key="d4">PDF_58_2023</data>
</node>
<node id="PDF_58_2023_Result_533722152885788374">
  <data key="d0">Result</data>
  <data key="d1">Rim4 represses translation when it binds the transcripts at their 5' end, while it does not have any effect when it binds their 3' end</data>
  <data key="d3">Rim4 represses translation when it binds the transcripts at their 5' end, while it does not have any effect when it binds their 3' end</data>
  <data key="d4">PDF_58_2023</data>
</node>
<node id="PDF_58_2023_Result_3460477371086700921">
  <data key="d0">Result</data>
  <data key="d1">Rim4 assembly depends exclusively on its intrinsically disordered region (IDR)</data>
  <data key="d3">Rim4 assembly depends exclusively on its intrinsically disordered region (IDR)</data>
  <data key="d4">PDF_58_2023</data>
</node>
<node id="PDF_58_2023_Result_7550864938787887815">
  <data key="d0">Result</data>
  <data key="d1">Assembly is prevented by protein kinase A (PKA) which promotes growth and suppresses meiotic entry</data>
  <data key="d3">Assembly is prevented by protein kinase A (PKA) which promotes growth and suppresses meiotic entry</data>
  <data key="d4">PDF_58_2023</data>
</node>
<node id="Protein_PKA">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">PKA</data>
  <data key="d7">PKA</data>
</node>
<node id="PDF_58_2023_Conclusion_9069111716801773710">
  <data key="d0">Conclusion</data>
  <data key="d1">the PKA signaling pathway transduces the carbon source input into Rim4 assembly</data>
  <data key="d3">the PKA signaling pathway transduces the carbon source input into Rim4 assembly</data>
  <data key="d4">PDF_58_2023</data>
</node>
<node id="PDF_58_2023_Conclusion_-7061615767234987994">
  <data key="d0">Conclusion</data>
  <data key="d1">prevention of assembly in starvation also prevents translational repression</data>
  <data key="d3">prevention of assembly in starvation also prevents translational repression</data>
  <data key="d4">PDF_58_2023</data>
</node>
<node id="PDF_25_2015">
  <data key="d0">Paper</data>
  <data key="d1">Journal of Virological Methods 225 (2015) 59-63
Contents lists available at ScienceDirect
Journal of Virological Methods
journal homepage: www.elsevier.com/locate/jviromet
Journal of
Virological
Methods
ELSEVIER
Protocol
A protocol for the gentle purification of virus-like
particles produced in plants
Hadrien Peyret*
Department of Biological Chemistry, John Innes Centre, Norwich, UK
CrossMark
Article history:
Received 25 February 2015
Received in revised form 1 September 2015
Accepted 13 Septemb</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_25_2015_Method_1266927071867598665">
  <data key="d0">Method</data>
  <data key="d1">The method presented here is based on ultracentrifugation and density gradients, with no pelleting or precipitation step.</data>
  <data key="d3">The method presented here is based on ultracentrifugation and density gradients, with no pelleting or precipitation step.</data>
  <data key="d4">PDF_25_2015</data>
</node>
<node id="PDF_25_2015_Method_5370093709698939040">
  <data key="d0">Method</data>
  <data key="d1">The protocol described here is suitable for determining whether VLPs are formed after recombinant protein expression in plants, using sucrose cushion and Nycodenz gradient.</data>
  <data key="d3">The protocol described here is suitable for determining whether VLPs are formed after recombinant protein expression in plants, using sucrose cushion and Nycodenz gradient.</data>
  <data key="d4">PDF_25_2015</data>
</node>
<node id="Protein_VLP">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">VLP</data>
  <data key="d7">VLP</data>
</node>
<node id="PDF_25_2015_Result_5911189686826317284">
  <data key="d0">Result</data>
  <data key="d1">Blended leaf material forms a thick slurry which is significantly more fluid after filtration over Miracloth. The clarification centrifugation step yields a thick green pellet and a brownish supernatant. The double sucrose cushion will always result in a green band of dense impurities forming at the interface between the 25% and 70% sucrose layers</data>
  <data key="d3">Blended leaf material forms a thick slurry which is significantly more fluid after filtration over Miracloth. The clarification centrifugation step yields a thick green pellet and a brownish supernatant. The double sucrose cushion will always result in a green band of dense impurities forming at the interface between the 25% and 70% sucrose layers</data>
  <data key="d4">PDF_25_2015</data>
</node>
<node id="PDF_25_2015_Result_8421603819451325932">
  <data key="d0">Result</data>
  <data key="d1">VLPs are detectable in the 70% sucrose fraction as well as in the interface, although the 70% fraction will normally look cleaner</data>
  <data key="d3">VLPs are detectable in the 70% sucrose fraction as well as in the interface, although the 70% fraction will normally look cleaner</data>
  <data key="d4">PDF_25_2015</data>
</node>
<node id="PDF_25_2015_Result_8052546391498430882">
  <data key="d0">Result</data>
  <data key="d1">TEM analysis of Nycodenz gradient fractions containing VLPs will appear cleaner than fractions obtained from the sucrose cushion</data>
  <data key="d3">TEM analysis of Nycodenz gradient fractions containing VLPs will appear cleaner than fractions obtained from the sucrose cushion</data>
  <data key="d4">PDF_25_2015</data>
</node>
<node id="PDF_25_2015_Conclusion_-3211183483896047280">
  <data key="d0">Conclusion</data>
  <data key="d1">Every correctly assembled virion or VLP should fulfil this assumption that the protein forms particulate material which will migrate through a sucrose cushion and Nycodenz gradient.</data>
  <data key="d3">Every correctly assembled virion or VLP should fulfil this assumption that the protein forms particulate material which will migrate through a sucrose cushion and Nycodenz gradient.</data>
  <data key="d4">PDF_25_2015</data>
</node>
<node id="PDF_44_2021">
  <data key="d0">Paper</data>
  <data key="d1">LTH &amp; HUMAN SERVICES-US,
Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript
HHS Public Access
Author manuscript
Nature. Author manuscript; available in PMC 2022 January 01.
Published in final edited form as:
Nature. 2021 July ; 595(7866): 303-308. doi:10.1038/s41586-021-03633-w.
NORAD-induced PUMILIO phase separation is required for
genome stability
Mahmoud M. Elguindy1,2, Joshua T. Mendell1,3,4,5,*
1Department of Molecular Biology, University of Texas Southwestern Medical C</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_44_2021_Hypothesis_-2890070289513742288">
  <data key="d0">Hypothesis</data>
  <data key="d1">NORAD is able to negatively regulate PUM proteins by nucleating the formation of phase-separated cytoplasmic PUM condensates, which we termed NORAD-PUM (NP) bodies.</data>
  <data key="d3">NORAD is able to negatively regulate PUM proteins by nucleating the formation of phase-separated cytoplasmic PUM condensates, which we termed NORAD-PUM (NP) bodies.</data>
  <data key="d4">PDF_44_2021</data>
</node>
<node id="Gene_NORAD">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">NORAD</data>
  <data key="d7">NORAD</data>
</node>
<node id="Protein_PUMILIO">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">PUMILIO</data>
  <data key="d7">Pumilio</data>
</node>
<node id="PDF_44_2021_Method_7331792267970534220">
  <data key="d0">Method</data>
  <data key="d1">We synthesized a series of fluorescently-labeled RNA oligonucleotides containing varying numbers of PREs to test whether the multivalent binding of PUM to a PRE-containing transcript is sufficient to promote phase separation</data>
  <data key="d3">We synthesized a series of fluorescently-labeled RNA oligonucleotides containing varying numbers of PREs to test whether the multivalent binding of PUM to a PRE-containing transcript is sufficient to promote phase separation</data>
  <data key="d4">PDF_44_2021</data>
</node>
<node id="PDF_44_2021_Result_8778780853808610518">
  <data key="d0">Result</data>
  <data key="d1">NORAD and PUM co-localize in NP bodies</data>
  <data key="d3">NORAD and PUM co-localize in NP bodies</data>
  <data key="d4">PDF_44_2021</data>
</node>
<node id="PDF_44_2021_Result_4207171578410820690">
  <data key="d0">Result</data>
  <data key="d1">NORAD promotes PUM phase separation</data>
  <data key="d3">NORAD promotes PUM phase separation</data>
  <data key="d4">PDF_44_2021</data>
</node>
<node id="PDF_44_2021_Result_1999710543803669641">
  <data key="d0">Result</data>
  <data key="d1">RNA valency and abundance drive PUM LLPS</data>
  <data key="d3">RNA valency and abundance drive PUM LLPS</data>
  <data key="d4">PDF_44_2021</data>
</node>
<node id="PDF_44_2021_Result_-7207908545179264720">
  <data key="d0">Result</data>
  <data key="d1">LLPS enables competitive PUM recruitment</data>
  <data key="d3">LLPS enables competitive PUM recruitment</data>
  <data key="d4">PDF_44_2021</data>
</node>
<node id="PDF_44_2021_Result_2489551907130943990">
  <data key="d0">Result</data>
  <data key="d1">Dual mechanisms of PUM recruitment</data>
  <data key="d3">Dual mechanisms of PUM recruitment</data>
  <data key="d4">PDF_44_2021</data>
</node>
<node id="PDF_44_2021_Result_-7836916781230135730">
  <data key="d0">Result</data>
  <data key="d1">PUM LLPS maintains genome stability</data>
  <data key="d3">PUM LLPS maintains genome stability</data>
  <data key="d4">PDF_44_2021</data>
</node>
<node id="PDF_44_2021_Conclusion_-3795922340976508904">
  <data key="d0">Conclusion</data>
  <data key="d1">NORAD drives the highly efficient condensation and sequestration of PUM proteins in NP bodies through at least two complementary mechanisms: multivalent PUM-NORAD RNA binding interactions and IDR-driven PUM-PUM interactions.</data>
  <data key="d3">NORAD drives the highly efficient condensation and sequestration of PUM proteins in NP bodies through at least two complementary mechanisms: multivalent PUM-NORAD RNA binding interactions and IDR-driven PUM-PUM interactions.</data>
  <data key="d4">PDF_44_2021</data>
</node>
<node id="PDF_51_2019">
  <data key="d0">Paper</data>
  <data key="d1">Check for
updates
Chapter 17
Visualization and Functional Analysis of Spindle Actin
and Chromosome Segregation in Mammalian Oocytes
Binyam Mogessie
Abstract
Chromosome segregation is conserved throughout eukaryotes. In most systems, it is solely driven by a
spindle machinery that is assembled from microtubules. We have recently discovered that actin filaments
that are embedded inside meiotic spindles (spindle actin) are needed for accurate chromosome segregation
in mammalian oocytes. To understa</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_51_2019_Result_-3569765945771674079">
  <data key="d0">Result</data>
  <data key="d1">actin filaments embedded inside the spindle help to organize microtubules into functional bundles that can accurately separate the chromosomes</data>
  <data key="d3">actin filaments embedded inside the spindle help to organize microtubules into functional bundles that can accurately separate the chromosomes</data>
  <data key="d4">PDF_51_2019</data>
</node>
<node id="Gene_ACTIN">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ACTIN</data>
  <data key="d7">actin</data>
</node>
<node id="Gene_MICROTUBULES">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">MICROTUBULES</data>
  <data key="d7">microtubules</data>
</node>
<node id="Gene_CHROMOSOMES">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CHROMOSOMES</data>
  <data key="d7">chromosomes</data>
</node>
<node id="PDF_51_2019_Method_-3039018007016841882">
  <data key="d0">Method</data>
  <data key="d1">live and immunofluorescence microscopy assays</data>
  <data key="d3">live and immunofluorescence microscopy assays</data>
  <data key="d4">PDF_51_2019</data>
</node>
<node id="PDF_57_2014">
  <data key="d0">Paper</data>
  <data key="d1">Love et al. Genome Biology (2014) 15:550
Page 1 of 21
Genome Biology
Open Access
METHOD
Moderated estimation of fold change and
dispersion for RNA-seq data with DESeq2
Michael I Love 1,2,3, Wolfgang Huber² and Simon Anders2*
Abstract
In comparative high-throughput sequencing assays, a fundamental task is the analysis of count data, such as read
counts per gene in RNA-seq, for evidence of systematic changes across experimental conditions. Small replicate
numbers, discreteness, large dynamic range</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_57_2014_Method_6712150288663736186">
  <data key="d0">Method</data>
  <data key="d1">DESeq2, a method for differential analysis of count data, using shrinkage estimation for dispersions and fold changes to improve stability and interpretability of estimates.</data>
  <data key="d3">DESeq2, a method for differential analysis of count data, using shrinkage estimation for dispersions and fold changes to improve stability and interpretability of estimates.</data>
  <data key="d4">PDF_57_2014</data>
</node>
<node id="PDF_57_2014_Method_4009134471863954483">
  <data key="d0">Method</data>
  <data key="d1">We present DESeq2, a successor to our DESeq method [4]. DESeq2 integrates methodological advances with several novel features to facilitate a more quantitative analysis of comparative RNA-seq data using shrinkage estimators for dispersion and fold change.</data>
  <data key="d3">We present DESeq2, a successor to our DESeq method [4]. DESeq2 integrates methodological advances with several novel features to facilitate a more quantitative analysis of comparative RNA-seq data using shrinkage estimators for dispersion and fold change.</data>
  <data key="d4">PDF_57_2014</data>
</node>
<node id="PDF_57_2014_Method_-4196302596036995745">
  <data key="d0">Method</data>
  <data key="d1">We use GLMs with a logarithmic link, log2 qij = ∑, xjrßir, with design matrix elements xjr and coefficients Bir.</data>
  <data key="d3">We use GLMs with a logarithmic link, log2 qij = ∑, xjrßir, with design matrix elements xjr and coefficients Bir.</data>
  <data key="d4">PDF_57_2014</data>
</node>
<node id="PDF_57_2014_Method_3041812272966518866">
  <data key="d0">Method</data>
  <data key="d1">Empirical Bayes shrinkage for dispersion estimation</data>
  <data key="d3">Empirical Bayes shrinkage for dispersion estimation</data>
  <data key="d4">PDF_57_2014</data>
</node>
<node id="PDF_57_2014_Method_-5385669441163379192">
  <data key="d0">Method</data>
  <data key="d1">Empirical Bayes shrinkage for fold-change estimation</data>
  <data key="d3">Empirical Bayes shrinkage for fold-change estimation</data>
  <data key="d4">PDF_57_2014</data>
</node>
<node id="PDF_57_2014_Method_-3449099108385238925">
  <data key="d0">Method</data>
  <data key="d1">For significance testing, DESeq2 uses a Wald test: the shrunken estimate of LFC is divided by its standard error, resulting in a z-statistic, which is compared to a standard normal distribution.</data>
  <data key="d3">For significance testing, DESeq2 uses a Wald test: the shrunken estimate of LFC is divided by its standard error, resulting in a z-statistic, which is compared to a standard normal distribution.</data>
  <data key="d4">PDF_57_2014</data>
</node>
<node id="PDF_57_2014_Method_-4632433267646643152">
  <data key="d0">Method</data>
  <data key="d1">DESeq2 offers tests for composite null hypotheses of the form Bir ≤ 0, where ẞir is the shrunken LFC from the estimation procedure described above.</data>
  <data key="d3">DESeq2 offers tests for composite null hypotheses of the form Bir ≤ 0, where ẞir is the shrunken LFC from the estimation procedure described above.</data>
  <data key="d4">PDF_57_2014</data>
</node>
<node id="PDF_57_2014_Method_-6766091978779411187">
  <data key="d0">Method</data>
  <data key="d1">For such analyses, DESeq2 offers a test of the composite null hypothesis |ẞir| ≥ 0, which will report genes as significant for which there is evidence that their LFC is weaker than 0.</data>
  <data key="d3">For such analyses, DESeq2 offers a test of the composite null hypothesis |ẞir| ≥ 0, which will report genes as significant for which there is evidence that their LFC is weaker than 0.</data>
  <data key="d4">PDF_57_2014</data>
</node>
<node id="PDF_57_2014_Method_6308390223147394036">
  <data key="d0">Method</data>
  <data key="d1">As the outlier is replaced with the value predicted by the null hypothesis of no differential expression, this is a more conservative choice than simply omitting the out-lier.</data>
  <data key="d3">As the outlier is replaced with the value predicted by the null hypothesis of no differential expression, this is a more conservative choice than simply omitting the out-lier.</data>
  <data key="d4">PDF_57_2014</data>
</node>
<node id="PDF_57_2014_Method_-2836767369846950065">
  <data key="d0">Method</data>
  <data key="d1">Therefore, we use the shrinkage approach of DESeq2 to implement a regularized logarithm transformation (rlog), which behaves similarly to a log2 transformation for genes with high counts, while shrinking together the values for different samples for genes with low counts.</data>
  <data key="d3">Therefore, we use the shrinkage approach of DESeq2 to implement a regularized logarithm transformation (rlog), which behaves similarly to a log2 transformation for genes with high counts, while shrinking together the values for different samples for genes with low counts.</data>
  <data key="d4">PDF_57_2014</data>
</node>
<node id="PDF_11_2021">
  <data key="d0">Paper</data>
  <data key="d1">Received: 31 December 2020 Revised: 18 March 2021 Accepted: 13 April 2021
DOI: 10.1111/jcmm.16594
ORIGINAL ARTICLE
Check for updates
WILEY
Single-cell transcriptome analysis of human oocyte ageing
Lihua Yuan 1,2 | Ping Yin² | Hua Yan² | Xiufang Zhong2 | Chunxia Ren² | Kai Li² |
Boon Chin Heng³ | Wuwen Zhang2 | Guoqing Tong2
3
1Shuguang Clinical Medical College,
Shanghai University of Traditional Chinese
Medicine, Shanghai, China
2Center of Reproductive Medicine,
Shuguang Hospital Affiliated to S</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_11_2021_Result_4545149482106579378">
  <data key="d0">Result</data>
  <data key="d1">481 differentially expressed genes (DEGs) were identified, including 322 upregulated genes enriched in transcription, ubiquitination, epigenetic regulation, and cellular processes, and 159 downregulated genes enriched in ubiquitination, cell cycle, signalling pathway, and DNA repair.</data>
  <data key="d3">481 differentially expressed genes (DEGs) were identified, including 322 upregulated genes enriched in transcription, ubiquitination, epigenetic regulation, and cellular processes, and 159 downregulated genes enriched in ubiquitination, cell cycle, signalling pathway, and DNA repair.</data>
  <data key="d4">PDF_11_2021</data>
</node>
<node id="PDF_11_2021_Result_747923047402519578">
  <data key="d0">Result</data>
  <data key="d1">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
  <data key="d3">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
  <data key="d4">PDF_11_2021</data>
</node>
<node id="Gene_UBE2C">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">UBE2C</data>
  <data key="d7">UBE2C</data>
</node>
<node id="Gene_UBC">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">UBC</data>
  <data key="d7">UBC</data>
</node>
<node id="Gene_CDC34">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CDC34</data>
  <data key="d7">CDC34</data>
</node>
<node id="Gene_UBR1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">UBR1</data>
  <data key="d7">UBR1</data>
</node>
<node id="Gene_KIF11">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">KIF11</data>
  <data key="d7">KIF11</data>
</node>
<node id="Gene_ASF1B">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ASF1B</data>
  <data key="d7">ASF1B</data>
</node>
<node id="Gene_PRC1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">PRC1</data>
  <data key="d7">PRC1</data>
</node>
<node id="Gene_ESPL1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ESPL1</data>
  <data key="d7">ESPL1</data>
</node>
<node id="Gene_GTSE1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">GTSE1</data>
  <data key="d7">GTSE1</data>
</node>
<node id="Gene_EXO1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">EXO1</data>
  <data key="d7">EXO1</data>
</node>
<node id="Gene_UBA1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">UBA1</data>
  <data key="d7">UBA1</data>
</node>
<node id="Gene_KIF4A">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">KIF4A</data>
  <data key="d7">KIF4A</data>
</node>
<node id="Gene_UBA52">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">UBA52</data>
  <data key="d7">UBA52</data>
</node>
<node id="Gene_UBE2V2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">UBE2V2</data>
  <data key="d7">UBE2V2</data>
</node>
<node id="Gene_SKP1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SKP1</data>
  <data key="d7">SKP1</data>
</node>
<node id="Gene_CCNB1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CCNB1</data>
  <data key="d7">CCNB1</data>
</node>
<node id="Gene_MAD2L1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">MAD2L1</data>
  <data key="d7">MAD2L1</data>
</node>
<node id="PDF_11_2021_Result_-4471648538808608262">
  <data key="d0">Result</data>
  <data key="d1">significant key biological processes that are associated with these hub genes include ubiquitin-mediated proteolysis, ubiquitination-related pathways, oocyte meiosis, and cell cycle</data>
  <data key="d3">significant key biological processes that are associated with these hub genes include ubiquitin-mediated proteolysis, ubiquitination-related pathways, oocyte meiosis, and cell cycle</data>
  <data key="d4">PDF_11_2021</data>
</node>
<node id="Process_UBIQUITINATION-RELATED PATHWAYS">
  <data key="d0">Entity</data>
  <data key="d5">Process</data>
  <data key="d6">UBIQUITINATION-RELATED PATHWAYS</data>
  <data key="d7">ubiquitination-related pathways</data>
</node>
<node id="Process_MEIOSIS">
  <data key="d0">Entity</data>
  <data key="d5">Process</data>
  <data key="d6">MEIOSIS</data>
  <data key="d7">meiosis</data>
</node>
<node id="Process_CELL CYCLE">
  <data key="d0">Entity</data>
  <data key="d5">Process</data>
  <data key="d6">CELL CYCLE</data>
  <data key="d7">cell cycle</data>
</node>
<node id="PDF_11_2021_Result_9155848952570057070">
  <data key="d0">Result</data>
  <data key="d1">UBE2C may play a crucial role in human oocyte ageing</data>
  <data key="d3">UBE2C may play a crucial role in human oocyte ageing</data>
  <data key="d4">PDF_11_2021</data>
</node>
<node id="PDF_11_2021_Method_2711460924351622335">
  <data key="d0">Method</data>
  <data key="d1">single-cell RNA sequencing from MII human oocytes</data>
  <data key="d3">single-cell RNA sequencing from MII human oocytes</data>
  <data key="d4">PDF_11_2021</data>
</node>
<node id="PDF_11_2021_Method_6759470100232400240">
  <data key="d0">Method</data>
  <data key="d1">STRING database was used to analyse protein-protein interactions</data>
  <data key="d3">STRING database was used to analyse protein-protein interactions</data>
  <data key="d4">PDF_11_2021</data>
</node>
<node id="PDF_11_2021_Method_1495249140752136449">
  <data key="d0">Method</data>
  <data key="d1">Cytoscape software was used to identify hub genes</data>
  <data key="d3">Cytoscape software was used to identify hub genes</data>
  <data key="d4">PDF_11_2021</data>
</node>
<node id="PDF_28_2020">
  <data key="d0">Paper</data>
  <data key="d1">Europe PMC Funders Group
Author Manuscript
Nat Med. Author manuscript; available in PMC 2020 August 10.
Published in final edited form as:
Nat Med. 2020 February ; 26(2): 252–258. doi:10.1038/s41591-020-0751-5.
Using human genetics to understand the disease impacts of
testosterone in men and women
Katherine S Ruth1,*, Felix R Day2,*, Jessica Tyrrell¹,*, Deborah J Thompson³,*, Andrew R
Wood¹, Anubha Mahajan, Robin N Beaumont¹, Laura Wittemans2,4, Susan Martin¹,
Alexander S. Busch2,5,6, A. Mesut E</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_28_2020_Result_-3506536314743552721">
  <data key="d0">Result</data>
  <data key="d1">Genetic determinants of testosterone levels are substantially different between sexes.</data>
  <data key="d3">Genetic determinants of testosterone levels are substantially different between sexes.</data>
  <data key="d4">PDF_28_2020</data>
</node>
<node id="Compound_TESTOSTERONE">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">TESTOSTERONE</data>
  <data key="d7">testosterone</data>
</node>
<node id="PDF_28_2020_Result_4029085613184699148">
  <data key="d0">Result</data>
  <data key="d1">Genetically higher testosterone is harmful for metabolic diseases in women but beneficial in men.</data>
  <data key="d3">Genetically higher testosterone is harmful for metabolic diseases in women but beneficial in men.</data>
  <data key="d4">PDF_28_2020</data>
</node>
<node id="PDF_28_2020_Result_4276858518438925913">
  <data key="d0">Result</data>
  <data key="d1">A genetically determined 1-standard deviation higher testosterone increases the risks of Type 2 diabetes (T2D) and polycystic ovary syndrome in women, but reduces T2D risk in men.</data>
  <data key="d3">A genetically determined 1-standard deviation higher testosterone increases the risks of Type 2 diabetes (T2D) and polycystic ovary syndrome in women, but reduces T2D risk in men.</data>
  <data key="d4">PDF_28_2020</data>
</node>
<node id="Disease_TYPE 2 DIABETES">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">TYPE 2 DIABETES</data>
  <data key="d7">Type 2 diabetes</data>
</node>
<node id="Disease_POLYCYSTIC OVARY SYNDROME">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">POLYCYSTIC OVARY SYNDROME</data>
  <data key="d7">polycystic ovary syndrome</data>
</node>
<node id="PDF_28_2020_Result_-1763742948628417109">
  <data key="d0">Result</data>
  <data key="d1">Adverse effects of higher testosterone on breast and endometrial cancers in women, and prostate cancer in men.</data>
  <data key="d3">Adverse effects of higher testosterone on breast and endometrial cancers in women, and prostate cancer in men.</data>
  <data key="d4">PDF_28_2020</data>
</node>
<node id="Disease_BREAST CANCER">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">BREAST CANCER</data>
  <data key="d7">breast cancer</data>
</node>
<node id="Disease_ENDOMETRIAL CANCER">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">ENDOMETRIAL CANCER</data>
  <data key="d7">endometrial cancer</data>
</node>
<node id="Disease_PROSTATE CANCER">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">PROSTATE CANCER</data>
  <data key="d7">prostate cancer</data>
</node>
<node id="PDF_28_2020_Result_-6615976712426358734">
  <data key="d0">Result</data>
  <data key="d1">Higher testosterone increases the risk of PCOS in women.</data>
  <data key="d3">Higher testosterone increases the risk of PCOS in women.</data>
  <data key="d4">PDF_28_2020</data>
</node>
<node id="Disease_PCOS">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">PCOS</data>
  <data key="d7">PCOS</data>
</node>
<node id="PDF_28_2020_Result_-3557385827310005528">
  <data key="d0">Result</data>
  <data key="d1">Testosterone increases the risk of ER+ breast cancer.</data>
  <data key="d3">Testosterone increases the risk of ER+ breast cancer.</data>
  <data key="d4">PDF_28_2020</data>
</node>
<node id="PDF_28_2020_Result_-260840842823475328">
  <data key="d0">Result</data>
  <data key="d1">Testosterone increased the risk of endometrial cancer but reduced the risk of ovarian cancer.</data>
  <data key="d3">Testosterone increased the risk of endometrial cancer but reduced the risk of ovarian cancer.</data>
  <data key="d4">PDF_28_2020</data>
</node>
<node id="Disease_OVARIAN CANCER">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">OVARIAN CANCER</data>
  <data key="d7">ovarian cancer</data>
</node>
<node id="PDF_28_2020_Result_-8203877554228120262">
  <data key="d0">Result</data>
  <data key="d1">Higher testosterone, independent of SHBG, conferred lower T2D risk and lower fasting glucose in men.</data>
  <data key="d3">Higher testosterone, independent of SHBG, conferred lower T2D risk and lower fasting glucose in men.</data>
  <data key="d4">PDF_28_2020</data>
</node>
<node id="Protein_SEX HORMONE BINDING GLOBULIN">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">SEX HORMONE BINDING GLOBULIN</data>
  <data key="d7">sex hormone binding globulin</data>
</node>
<node id="PDF_28_2020_Result_4472470031596683723">
  <data key="d0">Result</data>
  <data key="d1">Testosterone increases prostate cancer risk in men.</data>
  <data key="d3">Testosterone increases prostate cancer risk in men.</data>
  <data key="d4">PDF_28_2020</data>
</node>
<node id="PDF_28_2020_Method_-2589034834822375471">
  <data key="d0">Method</data>
  <data key="d1">Mendelian randomization is a genetic approach to understand the causal effects of putative risk factors on disease.</data>
  <data key="d3">Mendelian randomization is a genetic approach to understand the causal effects of putative risk factors on disease.</data>
  <data key="d4">PDF_28_2020</data>
</node>
<node id="PDF_28_2020_Method_3976456801352914638">
  <data key="d0">Method</data>
  <data key="d1">Genome wide association studies (GWAS) are needed to identify additional genetic variants that can be used to test the effects of testosterone.</data>
  <data key="d3">Genome wide association studies (GWAS) are needed to identify additional genetic variants that can be used to test the effects of testosterone.</data>
  <data key="d4">PDF_28_2020</data>
</node>
<node id="PDF_56_2013">
  <data key="d0">Paper</data>
  <data key="d1">Published online 4 April 2013
Nucleic Acids Research, 2013, Vol. 41, No. 10 e108
doi:10.1093/nar/gkt214
The Subread aligner: fast, accurate and scalable
read mapping by seed-and-vote
Yang Liao1,2, Gordon K. Smyth1,3 and Wei Shi1,2,*
'Division of Bioinformatics, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville,
Victoria 3052, Australia, 2Department of Computing and Information Systems, The University of Melbourne,
Parkville, Victoria 3010, Australia and Departme</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_56_2013_Method_-476371590765220008">
  <data key="d0">Method</data>
  <data key="d1">The article proposes a new multi-seed strategy that differs from previous algorithms by choosing the mapped genomic location for the read directly from the seeds. The strategy consists of a seed-and-vote step, which achieves local alignment simultaneously in multiple parts of the read, followed by an in-fill step to complete the alignment.</data>
  <data key="d3">The article proposes a new multi-seed strategy that differs from previous algorithms by choosing the mapped genomic location for the read directly from the seeds. The strategy consists of a seed-and-vote step, which achieves local alignment simultaneously in multiple parts of the read, followed by an in-fill step to complete the alignment.</data>
  <data key="d4">PDF_56_2013</data>
</node>
<node id="PDF_56_2013_Method_-3123513686382491932">
  <data key="d0">Method</data>
  <data key="d1">The new strategy uses a relatively large number of short equi-spaced seeds from each read, which we call subreads.</data>
  <data key="d3">The new strategy uses a relatively large number of short equi-spaced seeds from each read, which we call subreads.</data>
  <data key="d4">PDF_56_2013</data>
</node>
<node id="PDF_56_2013_Method_994679622489463835">
  <data key="d0">Method</data>
  <data key="d1">The subread procedure then uses conventional algorithms including dynamic programming to complete the alignment, filling in the detailed mismatch and indel information between the subreads that make up the winning voting block.</data>
  <data key="d3">The subread procedure then uses conventional algorithms including dynamic programming to complete the alignment, filling in the detailed mismatch and indel information between the subreads that make up the winning voting block.</data>
  <data key="d4">PDF_56_2013</data>
</node>
<node id="PDF_56_2013_Result_-2843952847225168039">
  <data key="d0">Result</data>
  <data key="d1">In extensive testing, the strategy proves to be not only fast but more than competitive with existing aligners in terms of sensitivity and accuracy.</data>
  <data key="d3">In extensive testing, the strategy proves to be not only fast but more than competitive with existing aligners in terms of sensitivity and accuracy.</data>
  <data key="d4">PDF_56_2013</data>
</node>
<node id="PDF_56_2013_Result_-5653130319489697596">
  <data key="d0">Result</data>
  <data key="d1">The strategy is sensitive because no individual subread is required to map exactly, nor are individual subreads constrained to map close by other subreads.</data>
  <data key="d3">The strategy is sensitive because no individual subread is required to map exactly, nor are individual subreads constrained to map close by other subreads.</data>
  <data key="d4">PDF_56_2013</data>
</node>
<node id="PDF_56_2013_Result_-387495421321406550">
  <data key="d0">Result</data>
  <data key="d1">The strategy is accurate because the final location must be supported by several different subreads.</data>
  <data key="d3">The strategy is accurate because the final location must be supported by several different subreads.</data>
  <data key="d4">PDF_56_2013</data>
</node>
<node id="PDF_56_2013_Result_-133007962228439525">
  <data key="d0">Result</data>
  <data key="d1">Crucially, the strategy scales up efficiently for longer reads.</data>
  <data key="d3">Crucially, the strategy scales up efficiently for longer reads.</data>
  <data key="d4">PDF_56_2013</data>
</node>
<node id="PDF_56_2013_Result_-7166499766531524492">
  <data key="d0">Result</data>
  <data key="d1">a 6 bp indel in the promoter region of gene Casp8 was identified to be associated with susceptibility to multiple cancers</data>
  <data key="d3">a 6 bp indel in the promoter region of gene Casp8 was identified to be associated with susceptibility to multiple cancers</data>
  <data key="d4">PDF_56_2013</data>
</node>
<node id="Gene_CASP8">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CASP8</data>
  <data key="d7">Casp8</data>
</node>
<node id="Disease_CANCER">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">CANCER</data>
  <data key="d7">cancer</data>
</node>
<node id="PDF_56_2013_Result_5624013977863266128">
  <data key="d0">Result</data>
  <data key="d1">A 14 bp indel in the gene Ncx1 was found to modulate the age at onset in late-onset Alzheimer's disease</data>
  <data key="d3">A 14 bp indel in the gene Ncx1 was found to modulate the age at onset in late-onset Alzheimer's disease</data>
  <data key="d4">PDF_56_2013</data>
</node>
<node id="Gene_NCX1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">NCX1</data>
  <data key="d7">Ncx1</data>
</node>
<node id="Disease_ALZHEIMER'S DISEASE">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">ALZHEIMER'S DISEASE</data>
  <data key="d7">Alzheimer's disease</data>
</node>
<node id="PDF_60_2012">
  <data key="d0">Paper</data>
  <data key="d1">Here is the complete extracted text from the scientific PDF, with all content in English:

**The Journal of Neuroscience, May 9, 2012 32(19):6525-6541.6525**

**Behavioral/Systems/Cognitive**

**Reduced Excitatory Neurotransmission and Mild Autism-Relevant Phenotypes in Adolescent Shank3 Null Mutant Mice**

Mu Yang,¹ Ozlem Bozdagi, Maria Luisa Scattoni,¹ Markus Wöhr,¹ Florence I. Roullet,¹ Adam M. Katz,¹
Danielle N. Abrams,¹ David Kalikhman,¹ Harrison Simon,¹ Leuk Woldeyohannes,¹ James Y. Zhang,</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_60_2012_Result_-3460396310477957540">
  <data key="d0">Result</data>
  <data key="d1">Both homozygous and heterozygous mice showed reduced glutamatergic transmission and long-term potentiation in the hippocampus with more severe deficits detected in the homozygous mice.</data>
  <data key="d3">Both homozygous and heterozygous mice showed reduced glutamatergic transmission and long-term potentiation in the hippocampus with more severe deficits detected in the homozygous mice.</data>
  <data key="d4">PDF_60_2012</data>
</node>
<node id="Gene_SHANK3">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SHANK3</data>
  <data key="d7">Shank3</data>
</node>
<node id="PDF_60_2012_Result_8151029886933108466">
  <data key="d0">Result</data>
  <data key="d1">Mild social impairments were detected, primarily in juveniles during reciprocal interactions, while all genotypes displayed normal adult sociability on the three-chambered task.</data>
  <data key="d3">Mild social impairments were detected, primarily in juveniles during reciprocal interactions, while all genotypes displayed normal adult sociability on the three-chambered task.</data>
  <data key="d4">PDF_60_2012</data>
</node>
<node id="PDF_60_2012_Result_9113303972890400832">
  <data key="d0">Result</data>
  <data key="d1">Impaired novel object recognition and rotarod performance were consistent across cohorts of null mutants.</data>
  <data key="d3">Impaired novel object recognition and rotarod performance were consistent across cohorts of null mutants.</data>
  <data key="d4">PDF_60_2012</data>
</node>
<node id="PDF_60_2012_Result_6931986617788441699">
  <data key="d0">Result</data>
  <data key="d1">Repetitive self-grooming, reduced ultrasonic vocalizations, and deficits in reversal of water maze learning were detected only in some cohorts, emphasizing the importance of replication analyses.</data>
  <data key="d3">Repetitive self-grooming, reduced ultrasonic vocalizations, and deficits in reversal of water maze learning were detected only in some cohorts, emphasizing the importance of replication analyses.</data>
  <data key="d4">PDF_60_2012</data>
</node>
<node id="PDF_60_2012_Method_6399464483961650502">
  <data key="d0">Method</data>
  <data key="d1">Mice with mutations in the gene coding for the Shank3 protein were generated at the Mount Sinai School of Medicine as previously described (Bozdagi et al., 2010).</data>
  <data key="d3">Mice with mutations in the gene coding for the Shank3 protein were generated at the Mount Sinai School of Medicine as previously described (Bozdagi et al., 2010).</data>
  <data key="d4">PDF_60_2012</data>
</node>
<node id="PDF_60_2012_Method_105083118773543844">
  <data key="d0">Method</data>
  <data key="d1">Extracellular recording. Methods were conducted as previously described (Bozdagi et al., 2010). Acute hippocampal slices were prepared from 4- to 6-week-old homozygous, heterozygous, and wild-type littermate mice.</data>
  <data key="d3">Extracellular recording. Methods were conducted as previously described (Bozdagi et al., 2010). Acute hippocampal slices were prepared from 4- to 6-week-old homozygous, heterozygous, and wild-type littermate mice.</data>
  <data key="d4">PDF_60_2012</data>
</node>
<node id="PDF_60_2012_Method_78287496728053011">
  <data key="d0">Method</data>
  <data key="d1">Behavioral phenotyping. Comprehensive behavioral phenotyping was conducted in male and female mice as previously described (Miyakawa et al., 2001; Paylor et al., 2001; Wrenn et al., 2004; Bailey et al., 2007; Chad- man et al., 2008; Silverman et al., 2011).</data>
  <data key="d3">Behavioral phenotyping. Comprehensive behavioral phenotyping was conducted in male and female mice as previously described (Miyakawa et al., 2001; Paylor et al., 2001; Wrenn et al., 2004; Bailey et al., 2007; Chad- man et al., 2008; Silverman et al., 2011).</data>
  <data key="d4">PDF_60_2012</data>
</node>
<node id="PDF_16_2017">
  <data key="d0">Paper</data>
  <data key="d1">Here is the extracted text from the scientific PDF you provided:

Molecular Human Reproduction, Vol.23, No.3 pp. 177-186, 2017
Advanced Access publication on February 18, 2017 doi:10.1093/molehr/gax004

molecular
human
reproduction

ORIGINAL ARTICLE

RNA immunoprecipitation identifies
novel targets of DAZL in human
foetal ovary

Roseanne Rosario*, *, Richard W.P. Smith', Ian R. Adams²,
and Richard A. Anderson'

'MRC Centre for Reproductive Health, Queens Medical Research Institute, University of</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_16_2017_Hypothesis_1314856865614482660">
  <data key="d0">Hypothesis</data>
  <data key="d1">Can novel meiotic RNA targets of DAZL (deleted in azoospermia-like) be identified in the human foetal ovary?</data>
  <data key="d3">Can novel meiotic RNA targets of DAZL (deleted in azoospermia-like) be identified in the human foetal ovary?</data>
  <data key="d4">PDF_16_2017</data>
</node>
<node id="PDF_16_2017_Method_-2993343221340655616">
  <data key="d0">Method</data>
  <data key="d1">We carried out RNA sequencing after immunoprecipitation of endogenous DAZL from human foetal ovarian tissue to identify novel DAZL targets involved in meiosis.</data>
  <data key="d3">We carried out RNA sequencing after immunoprecipitation of endogenous DAZL from human foetal ovarian tissue to identify novel DAZL targets involved in meiosis.</data>
  <data key="d4">PDF_16_2017</data>
</node>
<node id="PDF_16_2017_Method_2376836183844078075">
  <data key="d0">Method</data>
  <data key="d1">Using quantitative RT-PCR, we examined the expression of selected RNAs identified by our immunoprecipitation across gestation, and visualised the expression of potential target SMCIB in relation to DAZL, with a combination of in situ hybridisation and immunohistochemistry.</data>
  <data key="d3">Using quantitative RT-PCR, we examined the expression of selected RNAs identified by our immunoprecipitation across gestation, and visualised the expression of potential target SMCIB in relation to DAZL, with a combination of in situ hybridisation and immunohistochemistry.</data>
  <data key="d4">PDF_16_2017</data>
</node>
<node id="Protein_SMCIB">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">SMCIB</data>
  <data key="d7">SMCIB</data>
</node>
<node id="PDF_16_2017_Method_-6167142702891750207">
  <data key="d0">Method</data>
  <data key="d1">3' untranslated region (3'UTR)-luciferase reporter assays and polysome profile analysis were used to investigate the regulation of three RNA targets by DAZL, representing key functionalities: SYCPI, TEXII and SMCIB.</data>
  <data key="d3">3' untranslated region (3'UTR)-luciferase reporter assays and polysome profile analysis were used to investigate the regulation of three RNA targets by DAZL, representing key functionalities: SYCPI, TEXII and SMCIB.</data>
  <data key="d4">PDF_16_2017</data>
</node>
<node id="Protein_SYCP1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">SYCP1</data>
  <data key="d7">SYCP1</data>
</node>
<node id="Protein_TEX12">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">TEX12</data>
  <data key="d7">TEX12</data>
</node>
<node id="PDF_16_2017_Result_-1739999805386391909">
  <data key="d0">Result</data>
  <data key="d1">We identified 764 potential RNA targets of DAZL in the human foetal ovary, with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13), and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
  <data key="d3">We identified 764 potential RNA targets of DAZL in the human foetal ovary, with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13), and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
  <data key="d4">PDF_16_2017</data>
</node>
<node id="Protein_SYCP3">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">SYCP3</data>
  <data key="d7">SYCP3</data>
</node>
<node id="Gene_RAD21">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">RAD21</data>
  <data key="d7">RAD21</data>
</node>
<node id="Gene_TRIP13">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">TRIP13</data>
  <data key="d7">TRIP13</data>
</node>
<node id="Gene_HORMAD1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">HORMAD1</data>
  <data key="d7">HORMAD1</data>
</node>
<node id="Gene_RAD18">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">RAD18</data>
  <data key="d7">RAD18</data>
</node>
<node id="Gene_RAD51">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">RAD51</data>
  <data key="d7">RAD51</data>
</node>
<node id="PDF_16_2017_Result_6131539558149926170">
  <data key="d0">Result</data>
  <data key="d1">We demonstrated that the translation of novel targets SYCPI, TEXII and SMCIB is stimulated by the presence of DAZL but not by a mutant DAZL with impaired RNA-binding activity.</data>
  <data key="d3">We demonstrated that the translation of novel targets SYCPI, TEXII and SMCIB is stimulated by the presence of DAZL but not by a mutant DAZL with impaired RNA-binding activity.</data>
  <data key="d4">PDF_16_2017</data>
</node>
<node id="PDF_16_2017_Conclusion_-1239221863231033063">
  <data key="d0">Conclusion</data>
  <data key="d1">Through the translational regulation of novel RNA targets SMCIB and TEXII, DAZL may have a key role in regulating chromosome cohesion and DNA recombination; two processes fundamental in determining oocyte quality and whose establishment in foetal life may support lifelong fertility.</data>
  <data key="d3">Through the translational regulation of novel RNA targets SMCIB and TEXII, DAZL may have a key role in regulating chromosome cohesion and DNA recombination; two processes fundamental in determining oocyte quality and whose establishment in foetal life may support lifelong fertility.</data>
  <data key="d4">PDF_16_2017</data>
</node>
<node id="PDF_42_2001">
  <data key="d0">Paper</data>
  <data key="d1">THE JOURNAL OF BIOLOGICAL CHEMISTRY
© 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Vol. 276, No. 4, Issue of January 26, pp. 2802-2807, 2001
Printed in U.S.A.

MAP-1, a Novel Proapoptotic Protein Containing a BH3-like Motif
That Associates with Bax through Its Bcl-2 Homology Domains*

Kuan Onn Tan, Karen Mei Ling Tan, Shing-Leng Chan, Karen S. Y. Yee, Maja Bévort,
Khay Chun Ang, and Victor C. Yu‡

From the Institute of Molecular and Cell Biology, 30 Medical Dr., Sing</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_42_2001_Hypothesis_8948168157081769195">
  <data key="d0">Hypothesis</data>
  <data key="d1">MAP-1 mediates apoptosis through a mechanism that involves binding to Bax.</data>
  <data key="d3">MAP-1 mediates apoptosis through a mechanism that involves binding to Bax.</data>
  <data key="d4">PDF_42_2001</data>
</node>
<node id="Protein_MAP-1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">MAP-1</data>
  <data key="d7">MAP-1</data>
</node>
<node id="Protein_BAX">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">BAX</data>
  <data key="d7">Bax</data>
</node>
<node id="PDF_42_2001_Method_-5350663781838135745">
  <data key="d0">Method</data>
  <data key="d1">Yeast two-hybrid screen was used to identify Bax-associating proteins.</data>
  <data key="d3">Yeast two-hybrid screen was used to identify Bax-associating proteins.</data>
  <data key="d4">PDF_42_2001</data>
</node>
<node id="PDF_42_2001_Method_1633846816564335947">
  <data key="d0">Method</data>
  <data key="d1">Coimmunoprecipitation was used to confirm protein interactions.</data>
  <data key="d3">Coimmunoprecipitation was used to confirm protein interactions.</data>
  <data key="d4">PDF_42_2001</data>
</node>
<node id="PDF_42_2001_Method_3074820796691479520">
  <data key="d0">Method</data>
  <data key="d1">In vitro binding assay (GST pulldown) was used to confirm protein interactions.</data>
  <data key="d3">In vitro binding assay (GST pulldown) was used to confirm protein interactions.</data>
  <data key="d4">PDF_42_2001</data>
</node>
<node id="PDF_42_2001_Method_3104162734557743250">
  <data key="d0">Method</data>
  <data key="d1">Apoptosis assay was performed to assess cell death.</data>
  <data key="d3">Apoptosis assay was performed to assess cell death.</data>
  <data key="d4">PDF_42_2001</data>
</node>
<node id="PDF_42_2001_Result_8649051848906610438">
  <data key="d0">Result</data>
  <data key="d1">MAP-1 homodimerizes and associates with Bax, Bcl-2, and Bcl-X₁ in vitro and in vivo in mammalian cells.</data>
  <data key="d3">MAP-1 homodimerizes and associates with Bax, Bcl-2, and Bcl-X₁ in vitro and in vivo in mammalian cells.</data>
  <data key="d4">PDF_42_2001</data>
</node>
<node id="Protein_BCL-2">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">BCL-2</data>
  <data key="d7">Bcl-2</data>
</node>
<node id="Protein_BCL-XL">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">BCL-XL</data>
  <data key="d7">Bcl-XL</data>
</node>
<node id="PDF_42_2001_Result_8108291916909211586">
  <data key="d0">Result</data>
  <data key="d1">MAP-1 induces caspase-dependent apoptosis in mammalian cells when overexpressed.</data>
  <data key="d3">MAP-1 induces caspase-dependent apoptosis in mammalian cells when overexpressed.</data>
  <data key="d4">PDF_42_2001</data>
</node>
<node id="Protein_CASPASE">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">CASPASE</data>
  <data key="d7">caspase</data>
</node>
<node id="PDF_42_2001_Result_-2720474815089682321">
  <data key="d0">Result</data>
  <data key="d1">The BH3-like domain in MAP-1 is required for mediating apoptosis and its binding to Bax, but not Bcl-XL.</data>
  <data key="d3">The BH3-like domain in MAP-1 is required for mediating apoptosis and its binding to Bax, but not Bcl-XL.</data>
  <data key="d4">PDF_42_2001</data>
</node>
<node id="Protein_BH3">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">BH3</data>
  <data key="d7">BH3</data>
</node>
<node id="PDF_42_2001_Result_-7672314093551496806">
  <data key="d0">Result</data>
  <data key="d1">The binding of MAP-1 to Bax requires all three BH (BH1, BH2, and BH3) domains of Bax.</data>
  <data key="d3">The binding of MAP-1 to Bax requires all three BH (BH1, BH2, and BH3) domains of Bax.</data>
  <data key="d4">PDF_42_2001</data>
</node>
<node id="Protein_BH1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">BH1</data>
  <data key="d7">BH1</data>
</node>
<node id="Protein_BH2">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">BH2</data>
  <data key="d7">BH2</data>
</node>
<node id="PDF_42_2001_Conclusion_6533134157357704615">
  <data key="d0">Conclusion</data>
  <data key="d1">MAP-1 represents a novel Bax-associating protein that may mediate apoptosis through binding to Bax.</data>
  <data key="d3">MAP-1 represents a novel Bax-associating protein that may mediate apoptosis through binding to Bax.</data>
  <data key="d4">PDF_42_2001</data>
</node>
<node id="PDF_01_2012">
  <data key="d0">Paper</data>
  <data key="d1">frontiers in
MICROBIOLOGY
REVIEW ARTICLE
published: 27 July 2012
doi: 10.3389/fmicb.2012.00262
The role of genes domesticated from LTR retrotransposons
and retroviruses in mammals
Tomoko Kaneko-Ishino1* and Fumitoshi Ishino2
1 School of Health Sciences, Tokai University, Isehara, Kanagawa, Japan
2 Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan
Edited by:
Yukihito Ishizaka, National Center for
Global Health and Medicine, Japan
Reviewed by:
Matthew Lorincz, Universit</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_01_2012_Result_6847604029630155249">
  <data key="d0">Result</data>
  <data key="d1">PEG10 and PEG11/RTL1 play essential roles in early placenta formation and maintenance of the placenta in the mid-to-late stages of gestation, respectively.</data>
  <data key="d3">PEG10 and PEG11/RTL1 play essential roles in early placenta formation and maintenance of the placenta in the mid-to-late stages of gestation, respectively.</data>
  <data key="d4">PDF_01_2012</data>
</node>
<node id="Gene_MMPEG10">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">MMPEG10</data>
  <data key="d7">MmPEG10</data>
</node>
<node id="Gene_PEG11/RTL1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">PEG11/RTL1</data>
  <data key="d7">PEG11/RTL1</data>
</node>
<node id="PDF_01_2012_Result_9005381443327010603">
  <data key="d0">Result</data>
  <data key="d1">PEG10 protein is reportedly associated with a member of the "seven in absentia homolog" family (SIAH1 protein) that acts as a mediator of apoptosis.</data>
  <data key="d3">PEG10 protein is reportedly associated with a member of the "seven in absentia homolog" family (SIAH1 protein) that acts as a mediator of apoptosis.</data>
  <data key="d4">PDF_01_2012</data>
</node>
<node id="Protein_MMPEG10">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">MMPEG10</data>
  <data key="d7">MmPEG10</data>
</node>
<node id="Protein_SIAH1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">SIAH1</data>
  <data key="d7">SIAH1</data>
</node>
<node id="PDF_01_2012_Result_-8247913670897431649">
  <data key="d0">Result</data>
  <data key="d1">Loss and overexpression of PEG11/RTL1 are thought to attribute to the etiology of two different human imprinted diseases, maternal and paternal disomies of human chromosome 14 (matUPD14 and patUPD14).</data>
  <data key="d3">Loss and overexpression of PEG11/RTL1 are thought to attribute to the etiology of two different human imprinted diseases, maternal and paternal disomies of human chromosome 14 (matUPD14 and patUPD14).</data>
  <data key="d4">PDF_01_2012</data>
</node>
<node id="Disease_MATUPD14">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">MATUPD14</data>
  <data key="d7">matUPD14</data>
</node>
<node id="Disease_PATUPD14">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">PATUPD14</data>
  <data key="d7">patUPD14</data>
</node>
<node id="PDF_01_2012_Result_-8179251931439498498">
  <data key="d0">Result</data>
  <data key="d1">PNMA4-deficient cells exhibit aggressive anchorage-independent growth, suggesting that PNMA4 has an important role in regulating apoptosis signaling in a strict temporal manner in mammalian cells</data>
  <data key="d3">PNMA4-deficient cells exhibit aggressive anchorage-independent growth, suggesting that PNMA4 has an important role in regulating apoptosis signaling in a strict temporal manner in mammalian cells</data>
  <data key="d4">PDF_01_2012</data>
</node>
<node id="Gene_PNMA4">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">PNMA4</data>
  <data key="d7">PNMA4</data>
</node>
<node id="PDF_01_2012_Result_2743507154434502038">
  <data key="d0">Result</data>
  <data key="d1">PNMA10 is related to the evolution of brain function in mammals.</data>
  <data key="d3">PNMA10 is related to the evolution of brain function in mammals.</data>
  <data key="d4">PDF_01_2012</data>
</node>
<node id="Gene_PNMA10">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">PNMA10</data>
  <data key="d7">PNMA10</data>
</node>
<node id="PDF_01_2012_Result_-3711517568656442077">
  <data key="d0">Result</data>
  <data key="d1">Pnma14/CCDC8 was suggested to be one of the genes responsible for 3-M syndrome.</data>
  <data key="d3">Pnma14/CCDC8 was suggested to be one of the genes responsible for 3-M syndrome.</data>
  <data key="d4">PDF_01_2012</data>
</node>
<node id="Gene_PNMA14/CCDC8">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">PNMA14/CCDC8</data>
  <data key="d7">Pnma14/CCDC8</data>
</node>
<node id="Disease_3-M SYNDROME">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">3-M SYNDROME</data>
  <data key="d7">3-M syndrome</data>
</node>
<node id="PDF_01_2012_Result_6661844184217701909">
  <data key="d0">Result</data>
  <data key="d1">Filaggrin gene has recently been identified to be etiologically responsible for atopic dermatitis</data>
  <data key="d3">Filaggrin gene has recently been identified to be etiologically responsible for atopic dermatitis</data>
  <data key="d4">PDF_01_2012</data>
</node>
<node id="Gene_FILAGGRIN">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">FILAGGRIN</data>
  <data key="d7">Filaggrin</data>
</node>
<node id="Disease_ATOPIC DERMATITIS">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">ATOPIC DERMATITIS</data>
  <data key="d7">atopic dermatitis</data>
</node>
<node id="PDF_01_2012_Result_-4662230457726497710">
  <data key="d0">Result</data>
  <data key="d1">Peg3 KO offspring are approximately 20% smaller at birth, with markedly reduced nursing behavior and a reduced number of oxytocin-positive neurons in the hypothalamus of Peg3 KO females</data>
  <data key="d3">Peg3 KO offspring are approximately 20% smaller at birth, with markedly reduced nursing behavior and a reduced number of oxytocin-positive neurons in the hypothalamus of Peg3 KO females</data>
  <data key="d4">PDF_01_2012</data>
</node>
<node id="Gene_PEG3">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">PEG3</data>
  <data key="d7">PEG3</data>
</node>
<node id="PDF_01_2012_Result_-5302554718486720449">
  <data key="d0">Result</data>
  <data key="d1">Human PEG3 has tumor-suppressing activity in glioma cell lines by its capacity to inhibit Wnt signaling, and the loss of its expression is reportedly observed in gliomas.</data>
  <data key="d3">Human PEG3 has tumor-suppressing activity in glioma cell lines by its capacity to inhibit Wnt signaling, and the loss of its expression is reportedly observed in gliomas.</data>
  <data key="d4">PDF_01_2012</data>
</node>
<node id="Process_WNT SIGNALING">
  <data key="d0">Entity</data>
  <data key="d5">Process</data>
  <data key="d6">WNT SIGNALING</data>
  <data key="d7">Wnt signaling</data>
</node>
<node id="Disease_GLIOMAS">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">GLIOMAS</data>
  <data key="d7">gliomas</data>
</node>
<node id="PDF_01_2012_Conclusion_2860140093006074194">
  <data key="d0">Conclusion</data>
  <data key="d1">domesticated genes could be major players in the macroevolution of mammals</data>
  <data key="d3">domesticated genes could be major players in the macroevolution of mammals</data>
  <data key="d4">PDF_01_2012</data>
</node>
<node id="PDF_01_2012_Conclusion_1390741747946254137">
  <data key="d0">Conclusion</data>
  <data key="d1">PEG10 contributed to the establishment of the current developmental systems of viviparous mammalian groups as a positively selected gene</data>
  <data key="d3">PEG10 contributed to the establishment of the current developmental systems of viviparous mammalian groups as a positively selected gene</data>
  <data key="d4">PDF_01_2012</data>
</node>
<node id="PDF_01_2012_Conclusion_-1817902315861890616">
  <data key="d0">Conclusion</data>
  <data key="d1">PEG11/RTL1 has a role in the reproduction system of eutherians, which have the chorioallantoic placenta and that it thus contributed to the diversification of these two viviparous mammalian groups.</data>
  <data key="d3">PEG11/RTL1 has a role in the reproduction system of eutherians, which have the chorioallantoic placenta and that it thus contributed to the diversification of these two viviparous mammalian groups.</data>
  <data key="d4">PDF_01_2012</data>
</node>
<node id="PDF_45_2016">
  <data key="d0">Paper</data>
  <data key="d1">Here is the full text from the scientific PDF provided:

© 2016. Published by The Company of Biologists Ltd | Journal of Cell Science (2016) 129, 1271-1282 doi:10.1242/jcs.179218
The Company of
Biologists
TOOLS AND TECHNIQUES
DAZL and CPEB1 regulate mRNA translation synergistically
during oocyte maturation
Joao P. Sousa Martins 1,2,3, Xueqing Liu1,2,3, Ashwini Oke1,3,4, Ripla Arora1,2,3, Federica Franciosi 1,2,3,5,
Stephan Viville6,7, Diana J. Laird1,2,3, Jennifer C. Fung1,3,4 and Marco Conti 1,</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_45_2016_Hypothesis_-1553147097003440318">
  <data key="d0">Hypothesis</data>
  <data key="d1">DAZL cooperates with CPEB1 to regulate maternal mRNA translation.</data>
  <data key="d3">DAZL cooperates with CPEB1 to regulate maternal mRNA translation.</data>
  <data key="d4">PDF_45_2016</data>
</node>
<node id="Protein_DAZL">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">DAZL</data>
  <data key="d7">DAZL</data>
</node>
<node id="Protein_CPEB1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">CPEB1</data>
  <data key="d7">CPEB1</data>
</node>
<node id="Compound_MRNA">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">MRNA</data>
  <data key="d7">mRNA</data>
</node>
<node id="PDF_45_2016_Method_-8915966741790558701">
  <data key="d0">Method</data>
  <data key="d1">Using a mouse line expressing an epitope-tagged ribosomal protein (RiboTag), which is activated by the tissue-specific cre recombinase, we recovered transcripts that are associated with ribosomes by using immunoprecipitation.</data>
  <data key="d3">Using a mouse line expressing an epitope-tagged ribosomal protein (RiboTag), which is activated by the tissue-specific cre recombinase, we recovered transcripts that are associated with ribosomes by using immunoprecipitation.</data>
  <data key="d4">PDF_45_2016</data>
</node>
<node id="Compound_RIBOTAG">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">RIBOTAG</data>
  <data key="d7">RiboTag</data>
</node>
<node id="PDF_45_2016_Method_-3480396298746657110">
  <data key="d0">Method</data>
  <data key="d1">morpholino oligonucleotide (MO) knockdown.</data>
  <data key="d3">morpholino oligonucleotide (MO) knockdown.</data>
  <data key="d4">PDF_45_2016</data>
</node>
<node id="PDF_45_2016_Result_-4589350216914818784">
  <data key="d0">Result</data>
  <data key="d1">ribosome loading is induced in a DAZL- and CPEB1-dependent manner, as the oocyte reenters meiosis.</data>
  <data key="d3">ribosome loading is induced in a DAZL- and CPEB1-dependent manner, as the oocyte reenters meiosis.</data>
  <data key="d4">PDF_45_2016</data>
</node>
<node id="PDF_45_2016_Result_-908377324346105843">
  <data key="d0">Result</data>
  <data key="d1">Depletion of the two RBPs from oocytes and mutagenesis of the 3' untranslated regions (UTRs) demonstrate that both RBPs interact with the Tex19.1 3' UTR and cooperate in translation activation of this mRNA.</data>
  <data key="d3">Depletion of the two RBPs from oocytes and mutagenesis of the 3' untranslated regions (UTRs) demonstrate that both RBPs interact with the Tex19.1 3' UTR and cooperate in translation activation of this mRNA.</data>
  <data key="d4">PDF_45_2016</data>
</node>
<node id="Gene_TEX19">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">TEX19</data>
  <data key="d7">TEX19</data>
</node>
<node id="PDF_45_2016_Result_-7153334455177507801">
  <data key="d0">Result</data>
  <data key="d1">We observed a synergism between DAZL and cytoplasmic polyadenylation elements (CPEs) in the translation pattern of maternal mRNAs when using a genome-wide analysis.</data>
  <data key="d3">We observed a synergism between DAZL and cytoplasmic polyadenylation elements (CPEs) in the translation pattern of maternal mRNAs when using a genome-wide analysis.</data>
  <data key="d4">PDF_45_2016</data>
</node>
<node id="PDF_45_2016_Result_8209822599145596674">
  <data key="d0">Result</data>
  <data key="d1">The knockdown of CPEB1 was associated with a reduction in the number of oocytes that reached MII after 17 h of in vitro maturation, whereas depletion in DAZL resulted in an almost complete block of progression into MII</data>
  <data key="d3">The knockdown of CPEB1 was associated with a reduction in the number of oocytes that reached MII after 17 h of in vitro maturation, whereas depletion in DAZL resulted in an almost complete block of progression into MII</data>
  <data key="d4">PDF_45_2016</data>
</node>
<node id="PDF_45_2016_Result_-1006441427067008625">
  <data key="d0">Result</data>
  <data key="d1">We observed a significant decrease in ribosome recruitment to the Tex19.1 and Ccnbl mRNAs after injection of the morpholino targeting CPEВ1 (СРЕВ1-MO).</data>
  <data key="d3">We observed a significant decrease in ribosome recruitment to the Tex19.1 and Ccnbl mRNAs after injection of the morpholino targeting CPEВ1 (СРЕВ1-MO).</data>
  <data key="d4">PDF_45_2016</data>
</node>
<node id="PDF_45_2016_Result_-1485383280183728608">
  <data key="d0">Result</data>
  <data key="d1">A DAZL concentration-dependent decrease in ribosome loading onto Tex19.1 mRNA was proportional to the depletion of DAZL</data>
  <data key="d3">A DAZL concentration-dependent decrease in ribosome loading onto Tex19.1 mRNA was proportional to the depletion of DAZL</data>
  <data key="d4">PDF_45_2016</data>
</node>
<node id="PDF_45_2016_Result_-3730996765766011008">
  <data key="d0">Result</data>
  <data key="d1">Mutation of the CPE significantly decreased translation of the reporter</data>
  <data key="d3">Mutation of the CPE significantly decreased translation of the reporter</data>
  <data key="d4">PDF_45_2016</data>
</node>
<node id="PDF_45_2016_Result_-649955863056853271">
  <data key="d0">Result</data>
  <data key="d1">single mutation of each of these sites caused a decrease in the rate of reporter synthesis</data>
  <data key="d3">single mutation of each of these sites caused a decrease in the rate of reporter synthesis</data>
  <data key="d4">PDF_45_2016</data>
</node>
<node id="PDF_45_2016_Result_5085690336790710673">
  <data key="d0">Result</data>
  <data key="d1">Combined mutation of DAZL sites 1 and 3 (41+3) further decreased the translation of the reporter to minimal levels.</data>
  <data key="d3">Combined mutation of DAZL sites 1 and 3 (41+3) further decreased the translation of the reporter to minimal levels.</data>
  <data key="d4">PDF_45_2016</data>
</node>
<node id="PDF_45_2016_Result_-2279688250594086410">
  <data key="d0">Result</data>
  <data key="d1">CPEB1 and DAZL interact with the same RNA targets, but possibly not through a direct interaction between both proteins.</data>
  <data key="d3">CPEB1 and DAZL interact with the same RNA targets, but possibly not through a direct interaction between both proteins.</data>
  <data key="d4">PDF_45_2016</data>
</node>
<node id="PDF_45_2016_Result_-8868307895684558241">
  <data key="d0">Result</data>
  <data key="d1">A decrease in CPEB1 binding could be detected for both mutants compared to the wild-type reporter</data>
  <data key="d3">A decrease in CPEB1 binding could be detected for both mutants compared to the wild-type reporter</data>
  <data key="d4">PDF_45_2016</data>
</node>
<node id="PDF_45_2016_Conclusion_3085968706911168016">
  <data key="d0">Conclusion</data>
  <data key="d1">Mechanistically, the number of DAZL proteins loaded onto the mRNA and the characteristics of the CPE might define the degree of cooperation between the two RBPs in activating translation and meiotic progression.</data>
  <data key="d3">Mechanistically, the number of DAZL proteins loaded onto the mRNA and the characteristics of the CPE might define the degree of cooperation between the two RBPs in activating translation and meiotic progression.</data>
  <data key="d4">PDF_45_2016</data>
</node>
<node id="PDF_45_2016_Conclusion_7530143935422672266">
  <data key="d0">Conclusion</data>
  <data key="d1">These findings confirm the weaker activity of the non-consensus CPE found in the 3' UTR of Tex19.1.</data>
  <data key="d3">These findings confirm the weaker activity of the non-consensus CPE found in the 3' UTR of Tex19.1.</data>
  <data key="d4">PDF_45_2016</data>
</node>
<node id="PDF_45_2016_Conclusion_-3805813853744680934">
  <data key="d0">Conclusion</data>
  <data key="d1">This experiment shows that only the non-consensus CPE allows CРЕВ1 and DAZL to act synergistically.</data>
  <data key="d3">This experiment shows that only the non-consensus CPE allows CРЕВ1 and DAZL to act synergistically.</data>
  <data key="d4">PDF_45_2016</data>
</node>
<node id="PDF_47_2015">
  <data key="d0">Paper</data>
  <data key="d1">INTRODUCTION

Different types of virus-like particles (VLPs) can be produced
using virus capsid protein, which self-assembles to form VLPs.
The VLPs are devoid of any genetic material, and they provide
useful information for viral infection mechanisms and also serve
as a very effective tool for vaccination.1,2 There are many types
of capsid proteins, but here, the primary focus was on lipid
layer-surrounded VLPs, because the lipid surface can be used to
display proteins for functionalization wit</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_47_2015_Method_-54781574078941181">
  <data key="d0">Method</data>
  <data key="d1">Chimeric VLPs were prepared using gag and M1 capsid proteins.</data>
  <data key="d3">Chimeric VLPs were prepared using gag and M1 capsid proteins.</data>
  <data key="d4">PDF_47_2015</data>
</node>
<node id="Protein_GAG">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">GAG</data>
  <data key="d7">Gag</data>
</node>
<node id="Protein_M1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">M1</data>
  <data key="d7">M1</data>
</node>
<node id="PDF_47_2015_Result_4893860246615182674">
  <data key="d0">Result</data>
  <data key="d1">Chimeric VLPs were expressed in silkworms, and larval hemolymph was collected, which was used for purification using DDDDK-tagged protein purification gel.</data>
  <data key="d3">Chimeric VLPs were expressed in silkworms, and larval hemolymph was collected, which was used for purification using DDDDK-tagged protein purification gel.</data>
  <data key="d4">PDF_47_2015</data>
</node>
<node id="PDF_47_2015_Result_1783835243512145812">
  <data key="d0">Result</data>
  <data key="d1">Chimeric VLPs were composed of gag (61 kDa), M1 (28 kDa), glycoprotein 64 GP64 (64 kDa), and rscFvs (32 kDa), and the presence of all proteins was confirmed by Western blotting.</data>
  <data key="d3">Chimeric VLPs were composed of gag (61 kDa), M1 (28 kDa), glycoprotein 64 GP64 (64 kDa), and rscFvs (32 kDa), and the presence of all proteins was confirmed by Western blotting.</data>
  <data key="d4">PDF_47_2015</data>
</node>
<node id="Protein_GP64">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">GP64</data>
  <data key="d7">GP64</data>
</node>
<node id="PDF_47_2015_Result_1488196317240352265">
  <data key="d0">Result</data>
  <data key="d1">The amount of M1 present on the chimeric VLPs per microgram was estimated to be 305 ng, which was about 30.5% of total chimera protein.</data>
  <data key="d3">The amount of M1 present on the chimeric VLPs per microgram was estimated to be 305 ng, which was about 30.5% of total chimera protein.</data>
  <data key="d4">PDF_47_2015</data>
</node>
<node id="PDF_47_2015_Result_2165500294956861730">
  <data key="d0">Result</data>
  <data key="d1">Chimeric VLPs showed specificity for the LS174T cells displaying TAG-72, a known marker for colon carcinoma compared with HEK293T cells as negative control.</data>
  <data key="d3">Chimeric VLPs showed specificity for the LS174T cells displaying TAG-72, a known marker for colon carcinoma compared with HEK293T cells as negative control.</data>
  <data key="d4">PDF_47_2015</data>
</node>
<node id="PDF_47_2015_Result_2332962644881182286">
  <data key="d0">Result</data>
  <data key="d1">LS174T cells when treated with chimeric VLPs packaged with calcein-AM showed fluorescence.</data>
  <data key="d3">LS174T cells when treated with chimeric VLPs packaged with calcein-AM showed fluorescence.</data>
  <data key="d4">PDF_47_2015</data>
</node>
<node id="PDF_47_2015_Result_-2718079740960111134">
  <data key="d0">Result</data>
  <data key="d1">The delivery of dye (red channel) was confirmed along with the presence of displayed rscFvs fluorescence (green channel) targeting the tumor-specific marker (TAG-72).</data>
  <data key="d3">The delivery of dye (red channel) was confirmed along with the presence of displayed rscFvs fluorescence (green channel) targeting the tumor-specific marker (TAG-72).</data>
  <data key="d4">PDF_47_2015</data>
</node>
<node id="PDF_47_2015_Result_1959305655694642448">
  <data key="d0">Result</data>
  <data key="d1">The delivery of doxorubicin to spheroids was confirmed (red channel) along with the presence of rscFvs fluorescence (green channel).</data>
  <data key="d3">The delivery of doxorubicin to spheroids was confirmed (red channel) along with the presence of rscFvs fluorescence (green channel).</data>
  <data key="d4">PDF_47_2015</data>
</node>
<node id="Compound_DOXORUBICIN">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">DOXORUBICIN</data>
  <data key="d7">doxorubicin</data>
</node>
<node id="PDF_47_2015_Result_-181533159906841637">
  <data key="d0">Result</data>
  <data key="d1">The serum showed specificity for chimera as well as swine flu-influenza A virus (H1N1).</data>
  <data key="d3">The serum showed specificity for chimera as well as swine flu-influenza A virus (H1N1).</data>
  <data key="d4">PDF_47_2015</data>
</node>
<node id="Disease_SWINE FLU-INFLUENZA A VIRUS (H1N1)">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">SWINE FLU-INFLUENZA A VIRUS (H1N1)</data>
  <data key="d7">swine flu-influenza A virus (H1N1)</data>
</node>
<node id="PDF_47_2015_Conclusion_7439052657272579615">
  <data key="d0">Conclusion</data>
  <data key="d1">We prepared a nanobiomaterial with dual function of DDS and vaccination using two capsid proteins, gag-577 and M1, to target tumors and provide immunity against influenza virus</data>
  <data key="d3">We prepared a nanobiomaterial with dual function of DDS and vaccination using two capsid proteins, gag-577 and M1, to target tumors and provide immunity against influenza virus</data>
  <data key="d4">PDF_47_2015</data>
</node>
<node id="Disease_INFLUENZA VIRUS">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">INFLUENZA VIRUS</data>
  <data key="d7">influenza virus</data>
</node>
<node id="PDF_59_2021">
  <data key="d0">Paper</data>
  <data key="d1">Here is the full text from the scientific PDF, extracted for you in English:

Resource
Cell
Integrated analysis of multimodal single-cell data
Graphical abstract
Single-cell multimodal
Weighted nearest neighbors Multimodal reference atlas
data technologies
CITE-seq
AAAA
AAAA
AAAA
AAAA
Surface protein Gene expression
10x multiome, SHARE-seq
AAAA
WAAAA
AAAA
AAAA
Open chromatin Gene expression
ASAP-seq
Surface protein Open chromatin
RNA
+
Protein
Modality weights
יוויייייי
UMAP 2
WNN
scRNA query ma</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_59_2021_Method_8084785180202623832">
  <data key="d0">Method</data>
  <data key="d1">"weighted-nearest neighbor" (WNN) analysis, an analytical framework to integrate multiple data types measured within a cell and to obtain a joint definition of cellular state.</data>
  <data key="d3">"weighted-nearest neighbor" (WNN) analysis, an analytical framework to integrate multiple data types measured within a cell and to obtain a joint definition of cellular state.</data>
  <data key="d4">PDF_59_2021</data>
</node>
<node id="PDF_59_2021_Method_8884767966340028883">
  <data key="d0">Method</data>
  <data key="d1">CITE-seq (Stoeckius et al., 2017), which leverages oligonucleotide-conjugated antibodies to simultaneously quantify RNA and surface protein abundance in single cells via the sequencing of antibody-derived tags (ADTs).</data>
  <data key="d3">CITE-seq (Stoeckius et al., 2017), which leverages oligonucleotide-conjugated antibodies to simultaneously quantify RNA and surface protein abundance in single cells via the sequencing of antibody-derived tags (ADTs).</data>
  <data key="d4">PDF_59_2021</data>
</node>
<node id="PDF_59_2021_Method_9000689309584930492">
  <data key="d0">Method</data>
  <data key="d1">10x Genomics Multiome ATAC+RNA kit</data>
  <data key="d3">10x Genomics Multiome ATAC+RNA kit</data>
  <data key="d4">PDF_59_2021</data>
</node>
<node id="PDF_59_2021_Method_6134842963143498965">
  <data key="d0">Method</data>
  <data key="d1">ASAP-seq (Mimitou et al., 2020), a third multimodal technology, that pairs measurements of surface protein abundance with ATAC-seq profiles in single cells</data>
  <data key="d3">ASAP-seq (Mimitou et al., 2020), a third multimodal technology, that pairs measurements of surface protein abundance with ATAC-seq profiles in single cells</data>
  <data key="d4">PDF_59_2021</data>
</node>
<node id="PDF_59_2021_Method_9164412909000990652">
  <data key="d0">Method</data>
  <data key="d1">SHARE-seq (Ma et al., 2020), which gener- ates paired measurements of chromatin accessibility and gene expression.</data>
  <data key="d3">SHARE-seq (Ma et al., 2020), which gener- ates paired measurements of chromatin accessibility and gene expression.</data>
  <data key="d4">PDF_59_2021</data>
</node>
<node id="PDF_59_2021_Result_5263780920456016974">
  <data key="d0">Result</data>
  <data key="d1">For example, CD8+ and CD4+ T cells were partially blended together when analyzing the transcrip- tome but separated clearly in the protein data.</data>
  <data key="d3">For example, CD8+ and CD4+ T cells were partially blended together when analyzing the transcrip- tome but separated clearly in the protein data.</data>
  <data key="d4">PDF_59_2021</data>
</node>
<node id="Gene_CD8">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CD8</data>
  <data key="d7">CD8</data>
</node>
<node id="Gene_CD4">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CD4</data>
  <data key="d7">CD4</data>
</node>
<node id="Process_T CELL">
  <data key="d0">Entity</data>
  <data key="d5">Process</data>
  <data key="d6">T CELL</data>
  <data key="d7">T cell</data>
</node>
<node id="PDF_59_2021_Result_8331701323369931557">
  <data key="d0">Result</data>
  <data key="d1">Contrastingly, conventional dendritic cells (cDCs), along with a rare population of erythroid progenitors and spiked-in murine 3T3 controls, formed distinct clusters when analyzing RNA but were inter- mixed with other cell types based on surface protein abundance.</data>
  <data key="d3">Contrastingly, conventional dendritic cells (cDCs), along with a rare population of erythroid progenitors and spiked-in murine 3T3 controls, formed distinct clusters when analyzing RNA but were inter- mixed with other cell types based on surface protein abundance.</data>
  <data key="d4">PDF_59_2021</data>
</node>
<node id="PDF_59_2021_Result_-1877269811622938180">
  <data key="d0">Result</data>
  <data key="d1">For CD8+ T cells, protein KNN-based predictions were more accurate compared to RNA KNN-based predictions</data>
  <data key="d3">For CD8+ T cells, protein KNN-based predictions were more accurate compared to RNA KNN-based predictions</data>
  <data key="d4">PDF_59_2021</data>
</node>
<node id="PDF_59_2021_Result_-4511610816675086746">
  <data key="d0">Result</data>
  <data key="d1">cells classified as CD8+ T cells were assigned higher protein modality weights, whereas DCs were assigned higher RNA modality weights</data>
  <data key="d3">cells classified as CD8+ T cells were assigned higher protein modality weights, whereas DCs were assigned higher RNA modality weights</data>
  <data key="d4">PDF_59_2021</data>
</node>
<node id="PDF_59_2021_Result_235750629806043123">
  <data key="d0">Result</data>
  <data key="d1">WNN integration sub- stantially increased our ability to resolve hematopoietic cell states</data>
  <data key="d3">WNN integration sub- stantially increased our ability to resolve hematopoietic cell states</data>
  <data key="d4">PDF_59_2021</data>
</node>
<node id="PDF_59_2021_Result_8321466901512663758">
  <data key="d0">Result</data>
  <data key="d1">T cell groups-and in particular, populations that were masked in scRNA-seq analyses-all received higher protein modality weights</data>
  <data key="d3">T cell groups-and in particular, populations that were masked in scRNA-seq analyses-all received higher protein modality weights</data>
  <data key="d4">PDF_59_2021</data>
</node>
<node id="PDF_59_2021_Result_-822497605866246829">
  <data key="d0">Result</data>
  <data key="d1">each of the cell populations with the highest RNA weights represented hematopoietic progenitor populations</data>
  <data key="d3">each of the cell populations with the highest RNA weights represented hematopoietic progenitor populations</data>
  <data key="d4">PDF_59_2021</data>
</node>
<node id="PDF_59_2021_Result_-8722289623207287559">
  <data key="d0">Result</data>
  <data key="d1">ATAC-seq data were more capable of separating naive CD8+ and CD4+ T cell states due to reliable detection of cell-type-spe- cific open chromatin regions</data>
  <data key="d3">ATAC-seq data were more capable of separating naive CD8+ and CD4+ T cell states due to reliable detection of cell-type-spe- cific open chromatin regions</data>
  <data key="d4">PDF_59_2021</data>
</node>
<node id="PDF_59_2021_Result_-5834581784832178746">
  <data key="d0">Result</data>
  <data key="d1">ATAC- seq peaks accessible in MAIT cells were highly enriched for mo- tifs for the pro-inflammatory transcription factor RORyt (Ivanov et al., 2006; Willing et al., 2018), which was also upregulated transcriptionally in these cells</data>
  <data key="d3">ATAC- seq peaks accessible in MAIT cells were highly enriched for mo- tifs for the pro-inflammatory transcription factor RORyt (Ivanov et al., 2006; Willing et al., 2018), which was also upregulated transcriptionally in these cells</data>
  <data key="d4">PDF_59_2021</data>
</node>
<node id="PDF_59_2021_Result_-8563409432147183205">
  <data key="d0">Result</data>
  <data key="d1">WNN analysis identified a novel population of Basal cells that exhibits distinct chromatin accessibility profiles, but does not exhibit unique transcriptomic characteristics</data>
  <data key="d3">WNN analysis identified a novel population of Basal cells that exhibits distinct chromatin accessibility profiles, but does not exhibit unique transcriptomic characteristics</data>
  <data key="d4">PDF_59_2021</data>
</node>
<node id="PDF_59_2021_Result_-5676837304885577544">
  <data key="d0">Result</data>
  <data key="d1">the Basal_4 population was specifically characterized by increased chromatin accessi- bility at CTCF and p53 motifs</data>
  <data key="d3">the Basal_4 population was specifically characterized by increased chromatin accessi- bility at CTCF and p53 motifs</data>
  <data key="d4">PDF_59_2021</data>
</node>
<node id="PDF_59_2021_Conclusion_761728912910396060">
  <data key="d0">Conclusion</data>
  <data key="d1">WNN analysis is capable of sensitively and robustly characterizing populations that cannot be identified by a single modality, exhibits best-in-class perfor- mance, and can be flexibly applied to multiple data types for inte- grative and multimodal analysis.</data>
  <data key="d3">WNN analysis is capable of sensitively and robustly characterizing populations that cannot be identified by a single modality, exhibits best-in-class perfor- mance, and can be flexibly applied to multiple data types for inte- grative and multimodal analysis.</data>
  <data key="d4">PDF_59_2021</data>
</node>
<node id="PDF_40_2006">
  <data key="d0">Paper</data>
  <data key="d1">Here is the requested text from the PDF:

The RASSF1A Tumor Suppressor Activates Bax via MOAP-1*
Received for publication, November 10, 2005 Published, JBC Papers in Press, December 12, 2005, DOI 10.1074/jbc.M512128200
Michele D. Vos, Ashraf Dallol, Kristin Eckfeld, Nadia P. C. Allen, Howard Donninger, Luke B. Hesson,
Diego Calvisi, Farida Latif¹, and Geoffrey J. Clark#2
From the Department of Cell and Cancer Biology, NCI, National Institutes of Health, Rockville, Maryland 20850-3300, the
"Depar</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_40_2006_Hypothesis_3683953763906390933">
  <data key="d0">Hypothesis</data>
  <data key="d1">We have hypothesized that RASSF family proteins may serve as effectors that mediate some of the growth inhibitory aspects of Ras, including Ras-induced apoptosis</data>
  <data key="d3">We have hypothesized that RASSF family proteins may serve as effectors that mediate some of the growth inhibitory aspects of Ras, including Ras-induced apoptosis</data>
  <data key="d4">PDF_40_2006</data>
</node>
<node id="Protein_RASSF">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">RASSF</data>
  <data key="d7">RASSF</data>
</node>
<node id="Protein_RAS">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">RAS</data>
  <data key="d7">Ras</data>
</node>
<node id="PDF_40_2006_Method_-683990889861317871">
  <data key="d0">Method</data>
  <data key="d1">Yeast two-hybrid analysis was performed using a full-length RASSF1A clone</data>
  <data key="d3">Yeast two-hybrid analysis was performed using a full-length RASSF1A clone</data>
  <data key="d4">PDF_40_2006</data>
</node>
<node id="Gene_RASSF1A">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">RASSF1A</data>
  <data key="d7">RASSF1A</data>
</node>
<node id="PDF_40_2006_Method_-1587955044789052164">
  <data key="d0">Method</data>
  <data key="d1">co-transfected RFP-RASSF1A and GFP-MOAP-1 into 293-T cells and examined expressing cells by fluorescence microscopy</data>
  <data key="d3">co-transfected RFP-RASSF1A and GFP-MOAP-1 into 293-T cells and examined expressing cells by fluorescence microscopy</data>
  <data key="d4">PDF_40_2006</data>
</node>
<node id="PDF_40_2006_Method_-7160951234920139849">
  <data key="d0">Method</data>
  <data key="d1">immunoprecipitated liver lysates with a mouse monoclonal RASSF1A antibody and detected the presence of endogenous MOAP-1</data>
  <data key="d3">immunoprecipitated liver lysates with a mouse monoclonal RASSF1A antibody and detected the presence of endogenous MOAP-1</data>
  <data key="d4">PDF_40_2006</data>
</node>
<node id="PDF_40_2006_Method_-7144305972820793422">
  <data key="d0">Method</data>
  <data key="d1">Cell death assays were performed by transient transfection of 293-T cells followed by trypan blue staining after 48 h</data>
  <data key="d3">Cell death assays were performed by transient transfection of 293-T cells followed by trypan blue staining after 48 h</data>
  <data key="d4">PDF_40_2006</data>
</node>
<node id="PDF_40_2006_Method_-9082245207375802968">
  <data key="d0">Method</data>
  <data key="d1">co-transfected GFP-Bax and RFP-RASSF1A into H1299 human lung tumor cells</data>
  <data key="d3">co-transfected GFP-Bax and RFP-RASSF1A into H1299 human lung tumor cells</data>
  <data key="d4">PDF_40_2006</data>
</node>
<node id="PDF_40_2006_Method_-1136047486022654854">
  <data key="d0">Method</data>
  <data key="d1">transfected H1792 cells with an shRNA construct designed against RASSF1A</data>
  <data key="d3">transfected H1792 cells with an shRNA construct designed against RASSF1A</data>
  <data key="d4">PDF_40_2006</data>
</node>
<node id="PDF_40_2006_Result_16013246130922863">
  <data key="d0">Result</data>
  <data key="d1">the C65R mutant of RASSF1A is defective for MOAP-1 binding and does not exhibit enhanced MOAP-1 binding in the presence of activated K-Ras</data>
  <data key="d3">the C65R mutant of RASSF1A is defective for MOAP-1 binding and does not exhibit enhanced MOAP-1 binding in the presence of activated K-Ras</data>
  <data key="d4">PDF_40_2006</data>
</node>
<node id="Protein_K-RAS">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">K-RAS</data>
  <data key="d7">K-Ras</data>
</node>
<node id="PDF_40_2006_Result_5606897750963540037">
  <data key="d0">Result</data>
  <data key="d1">RASSF1A induces the relocalization and clustering of Bax</data>
  <data key="d3">RASSF1A induces the relocalization and clustering of Bax</data>
  <data key="d4">PDF_40_2006</data>
</node>
<node id="PDF_40_2006_Result_5883488902810301376">
  <data key="d0">Result</data>
  <data key="d1">Co-transfection of the BH3 domain of MOAP-1 blocked the ability of RASSF1A to activate Bax</data>
  <data key="d3">Co-transfection of the BH3 domain of MOAP-1 blocked the ability of RASSF1A to activate Bax</data>
  <data key="d4">PDF_40_2006</data>
</node>
<node id="PDF_40_2006_Result_1679627554638903512">
  <data key="d0">Result</data>
  <data key="d1">RASSF1A C65R is defective for Bax activation in H1299 lung tumor cells</data>
  <data key="d3">RASSF1A C65R is defective for Bax activation in H1299 lung tumor cells</data>
  <data key="d4">PDF_40_2006</data>
</node>
<node id="PDF_40_2006_Result_8308012542702244040">
  <data key="d0">Result</data>
  <data key="d1">A strong activation of Bax by K-Ras12v was only detected in the cells expressing RASSF1A</data>
  <data key="d3">A strong activation of Bax by K-Ras12v was only detected in the cells expressing RASSF1A</data>
  <data key="d4">PDF_40_2006</data>
</node>
<node id="PDF_40_2006_Conclusion_-3781462944046668637">
  <data key="d0">Conclusion</data>
  <data key="d1">Thus, we identify a novel pro-apoptotic pathway linking K-Ras, RASSF1A and Bax that is specifically impaired in some human tumors.</data>
  <data key="d3">Thus, we identify a novel pro-apoptotic pathway linking K-Ras, RASSF1A and Bax that is specifically impaired in some human tumors.</data>
  <data key="d4">PDF_40_2006</data>
</node>
<node id="PDF_40_2006_Conclusion_6779262816191981106">
  <data key="d0">Conclusion</data>
  <data key="d1">Our determination that the tumor-derived C65R mutant of RASSF1A is defective for MOAP-1 association and Bax activation suggests the interaction of RASSF1A with MOAP-1 is a significant component of its tumor suppressor function.</data>
  <data key="d3">Our determination that the tumor-derived C65R mutant of RASSF1A is defective for MOAP-1 association and Bax activation suggests the interaction of RASSF1A with MOAP-1 is a significant component of its tumor suppressor function.</data>
  <data key="d4">PDF_40_2006</data>
</node>
<node id="PDF_26_2021">
  <data key="d0">Paper</data>
  <data key="d1">Europe PMC Funders Group
Author Manuscript
Nat Genet. Author manuscript; available in PMC 2022 April 28.
Published in final edited form as:
Nat Genet. 2021 November 01; 53(11): 1527–1533. doi:10.1038/s41588-021-00945-5.
An open approach to systematically prioritize causal variants
and genes at all published human GWAS trait-associated loci
Edward Mountjoy1,2, Ellen M. Schmidt1,2, Miguel Carmona2,3, Jeremy
Schwartzentruber 1,2,3, Gareth Peat2,3, Alfredo Miranda2,3, Luca Fumis2,3, James
Hayhurst2,</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_26_2021_Hypothesis_-5082930849196607872">
  <data key="d0">Hypothesis</data>
  <data key="d1">GWAS trait-associated SNPs affect expression of neighboring genes through regulatory mechanisms.</data>
  <data key="d3">GWAS trait-associated SNPs affect expression of neighboring genes through regulatory mechanisms.</data>
  <data key="d4">PDF_26_2021</data>
</node>
<node id="PDF_26_2021_Method_2151172292187832547">
  <data key="d0">Method</data>
  <data key="d1">Fine-mapping and systematic disease-disease and disease-molecular trait colocalization analysis.</data>
  <data key="d3">Fine-mapping and systematic disease-disease and disease-molecular trait colocalization analysis.</data>
  <data key="d4">PDF_26_2021</data>
</node>
<node id="PDF_26_2021_Method_-8691077547092582639">
  <data key="d0">Method</data>
  <data key="d1">Integration of GWAS, expression and protein quantitative trait loci (eQTL and pQTL) and epigenomics data.</data>
  <data key="d3">Integration of GWAS, expression and protein quantitative trait loci (eQTL and pQTL) and epigenomics data.</data>
  <data key="d4">PDF_26_2021</data>
</node>
<node id="PDF_26_2021_Method_-5594211197849721181">
  <data key="d0">Method</data>
  <data key="d1">Development of a machine learning model trained on curated gold-standard GWAS loci.</data>
  <data key="d3">Development of a machine learning model trained on curated gold-standard GWAS loci.</data>
  <data key="d4">PDF_26_2021</data>
</node>
<node id="PDF_26_2021_Result_6192805185311629188">
  <data key="d0">Result</data>
  <data key="d1">Identified 2,284 single coding variants linking 378 genes to 303 traits.</data>
  <data key="d3">Identified 2,284 single coding variants linking 378 genes to 303 traits.</data>
  <data key="d4">PDF_26_2021</data>
</node>
<node id="PDF_26_2021_Result_4920982137656896410">
  <data key="d0">Result</data>
  <data key="d1">rs35383942, associated with breast cancer, is a predicted deleterious missense variant in PHLDA3.</data>
  <data key="d3">rs35383942, associated with breast cancer, is a predicted deleterious missense variant in PHLDA3.</data>
  <data key="d4">PDF_26_2021</data>
</node>
<node id="Gene_PHLDA3">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">PHLDA3</data>
  <data key="d7">PHLDA3</data>
</node>
<node id="Gene_AKT1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">AKT1</data>
  <data key="d7">AKT1</data>
</node>
<node id="PDF_26_2021_Result_-3117426508078294293">
  <data key="d0">Result</data>
  <data key="d1">splice region variant rs11589479, which causes increase in ADAM15 expression in several monocytes states and also colocalizes (H4 = 0.99) with Crohn's disease</data>
  <data key="d3">splice region variant rs11589479, which causes increase in ADAM15 expression in several monocytes states and also colocalizes (H4 = 0.99) with Crohn's disease</data>
  <data key="d4">PDF_26_2021</data>
</node>
<node id="Gene_ADAM15">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ADAM15</data>
  <data key="d7">ADAM15</data>
</node>
<node id="Disease_CROHN'S DISEASE">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">CROHN'S DISEASE</data>
  <data key="d7">Crohn's disease</data>
</node>
<node id="PDF_26_2021_Conclusion_-5294938487575171592">
  <data key="d0">Conclusion</data>
  <data key="d1">The L2G score output by the model represents the likelihood that a gene is causal for that trait.</data>
  <data key="d3">The L2G score output by the model represents the likelihood that a gene is causal for that trait.</data>
  <data key="d4">PDF_26_2021</data>
</node>
<node id="PDF_31_2019">
  <data key="d0">Paper</data>
  <data key="d1">ARTICLE
Leveraging Polygenic Functional Enrichment
to Improve GWAS Power
Gleb Kichaev, 1,* Gaurav Bhatia,2 Po-Ru Loh, 2,3 Steven Gazal, 2,3 Kathryn Burch,¹ Malika K. Freund, 4
Armin Schoech,2,3 Bogdan Pasaniuc, 1,4,5,7 and Alkes L. Price2,3,6,7,*
Functional genomics data has the potential to increase GWAS power by identifying SNPs that have a higher prior probability of associ-
ation. Here, we introduce a method that leverages polygenic functional enrichment to incorporate coding, conserved, reg</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_31_2019_Hypothesis_-1056833595134377367">
  <data key="d0">Hypothesis</data>
  <data key="d1">incorporating functional information into association analyses has the potential to increase GWAS power</data>
  <data key="d3">incorporating functional information into association analyses has the potential to increase GWAS power</data>
  <data key="d4">PDF_31_2019</data>
</node>
<node id="PDF_31_2019_Method_-1439198623860928750">
  <data key="d0">Method</data>
  <data key="d1">stratified LD score regression to compute the expected x2 statistic of each SNP based on the functional annotations that it tags</data>
  <data key="d3">stratified LD score regression to compute the expected x2 statistic of each SNP based on the functional annotations that it tags</data>
  <data key="d4">PDF_31_2019</data>
</node>
<node id="PDF_31_2019_Method_-7244849363223085226">
  <data key="d0">Method</data>
  <data key="d1">stratify SNPs into bins of expected x² and estimate the proportion of null (π0) and alternative (1) SNPs within each bin using the Storey π0 estimator to obtain bin-specific weights</data>
  <data key="d3">stratify SNPs into bins of expected x² and estimate the proportion of null (π0) and alternative (1) SNPs within each bin using the Storey π0 estimator to obtain bin-specific weights</data>
  <data key="d4">PDF_31_2019</data>
</node>
<node id="PDF_31_2019_Method_-3471959365747463789">
  <data key="d0">Method</data>
  <data key="d1">weighted-Bonferroni procedure</data>
  <data key="d3">weighted-Bonferroni procedure</data>
  <data key="d4">PDF_31_2019</data>
</node>
<node id="PDF_31_2019_Method_7023445881201550886">
  <data key="d0">Method</data>
  <data key="d1">mixed model association statistics using BOLT-LMM</data>
  <data key="d3">mixed model association statistics using BOLT-LMM</data>
  <data key="d4">PDF_31_2019</data>
</node>
<node id="PDF_31_2019_Result_-119217658207850139">
  <data key="d0">Result</data>
  <data key="d1">FINDOR was well calibrated, producing a similar number of false-positive associations at null loci as the unweighted approach</data>
  <data key="d3">FINDOR was well calibrated, producing a similar number of false-positive associations at null loci as the unweighted approach</data>
  <data key="d4">PDF_31_2019</data>
</node>
<node id="PDF_31_2019_Result_5633783855499589783">
  <data key="d0">Result</data>
  <data key="d1">FINDOR attains a 9%-38% increase in the number of independent associations detected at causal loci, depending on trait polygenicity and sample size</data>
  <data key="d3">FINDOR attains a 9%-38% increase in the number of independent associations detected at causal loci, depending on trait polygenicity and sample size</data>
  <data key="d4">PDF_31_2019</data>
</node>
<node id="PDF_31_2019_Result_-7315920823835259182">
  <data key="d0">Result</data>
  <data key="d1">FINDOR attained a 13% increase in genome-wide significant loci detected compared to unweighted raw p values</data>
  <data key="d3">FINDOR attained a 13% increase in genome-wide significant loci detected compared to unweighted raw p values</data>
  <data key="d4">PDF_31_2019</data>
</node>
<node id="PDF_31_2019_Conclusion_-1911165917813386521">
  <data key="d0">Conclusion</data>
  <data key="d1">leveraging functional enrichment using our method robustly increases GWAS power</data>
  <data key="d3">leveraging functional enrichment using our method robustly increases GWAS power</data>
  <data key="d4">PDF_31_2019</data>
</node>
<node id="PDF_46_2010">
  <data key="d0">Paper</data>
  <data key="d1">Pumilio 2 controls translation by competing with eIF4E
for 7-methyl guanosine cap recognition
QUIPING CAO, KIRAN PADMANABHAN,¹ and JOEL D. RICHTER
Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA
ABSTRACT
Pumilio 2 (Pum2) interacts with the 3' UTR-containing pumilio binding element (PBE) of RINGO/SPY mRNA to repress
translation in Xenopus oocytes. Here, we show that Pum2 also binds directly to the 5' 7mG cap structure; in so doing, it</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_46_2010_Hypothesis_701123404578016755">
  <data key="d0">Hypothesis</data>
  <data key="d1">Pum2 can repress translation by blocking the assembly of the essential initiation complex on the cap.</data>
  <data key="d3">Pum2 can repress translation by blocking the assembly of the essential initiation complex on the cap.</data>
  <data key="d4">PDF_46_2010</data>
</node>
<node id="Protein_PUM2">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">PUM2</data>
  <data key="d7">Pum2</data>
</node>
<node id="Protein_EIF4E">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">EIF4E</data>
  <data key="d7">eIF4E</data>
</node>
<node id="PDF_46_2010_Method_-441247898462120587">
  <data key="d0">Method</data>
  <data key="d1">Using deletion analysis, we have mapped the cap interaction domain of Pum2 to the amino terminus of the protein and identified a conserved tryptophan residue that mediates this specific interaction.</data>
  <data key="d3">Using deletion analysis, we have mapped the cap interaction domain of Pum2 to the amino terminus of the protein and identified a conserved tryptophan residue that mediates this specific interaction.</data>
  <data key="d4">PDF_46_2010</data>
</node>
<node id="PDF_46_2010_Method_2696937838462256372">
  <data key="d0">Method</data>
  <data key="d1">Reporter mRNA-based assays demonstrate that Pum2 requires the conserved tryptophan to repress translation in injected Xenopus oocytes.</data>
  <data key="d3">Reporter mRNA-based assays demonstrate that Pum2 requires the conserved tryptophan to repress translation in injected Xenopus oocytes.</data>
  <data key="d4">PDF_46_2010</data>
</node>
<node id="PDF_46_2010_Result_5563776965883224748">
  <data key="d0">Result</data>
  <data key="d1">Pum2 binds directly to the 5' 7mG cap structure; in so doing, it precludes eIF4E from binding the cap.</data>
  <data key="d3">Pum2 binds directly to the 5' 7mG cap structure; in so doing, it precludes eIF4E from binding the cap.</data>
  <data key="d4">PDF_46_2010</data>
</node>
<node id="PDF_46_2010_Result_-1436724849490238434">
  <data key="d0">Result</data>
  <data key="d1">Pum2, like Maskin, was retained on the affinity matrix and that it was competed off by excess cap analog.</data>
  <data key="d3">Pum2, like Maskin, was retained on the affinity matrix and that it was competed off by excess cap analog.</data>
  <data key="d4">PDF_46_2010</data>
</node>
<node id="Protein_MASKIN">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">MASKIN</data>
  <data key="d7">Maskin</data>
</node>
<node id="PDF_46_2010_Result_-3076783188810283608">
  <data key="d0">Result</data>
  <data key="d1">progressively more Pum2 was retained on the cap analog matrix as the cell cycle progressed</data>
  <data key="d3">progressively more Pum2 was retained on the cap analog matrix as the cell cycle progressed</data>
  <data key="d4">PDF_46_2010</data>
</node>
<node id="PDF_46_2010_Result_4291168305466479502">
  <data key="d0">Result</data>
  <data key="d1">Pum2, as well as eIF4E, were both retained on the m'G-Sepharose matrix, but not on the GDP matrix</data>
  <data key="d3">Pum2, as well as eIF4E, were both retained on the m'G-Sepharose matrix, but not on the GDP matrix</data>
  <data key="d4">PDF_46_2010</data>
</node>
<node id="PDF_46_2010_Result_4635522752032459763">
  <data key="d0">Result</data>
  <data key="d1">In the presence of excess free cap analog, but not free GTP, both Pum2 and eIF4E failed to be retained on the m'G-Sepharose matrix</data>
  <data key="d3">In the presence of excess free cap analog, but not free GTP, both Pum2 and eIF4E failed to be retained on the m'G-Sepharose matrix</data>
  <data key="d4">PDF_46_2010</data>
</node>
<node id="PDF_46_2010_Result_-7601699126870717197">
  <data key="d0">Result</data>
  <data key="d1">Pum2 bound the m G-Sepharose in the presence of GTP, but not the free cap analog.</data>
  <data key="d3">Pum2 bound the m G-Sepharose in the presence of GTP, but not the free cap analog.</data>
  <data key="d4">PDF_46_2010</data>
</node>
<node id="PDF_46_2010_Result_-7694673687348091914">
  <data key="d0">Result</data>
  <data key="d1">both recombinant Pum2 and eIF4E were retained on cap analog, but not GDP Sepharose.</data>
  <data key="d3">both recombinant Pum2 and eIF4E were retained on cap analog, but not GDP Sepharose.</data>
  <data key="d4">PDF_46_2010</data>
</node>
<node id="PDF_46_2010_Result_-734895794085640200">
  <data key="d0">Result</data>
  <data key="d1">As more eIF4E was retained on the matrix, progressively less Pum2 was retained. However, increased Pum2 retention caused no detectable decrease in eIF4E retention</data>
  <data key="d3">As more eIF4E was retained on the matrix, progressively less Pum2 was retained. However, increased Pum2 retention caused no detectable decrease in eIF4E retention</data>
  <data key="d4">PDF_46_2010</data>
</node>
<node id="PDF_46_2010_Result_-4724971973414181120">
  <data key="d0">Result</data>
  <data key="d1">the preponderance of Pum2 binding activity resided in residues 334-689.</data>
  <data key="d3">the preponderance of Pum2 binding activity resided in residues 334-689.</data>
  <data key="d4">PDF_46_2010</data>
</node>
<node id="PDF_46_2010_Result_1824116455646388372">
  <data key="d0">Result</data>
  <data key="d1">the substitution of W344, which is conserved among Pum2 proteins from several vertebrate species, consistently abrogated cap binding</data>
  <data key="d3">the substitution of W344, which is conserved among Pum2 proteins from several vertebrate species, consistently abrogated cap binding</data>
  <data key="d4">PDF_46_2010</data>
</node>
<node id="PDF_46_2010_Conclusion_-571866029861193511">
  <data key="d0">Conclusion</data>
  <data key="d1">vertebrate Pumilio can repress translation by blocking the assembly of the essential initiation complex on the cap.</data>
  <data key="d3">vertebrate Pumilio can repress translation by blocking the assembly of the essential initiation complex on the cap.</data>
  <data key="d4">PDF_46_2010</data>
</node>
<node id="PDF_46_2010_Conclusion_4127119109142202898">
  <data key="d0">Conclusion</data>
  <data key="d1">Pum2 combines two binding specificities, with the cap and the 3' UTR PBE, to repress translation.</data>
  <data key="d3">Pum2 combines two binding specificities, with the cap and the 3' UTR PBE, to repress translation.</data>
  <data key="d4">PDF_46_2010</data>
</node>
<node id="PDF_53_2019">
  <data key="d0">Paper</data>
  <data key="d1">Negative-Stain Transmission Electron
Microscopy of Molecular Complexes for
Image Analysis by 2D Class Averaging
John R. Gallagher,¹ Alexander J. Kim,¹ Neetu M. Gulati,¹
and Audray K. Harris1,2
Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Bethesda, Maryland
2Corresponding author: harrisau@mail.nih.gov
Negative-stain transmission electron microscopy (EM) is a technique that has
provided nanometer resolution images of macro</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_53_2019_Method_-1599774961034013939">
  <data key="d0">Method</data>
  <data key="d1">Negative-stain transmission electron microscopy (EM) is a technique that has provided nanometer resolution images of macromolecules for about 60 years.</data>
  <data key="d3">Negative-stain transmission electron microscopy (EM) is a technique that has provided nanometer resolution images of macromolecules for about 60 years.</data>
  <data key="d4">PDF_53_2019</data>
</node>
<node id="PDF_53_2019_Method_4462753343622714275">
  <data key="d0">Method</data>
  <data key="d1">Using uranyl acetate stained molecular com- plexes of influenza hemagglutinin bound to Fab 441D6, we describe a simple and efficient means to collect several hundred micrographs with SerialEM.</data>
  <data key="d3">Using uranyl acetate stained molecular com- plexes of influenza hemagglutinin bound to Fab 441D6, we describe a simple and efficient means to collect several hundred micrographs with SerialEM.</data>
  <data key="d4">PDF_53_2019</data>
</node>
<node id="Protein_HEMAGGLUTININ">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">HEMAGGLUTININ</data>
  <data key="d7">hemagglutinin</data>
</node>
<node id="PDF_53_2019_Result_-2904868856983182395">
  <data key="d0">Result</data>
  <data key="d1">Using RELION, we illustrate how tens of thousands of complexes can be auto-picked and classified to accurately describe the domain level topology of this unconventional hemagglutinin head-domain epitope.</data>
  <data key="d3">Using RELION, we illustrate how tens of thousands of complexes can be auto-picked and classified to accurately describe the domain level topology of this unconventional hemagglutinin head-domain epitope.</data>
  <data key="d4">PDF_53_2019</data>
</node>
<node id="PDF_53_2019_Result_-1666800357086250499">
  <data key="d0">Result</data>
  <data key="d1">By comparing to the cryo-EM density map of the same complex, we show that questions about epitope mapping and conformational heterogeneity can readily be answered by this negative-stain method.</data>
  <data key="d3">By comparing to the cryo-EM density map of the same complex, we show that questions about epitope mapping and conformational heterogeneity can readily be answered by this negative-stain method.</data>
  <data key="d4">PDF_53_2019</data>
</node>
<node id="PDF_53_2019_Result_-3025535816794254610">
  <data key="d0">Result</data>
  <data key="d1">The structure of this complex was previously published as a cryo-EM map at 8 Å resolution (Kanekiyo et al., 2019), and this map is available in the EM data bank as entry EMD-7021.</data>
  <data key="d3">The structure of this complex was previously published as a cryo-EM map at 8 Å resolution (Kanekiyo et al., 2019), and this map is available in the EM data bank as entry EMD-7021.</data>
  <data key="d4">PDF_53_2019</data>
</node>
<node id="PDF_53_2019_Method_-5787164148879896390">
  <data key="d0">Method</data>
  <data key="d1">As an example for this article, we use the molecular complex of the antibody fragment antigen-binding (Fab) 441D6 in complex with influenza hemagglutinin (HA) A/New York/653/1996.</data>
  <data key="d3">As an example for this article, we use the molecular complex of the antibody fragment antigen-binding (Fab) 441D6 in complex with influenza hemagglutinin (HA) A/New York/653/1996.</data>
  <data key="d4">PDF_53_2019</data>
</node>
<node id="PDF_30_2021">
  <data key="d0">Paper</data>
  <data key="d1">Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript
LTH &amp; HUMAN SERVICES-US,
HHS Public Access
Author manuscript
Nat Genet. Author manuscript; available in PMC 2022 January 05.
Published in final edited form as:
Nat Genet. 2021 August; 53(8): 1260–1269. doi:10.1038/s41588-021-00892-1.
Whole-exome imputation within UK Biobank powers rare coding
variant association and fine-mapping analyses
Alison R. Barton1,2,3,*, Maxwell A. Sherman1,2,4, Ronen E. Mukamel1,2, Po-Ru Loh1,2,*
1D</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_30_2021_Hypothesis_-8818541740068170277">
  <data key="d0">Hypothesis</data>
  <data key="d1">We reasoned that although exome sequencing of ~10% of the UKB cohort provided insufficient power to directly assess the effects of ultra-rare variants (which have &lt;10 carriers in N~50,000 sequenced participants), we could leverage the extensive haplotype sharing within the UKB cohort15,16 to accurately impute these variants into up to ~100 carriers in the full cohort, thereby powering association analysis.</data>
  <data key="d3">We reasoned that although exome sequencing of ~10% of the UKB cohort provided insufficient power to directly assess the effects of ultra-rare variants (which have &lt;10 carriers in N~50,000 sequenced participants), we could leverage the extensive haplotype sharing within the UKB cohort15,16 to accurately impute these variants into up to ~100 carriers in the full cohort, thereby powering association analysis.</data>
  <data key="d4">PDF_30_2021</data>
</node>
<node id="PDF_30_2021_Method_6290913108374888870">
  <data key="d0">Method</data>
  <data key="d1">We leveraged whole-exome sequencing of 49,960 UKB participants together with SNP-array genotyping in the full cohort to impute exome-wide variants into all UKB participants.</data>
  <data key="d3">We leveraged whole-exome sequencing of 49,960 UKB participants together with SNP-array genotyping in the full cohort to impute exome-wide variants into all UKB participants.</data>
  <data key="d4">PDF_30_2021</data>
</node>
<node id="PDF_30_2021_Method_1795151608853513841">
  <data key="d0">Method</data>
  <data key="d1">We tested the imputed variants for association with 54 heritable quantitative traits by running linear mixed model association analysis on N=459,259 participants of European ancestry using BOLT-LMM23,24, which we verified was robust to potential population stratification in rare variant association analysis</data>
  <data key="d3">We tested the imputed variants for association with 54 heritable quantitative traits by running linear mixed model association analysis on N=459,259 participants of European ancestry using BOLT-LMM23,24, which we verified was robust to potential population stratification in rare variant association analysis</data>
  <data key="d4">PDF_30_2021</data>
</node>
<node id="PDF_30_2021_Method_2261030653331385831">
  <data key="d0">Method</data>
  <data key="d1">we developed a stringent filtering pipeline that combined variant annotation filters (to increase the prior on causality) with statistical fine-mapping</data>
  <data key="d3">we developed a stringent filtering pipeline that combined variant annotation filters (to increase the prior on causality) with statistical fine-mapping</data>
  <data key="d4">PDF_30_2021</data>
</node>
<node id="PDF_30_2021_Method_2063425435594633472">
  <data key="d0">Method</data>
  <data key="d1">applied a second filtering pipeline based on iterative runs of the FINEMAP software</data>
  <data key="d3">applied a second filtering pipeline based on iterative runs of the FINEMAP software</data>
  <data key="d4">PDF_30_2021</data>
</node>
<node id="PDF_30_2021_Result_-6073832681468716012">
  <data key="d0">Result</data>
  <data key="d1">This procedure identified tens of thousands of associations between coding variants and traits that reached nominal genome-wide significance (P&lt;5 x 10¯8)</data>
  <data key="d3">This procedure identified tens of thousands of associations between coding variants and traits that reached nominal genome-wide significance (P&lt;5 x 10¯8)</data>
  <data key="d4">PDF_30_2021</data>
</node>
<node id="PDF_30_2021_Result_915134545367537338">
  <data key="d0">Result</data>
  <data key="d1">These analyses revealed very long allelic series of rare coding variants likely to alter phenotypes: for 56 gene-trait pairs, the allelic series contained 10 or more variants on distinct haplotypes, and eight distinct genes contained allelic series of 30 or more variants</data>
  <data key="d3">These analyses revealed very long allelic series of rare coding variants likely to alter phenotypes: for 56 gene-trait pairs, the allelic series contained 10 or more variants on distinct haplotypes, and eight distinct genes contained allelic series of 30 or more variants</data>
  <data key="d4">PDF_30_2021</data>
</node>
<node id="PDF_30_2021_Result_-8878043653176464976">
  <data key="d0">Result</data>
  <data key="d1">In the longest allelic series, 45 rare coding variants in ALPL independently associated with serum alkaline phosphatase levels, all with negative effect directions for the rare minor allele.</data>
  <data key="d3">In the longest allelic series, 45 rare coding variants in ALPL independently associated with serum alkaline phosphatase levels, all with negative effect directions for the rare minor allele.</data>
  <data key="d4">PDF_30_2021</data>
</node>
<node id="Gene_ALKALINE PHOSPHATASE">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ALKALINE PHOSPHATASE</data>
  <data key="d7">alkaline phosphatase</data>
</node>
<node id="PDF_30_2021_Result_7694964158821428791">
  <data key="d0">Result</data>
  <data key="d1">At IFRD2 (interferon-related developmental regulator 2, which has an unknown function), 24 rare coding variants independently associated with high light scatter reticulocyte count</data>
  <data key="d3">At IFRD2 (interferon-related developmental regulator 2, which has an unknown function), 24 rare coding variants independently associated with high light scatter reticulocyte count</data>
  <data key="d4">PDF_30_2021</data>
</node>
<node id="Gene_IFRD2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">IFRD2</data>
  <data key="d7">IFRD2</data>
</node>
<node id="PDF_30_2021_Result_-4011479752700675712">
  <data key="d0">Result</data>
  <data key="d1">At NPR2, which encodes a natriuretic peptide receptor involved in bone growth regulation35, 11 rare coding variants independently associated with height</data>
  <data key="d3">At NPR2, which encodes a natriuretic peptide receptor involved in bone growth regulation35, 11 rare coding variants independently associated with height</data>
  <data key="d4">PDF_30_2021</data>
</node>
<node id="Gene_NPR2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">NPR2</data>
  <data key="d7">NPR2</data>
</node>
<node id="PDF_30_2021_Result_7287794434995970486">
  <data key="d0">Result</data>
  <data key="d1">At PLA2G12A and PLINI, allelic series containing up to seven rare coding variants in PLA2G12A and eight in PLINI associated with serum lipid levels</data>
  <data key="d3">At PLA2G12A and PLINI, allelic series containing up to seven rare coding variants in PLA2G12A and eight in PLINI associated with serum lipid levels</data>
  <data key="d4">PDF_30_2021</data>
</node>
<node id="Gene_PLA2G12A">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">PLA2G12A</data>
  <data key="d7">PLA2G12A</data>
</node>
<node id="Gene_PLINI">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">PLINI</data>
  <data key="d7">PLINI</data>
</node>
<node id="PDF_30_2021_Result_-6309994986059093048">
  <data key="d0">Result</data>
  <data key="d1">the cell cycle regulators CHEK2 and JAK2 both contained likely-causal variants associated with white blood cell, red blood cell and platelet traits; a JAK2 missense variant also associated with IGF-1 measurements</data>
  <data key="d3">the cell cycle regulators CHEK2 and JAK2 both contained likely-causal variants associated with white blood cell, red blood cell and platelet traits; a JAK2 missense variant also associated with IGF-1 measurements</data>
  <data key="d4">PDF_30_2021</data>
</node>
<node id="Gene_CHEK2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CHEK2</data>
  <data key="d7">CHEK2</data>
</node>
<node id="Gene_JAK2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">JAK2</data>
  <data key="d7">JAK2</data>
</node>
<node id="Protein_IGF-1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">IGF-1</data>
  <data key="d7">IGF-1</data>
</node>
<node id="PDF_30_2021_Result_6731876750101381095">
  <data key="d0">Result</data>
  <data key="d1">three genes that regulate Rho GTPases (DENND2C, DOCK8, and KALRN) contained likely-causal variants associated with multiple platelet traits</data>
  <data key="d3">three genes that regulate Rho GTPases (DENND2C, DOCK8, and KALRN) contained likely-causal variants associated with multiple platelet traits</data>
  <data key="d4">PDF_30_2021</data>
</node>
<node id="Gene_DENND2C">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">DENND2C</data>
  <data key="d7">DENND2C</data>
</node>
<node id="Gene_DOCK8">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">DOCK8</data>
  <data key="d7">DOCK8</data>
</node>
<node id="Gene_KALRN">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">KALRN</data>
  <data key="d7">KALRN</data>
</node>
<node id="PDF_30_2021_Result_1686584626329549693">
  <data key="d0">Result</data>
  <data key="d1">APOC3 exhibited the widest variety of likely-causal associations, with the splice donor variant rs138326449 associating with 13 distinct traits including lipid levels, white blood cell and red blood cell traits, and kidney biomarkers.</data>
  <data key="d3">APOC3 exhibited the widest variety of likely-causal associations, with the splice donor variant rs138326449 associating with 13 distinct traits including lipid levels, white blood cell and red blood cell traits, and kidney biomarkers.</data>
  <data key="d4">PDF_30_2021</data>
</node>
<node id="Gene_APOC3">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">APOC3</data>
  <data key="d7">APOC3</data>
</node>
<node id="PDF_30_2021_Result_5072087701384916043">
  <data key="d0">Result</data>
  <data key="d1">In PDE3B, the stop gain variant rs150090666 associated likely-causally with 10 distinct traits, including expected associations with waist-hip-ratio and lipid measurements38, but also associations with red blood cell traits, SHBG levels, and height.</data>
  <data key="d3">In PDE3B, the stop gain variant rs150090666 associated likely-causally with 10 distinct traits, including expected associations with waist-hip-ratio and lipid measurements38, but also associations with red blood cell traits, SHBG levels, and height.</data>
  <data key="d4">PDF_30_2021</data>
</node>
<node id="Gene_PDE3B">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">PDE3B</data>
  <data key="d7">PDE3B</data>
</node>
<node id="PDF_30_2021_Result_8635076780095329992">
  <data key="d0">Result</data>
  <data key="d1">We also detected one very-large-effect variant for BMI in MC4R (+0.62 (0.12) s.d.; Supplementary Table 10); this variant had previously been associated with obesity in a Mendelian fashion41.</data>
  <data key="d3">We also detected one very-large-effect variant for BMI in MC4R (+0.62 (0.12) s.d.; Supplementary Table 10); this variant had previously been associated with obesity in a Mendelian fashion41.</data>
  <data key="d4">PDF_30_2021</data>
</node>
<node id="Gene_MC4R">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">MC4R</data>
  <data key="d7">MC4R</data>
</node>
<node id="Disease_OBESITY">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">OBESITY</data>
  <data key="d7">obesity</data>
</node>
<node id="PDF_30_2021_Conclusion_2061329940680074376">
  <data key="d0">Conclusion</data>
  <data key="d1">These results demonstrate the power of using a large, well-matched reference panel to impute very rare variants into biobank data.</data>
  <data key="d3">These results demonstrate the power of using a large, well-matched reference panel to impute very rare variants into biobank data.</data>
  <data key="d4">PDF_30_2021</data>
</node>
<node id="PDF_30_2021_Conclusion_2274660399732934383">
  <data key="d0">Conclusion</data>
  <data key="d1">Our results also have several implications for the analysis of exome association studies.</data>
  <data key="d3">Our results also have several implications for the analysis of exome association studies.</data>
  <data key="d4">PDF_30_2021</data>
</node>
<node id="PDF_30_2021_Conclusion_-8226118059089604154">
  <data key="d0">Conclusion</data>
  <data key="d1">linear mixed model association analysis is robust to population stratification for rare variants as well as for common variants</data>
  <data key="d3">linear mixed model association analysis is robust to population stratification for rare variants as well as for common variants</data>
  <data key="d4">PDF_30_2021</data>
</node>
<node id="PDF_21_2018">
  <data key="d0">Paper</data>
  <data key="d1">i An update to this article is included at the end
Article
Cell
The Neuronal Gene Arc Encodes a Repurposed
Retrotransposon Gag Protein that Mediates
Intercellular RNA Transfer
Graphical Abstract
Donor Neuron
mRNAs are released
in recipient neurons
mRNAs are
encapsulated by Arc
mRNAs travel
neuron-to-neuron in
ACBARS
Authors
Elissa D. Pastuzyn, Cameron E. Day,
....
Rachel B. Kearns, John A.G. Briggs,
Cédric Feschotte, Jason D. Shepherd
Correspondence
jason.shepherd@neuro.utah.edu
In Brief
The neu</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_21_2018_Hypothesis_-3563607693496270283">
  <data key="d0">Hypothesis</data>
  <data key="d1">Arc might bind and encapsulate RNA.</data>
  <data key="d3">Arc might bind and encapsulate RNA.</data>
  <data key="d4">PDF_21_2018</data>
</node>
<node id="Gene_ARC">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ARC</data>
  <data key="d7">Arc</data>
</node>
<node id="PDF_21_2018_Method_-8783716829984003002">
  <data key="d0">Method</data>
  <data key="d1">Expressed rat Arc in bacteria as a glutathione S-transferase (GST) fusion protein.</data>
  <data key="d3">Expressed rat Arc in bacteria as a glutathione S-transferase (GST) fusion protein.</data>
  <data key="d4">PDF_21_2018</data>
</node>
<node id="PDF_21_2018_Method_-4106576273646245627">
  <data key="d0">Method</data>
  <data key="d1">Performed phylogenomic analyses.</data>
  <data key="d3">Performed phylogenomic analyses.</data>
  <data key="d4">PDF_21_2018</data>
</node>
<node id="PDF_21_2018_Method_-6184085133573977298">
  <data key="d0">Method</data>
  <data key="d1">Used RT-PCR to show that Arc mRNA is also present in EVs purified from neurons.</data>
  <data key="d3">Used RT-PCR to show that Arc mRNA is also present in EVs purified from neurons.</data>
  <data key="d4">PDF_21_2018</data>
</node>
<node id="Compound_ARC">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">ARC</data>
  <data key="d7">Arc</data>
</node>
<node id="PDF_21_2018_Result_-6159745445870016260">
  <data key="d0">Result</data>
  <data key="d1">prArc spontaneously forms oligomeric structures that resemble virus-like capsids.</data>
  <data key="d3">prArc spontaneously forms oligomeric structures that resemble virus-like capsids.</data>
  <data key="d4">PDF_21_2018</data>
</node>
<node id="Protein_ARC">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">ARC</data>
  <data key="d7">Arc</data>
</node>
<node id="PDF_21_2018_Result_-4579426345443929590">
  <data key="d0">Result</data>
  <data key="d1">Arc is released from neurons in EVs and is able to transfer its own mRNA into neurons.</data>
  <data key="d3">Arc is released from neurons in EVs and is able to transfer its own mRNA into neurons.</data>
  <data key="d4">PDF_21_2018</data>
</node>
<node id="Process_NEURONS">
  <data key="d0">Entity</data>
  <data key="d5">Process</data>
  <data key="d6">NEURONS</data>
  <data key="d7">Neurons</data>
</node>
<node id="PDF_21_2018_Result_-2721047602620332017">
  <data key="d0">Result</data>
  <data key="d1">Stripping RNA resulted in significantly fewer fully formed capsids, suggesting that Arc capsids require RNA for normal assembly.</data>
  <data key="d3">Stripping RNA resulted in significantly fewer fully formed capsids, suggesting that Arc capsids require RNA for normal assembly.</data>
  <data key="d4">PDF_21_2018</data>
</node>
<node id="PDF_21_2018_Conclusion_2143140091600789523">
  <data key="d0">Conclusion</data>
  <data key="d1">Co-option of retroviral-like Gag elements may have provided an evolutionary pathway for novel mechanisms that mediate intercellular signaling and have been intricately involved in the evolution of synaptic plasticity and animal cognition.</data>
  <data key="d3">Co-option of retroviral-like Gag elements may have provided an evolutionary pathway for novel mechanisms that mediate intercellular signaling and have been intricately involved in the evolution of synaptic plasticity and animal cognition.</data>
  <data key="d4">PDF_21_2018</data>
</node>
<node id="PDF_38_2024">
  <data key="d0">Paper</data>
  <data key="d1">bioRxiv preprint doi: https://doi.org/10.1101/2024.03.11.584343; this version posted March 13, 2024. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY-NC-ND 4.0 International license.
1 Rejuvenation of aged oocyte through exposure to young follicular microenvironment
2
3
4
5
HaiYang Wang¹*, Zhongwei Huang2,3,4, Yaelim Lee¹, XinJie Song¹, X</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_38_2024_Hypothesis_4164567301117783779">
  <data key="d0">Hypothesis</data>
  <data key="d1">Follicular somatic cell aging compromises the quality and developmental competence of oocytes</data>
  <data key="d3">Follicular somatic cell aging compromises the quality and developmental competence of oocytes</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Method_7297217210385788847">
  <data key="d0">Method</data>
  <data key="d1">Transplantation of young oocytes into aged r-follicles (YA) or young r-follicles (YY) as a control</data>
  <data key="d3">Transplantation of young oocytes into aged r-follicles (YA) or young r-follicles (YY) as a control</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_-6553612527542556915">
  <data key="d0">Result</data>
  <data key="d1">Culturing in aged r-follicles significantly reduced the meiotic maturation of young oocytes</data>
  <data key="d3">Culturing in aged r-follicles significantly reduced the meiotic maturation of young oocytes</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_7475989343544700684">
  <data key="d0">Result</data>
  <data key="d1">YA RCFs-derived oocytes manifested elevated ROS and declined mitochondrial AΨm compared to those from Y or from YY RCFs</data>
  <data key="d3">YA RCFs-derived oocytes manifested elevated ROS and declined mitochondrial AΨm compared to those from Y or from YY RCFs</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_-4004399965614423551">
  <data key="d0">Result</data>
  <data key="d1">oocytes from YA RCFs exhibited reduced frequency of blastocyst formation compared to those from Y or YY RCFs, indicating an impaired developmental potential of those young oocytes exposed to an aged follicular environment</data>
  <data key="d3">oocytes from YA RCFs exhibited reduced frequency of blastocyst formation compared to those from Y or YY RCFs, indicating an impaired developmental potential of those young oocytes exposed to an aged follicular environment</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Hypothesis_-5316617838561894012">
  <data key="d0">Hypothesis</data>
  <data key="d1">Exposure to the young follicular environment could reduce defects of aged oocytes</data>
  <data key="d3">Exposure to the young follicular environment could reduce defects of aged oocytes</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Method_-1673455566313239752">
  <data key="d0">Method</data>
  <data key="d1">Transplanting aged oocytes into young r-follicles (AY) or aged r-follicles (AA) as a control</data>
  <data key="d3">Transplanting aged oocytes into young r-follicles (AY) or aged r-follicles (AA) as a control</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_6064804342065993759">
  <data key="d0">Result</data>
  <data key="d1">Culturing in young r-follicles significantly reduced the death rate and restored meiotic maturation of aged oocytes to a level similar to young oocytes YY RCFs</data>
  <data key="d3">Culturing in young r-follicles significantly reduced the death rate and restored meiotic maturation of aged oocytes to a level similar to young oocytes YY RCFs</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_-1397549757452382402">
  <data key="d0">Result</data>
  <data key="d1">The occurrence of aberrant spindle and chromosome misalignment were significantly reduced in oocytes from AY, compared to AA, RCFs</data>
  <data key="d3">The occurrence of aberrant spindle and chromosome misalignment were significantly reduced in oocytes from AY, compared to AA, RCFs</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_8000450620091172683">
  <data key="d0">Result</data>
  <data key="d1">AY RCFs significantly improved the rate of blastocyst formation of aged oocytes</data>
  <data key="d3">AY RCFs significantly improved the rate of blastocyst formation of aged oocytes</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_-9071224477929579481">
  <data key="d0">Result</data>
  <data key="d1">Oocytes from AY RCFs produced a significantly higher (~3.5x higher) rate of live birth than those from AA RCFs or aged intact follicles (A), although the live birth rate of the former was still lower (~1x) than those from YY RCFs</data>
  <data key="d3">Oocytes from AY RCFs produced a significantly higher (~3.5x higher) rate of live birth than those from AA RCFs or aged intact follicles (A), although the live birth rate of the former was still lower (~1x) than those from YY RCFs</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Conclusion_-2630366916512089137">
  <data key="d0">Conclusion</data>
  <data key="d1">The young follicular environment can partially restore the quality and developmental competence of aged oocytes</data>
  <data key="d3">The young follicular environment can partially restore the quality and developmental competence of aged oocytes</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_3177759640078138706">
  <data key="d0">Result</data>
  <data key="d1">AY RCFs formed a greater number of TZPs per unit length of the oocyte periphery than AA RCFs or aged intact follicles (A), although the TZP density was still lower than YY RCFs</data>
  <data key="d3">AY RCFs formed a greater number of TZPs per unit length of the oocyte periphery than AA RCFs or aged intact follicles (A), although the TZP density was still lower than YY RCFs</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_1470432972548654560">
  <data key="d0">Result</data>
  <data key="d1">the metabolic profile of oocytes from AY RCFs partially separated from that of oocytes from AA RCFs, suggesting metabolic remodelling of aged oocytes by the young r-follicles</data>
  <data key="d3">the metabolic profile of oocytes from AY RCFs partially separated from that of oocytes from AA RCFs, suggesting metabolic remodelling of aged oocytes by the young r-follicles</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_-3379324757801553436">
  <data key="d0">Result</data>
  <data key="d1">AY oocytes displayed similar levels to those in YY oocytes</data>
  <data key="d3">AY oocytes displayed similar levels to those in YY oocytes</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_9182419568005416721">
  <data key="d0">Result</data>
  <data key="d1">RNA sequencing identified a significant divergence, encompassing 1,774 differentially expressed genes (DEGs) between oocytes from YY and AA RCFs, with 1,116 genes upregulated and 658 downregulated</data>
  <data key="d3">RNA sequencing identified a significant divergence, encompassing 1,774 differentially expressed genes (DEGs) between oocytes from YY and AA RCFs, with 1,116 genes upregulated and 658 downregulated</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_-7548824776608565829">
  <data key="d0">Result</data>
  <data key="d1">Genes that were upregulated in aged oocytes from AA RCFs were associated with metabolic processes and mitochondrial functions</data>
  <data key="d3">Genes that were upregulated in aged oocytes from AA RCFs were associated with metabolic processes and mitochondrial functions</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_1752204976944477647">
  <data key="d0">Result</data>
  <data key="d1">Culturing aged oocytes in young RCFs reversed the age-associated expression changes of a large number of genes</data>
  <data key="d3">Culturing aged oocytes in young RCFs reversed the age-associated expression changes of a large number of genes</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_-4811669220701434189">
  <data key="d0">Result</data>
  <data key="d1">The AY RCFs potentially restored several affected pathways in aged oocytes, such as the estrogen signalling, Ras signalling, and nucleotide excision repair</data>
  <data key="d3">The AY RCFs potentially restored several affected pathways in aged oocytes, such as the estrogen signalling, Ras signalling, and nucleotide excision repair</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_-8472024034684665930">
  <data key="d0">Result</data>
  <data key="d1">lower ATP production was observed in aged oocytes from AA RCFs, ATP production was largely restored in oocytes from AY RCFs</data>
  <data key="d3">lower ATP production was observed in aged oocytes from AA RCFs, ATP production was largely restored in oocytes from AY RCFs</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_-7248658781969017657">
  <data key="d0">Result</data>
  <data key="d1">Mitochondria in oocytes from AY RCFS exhibited more uniform cytoplasmic distribution than in oocytes from AA RCFs</data>
  <data key="d3">Mitochondria in oocytes from AY RCFS exhibited more uniform cytoplasmic distribution than in oocytes from AA RCFs</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_-9190880975557393590">
  <data key="d0">Result</data>
  <data key="d1">culturing within young r-follicles largely restored mitochondrial membrane potential in aged oocytes</data>
  <data key="d3">culturing within young r-follicles largely restored mitochondrial membrane potential in aged oocytes</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_4733603008324162908">
  <data key="d0">Result</data>
  <data key="d1">Oocytes from AY RCFs exhibited lower mitochondrial and cellular ROS than aged oocytes from AA RCFs</data>
  <data key="d3">Oocytes from AY RCFs exhibited lower mitochondrial and cellular ROS than aged oocytes from AA RCFs</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_-1205846018493210175">
  <data key="d0">Result</data>
  <data key="d1">Oocytes from AY RCFs exhibited a reduced rate of chromosomal abnormalities compared to oocytes from AA RCFs</data>
  <data key="d3">Oocytes from AY RCFs exhibited a reduced rate of chromosomal abnormalities compared to oocytes from AA RCFs</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_-1858247962095125921">
  <data key="d0">Result</data>
  <data key="d1">The level of chromosomal Rec8 in oocytes from AY RCFs was significantly higher than that in AA RCFs</data>
  <data key="d3">The level of chromosomal Rec8 in oocytes from AY RCFs was significantly higher than that in AA RCFs</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_3552208912935154417">
  <data key="d0">Result</data>
  <data key="d1">oocytes from AY exhibited shorter distances between sister kinetochores than oocytes from AA RCFS</data>
  <data key="d3">oocytes from AY exhibited shorter distances between sister kinetochores than oocytes from AA RCFS</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_-7396469426040130416">
  <data key="d0">Result</data>
  <data key="d1">the incidence of lagging chromosomes during the anaphase of meiosis I was significantly lower in oocytes from AY RCFs than AA RCFs</data>
  <data key="d3">the incidence of lagging chromosomes during the anaphase of meiosis I was significantly lower in oocytes from AY RCFs than AA RCFs</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Result_-3238329267919947274">
  <data key="d0">Result</data>
  <data key="d1">The rate of incorrect KT-MT attachments was significantly decreased in the aged oocytes cultured with young r-follicles</data>
  <data key="d3">The rate of incorrect KT-MT attachments was significantly decreased in the aged oocytes cultured with young r-follicles</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_38_2024_Conclusion_-6789794902732702756">
  <data key="d0">Conclusion</data>
  <data key="d1">the young follicular microenvironment improved meiotic chromosome transmission in oocytes through better maintenance of chromosome cohesion and reduction in chromosome mis-segregation</data>
  <data key="d3">the young follicular microenvironment improved meiotic chromosome transmission in oocytes through better maintenance of chromosome cohesion and reduction in chromosome mis-segregation</data>
  <data key="d4">PDF_38_2024</data>
</node>
<node id="PDF_36_2014">
  <data key="d0">Paper</data>
  <data key="d1">INTRODUCTION
It is known that mammalian oocytes spontaneously resume meiosis once extracted from
their follicular environment and are placed in in vitro culture [1]. Despite 35 years of in vitro
fertilization research we still have a limited understanding of the involved processes. In all
mammalian species, in vitro maturation (IVM) of fully-grown oocytes from small follicles
translates into lower embryonic developmental rates compared to in vivo matured counterparts
[2,3]. Human oocytes matured</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_36_2014_Hypothesis_4972182180303622502">
  <data key="d0">Hypothesis</data>
  <data key="d1">We hypothesized that the cumulus cells transfer mRNAs benefitting oocyte maturation in an orchestrated fashion.</data>
  <data key="d3">We hypothesized that the cumulus cells transfer mRNAs benefitting oocyte maturation in an orchestrated fashion.</data>
  <data key="d4">PDF_36_2014</data>
</node>
<node id="PDF_36_2014_Method_-2295714312279089060">
  <data key="d0">Method</data>
  <data key="d1">Oocytes were exposed to [H]-uridine during the first three hours of maturation.</data>
  <data key="d3">Oocytes were exposed to [H]-uridine during the first three hours of maturation.</data>
  <data key="d4">PDF_36_2014</data>
</node>
<node id="PDF_36_2014_Method_-7972339232864600486">
  <data key="d0">Method</data>
  <data key="d1">Sequences were then aligned to the UMD3.1 assembly of the bovine genome using TopHat2 software.</data>
  <data key="d3">Sequences were then aligned to the UMD3.1 assembly of the bovine genome using TopHat2 software.</data>
  <data key="d4">PDF_36_2014</data>
</node>
<node id="PDF_36_2014_Result_-389420263346194733">
  <data key="d0">Result</data>
  <data key="d1">Nascent RNA was detected within the TZPs of treated cumulus oocyte complexes (COCs).</data>
  <data key="d3">Nascent RNA was detected within the TZPs of treated cumulus oocyte complexes (COCs).</data>
  <data key="d4">PDF_36_2014</data>
</node>
<node id="PDF_36_2014_Result_2699379388307985870">
  <data key="d0">Result</data>
  <data key="d1">Abundant silver deposition was observed in the transcriptionally active nucleus of the cumulus cells, and also within other regions of their cytoplasm including the TZP.</data>
  <data key="d3">Abundant silver deposition was observed in the transcriptionally active nucleus of the cumulus cells, and also within other regions of their cytoplasm including the TZP.</data>
  <data key="d4">PDF_36_2014</data>
</node>
<node id="PDF_36_2014_Result_8662810041692786578">
  <data key="d0">Result</data>
  <data key="d1">Evidence of active transfer of RNA from the cumulus cells to the oocyte was found by comparing signal distribution of labeled nascent RNA within a fully enclosed oocyte to the signal detected in a partially denuded oocyte.</data>
  <data key="d3">Evidence of active transfer of RNA from the cumulus cells to the oocyte was found by comparing signal distribution of labeled nascent RNA within a fully enclosed oocyte to the signal detected in a partially denuded oocyte.</data>
  <data key="d4">PDF_36_2014</data>
</node>
<node id="PDF_36_2014_Result_-7182093143440056343">
  <data key="d0">Result</data>
  <data key="d1">Comparing this list to those found associated with the polyribosomes, 1,226 transcripts intersected.</data>
  <data key="d3">Comparing this list to those found associated with the polyribosomes, 1,226 transcripts intersected.</data>
  <data key="d4">PDF_36_2014</data>
</node>
<node id="PDF_36_2014_Result_2878733584736117557">
  <data key="d0">Result</data>
  <data key="d1">Gene list analysis showed enrichment for biological processes such as transcript regulation, protein localization, protein transport, and RNA processing</data>
  <data key="d3">Gene list analysis showed enrichment for biological processes such as transcript regulation, protein localization, protein transport, and RNA processing</data>
  <data key="d4">PDF_36_2014</data>
</node>
<node id="PDF_36_2014_Result_-1531446935205058615">
  <data key="d0">Result</data>
  <data key="d1">Oocytes demonstrated an increasing number of RNA bearing TZPs over time, significantly increasing between 0 h, 2 h and 4 h post slaughter and appearing to plateau by 6 h</data>
  <data key="d3">Oocytes demonstrated an increasing number of RNA bearing TZPs over time, significantly increasing between 0 h, 2 h and 4 h post slaughter and appearing to plateau by 6 h</data>
  <data key="d4">PDF_36_2014</data>
</node>
<node id="PDF_36_2014_Conclusion_-3705689529277907024">
  <data key="d0">Conclusion</data>
  <data key="d1">The presented results highlight the additional contribution of the cumulus cells to the oocyte in the form of large cargo transfer. We focused on RNA transfer from the cumulus cells, and its importance for gamete maturation.</data>
  <data key="d3">The presented results highlight the additional contribution of the cumulus cells to the oocyte in the form of large cargo transfer. We focused on RNA transfer from the cumulus cells, and its importance for gamete maturation.</data>
  <data key="d4">PDF_36_2014</data>
</node>
<node id="PDF_52_2013">
  <data key="d0">Paper</data>
  <data key="d1">SHORT COMMUNICATION
Proteins
STRUCTURE FUNCTION BIOINFORMATICS
Optimized E. coli expression strain LOBSTR
eliminates common contaminants from
His-tag purification
Kasper R. Andersen, Nina C. Leksa, and Thomas U. Schwartz*
Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139
ABSTRACT
His-tag affinity purification is one of the most commonly used methods to purify recombinant proteins expressed in E. coli.
One drawback of using the H</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_52_2013_Hypothesis_-3618604179736161483">
  <data key="d0">Hypothesis</data>
  <data key="d1">We designed a new E. coli expression strain named LOBSTR (low-background-strain), which features genomic modifications in arnA and slyD based on surface engineering to address the problem of co-purification of histidine-rich host proteins ArnA and SlyD during His-tag affinity purification.</data>
  <data key="d3">We designed a new E. coli expression strain named LOBSTR (low-background-strain), which features genomic modifications in arnA and slyD based on surface engineering to address the problem of co-purification of histidine-rich host proteins ArnA and SlyD during His-tag affinity purification.</data>
  <data key="d4">PDF_52_2013</data>
</node>
<node id="Protein_ARNA">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">ARNA</data>
  <data key="d7">ArnA</data>
</node>
<node id="Protein_SLYD">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">SLYD</data>
  <data key="d7">SlyD</data>
</node>
<node id="PDF_52_2013_Method_5558943803450188274">
  <data key="d0">Method</data>
  <data key="d1">Genomic copies of arnA and slyD in the host strain BL21(DE3) were replaced with mutant versions to create LOBSTR using a modified recombineering approach.</data>
  <data key="d3">Genomic copies of arnA and slyD in the host strain BL21(DE3) were replaced with mutant versions to create LOBSTR using a modified recombineering approach.</data>
  <data key="d4">PDF_52_2013</data>
</node>
<node id="Gene_ARNA">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ARNA</data>
  <data key="d7">ArnA</data>
</node>
<node id="Gene_SLYD">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SLYD</data>
  <data key="d7">SlyD</data>
</node>
<node id="PDF_52_2013_Method_7459385719516688739">
  <data key="d0">Method</data>
  <data key="d1">Wild-type and mutant ArnA binding affinity was assessed by immobilizing purified protein onto a His-Trap FF column and eluting with a linear imidazole gradient.</data>
  <data key="d3">Wild-type and mutant ArnA binding affinity was assessed by immobilizing purified protein onto a His-Trap FF column and eluting with a linear imidazole gradient.</data>
  <data key="d4">PDF_52_2013</data>
</node>
<node id="Compound_IMIDAZOLE">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">IMIDAZOLE</data>
  <data key="d7">imidazole</data>
</node>
<node id="PDF_52_2013_Method_-5827387973616987370">
  <data key="d0">Method</data>
  <data key="d1">Growth analysis was performed at 18, 25, and 37°C for both LOBSTR and the BL21(DE3) strains.</data>
  <data key="d3">Growth analysis was performed at 18, 25, and 37°C for both LOBSTR and the BL21(DE3) strains.</data>
  <data key="d4">PDF_52_2013</data>
</node>
<node id="PDF_52_2013_Method_-878961672549594553">
  <data key="d0">Method</data>
  <data key="d1">Purifications were performed using Ni Sepharose 6 Fast Flow, Ni-NTA, and Talon resins.</data>
  <data key="d3">Purifications were performed using Ni Sepharose 6 Fast Flow, Ni-NTA, and Talon resins.</data>
  <data key="d4">PDF_52_2013</data>
</node>
<node id="PDF_52_2013_Result_4997911498934269511">
  <data key="d0">Result</data>
  <data key="d1">Mutating four histidine residues to serines in ArnA lowers the Ni-affinity to a level comparable to non-specific binding.</data>
  <data key="d3">Mutating four histidine residues to serines in ArnA lowers the Ni-affinity to a level comparable to non-specific binding.</data>
  <data key="d4">PDF_52_2013</data>
</node>
<node id="Compound_SERINE">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">SERINE</data>
  <data key="d7">serine</data>
</node>
<node id="Compound_HISTIDINE">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">HISTIDINE</data>
  <data key="d7">histidine</data>
</node>
<node id="PDF_52_2013_Result_7490315703337305613">
  <data key="d0">Result</data>
  <data key="d1">Truncating SlyD at residue 150 maintains the structural integrity of the catalytic N-terminal domain while removing the entire unstructured tail.</data>
  <data key="d3">Truncating SlyD at residue 150 maintains the structural integrity of the catalytic N-terminal domain while removing the entire unstructured tail.</data>
  <data key="d4">PDF_52_2013</data>
</node>
<node id="PDF_52_2013_Result_-3597215061576887774">
  <data key="d0">Result</data>
  <data key="d1">No significant difference in growth rate was observed between LOBSTR and BL21(DE3).</data>
  <data key="d3">No significant difference in growth rate was observed between LOBSTR and BL21(DE3).</data>
  <data key="d4">PDF_52_2013</data>
</node>
<node id="PDF_52_2013_Result_6878228180634941732">
  <data key="d0">Result</data>
  <data key="d1">In LOBSTR, the vast majority of contaminants ArnA and SlyD are eliminated, with the target protein now being the most prominent protein.</data>
  <data key="d3">In LOBSTR, the vast majority of contaminants ArnA and SlyD are eliminated, with the target protein now being the most prominent protein.</data>
  <data key="d4">PDF_52_2013</data>
</node>
<node id="PDF_52_2013_Conclusion_1635221794646452479">
  <data key="d0">Conclusion</data>
  <data key="d1">LOBSTR enables the pursuit of poorly expressed protein targets in E. coli by lowering the background contamination of ArnA and SlyD.</data>
  <data key="d3">LOBSTR enables the pursuit of poorly expressed protein targets in E. coli by lowering the background contamination of ArnA and SlyD.</data>
  <data key="d4">PDF_52_2013</data>
</node>
<node id="PDF_52_2013_Conclusion_8337539805626380235">
  <data key="d0">Conclusion</data>
  <data key="d1">LOBSTR incorporates genomic modifications to arnA and slyD in order to reduce the affinity of their gene products for metal affinity resins, eliminating them from co-purification with recombinant proteins of interest.</data>
  <data key="d3">LOBSTR incorporates genomic modifications to arnA and slyD in order to reduce the affinity of their gene products for metal affinity resins, eliminating them from co-purification with recombinant proteins of interest.</data>
  <data key="d4">PDF_52_2013</data>
</node>
<node id="PDF_07_2018_u">
  <data key="d0">Paper</data>
  <data key="d1">Accepted Manuscript
PNMA Family: Protein Interaction Network and Cell Signalling Pathways Implicated
in Cancer and Apoptosis
Siew Wai Panga, Chandrajit Lahiria, Chit Laa Pohb, Kuan Onn Tana*
Department of Biological Sciences, Research Centre for Biomedical Sciences, Sunway
University, Bandar Sunway, 47500 Selangor Darul Ehsan, Malaysia
*Corresponding author
Email address: jefft@sunway.edu.my
ABSTRACT
Paraneoplastic Ma Family (PNMA) comprises a growing number of family members
which share relativ</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_07_2018_u_Hypothesis_5873392826698736435">
  <data key="d0">Hypothesis</data>
  <data key="d1">PNMA family represents a novel set of proteins that are involved in regulation of cell growth, apoptosis, or cell fate determination in different cell types</data>
  <data key="d3">PNMA family represents a novel set of proteins that are involved in regulation of cell growth, apoptosis, or cell fate determination in different cell types</data>
  <data key="d4">PDF_07_2018_u</data>
</node>
<node id="Protein_PNMA FAMILY">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">PNMA FAMILY</data>
  <data key="d7">PNMA family</data>
</node>
<node id="PDF_07_2018_u_Method_-55218238772028976">
  <data key="d0">Method</data>
  <data key="d1">Molecular diagnostic methodologies are often used to diagnose PND, including detection of auto- antibodies against PNMA proteins as well as identification of aberrantly expressed PNMA 1, 2 or 3 in the tumor tissues</data>
  <data key="d3">Molecular diagnostic methodologies are often used to diagnose PND, including detection of auto- antibodies against PNMA proteins as well as identification of aberrantly expressed PNMA 1, 2 or 3 in the tumor tissues</data>
  <data key="d4">PDF_07_2018_u</data>
</node>
<node id="Protein_PNMA">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">PNMA</data>
  <data key="d7">PNMA</data>
</node>
<node id="Protein_PNMA1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">PNMA1</data>
  <data key="d7">PNMA1</data>
</node>
<node id="Protein_PNMA2">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">PNMA2</data>
  <data key="d7">PNMA2</data>
</node>
<node id="Protein_PNMA3">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">PNMA3</data>
  <data key="d7">PNMA3</data>
</node>
<node id="PDF_07_2018_u_Result_701153642943013160">
  <data key="d0">Result</data>
  <data key="d1">MOAP-1 was reported to mediate apoptotic signalling by interacting with Bax, a pro-apoptotic member of Bcl-2 family</data>
  <data key="d3">MOAP-1 was reported to mediate apoptotic signalling by interacting with Bax, a pro-apoptotic member of Bcl-2 family</data>
  <data key="d4">PDF_07_2018_u</data>
</node>
<node id="PDF_07_2018_u_Result_-4708202846778036675">
  <data key="d0">Result</data>
  <data key="d1">MOAP-1 was shown to interact with RASSF1A tumor suppressor through TNF receptor mediated signalling upon activation of the TNF receptor by TNF ligand</data>
  <data key="d3">MOAP-1 was shown to interact with RASSF1A tumor suppressor through TNF receptor mediated signalling upon activation of the TNF receptor by TNF ligand</data>
  <data key="d4">PDF_07_2018_u</data>
</node>
<node id="Protein_RASSF1A">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">RASSF1A</data>
  <data key="d7">RASSF1A</data>
</node>
<node id="Protein_TNF">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">TNF</data>
  <data key="d7">TNF</data>
</node>
<node id="PDF_07_2018_u_Result_-7433035212583584034">
  <data key="d0">Result</data>
  <data key="d1">PNMA7A was reported to function as transcriptional co-activator and participate in Bone Morphogenic Protein (BMP) signalling by interacting with Smad1 and CBP</data>
  <data key="d3">PNMA7A was reported to function as transcriptional co-activator and participate in Bone Morphogenic Protein (BMP) signalling by interacting with Smad1 and CBP</data>
  <data key="d4">PDF_07_2018_u</data>
</node>
<node id="Protein_PNMA7A">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">PNMA7A</data>
  <data key="d7">PNMA7A</data>
</node>
<node id="Protein_SMAD1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">SMAD1</data>
  <data key="d7">SMAD1</data>
</node>
<node id="Protein_BMP">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">BMP</data>
  <data key="d7">BMP</data>
</node>
<node id="PDF_07_2018_u_Result_-2954653150365098046">
  <data key="d0">Result</data>
  <data key="d1">Mutations of CCDC8 gene were associated with post-natal growth restriction, one of the well described features of 3M-syndrome</data>
  <data key="d3">Mutations of CCDC8 gene were associated with post-natal growth restriction, one of the well described features of 3M-syndrome</data>
  <data key="d4">PDF_07_2018_u</data>
</node>
<node id="Gene_CCDC8">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CCDC8</data>
  <data key="d7">CCDC8</data>
</node>
<node id="PDF_07_2018_u_Result_6132546014739191182">
  <data key="d0">Result</data>
  <data key="d1">MOAP-1 interacts with poly-glutamic acid residues of RASSF1A</data>
  <data key="d3">MOAP-1 interacts with poly-glutamic acid residues of RASSF1A</data>
  <data key="d4">PDF_07_2018_u</data>
</node>
<node id="PDF_07_2018_u_Result_8851558357898745440">
  <data key="d0">Result</data>
  <data key="d1">Interaction with PNMA2 leads to inhibition of pro-apoptotic function of MOAP-1. In contrast, interaction with PNMA5 enhances pro-apoptotic function of MOAP-1</data>
  <data key="d3">Interaction with PNMA2 leads to inhibition of pro-apoptotic function of MOAP-1. In contrast, interaction with PNMA5 enhances pro-apoptotic function of MOAP-1</data>
  <data key="d4">PDF_07_2018_u</data>
</node>
<node id="Protein_PNMA5">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">PNMA5</data>
  <data key="d7">PNMA5</data>
</node>
<node id="PDF_07_2018_u_Result_1240758421043641278">
  <data key="d0">Result</data>
  <data key="d1">Activation of MOAP-1 requires death stimuli, RASSF1A or RASSF6, in the presence of K-RAS to promote or enhance apoptotic signalling through change of MOAP-1 conformation, leading to exposure of MOAP-1 BH3-like domain, which interacts with the pro-apoptotic Bax, resulting in activation of apoptotic cell death</data>
  <data key="d3">Activation of MOAP-1 requires death stimuli, RASSF1A or RASSF6, in the presence of K-RAS to promote or enhance apoptotic signalling through change of MOAP-1 conformation, leading to exposure of MOAP-1 BH3-like domain, which interacts with the pro-apoptotic Bax, resulting in activation of apoptotic cell death</data>
  <data key="d4">PDF_07_2018_u</data>
</node>
<node id="Protein_RASSF6">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">RASSF6</data>
  <data key="d7">RASSF6</data>
</node>
<node id="Protein_KRAS">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">KRAS</data>
  <data key="d7">KRAS</data>
</node>
<node id="PDF_07_2018_u_Result_-2916064496208044032">
  <data key="d0">Result</data>
  <data key="d1">PNMA2 antagonized the pro-apoptotic function of both MOAP-1 and PNMA1</data>
  <data key="d3">PNMA2 antagonized the pro-apoptotic function of both MOAP-1 and PNMA1</data>
  <data key="d4">PDF_07_2018_u</data>
</node>
<node id="PDF_07_2018_u_Result_3607880444052199621">
  <data key="d0">Result</data>
  <data key="d1">Trim39 ubiquitin ligase interacts with MOAP-1 and promotes stability of MOAP-1 by inhibiting the activity of APC/CCdh1-mediated ubiquitination and degradation</data>
  <data key="d3">Trim39 ubiquitin ligase interacts with MOAP-1 and promotes stability of MOAP-1 by inhibiting the activity of APC/CCdh1-mediated ubiquitination and degradation</data>
  <data key="d4">PDF_07_2018_u</data>
</node>
<node id="PDF_07_2018_u_Conclusion_-7261463142285962439">
  <data key="d0">Conclusion</data>
  <data key="d1">PNMA2, an onconeuronal antigen, was reported to be aberrantly expressed in a number of tumors, and its over-expression is likely to be closely associated with tumorigenesis</data>
  <data key="d3">PNMA2, an onconeuronal antigen, was reported to be aberrantly expressed in a number of tumors, and its over-expression is likely to be closely associated with tumorigenesis</data>
  <data key="d4">PDF_07_2018_u</data>
</node>
<node id="Disease_TUMOR">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">TUMOR</data>
  <data key="d7">tumor</data>
</node>
<node id="PDF_07_2018_u_Conclusion_-7051281338107796056">
  <data key="d0">Conclusion</data>
  <data key="d1">ZCCHC12 was found over-expressed in papillary thyroid tumours and ZCCHC12 knocked downed thyroid cancer cell lines exhibited reduced number of colonies formed in the colony formation assay, providing further evidence to support that ZCCHC12 functioned as an oncogene in papillary thyroid cancer</data>
  <data key="d3">ZCCHC12 was found over-expressed in papillary thyroid tumours and ZCCHC12 knocked downed thyroid cancer cell lines exhibited reduced number of colonies formed in the colony formation assay, providing further evidence to support that ZCCHC12 functioned as an oncogene in papillary thyroid cancer</data>
  <data key="d4">PDF_07_2018_u</data>
</node>
<node id="Protein_ZCCHC12">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">ZCCHC12</data>
  <data key="d7">ZCCHC12</data>
</node>
<node id="Disease_THYROID CANCER">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">THYROID CANCER</data>
  <data key="d7">thyroid cancer</data>
</node>
<node id="PDF_48_2024">
  <data key="d0">Paper</data>
  <data key="d1">PNAS
RESEARCH ARTICLE
BIOCHEMISTRY
OPEN ACCESS
Check for
updates
Human paraneoplastic antigen Ma2 (PNMA2) forms icosahedral
capsids that can be engineered for mRNA delivery
Victoria Madigan a,b,c,d,e,1, Yugang Zhanga,b,c,d,e,1, Rumya Raghavana,b,c,d,e, 1, Max E. Wilkinsona,b,c,d,e, Guilhem Faurea,b,c,d,e, Elena Puccioa,b,c,d,e,
Michael Segela,b,c,d,e, Blake Lasha,b,c,d,e, Rhiannon K. Macraea,b,c,d,e, and Feng Zhanga,b,c,d,e,2 D
Edited by Christine Seidman, Harvard Medical School, Boston, MA; rec</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_48_2024_Hypothesis_-8097966962975211921">
  <data key="d0">Hypothesis</data>
  <data key="d1">orchestrating PNMA2 disassembly and reassembly around RNA might facilitate RNA packaging</data>
  <data key="d3">orchestrating PNMA2 disassembly and reassembly around RNA might facilitate RNA packaging</data>
  <data key="d4">PDF_48_2024</data>
</node>
<node id="PDF_48_2024_Method_-4408217750595003763">
  <data key="d0">Method</data>
  <data key="d1">We used cryoelectron microscopy (cryo-EM) to resolve the structure of recombinant human PNMA2 expressed in E. coli at 3.1 Å resolution</data>
  <data key="d3">We used cryoelectron microscopy (cryo-EM) to resolve the structure of recombinant human PNMA2 expressed in E. coli at 3.1 Å resolution</data>
  <data key="d4">PDF_48_2024</data>
</node>
<node id="PDF_48_2024_Method_487949912162685570">
  <data key="d0">Method</data>
  <data key="d1">structure-guided engineering to modify the PNMA2 protein capsid to package mRNA</data>
  <data key="d3">structure-guided engineering to modify the PNMA2 protein capsid to package mRNA</data>
  <data key="d4">PDF_48_2024</data>
</node>
<node id="PDF_48_2024_Method_5001480191516639294">
  <data key="d0">Method</data>
  <data key="d1">replacing the C-terminal disordered region with an RNA-binding motif, cowpea chlorotic mottle virus N-terminal 30 residues (CCMV1-30)</data>
  <data key="d3">replacing the C-terminal disordered region with an RNA-binding motif, cowpea chlorotic mottle virus N-terminal 30 residues (CCMV1-30)</data>
  <data key="d4">PDF_48_2024</data>
</node>
<node id="PDF_48_2024_Result_3930217898354713551">
  <data key="d0">Result</data>
  <data key="d1">PNMA2 forms icosahedral capsids efficiently but does not naturally encapsidate nucleic acids</data>
  <data key="d3">PNMA2 forms icosahedral capsids efficiently but does not naturally encapsidate nucleic acids</data>
  <data key="d4">PDF_48_2024</data>
</node>
<node id="PDF_48_2024_Result_-4142428845467348943">
  <data key="d0">Result</data>
  <data key="d1">PNMA2 is robustly secreted as an icosahedral capsid from human cells and can self-assemble in vitro from recombinant protein.</data>
  <data key="d3">PNMA2 is robustly secreted as an icosahedral capsid from human cells and can self-assemble in vitro from recombinant protein.</data>
  <data key="d4">PDF_48_2024</data>
</node>
<node id="PDF_48_2024_Result_4035520068157967964">
  <data key="d0">Result</data>
  <data key="d1">self-assembled PNMA2 did not protect Cre mRNA from nuclease degradation</data>
  <data key="d3">self-assembled PNMA2 did not protect Cre mRNA from nuclease degradation</data>
  <data key="d4">PDF_48_2024</data>
</node>
<node id="Compound_CRE MRNA">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">CRE MRNA</data>
  <data key="d7">Cre mRNA</data>
</node>
<node id="PDF_48_2024_Result_4470377117851099983">
  <data key="d0">Result</data>
  <data key="d1">The interior of the capsid is rich in acidic residues, including the last resolvable residues, which form a poly-Glu tract (333-EEEEEEAS-340).</data>
  <data key="d3">The interior of the capsid is rich in acidic residues, including the last resolvable residues, which form a poly-Glu tract (333-EEEEEEAS-340).</data>
  <data key="d4">PDF_48_2024</data>
</node>
<node id="PDF_48_2024_Result_5994432042651290295">
  <data key="d0">Result</data>
  <data key="d1">ePNMA2 exhibited more efficient recombinant protein expression and capsid assembly</data>
  <data key="d3">ePNMA2 exhibited more efficient recombinant protein expression and capsid assembly</data>
  <data key="d4">PDF_48_2024</data>
</node>
<node id="PDF_48_2024_Result_-8892711395869718090">
  <data key="d0">Result</data>
  <data key="d1">LAH4 treatment of ePNMA2 before addition to cells increased the cytosolic localization of ePNMA2</data>
  <data key="d3">LAH4 treatment of ePNMA2 before addition to cells increased the cytosolic localization of ePNMA2</data>
  <data key="d4">PDF_48_2024</data>
</node>
<node id="PDF_48_2024_Conclusion_-3066554939127887280">
  <data key="d0">Conclusion</data>
  <data key="d1">engineered PNMA2 capsids can functionally deliver mRNA into recipient cells, demonstrating promise as a therapeutic mRNA delivery vehicle</data>
  <data key="d3">engineered PNMA2 capsids can functionally deliver mRNA into recipient cells, demonstrating promise as a therapeutic mRNA delivery vehicle</data>
  <data key="d4">PDF_48_2024</data>
</node>
<node id="PDF_48_2024_Conclusion_2419552112454791478">
  <data key="d0">Conclusion</data>
  <data key="d1">our work with PNMA2 may be extended to other PNMA family members, some of which also form capsids</data>
  <data key="d3">our work with PNMA2 may be extended to other PNMA family members, some of which also form capsids</data>
  <data key="d4">PDF_48_2024</data>
</node>
<node id="PDF_32_2020">
  <data key="d0">Paper</data>
  <data key="d1">nature
COMMUNICATIONS
ARTICLE
Check for updates
https://doi.org/10.1038/s41467-020-14451-5
OPEN
Genomic analysis of male puberty timing highlights
shared genetic basis with hair colour and lifespan
Ben Hollis 1,107, Felix R. Day 1,107, Alexander S. Busch 1,2,3, Deborah J. Thompson 4,
Ana Luiza G. Soares 5,6, Paul R.H.J. Timmers 6,7, Alex Kwong 5,8,9,10, Doug F. Easton 4,
Peter K. Joshi 6,7, Nicholas J. Timpson 5, The PRACTICAL Consortium*, 23andMe Research Team*,
Ken K. Ong
1,11,107✉ &amp; John R.B.</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_32_2020_Result_-5138253738568548245">
  <data key="d0">Result</data>
  <data key="d1">We find moderately strong genomic correlation in puberty timing between sexes (rg = 0.68) and identify 76 independent signals for male puberty timing.</data>
  <data key="d3">We find moderately strong genomic correlation in puberty timing between sexes (rg = 0.68) and identify 76 independent signals for male puberty timing.</data>
  <data key="d4">PDF_32_2020</data>
</node>
<node id="PDF_32_2020_Result_-3995889984062233605">
  <data key="d0">Result</data>
  <data key="d1">Earlier male puberty timing is genetically correlated with several adverse health outcomes and Mendelian randomization analyses show a genetic association between male puberty timing and shorter lifespan.</data>
  <data key="d3">Earlier male puberty timing is genetically correlated with several adverse health outcomes and Mendelian randomization analyses show a genetic association between male puberty timing and shorter lifespan.</data>
  <data key="d4">PDF_32_2020</data>
</node>
<node id="PDF_32_2020_Method_6719759838008404595">
  <data key="d0">Method</data>
  <data key="d1">We report a multi-trait genome-wide association study for male puberty timing with an effective sample size of 205,354 men.</data>
  <data key="d3">We report a multi-trait genome-wide association study for male puberty timing with an effective sample size of 205,354 men.</data>
  <data key="d4">PDF_32_2020</data>
</node>
<node id="PDF_32_2020_Result_601226181796264073">
  <data key="d0">Result</data>
  <data key="d1">The most significantly associated variant (rs11156429,GWAS-P = 3.5 × 10-52) was located in/near LIN28B</data>
  <data key="d3">The most significantly associated variant (rs11156429,GWAS-P = 3.5 × 10-52) was located in/near LIN28B</data>
  <data key="d4">PDF_32_2020</data>
</node>
<node id="Gene_LIN28B">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">LIN28B</data>
  <data key="d7">LIN28B</data>
</node>
<node id="PDF_32_2020_Result_-5033775488700588586">
  <data key="d0">Result</data>
  <data key="d1">In this combined MTAG dataset, we identified 7,897 variants associated with male puberty timing at the genome-wide statistical significance threshold (GWAS-P &lt; 5 × 10−8), comprising 76 independent signals</data>
  <data key="d3">In this combined MTAG dataset, we identified 7,897 variants associated with male puberty timing at the genome-wide statistical significance threshold (GWAS-P &lt; 5 × 10−8), comprising 76 independent signals</data>
  <data key="d4">PDF_32_2020</data>
</node>
<node id="PDF_32_2020_Result_-3744215661890310000">
  <data key="d0">Result</data>
  <data key="d1">Of these 76 signals, 29 were not in linkage disequilibrium (LD, conservatively defined as r² &gt; 0.05) with a previously reported signal for puberty timing (either AAM in women or voice breaking in men)</data>
  <data key="d3">Of these 76 signals, 29 were not in linkage disequilibrium (LD, conservatively defined as r² &gt; 0.05) with a previously reported signal for puberty timing (either AAM in women or voice breaking in men)</data>
  <data key="d4">PDF_32_2020</data>
</node>
<node id="PDF_32_2020_Result_-4672051410336722934">
  <data key="d0">Result</data>
  <data key="d1">a polygenic risk score for later puberty timing based on 73 of the male puberty timing signals was associated with older ages at voice breaking, peak height velocity and appearance of armpit hair</data>
  <data key="d3">a polygenic risk score for later puberty timing based on 73 of the male puberty timing signals was associated with older ages at voice breaking, peak height velocity and appearance of armpit hair</data>
  <data key="d4">PDF_32_2020</data>
</node>
<node id="PDF_32_2020_Result_4351999353499056023">
  <data key="d0">Result</data>
  <data key="d1">Men with red, dark brown and black natural hair colours showed progressively higher odds of early puberty timing, relative to men with blond hair.</data>
  <data key="d3">Men with red, dark brown and black natural hair colours showed progressively higher odds of early puberty timing, relative to men with blond hair.</data>
  <data key="d4">PDF_32_2020</data>
</node>
<node id="PDF_32_2020_Result_7342408560306002389">
  <data key="d0">Result</data>
  <data key="d1">susceptibility to darker natural hair colour also confers earlier puberty timing in men</data>
  <data key="d3">susceptibility to darker natural hair colour also confers earlier puberty timing in men</data>
  <data key="d4">PDF_32_2020</data>
</node>
<node id="PDF_32_2020_Result_4915610234547273028">
  <data key="d0">Result</data>
  <data key="d1">Two of the 76 lead variants associated with male pubertal timing were non-synonymous: a previously reported AAM signal in KDM4C (rs913588), encoding a lysine-specific demethylase, and a male-specific signal in ALX4 (rs3824915), encoding a homeobox gene involved in fibroblast growth factor (FGF) signalling that is mutated in rare disorders of cranium/central neural system (CNS) development with male-specific hypogonadism</data>
  <data key="d3">Two of the 76 lead variants associated with male pubertal timing were non-synonymous: a previously reported AAM signal in KDM4C (rs913588), encoding a lysine-specific demethylase, and a male-specific signal in ALX4 (rs3824915), encoding a homeobox gene involved in fibroblast growth factor (FGF) signalling that is mutated in rare disorders of cranium/central neural system (CNS) development with male-specific hypogonadism</data>
  <data key="d4">PDF_32_2020</data>
</node>
<node id="Gene_KDM4C">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">KDM4C</data>
  <data key="d7">KDM4C</data>
</node>
<node id="Gene_ALX4">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ALX4</data>
  <data key="d7">ALX4</data>
</node>
<node id="Protein_FIBROBLAST GROWTH FACTOR">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">FIBROBLAST GROWTH FACTOR</data>
  <data key="d7">fibroblast growth factor</data>
</node>
<node id="Disease_HYPOGONADISM">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">HYPOGONADISM</data>
  <data key="d7">hypogonadism</data>
</node>
<node id="PDF_32_2020_Result_1439348016575724462">
  <data key="d0">Result</data>
  <data key="d1">Consistent with genetic analyses of AAM in females, tissues in the CNS were the most strongly enriched for genes co-located near to male puberty timing associated variants</data>
  <data key="d3">Consistent with genetic analyses of AAM in females, tissues in the CNS were the most strongly enriched for genes co-located near to male puberty timing associated variants</data>
  <data key="d4">PDF_32_2020</data>
</node>
<node id="PDF_32_2020_Result_-4765660050882933824">
  <data key="d0">Result</data>
  <data key="d1">Four pathways showed evidence of enrichment: histone methyltransferase complex (FDR = 0.01); regulation of transcription (FDR = 0.02)); ATP binding (FDR = 0.03); and cAMP biosynthetic process (FDR = 0.03)</data>
  <data key="d3">Four pathways showed evidence of enrichment: histone methyltransferase complex (FDR = 0.01); regulation of transcription (FDR = 0.02)); ATP binding (FDR = 0.03); and cAMP biosynthetic process (FDR = 0.03)</data>
  <data key="d4">PDF_32_2020</data>
</node>
<node id="PDF_32_2020_Result_-5527902416486625596">
  <data key="d0">Result</data>
  <data key="d1">Genetic heterogeneity between sexes. Consistent with our pre-vious study, we observed a moderately strong genome-wide genetic correlation in pubertal timing between males and females (rg = 0.68, P = 2.6 × 10–213; based on continuous data on voice breaking and AAM in 23andMe), with similar effect estimates in both sexes for many individual variants</data>
  <data key="d3">Genetic heterogeneity between sexes. Consistent with our pre-vious study, we observed a moderately strong genome-wide genetic correlation in pubertal timing between males and females (rg = 0.68, P = 2.6 × 10–213; based on continuous data on voice breaking and AAM in 23andMe), with similar effect estimates in both sexes for many individual variants</data>
  <data key="d4">PDF_32_2020</data>
</node>
<node id="PDF_43_2015">
  <data key="d0">Paper</data>
  <data key="d1">Article
Cell
Regulated Formation of an Amyloid-like
Translational Repressor Governs Gametogenesis
Graphical Abstract
Starvation
Meiosis
nucleus
Meiosis II
Authors
Rim4 amyloid-like aggregates
repress translation of bound mRNA
5'UTR
RRM
RRM
RRM
RRM
AAAAAA
AAAAAA
AAAAAA
AAAAAA
Aggreates are cleared at MI-MII transition
activating mRNA translation
5'UTR
AAAAAA
AAAAAA
AAAAAA
Luke E. Berchowitz, Greg Kabachinski,
Margaret R. Walker, Wendy V. Gilbert,
....
Thomas U. Schwartz, Angelika Amon
Corresponde</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_43_2015_Result_-8665501615026760998">
  <data key="d0">Result</data>
  <data key="d1">Rim4 forms amyloid-like aggregates and that it is the amyloid-like form of Rim4 that is the active, translationally repressive form of the protein.</data>
  <data key="d3">Rim4 forms amyloid-like aggregates and that it is the amyloid-like form of Rim4 that is the active, translationally repressive form of the protein.</data>
  <data key="d4">PDF_43_2015</data>
</node>
<node id="PDF_43_2015_Result_167825607920829172">
  <data key="d0">Result</data>
  <data key="d1">Rim4 aggregation is a developmentally regulated process.</data>
  <data key="d3">Rim4 aggregation is a developmentally regulated process.</data>
  <data key="d4">PDF_43_2015</data>
</node>
<node id="PDF_43_2015_Result_2705350459434224624">
  <data key="d0">Result</data>
  <data key="d1">Starvation induces the conversion of monomeric Rim4 into amyloid-like aggregates, thereby activating the protein to bring about repression of translation.</data>
  <data key="d3">Starvation induces the conversion of monomeric Rim4 into amyloid-like aggregates, thereby activating the protein to bring about repression of translation.</data>
  <data key="d4">PDF_43_2015</data>
</node>
<node id="PDF_43_2015_Result_-3029878178375161098">
  <data key="d0">Result</data>
  <data key="d1">At the onset of meiosis II, Rim4 aggregates are abruptly degraded allowing translation to commence.</data>
  <data key="d3">At the onset of meiosis II, Rim4 aggregates are abruptly degraded allowing translation to commence.</data>
  <data key="d4">PDF_43_2015</data>
</node>
<node id="PDF_43_2015_Result_1380003361575204495">
  <data key="d0">Result</data>
  <data key="d1">Rim4, like prions and other proteins with amyloid-like properties, binds to b-isox and does so during the stages of meiosis when the protein actively inhibits CLB3 translation.</data>
  <data key="d3">Rim4, like prions and other proteins with amyloid-like properties, binds to b-isox and does so during the stages of meiosis when the protein actively inhibits CLB3 translation.</data>
  <data key="d4">PDF_43_2015</data>
</node>
<node id="Gene_CLB3">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CLB3</data>
  <data key="d7">CLB3</data>
</node>
<node id="PDF_43_2015_Result_-3818900363804058031">
  <data key="d0">Result</data>
  <data key="d1">Rim4 forms fibrillar helical structures with a fixed width of ~15 nm and length up to 15 µm</data>
  <data key="d3">Rim4 forms fibrillar helical structures with a fixed width of ~15 nm and length up to 15 µm</data>
  <data key="d4">PDF_43_2015</data>
</node>
<node id="PDF_43_2015_Result_-1883080806691592796">
  <data key="d0">Result</data>
  <data key="d1">The ability to form fibers depended on the protein's C-terminal LC sequences.</data>
  <data key="d3">The ability to form fibers depended on the protein's C-terminal LC sequences.</data>
  <data key="d4">PDF_43_2015</data>
</node>
<node id="PDF_43_2015_Result_-7775875949945022870">
  <data key="d0">Result</data>
  <data key="d1">Rim4 fibers are composed of β sheets, a hallmark of amyloid.</data>
  <data key="d3">Rim4 fibers are composed of β sheets, a hallmark of amyloid.</data>
  <data key="d4">PDF_43_2015</data>
</node>
<node id="PDF_43_2015_Result_-8881202664970378798">
  <data key="d0">Result</data>
  <data key="d1">Rim4 structures within the cell are largely static.</data>
  <data key="d3">Rim4 structures within the cell are largely static.</data>
  <data key="d4">PDF_43_2015</data>
</node>
<node id="PDF_43_2015_Result_-6987735620508999491">
  <data key="d0">Result</data>
  <data key="d1">The localization pattern of Rim4 is also consistent with the protein forming aggregates in cells during stages of meiosis when the protein inhibits translation.</data>
  <data key="d3">The localization pattern of Rim4 is also consistent with the protein forming aggregates in cells during stages of meiosis when the protein inhibits translation.</data>
  <data key="d4">PDF_43_2015</data>
</node>
<node id="PDF_43_2015_Result_7681704928127343375">
  <data key="d0">Result</data>
  <data key="d1">C-terminal 204 amino acids are important for Rim4 aggregation in vivo and contain elements necessary for proper Rim4 clearance at the onset of meiosis II.</data>
  <data key="d3">C-terminal 204 amino acids are important for Rim4 aggregation in vivo and contain elements necessary for proper Rim4 clearance at the onset of meiosis II.</data>
  <data key="d4">PDF_43_2015</data>
</node>
<node id="PDF_43_2015_Conclusion_-8844063316195757453">
  <data key="d0">Conclusion</data>
  <data key="d1">Regulated formation of amyloid-like aggregates establishes and upholds gametogenesis.</data>
  <data key="d3">Regulated formation of amyloid-like aggregates establishes and upholds gametogenesis.</data>
  <data key="d4">PDF_43_2015</data>
</node>
<node id="PDF_14_2024">
  <data key="d0">Paper</data>
  <data key="d1">nature aging
Resource
a
https://doi.org/10.1038/s43587-024-00762-5
Molecular and genetic insights into
human ovarian aging from single-nuclei
multi-omics analyses
Received: 9 April 2024
Accepted: 25 October 2024
Published online: 22 November 2024
Chen Jin 1,13 Xizhe Wang1,13, Jiping Yang1,13, Seungsoo Kim¹,
Adam D. Hudgins¹, Amir Gamliel², Mingzhuo Pei¹, Daniela Contreras¹,
Melody Devos¹, Qinghua Guo¹, Jan Vijg³, Marco Conti 4,5,6,
Jan Hoeijmakers 7,8,9, Judith Campisi 10,11, Rogerio Lobo¹, Zev </data>
  <data key="d2">2024</data>
</node>
<node id="PDF_14_2024_Result_-3109408136348264968">
  <data key="d0">Result</data>
  <data key="d1">Our analyses reveal coordinated changes in transcriptomes and chromatin accessibilities across cell types in the ovary during aging, notably mTOR signaling being a prominent ovary-specific aging pathway.</data>
  <data key="d3">Our analyses reveal coordinated changes in transcriptomes and chromatin accessibilities across cell types in the ovary during aging, notably mTOR signaling being a prominent ovary-specific aging pathway.</data>
  <data key="d4">PDF_14_2024</data>
</node>
<node id="Protein_MTOR">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">MTOR</data>
  <data key="d7">mTOR</data>
</node>
<node id="PDF_14_2024_Result_-6305622922967172267">
  <data key="d0">Result</data>
  <data key="d1">Cell-type-specific regulatory networks reveal enhanced activity of the transcription factor CEBPD across cell types in the aged ovary.</data>
  <data key="d3">Cell-type-specific regulatory networks reveal enhanced activity of the transcription factor CEBPD across cell types in the aged ovary.</data>
  <data key="d4">PDF_14_2024</data>
</node>
<node id="Gene_CEBPD">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CEBPD</data>
  <data key="d7">CEBPD</data>
</node>
<node id="PDF_14_2024_Result_8951654089548728117">
  <data key="d0">Result</data>
  <data key="d1">The abundance of granulosa and theca cells, critical components of ovarian follicles, was significantly decreased in aged compared to young ovaries.</data>
  <data key="d3">The abundance of granulosa and theca cells, critical components of ovarian follicles, was significantly decreased in aged compared to young ovaries.</data>
  <data key="d4">PDF_14_2024</data>
</node>
<node id="PDF_14_2024_Result_-3788353734610438696">
  <data key="d0">Result</data>
  <data key="d1">Blood vessel and lymphatic endothelial cells also markedly decreased in proportion in aged ovaries</data>
  <data key="d3">Blood vessel and lymphatic endothelial cells also markedly decreased in proportion in aged ovaries</data>
  <data key="d4">PDF_14_2024</data>
</node>
<node id="PDF_14_2024_Result_3270171566214665174">
  <data key="d0">Result</data>
  <data key="d1">epithelial cells were the only cell type that increased in proportion in aged ovaries</data>
  <data key="d3">epithelial cells were the only cell type that increased in proportion in aged ovaries</data>
  <data key="d4">PDF_14_2024</data>
</node>
<node id="PDF_14_2024_Result_-3950855886175765830">
  <data key="d0">Result</data>
  <data key="d1">Aged epithelial cells exhibited significantly elevated expression of cell-cycle-associated genes, whereas aged granulosa cells, theca cells and endothelial cells showed increased expression of apoptosis-associated genes and/or decreased expression of cell-cycle-associated genes compared to young counterparts</data>
  <data key="d3">Aged epithelial cells exhibited significantly elevated expression of cell-cycle-associated genes, whereas aged granulosa cells, theca cells and endothelial cells showed increased expression of apoptosis-associated genes and/or decreased expression of cell-cycle-associated genes compared to young counterparts</data>
  <data key="d4">PDF_14_2024</data>
</node>
<node id="PDF_14_2024_Result_1727081612218890504">
  <data key="d0">Result</data>
  <data key="d1">we identified 3,455 ovarian aging-associated DEGs (Supplementary Table 4), with granulosa cells showing the largest number (Extended Data Fig. 3b). Most aging-associated DEGs are shared among cell types (Extended Data Fig. 3c) and show congruent expression changes</data>
  <data key="d3">we identified 3,455 ovarian aging-associated DEGs (Supplementary Table 4), with granulosa cells showing the largest number (Extended Data Fig. 3b). Most aging-associated DEGs are shared among cell types (Extended Data Fig. 3c) and show congruent expression changes</data>
  <data key="d4">PDF_14_2024</data>
</node>
<node id="PDF_14_2024_Result_-1903928770928789546">
  <data key="d0">Result</data>
  <data key="d1">Common DEGs include known aging-related genes such as RICTOR, IGF1R, MAP3K5 and APOE</data>
  <data key="d3">Common DEGs include known aging-related genes such as RICTOR, IGF1R, MAP3K5 and APOE</data>
  <data key="d4">PDF_14_2024</data>
</node>
<node id="Gene_RICTOR">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">RICTOR</data>
  <data key="d7">RICTOR</data>
</node>
<node id="Gene_IGF1R">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">IGF1R</data>
  <data key="d7">IGF1R</data>
</node>
<node id="Gene_MAP3K5">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">MAP3K5</data>
  <data key="d7">MAP3K5</data>
</node>
<node id="Gene_APOE">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">APOE</data>
  <data key="d7">APOE</data>
</node>
<node id="PDF_14_2024_Result_-6880153114975964996">
  <data key="d0">Result</data>
  <data key="d1">Gene expression in histone modification, cellular senescence and nutrient-sensing signaling pathways, including mTOR and insulin pathways, increased in aged ovaries across cell types</data>
  <data key="d3">Gene expression in histone modification, cellular senescence and nutrient-sensing signaling pathways, including mTOR and insulin pathways, increased in aged ovaries across cell types</data>
  <data key="d4">PDF_14_2024</data>
</node>
<node id="PDF_14_2024_Result_8245876933059396761">
  <data key="d0">Result</data>
  <data key="d1">expression in pathways involved in proteasome, extracellular matrix (ECM), oxidative phosphorylation and base excision repair decreased</data>
  <data key="d3">expression in pathways involved in proteasome, extracellular matrix (ECM), oxidative phosphorylation and base excision repair decreased</data>
  <data key="d4">PDF_14_2024</data>
</node>
<node id="PDF_14_2024_Result_6329313869831559455">
  <data key="d0">Result</data>
  <data key="d1">We validated these age-related changes using in situ hybridization assays, confirming increased expression of the mTOR signaling gene RICTOR and decreased expression of the oxidative phosphorylation gene MT-ATP6 in aged ovaries</data>
  <data key="d3">We validated these age-related changes using in situ hybridization assays, confirming increased expression of the mTOR signaling gene RICTOR and decreased expression of the oxidative phosphorylation gene MT-ATP6 in aged ovaries</data>
  <data key="d4">PDF_14_2024</data>
</node>
<node id="Gene_MT-ATP6">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">MT-ATP6</data>
  <data key="d7">MT-ATP6</data>
</node>
<node id="PDF_14_2024_Result_-1965139603633213800">
  <data key="d0">Result</data>
  <data key="d1">mTOR signaling emerged as an ovary-specific aging-prevalent pathway</data>
  <data key="d3">mTOR signaling emerged as an ovary-specific aging-prevalent pathway</data>
  <data key="d4">PDF_14_2024</data>
</node>
<node id="PDF_14_2024_Result_8553078647428444333">
  <data key="d0">Result</data>
  <data key="d1">oxidative phosphorylation was identified as a prevalent aging pathway across tissues, with the ovary displaying the highest activity change</data>
  <data key="d3">oxidative phosphorylation was identified as a prevalent aging pathway across tissues, with the ovary displaying the highest activity change</data>
  <data key="d4">PDF_14_2024</data>
</node>
<node id="PDF_14_2024_Result_-3635699810532714596">
  <data key="d0">Result</data>
  <data key="d1">We found significant increases in CDKN1A+ cells with age in several cell types</data>
  <data key="d3">We found significant increases in CDKN1A+ cells with age in several cell types</data>
  <data key="d4">PDF_14_2024</data>
</node>
<node id="Gene_CDKN1A">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CDKN1A</data>
  <data key="d7">CDKN1A</data>
</node>
<node id="PDF_14_2024_Conclusion_23683077128086401">
  <data key="d0">Conclusion</data>
  <data key="d1">our comprehensive analysis reveals the distinct and accelerated nature of ovarian aging, characterized by high transcriptomic coordination and distinct pathway activity changes. Notably, we identify mTOR signaling as a unique factor in ovarian aging, offering potential insights into sex-specific longevity responses.</data>
  <data key="d3">our comprehensive analysis reveals the distinct and accelerated nature of ovarian aging, characterized by high transcriptomic coordination and distinct pathway activity changes. Notably, we identify mTOR signaling as a unique factor in ovarian aging, offering potential insights into sex-specific longevity responses.</data>
  <data key="d4">PDF_14_2024</data>
</node>
<node id="PDF_24_2019">
  <data key="d0">Paper</data>
  <data key="d1">Structure of the Ty3/Gypsy retrotransposon capsid
and the evolution of retroviruses
Svetlana O. Dodonovaa,b, Simone Prinza,¹, Virginia Bilanchone, Suzanne Sandmeyer, and John A. G. Briggsa,d,2

@Structural and Computational Biology Unit, European Molecular Biology Laboratory, 69117 Heidelberg, Germany; Department of Molecular Biology, Max
Planck Institute for Biophysical Chemistry, 37077 Gottingen, Germany; Department of Biological Chemistry, University of California, Irvine, CA 92697;
and Struc</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_24_2019_Hypothesis_-3453584697838837682">
  <data key="d0">Hypothesis</data>
  <data key="d1">Assembly via a structurally distinct immature capsid is a later retroviral adaptation.</data>
  <data key="d3">Assembly via a structurally distinct immature capsid is a later retroviral adaptation.</data>
  <data key="d4">PDF_24_2019</data>
</node>
<node id="PDF_24_2019_Method_7351416614653181741">
  <data key="d0">Method</data>
  <data key="d1">Electron tomography (ET) of immature and mature Ty3 particles within cells.</data>
  <data key="d3">Electron tomography (ET) of immature and mature Ty3 particles within cells.</data>
  <data key="d4">PDF_24_2019</data>
</node>
<node id="PDF_24_2019_Method_2739485742662363291">
  <data key="d0">Method</data>
  <data key="d1">Cryo-ET and cryo-electron microscopy of purified, immature Ty3 particles.</data>
  <data key="d3">Cryo-ET and cryo-electron microscopy of purified, immature Ty3 particles.</data>
  <data key="d4">PDF_24_2019</data>
</node>
<node id="PDF_24_2019_Method_-6925621107195890312">
  <data key="d0">Method</data>
  <data key="d1">3D and 2D cryo-electron microscopy (cryo-EM)</data>
  <data key="d3">3D and 2D cryo-electron microscopy (cryo-EM)</data>
  <data key="d4">PDF_24_2019</data>
</node>
<node id="PDF_24_2019_Result_-643056528189324795">
  <data key="d0">Result</data>
  <data key="d1">Ty3 capsids do not change size or shape upon maturation, in contrast to retroviruses.</data>
  <data key="d3">Ty3 capsids do not change size or shape upon maturation, in contrast to retroviruses.</data>
  <data key="d4">PDF_24_2019</data>
</node>
<node id="PDF_24_2019_Result_-4659394613518505422">
  <data key="d0">Result</data>
  <data key="d1">Tertiary and quaternary arrangement of the capsid (CA) C-terminal domain within the assembled capsid is conserved with mature HIV-1.</data>
  <data key="d3">Tertiary and quaternary arrangement of the capsid (CA) C-terminal domain within the assembled capsid is conserved with mature HIV-1.</data>
  <data key="d4">PDF_24_2019</data>
</node>
<node id="Disease_HIV-1">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">HIV-1</data>
  <data key="d7">HIV-1</data>
</node>
<node id="PDF_24_2019_Result_-6546740736136143929">
  <data key="d0">Result</data>
  <data key="d1">The structure of mature assembled capsids is conserved between LTR retrotransposons and retroviruses.</data>
  <data key="d3">The structure of mature assembled capsids is conserved between LTR retrotransposons and retroviruses.</data>
  <data key="d4">PDF_24_2019</data>
</node>
<node id="PDF_24_2019_Result_-987783024772160422">
  <data key="d0">Result</data>
  <data key="d1">Ty3 capsid structure shows striking similarity to mature HIV-1 capsids.</data>
  <data key="d3">Ty3 capsid structure shows striking similarity to mature HIV-1 capsids.</data>
  <data key="d4">PDF_24_2019</data>
</node>
<node id="PDF_24_2019_Result_-1686070901914360345">
  <data key="d0">Result</data>
  <data key="d1">Ty3 seems to directly assemble the mature form, suggesting retroviruses evolved their immature state to facilitate an extracellular step in the life cycle.</data>
  <data key="d3">Ty3 seems to directly assemble the mature form, suggesting retroviruses evolved their immature state to facilitate an extracellular step in the life cycle.</data>
  <data key="d4">PDF_24_2019</data>
</node>
<node id="PDF_24_2019_Result_2884434579122930344">
  <data key="d0">Result</data>
  <data key="d1">Arc encodes a bilobar capsid domain with structural similarity to retroviral CA proteins</data>
  <data key="d3">Arc encodes a bilobar capsid domain with structural similarity to retroviral CA proteins</data>
  <data key="d4">PDF_24_2019</data>
</node>
<node id="PDF_24_2019_Result_-9132036320385733918">
  <data key="d0">Result</data>
  <data key="d1">Arc was recently shown to form capsid-like structures, which are implicated in neuronal function and memory</data>
  <data key="d3">Arc was recently shown to form capsid-like structures, which are implicated in neuronal function and memory</data>
  <data key="d4">PDF_24_2019</data>
</node>
<node id="PDF_24_2019_Conclusion_-5480258274516350032">
  <data key="d0">Conclusion</data>
  <data key="d1">Interdomain flexibility is therefore a conserved property of both retrotransposon and retroviral CA proteins.</data>
  <data key="d3">Interdomain flexibility is therefore a conserved property of both retrotransposon and retroviral CA proteins.</data>
  <data key="d4">PDF_24_2019</data>
</node>
<node id="PDF_22_2021">
  <data key="d0">Paper</data>
  <data key="d1">LTH &amp; HUMAN SERVICES-US,
Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript
HHS Public Access
Author manuscript
Science. Author manuscript; available in PMC 2022 February 20.
Published in final edited form as:
Science. 2021 August 20; 373(6557): 882–889. doi:10.1126/science.abg6155.
Mammalian retrovirus-like protein PEG10 packages its own
mRNA and can be pseudotyped for mRNA delivery
Michael Segel 1,2,3,4,5, Blake Lash1,2,3,4,5, Jingwei Song1,2,3,4,5, Alim Ladha1,2,3,4,5, Ca</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_22_2021_Hypothesis_-1403530705624508273">
  <data key="d0">Hypothesis</data>
  <data key="d1">Additional retroelement-derived proteins encoded in the mammalian genome transfer specific nucleic acids, providing a potentially programmable mechanism for intercellular communication.</data>
  <data key="d3">Additional retroelement-derived proteins encoded in the mammalian genome transfer specific nucleic acids, providing a potentially programmable mechanism for intercellular communication.</data>
  <data key="d4">PDF_22_2021</data>
</node>
<node id="PDF_22_2021_Method_7612153954739874289">
  <data key="d0">Method</data>
  <data key="d1">We searched the human and mouse genomes for gag homologs to identify genes with the potential to transfer specific nucleic acids.</data>
  <data key="d3">We searched the human and mouse genomes for gag homologs to identify genes with the potential to transfer specific nucleic acids.</data>
  <data key="d4">PDF_22_2021</data>
</node>
<node id="Gene_GAG">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">GAG</data>
  <data key="d7">Gag</data>
</node>
<node id="PDF_22_2021_Method_-3540572276885414593">
  <data key="d0">Method</data>
  <data key="d1">We produced mouse versions of the selected CA-containing proteins in E. coli and found that a number of these formed higher molecular weight oligomers identified by size exclusion.</data>
  <data key="d3">We produced mouse versions of the selected CA-containing proteins in E. coli and found that a number of these formed higher molecular weight oligomers identified by size exclusion.</data>
  <data key="d4">PDF_22_2021</data>
</node>
<node id="Protein_CA">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">CA</data>
  <data key="d7">CA</data>
</node>
<node id="PDF_22_2021_Method_-4719631070988160495">
  <data key="d0">Method</data>
  <data key="d1">We overexpressed an epitope tagged mouse ortholog of each CA-containing gene in HEK293FT cells and harvested both the whole cell lysate and the virus-like particle (VLP) fraction by clarification and ultracentrifugation of the culture media.</data>
  <data key="d3">We overexpressed an epitope tagged mouse ortholog of each CA-containing gene in HEK293FT cells and harvested both the whole cell lysate and the virus-like particle (VLP) fraction by clarification and ultracentrifugation of the culture media.</data>
  <data key="d4">PDF_22_2021</data>
</node>
<node id="Gene_CA">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CA</data>
  <data key="d7">CA</data>
</node>
<node id="PDF_22_2021_Method_4081601807065825882">
  <data key="d0">Method</data>
  <data key="d1">We used CRISPR activation to induce expression of endogenous genes in mouse N2a cells.</data>
  <data key="d3">We used CRISPR activation to induce expression of endogenous genes in mouse N2a cells.</data>
  <data key="d4">PDF_22_2021</data>
</node>
<node id="Process_CRISPR">
  <data key="d0">Entity</data>
  <data key="d5">Process</data>
  <data key="d6">CRISPR</data>
  <data key="d7">CRISPR</data>
</node>
<node id="PDF_22_2021_Result_5590334583102740542">
  <data key="d0">Result</data>
  <data key="d1">MmPeg10 transcriptional activation led to accumulation of significant amounts of full length MmPeg10 mRNA transcripts in the VLP fraction.</data>
  <data key="d3">MmPeg10 transcriptional activation led to accumulation of significant amounts of full length MmPeg10 mRNA transcripts in the VLP fraction.</data>
  <data key="d4">PDF_22_2021</data>
</node>
<node id="PDF_22_2021_Result_-982050469218463871">
  <data key="d0">Result</data>
  <data key="d1">MmPEG10 binds and secretes its own mRNA into the VLP fraction.</data>
  <data key="d3">MmPEG10 binds and secretes its own mRNA into the VLP fraction.</data>
  <data key="d4">PDF_22_2021</data>
</node>
<node id="PDF_22_2021_Result_8226100373075108923">
  <data key="d0">Result</data>
  <data key="d1">mRNA export depends on the MmPEG10 NC, as loss of the nucleic acid-binding zinc finger CCHC motif (residues 416-429) from the MmPEG10 NC substantially reduced export of its mRNA.</data>
  <data key="d3">mRNA export depends on the MmPEG10 NC, as loss of the nucleic acid-binding zinc finger CCHC motif (residues 416-429) from the MmPEG10 NC substantially reduced export of its mRNA.</data>
  <data key="d4">PDF_22_2021</data>
</node>
<node id="PDF_22_2021_Method_1979361156444858157">
  <data key="d0">Method</data>
  <data key="d1">We performed eCLIP in N2a cells after transient transfection with HA-tagged MmPeg10 as well as the NC and RT mutants.</data>
  <data key="d3">We performed eCLIP in N2a cells after transient transfection with HA-tagged MmPeg10 as well as the NC and RT mutants.</data>
  <data key="d4">PDF_22_2021</data>
</node>
<node id="PDF_22_2021_Result_8631218194293664135">
  <data key="d0">Result</data>
  <data key="d1">Compared to the control, MmPEG10 strongly bound a number of mRNAs in N2a cells including its own mRNA.</data>
  <data key="d3">Compared to the control, MmPEG10 strongly bound a number of mRNAs in N2a cells including its own mRNA.</data>
  <data key="d4">PDF_22_2021</data>
</node>
<node id="PDF_22_2021_Result_5557861515758995316">
  <data key="d0">Result</data>
  <data key="d1">Both the NC and the RT domains are required for the binding of these mRNAs by MmPEG10.</data>
  <data key="d3">Both the NC and the RT domains are required for the binding of these mRNAs by MmPEG10.</data>
  <data key="d4">PDF_22_2021</data>
</node>
<node id="PDF_22_2021_Result_-6573448921126278675">
  <data key="d0">Result</data>
  <data key="d1">Endogenous MmPEG10 was also found to bind its own mRNA as well as other transcripts abundant in neurons.</data>
  <data key="d3">Endogenous MmPEG10 was also found to bind its own mRNA as well as other transcripts abundant in neurons.</data>
  <data key="d4">PDF_22_2021</data>
</node>
<node id="PDF_22_2021_Result_-6942168829170947879">
  <data key="d0">Result</data>
  <data key="d1">The mRNAs of 49 genes downregulated in the brain upon MmPeg10 knockout are bound to MmPEG10 in the age-matched mouse brain, suggesting that one of the functions of MmPEG10 is to bind and stabilize mRNAs with fundamental roles in neurodevelopment.</data>
  <data key="d3">The mRNAs of 49 genes downregulated in the brain upon MmPeg10 knockout are bound to MmPEG10 in the age-matched mouse brain, suggesting that one of the functions of MmPEG10 is to bind and stabilize mRNAs with fundamental roles in neurodevelopment.</data>
  <data key="d4">PDF_22_2021</data>
</node>
<node id="PDF_22_2021_Method_992049933037111916">
  <data key="d0">Method</data>
  <data key="d1">We tested whether a cargo mRNA consisting of both the 5' and 3' UTR of MmPeg10 flanking a gene of interest would be efficiently packaged, exported, delivered, and translated in recipient cells.</data>
  <data key="d3">We tested whether a cargo mRNA consisting of both the 5' and 3' UTR of MmPeg10 flanking a gene of interest would be efficiently packaged, exported, delivered, and translated in recipient cells.</data>
  <data key="d4">PDF_22_2021</data>
</node>
<node id="PDF_22_2021_Result_2612807020811944606">
  <data key="d0">Result</data>
  <data key="d1">Addition of the Peg10UTRs enables functional intercellular transfer of an mRNA via VLPs and that these VLPs require a fusogenic protein for cell entry.</data>
  <data key="d3">Addition of the Peg10UTRs enables functional intercellular transfer of an mRNA via VLPs and that these VLPs require a fusogenic protein for cell entry.</data>
  <data key="d4">PDF_22_2021</data>
</node>
<node id="PDF_22_2021_Result_1284482544037727418">
  <data key="d0">Result</data>
  <data key="d1">VLPs produced with rMmPEG10 can mediate the functional transfer of H2B-mCherry.</data>
  <data key="d3">VLPs produced with rMmPEG10 can mediate the functional transfer of H2B-mCherry.</data>
  <data key="d4">PDF_22_2021</data>
</node>
<node id="PDF_22_2021_Result_4018866932238782064">
  <data key="d0">Result</data>
  <data key="d1">Functional transfer of MmSYNA pseudotyped VLPs carrying the native PEG10 transcript into primary mouse cortical neurons led to upregulation of a number of genes involved in neurodevelopment.</data>
  <data key="d3">Functional transfer of MmSYNA pseudotyped VLPs carrying the native PEG10 transcript into primary mouse cortical neurons led to upregulation of a number of genes involved in neurodevelopment.</data>
  <data key="d4">PDF_22_2021</data>
</node>
<node id="PDF_22_2021_Result_-7744660373325422857">
  <data key="d0">Result</data>
  <data key="d1">SEND was able to functionally transfer SpCas9, leading to ~60% indels in recipient cells.</data>
  <data key="d3">SEND was able to functionally transfer SpCas9, leading to ~60% indels in recipient cells.</data>
  <data key="d4">PDF_22_2021</data>
</node>
<node id="Protein_CAS9">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">CAS9</data>
  <data key="d7">Cas9</data>
</node>
<node id="PDF_22_2021_Conclusion_-3093210777716935094">
  <data key="d0">Conclusion</data>
  <data key="d1">The LTR retrotransposon-derived Gag protein PEG10 can be harnessed to facilitate efficient and specific intercellular delivery of cargo mRNAs in mammalian cells.</data>
  <data key="d3">The LTR retrotransposon-derived Gag protein PEG10 can be harnessed to facilitate efficient and specific intercellular delivery of cargo mRNAs in mammalian cells.</data>
  <data key="d4">PDF_22_2021</data>
</node>
<node id="PDF_22_2021_Conclusion_-5636708818920378132">
  <data key="d0">Conclusion</data>
  <data key="d1">SEND is a modular platform suited for development as an efficient therapeutic delivery modality.</data>
  <data key="d3">SEND is a modular platform suited for development as an efficient therapeutic delivery modality.</data>
  <data key="d4">PDF_22_2021</data>
</node>
<node id="PDF_22_2021_Conclusion_6281965894368531425">
  <data key="d0">Conclusion</data>
  <data key="d1">As a modular, fully endogenous system, SEND has the potential to be extended into a minimally immunogenic delivery platform that can be repeatedly dosed, greatly expanding the applications for nucleic acid therapy.</data>
  <data key="d3">As a modular, fully endogenous system, SEND has the potential to be extended into a minimally immunogenic delivery platform that can be repeatedly dosed, greatly expanding the applications for nucleic acid therapy.</data>
  <data key="d4">PDF_22_2021</data>
</node>
<node id="PDF_05_2024">
  <data key="d0">Paper</data>
  <data key="d1">The Diverse Evolutionary Histories of Domesticated
Metaviral Capsid Genes in Mammals
William S. Henriques,¹ Janet M. Young,² Artem Nemudryi,¹ Anna Nemudraia,¹ Blake Wiedenheft,¹*
and Harmit S. Malik 2,3,*
'Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT 59717, USA
2Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA
Howard Hughes Medical Institute, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA
*Corresponding authors: E-mails: </data>
  <data key="d2">2024</data>
</node>
<node id="PDF_05_2024_Hypothesis_-2296086537642480149">
  <data key="d0">Hypothesis</data>
  <data key="d1">We sought a more in-depth structural and evolutionary understanding of these genes, focusing on different fates of domesticated genes.</data>
  <data key="d3">We sought a more in-depth structural and evolutionary understanding of these genes, focusing on different fates of domesticated genes.</data>
  <data key="d4">PDF_05_2024</data>
</node>
<node id="PDF_05_2024_Method_-2522657615328900174">
  <data key="d0">Method</data>
  <data key="d1">Using a complete human genome assembly and 25 additional vertebrate genomes, we re-analyzed the evolutionary trajectories and functional potential of capsid (CA) genes domesticated from Metaviridae, a lineage of retrovirus-like retrotransposons.</data>
  <data key="d3">Using a complete human genome assembly and 25 additional vertebrate genomes, we re-analyzed the evolutionary trajectories and functional potential of capsid (CA) genes domesticated from Metaviridae, a lineage of retrovirus-like retrotransposons.</data>
  <data key="d4">PDF_05_2024</data>
</node>
<node id="Gene_METAVIRIDAE">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">METAVIRIDAE</data>
  <data key="d7">Metaviridae</data>
</node>
<node id="PDF_05_2024_Method_-7317802560765773811">
  <data key="d0">Method</data>
  <data key="d1">We built Hidden Markov Models (HMMs) guided by atomic structures and AlphaFold predictions of retroviral and retrotransposon CA domains.</data>
  <data key="d3">We built Hidden Markov Models (HMMs) guided by atomic structures and AlphaFold predictions of retroviral and retrotransposon CA domains.</data>
  <data key="d4">PDF_05_2024</data>
</node>
<node id="PDF_05_2024_Method_8362744418732544509">
  <data key="d0">Method</data>
  <data key="d1">We performed searches of 17 additional representative mammalian genomes using sensitive HMM searches as well as iterative blast searches with both nucleotide and protein queries.</data>
  <data key="d3">We performed searches of 17 additional representative mammalian genomes using sensitive HMM searches as well as iterative blast searches with both nucleotide and protein queries.</data>
  <data key="d4">PDF_05_2024</data>
</node>
<node id="PDF_05_2024_Method_1840764957691302589">
  <data key="d0">Method</data>
  <data key="d1">We investigated the selective pressures on metaviral genes following their domestication, estimating the ratio of nonsynonymous (dN, amino acid altering) to synonymous (dS, amino acid preserving) nucleotide substitutions using the codeml algorithm from the PAML suite.</data>
  <data key="d3">We investigated the selective pressures on metaviral genes following their domestication, estimating the ratio of nonsynonymous (dN, amino acid altering) to synonymous (dS, amino acid preserving) nucleotide substitutions using the codeml algorithm from the PAML suite.</data>
  <data key="d4">PDF_05_2024</data>
</node>
<node id="PDF_05_2024_Result_-8901077775128653536">
  <data key="d0">Result</data>
  <data key="d1">We find that at least five independent domestication events occurred from diverse Metaviridae, giving rise to three universally retained single-copy genes evolving under purifying selection and two gene families unique to placental mammals, with multiple members showing evidence of rapid evolution.</data>
  <data key="d3">We find that at least five independent domestication events occurred from diverse Metaviridae, giving rise to three universally retained single-copy genes evolving under purifying selection and two gene families unique to placental mammals, with multiple members showing evidence of rapid evolution.</data>
  <data key="d4">PDF_05_2024</data>
</node>
<node id="PDF_05_2024_Result_-3731195017758500881">
  <data key="d0">Result</data>
  <data key="d1">Our analyses also reveal that most members of the PNMA family in mammalian genomes encode a conserved putative amino-terminal RNA-binding domain (RBD) both adjoining and independent from domesticated CA domains.</data>
  <data key="d3">Our analyses also reveal that most members of the PNMA family in mammalian genomes encode a conserved putative amino-terminal RNA-binding domain (RBD) both adjoining and independent from domesticated CA domains.</data>
  <data key="d4">PDF_05_2024</data>
</node>
<node id="Gene_PNMA">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">PNMA</data>
  <data key="d7">PNMA</data>
</node>
<node id="PDF_05_2024_Result_8824557692865093567">
  <data key="d0">Result</data>
  <data key="d1">We show that this putative RBD is also present in several extant Metaviridae, revealing a novel protein domain configuration in retrotransposons.</data>
  <data key="d3">We show that this putative RBD is also present in several extant Metaviridae, revealing a novel protein domain configuration in retrotransposons.</data>
  <data key="d4">PDF_05_2024</data>
</node>
<node id="PDF_05_2024_Result_-8333638060710176268">
  <data key="d0">Result</data>
  <data key="d1">Our survey found 24 of the 85 previously identified metaviral-derived CA genes.</data>
  <data key="d3">Our survey found 24 of the 85 previously identified metaviral-derived CA genes.</data>
  <data key="d4">PDF_05_2024</data>
</node>
<node id="PDF_05_2024_Result_-8427620530971476832">
  <data key="d0">Result</data>
  <data key="d1">Our phylogenomic analyses confirm previous estimates of the age of these genes.</data>
  <data key="d3">Our phylogenomic analyses confirm previous estimates of the age of these genes.</data>
  <data key="d4">PDF_05_2024</data>
</node>
<node id="PDF_05_2024_Result_5383194152894092445">
  <data key="d0">Result</data>
  <data key="d1">Most domesticated metaviral CA genes are at least ~100 million years (My) old, with orthologs found in shared syntenic locations in diverse placental mammals but not in marsupials.</data>
  <data key="d3">Most domesticated metaviral CA genes are at least ~100 million years (My) old, with orthologs found in shared syntenic locations in diverse placental mammals but not in marsupials.</data>
  <data key="d4">PDF_05_2024</data>
</node>
<node id="PDF_05_2024_Result_-4847983466372511851">
  <data key="d0">Result</data>
  <data key="d1">Despite an overall signature of purifying selection, domesticated CA genes might still be subject to positive selection (dN/dS &gt; 1) at a subset of codons as seen for host immunity-related genes such as Fv1.</data>
  <data key="d3">Despite an overall signature of purifying selection, domesticated CA genes might still be subject to positive selection (dN/dS &gt; 1) at a subset of codons as seen for host immunity-related genes such as Fv1.</data>
  <data key="d4">PDF_05_2024</data>
</node>
<node id="PDF_05_2024_Result_-554567313794346505">
  <data key="d0">Result</data>
  <data key="d1">These tests reveal that ten of these nineteen ancient metaviral genes contain a subset of sites evolving under positive selection in primates, suggesting ongoing involvement in evolutionary arms races.</data>
  <data key="d3">These tests reveal that ten of these nineteen ancient metaviral genes contain a subset of sites evolving under positive selection in primates, suggesting ongoing involvement in evolutionary arms races.</data>
  <data key="d4">PDF_05_2024</data>
</node>
<node id="PDF_05_2024_Conclusion_-2995618956841361330">
  <data key="d0">Conclusion</data>
  <data key="d1">Collectively, our study reveals the divergent outcomes of multiple domestication events from diverse Metaviridae in the common ancestor of placental mammals.</data>
  <data key="d3">Collectively, our study reveals the divergent outcomes of multiple domestication events from diverse Metaviridae in the common ancestor of placental mammals.</data>
  <data key="d4">PDF_05_2024</data>
</node>
<node id="PDF_05_2024_Conclusion_-5079616839098826086">
  <data key="d0">Conclusion</data>
  <data key="d1">Our study reveals that recurrent domestication of the gag domain from structurally diverse Metaviridae gave rise to genes with distinct evolutionary trajectories and structural features in placental mammals.</data>
  <data key="d3">Our study reveals that recurrent domestication of the gag domain from structurally diverse Metaviridae gave rise to genes with distinct evolutionary trajectories and structural features in placental mammals.</data>
  <data key="d4">PDF_05_2024</data>
</node>
<node id="PDF_54_2017">
  <data key="d0">Paper</data>
  <data key="d1">1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
Results
79
80
81
12,17.
Formally, structure determination by cryo-EM is an optimization problem and may be described
in a Bayesian likelihood framework12,17.
N
K
arg max log p (V.1....KX1...N)
V1...K
= arg max
V1...K
K
log p(xii) Vi)di + log p(V...k)
(1)
i=1
j=1
82
83
84
85
</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_54_2017_Method_-8356199968091872640">
  <data key="d0">Method</data>
  <data key="d1">stochastic gradient descent (SGD) optimization scheme to quickly identify one or several low-resolution 3-D structures that are consistent with a set of observed images</data>
  <data key="d3">stochastic gradient descent (SGD) optimization scheme to quickly identify one or several low-resolution 3-D structures that are consistent with a set of observed images</data>
  <data key="d4">PDF_54_2017</data>
</node>
<node id="PDF_54_2017_Method_4772072621524684472">
  <data key="d0">Method</data>
  <data key="d1">branch and bound algorithm for image alignment helps rapidly refine structures to high resolution</data>
  <data key="d3">branch and bound algorithm for image alignment helps rapidly refine structures to high resolution</data>
  <data key="d4">PDF_54_2017</data>
</node>
<node id="PDF_54_2017_Result_-779300938965813719">
  <data key="d0">Result</data>
  <data key="d1">SGD optimization resulted in a low-resolution 3-D map in 75 minutes from random initialization using a single inexpensive desktop workstation with an Intel i7-5820K Processor and a single NVIDIA Tesla K40 GPU.</data>
  <data key="d3">SGD optimization resulted in a low-resolution 3-D map in 75 minutes from random initialization using a single inexpensive desktop workstation with an Intel i7-5820K Processor and a single NVIDIA Tesla K40 GPU.</data>
  <data key="d4">PDF_54_2017</data>
</node>
<node id="PDF_54_2017_Result_7792002420144685221">
  <data key="d0">Result</data>
  <data key="d1">algorithm was able to discern three different conformational states for the enzyme, again from random initializations</data>
  <data key="d3">algorithm was able to discern three different conformational states for the enzyme, again from random initializations</data>
  <data key="d4">PDF_54_2017</data>
</node>
<node id="Protein_V/A-ATPASE">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">V/A-ATPASE</data>
  <data key="d7">V/A-ATPase</data>
</node>
<node id="PDF_54_2017_Result_6754054441199103548">
  <data key="d0">Result</data>
  <data key="d1">branch and bound orientation determination produced a 3.3 Å resolution map in 66 minutes with C4 symmetry enforced using a gold-standard refinement procedure</data>
  <data key="d3">branch and bound orientation determination produced a 3.3 Å resolution map in 66 minutes with C4 symmetry enforced using a gold-standard refinement procedure</data>
  <data key="d4">PDF_54_2017</data>
</node>
<node id="PDF_54_2017_Result_-3164133737264590558">
  <data key="d0">Result</data>
  <data key="d1">branch and bound search produced maps of all three states in a total of 2.4 hours</data>
  <data key="d3">branch and bound search produced maps of all three states in a total of 2.4 hours</data>
  <data key="d4">PDF_54_2017</data>
</node>
<node id="PDF_54_2017_Result_6818367579615438878">
  <data key="d0">Result</data>
  <data key="d1">application of the branch and bound method allowed high-resolution refinement of the 80S ribosome to 3.2 Å resolution, equivalent to the published resolution29, in 2.2 hours</data>
  <data key="d3">application of the branch and bound method allowed high-resolution refinement of the 80S ribosome to 3.2 Å resolution, equivalent to the published resolution29, in 2.2 hours</data>
  <data key="d4">PDF_54_2017</data>
</node>
<node id="Protein_80S RIBOSOME">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">80S RIBOSOME</data>
  <data key="d7">80S ribosome</data>
</node>
<node id="PDF_54_2017_Result_-4974036200211890152">
  <data key="d0">Result</data>
  <data key="d1">the 20S proteasome structure was refined to 2.8 Å with D7 symmetry enforced, matching the published sub-3 Å resolution from the dataset 28 (Figure 4B) but in only 70 minutes</data>
  <data key="d3">the 20S proteasome structure was refined to 2.8 Å with D7 symmetry enforced, matching the published sub-3 Å resolution from the dataset 28 (Figure 4B) but in only 70 minutes</data>
  <data key="d4">PDF_54_2017</data>
</node>
<node id="Protein_20S PROTEASOME">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">20S PROTEASOME</data>
  <data key="d7">20S proteasome</data>
</node>
<node id="PDF_15_2018">
  <data key="d0">Paper</data>
  <data key="d1">Cell Reports
DAZL Regulates Germ Cell Survival through a
Network of PolyA-Proximal mRNA Interactions
Graphical Abstract
Dazl
Wild Type
-GUU-AAAAA-
Dazl
GUU
Germ cell survival
Dazl-/-
-GUU-AAAAA
Germ cell loss
~GUU
AAAAAAA
-GUU-AAAAAAA
Dazl
-AAAAAAA
GUU-AAAAAAA
Dazl
-GUU-AAAAAAA
AAAAAAA
_ GUU-AAAAAAA
AAAAAAA
GUUGUUAAAAAAA
GUJAAAAAAA
Authors
Article
Leah L. Zagore, Thomas J. Sweet,
Molly M. Hannigan, ..., Maria Hatzoglou,
Chaolin Zhang, Donny D. Licatalosi
Correspondence
ddl33@case.edu
In Brief
Co</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_15_2018_Hypothesis_5708965719031571952">
  <data key="d0">Hypothesis</data>
  <data key="d1">DAZL regulates germ cell survival through a network of polyA-proximal mRNA interactions.</data>
  <data key="d3">DAZL regulates germ cell survival through a network of polyA-proximal mRNA interactions.</data>
  <data key="d4">PDF_15_2018</data>
</node>
<node id="Gene_MRNA">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">MRNA</data>
  <data key="d7">mRNA</data>
</node>
<node id="PDF_15_2018_Method_-1051758273803831627">
  <data key="d0">Method</data>
  <data key="d1">High-throughput sequencing after in vivo cross-linking and immunoprecipitation (HITS-CLIP) libraries were generated from DAZL-RNA complexes purified from UV cross-linked adult mouse testes and sequenced using the Illumina platform.</data>
  <data key="d3">High-throughput sequencing after in vivo cross-linking and immunoprecipitation (HITS-CLIP) libraries were generated from DAZL-RNA complexes purified from UV cross-linked adult mouse testes and sequenced using the Illumina platform.</data>
  <data key="d4">PDF_15_2018</data>
</node>
<node id="Gene_RNA">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">RNA</data>
  <data key="d7">RNA</data>
</node>
<node id="PDF_15_2018_Method_8549025233701299368">
  <data key="d0">Method</data>
  <data key="d1">Fluorescence-activated cell sorting (FACS) was used to isolate germ cells from Dazl KO testes and WT controls.</data>
  <data key="d3">Fluorescence-activated cell sorting (FACS) was used to isolate germ cells from Dazl KO testes and WT controls.</data>
  <data key="d4">PDF_15_2018</data>
</node>
<node id="PDF_15_2018_Method_7827999128385876098">
  <data key="d0">Method</data>
  <data key="d1">RNA-sequencing (RNA-seq) was used to identify mRNAs that are sensitive to DAZL deletion.</data>
  <data key="d3">RNA-sequencing (RNA-seq) was used to identify mRNAs that are sensitive to DAZL deletion.</data>
  <data key="d4">PDF_15_2018</data>
</node>
<node id="PDF_15_2018_Result_7162504357443096750">
  <data key="d0">Result</data>
  <data key="d1">DAZL directly and reproducibly binds distinct sites in &gt;3,900 transcripts in adult testis.</data>
  <data key="d3">DAZL directly and reproducibly binds distinct sites in &gt;3,900 transcripts in adult testis.</data>
  <data key="d4">PDF_15_2018</data>
</node>
<node id="PDF_15_2018_Result_-7119612070048112175">
  <data key="d0">Result</data>
  <data key="d1">DAZL predominantly binds GUU-rich sequences in vivo.</data>
  <data key="d3">DAZL predominantly binds GUU-rich sequences in vivo.</data>
  <data key="d4">PDF_15_2018</data>
</node>
<node id="PDF_15_2018_Result_-4495429513995912526">
  <data key="d0">Result</data>
  <data key="d1">DAZL preferentially binds GUU sites in close proximity to polyA sequences.</data>
  <data key="d3">DAZL preferentially binds GUU sites in close proximity to polyA sequences.</data>
  <data key="d4">PDF_15_2018</data>
</node>
<node id="PDF_15_2018_Result_5519043289604290788">
  <data key="d0">Result</data>
  <data key="d1">1,462 transcripts had reduced RNA levels and 1,584 increased in Dazl KO cells</data>
  <data key="d3">1,462 transcripts had reduced RNA levels and 1,584 increased in Dazl KO cells</data>
  <data key="d4">PDF_15_2018</data>
</node>
<node id="PDF_15_2018_Result_7208538871817750868">
  <data key="d0">Result</data>
  <data key="d1">DDX4 and SYCP3 were among the genes with reduced RNA in Dazl KO cells.</data>
  <data key="d3">DDX4 and SYCP3 were among the genes with reduced RNA in Dazl KO cells.</data>
  <data key="d4">PDF_15_2018</data>
</node>
<node id="Gene_DDX4">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">DDX4</data>
  <data key="d7">DDX4</data>
</node>
<node id="Gene_SYCP3">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SYCP3</data>
  <data key="d7">SYCP3</data>
</node>
<node id="PDF_15_2018_Result_8650488130552305924">
  <data key="d0">Result</data>
  <data key="d1">84% of P6 DAZL BR3 sites (5,400/6,465) mapped to 3' UTRs of 2,290 genes, indicating that DAZL also directly binds to a vast network of RNAs in spermatogonia via 3' UTR interactions.</data>
  <data key="d3">84% of P6 DAZL BR3 sites (5,400/6,465) mapped to 3' UTRs of 2,290 genes, indicating that DAZL also directly binds to a vast network of RNAs in spermatogonia via 3' UTR interactions.</data>
  <data key="d4">PDF_15_2018</data>
</node>
<node id="PDF_15_2018_Conclusion_7771580740347926323">
  <data key="d0">Conclusion</data>
  <data key="d1">DAZL functions as a master regulator of a post-transcriptional mRNA program essential for germ cell survival.</data>
  <data key="d3">DAZL functions as a master regulator of a post-transcriptional mRNA program essential for germ cell survival.</data>
  <data key="d4">PDF_15_2018</data>
</node>
<node id="PDF_15_2018_Conclusion_3265488575977149899">
  <data key="d0">Conclusion</data>
  <data key="d1">Dazl primarily functions as a positive post-transcriptional regulator of gene expression through polyA-proximal interactions.</data>
  <data key="d3">Dazl primarily functions as a positive post-transcriptional regulator of gene expression through polyA-proximal interactions.</data>
  <data key="d4">PDF_15_2018</data>
</node>
<node id="PDF_23_2024">
  <data key="d0">Paper</data>
  <data key="d1">Article
Cell
PNMA2 forms immunogenic non-enveloped virus-
like capsids associated with paraneoplastic
neurological syndrome
Junjie Xu, 1 Simon Erlendsson, 2,3 Manvendra Singh, 4 G. Aaron Holling, 5 Matthew Regier, 1 Iosune Ibiricu, 1 Jenifer Einstein, 1
Michael P. Hantak, 1 Gregory S. Day, 7 Amanda L. Piquet, 8 Tammy L. Smith, 7 Stacey L. Clardy, 9 Alexandra M. Whiteley, 5
Cédric Feschotte, 4 John A.G. Briggs, 2,6 and Jason D. Shepherd 1,10,11,*
1Department of Neurobiology, University of Utah, S</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_23_2024_Hypothesis_-3343978425397978656">
  <data key="d0">Hypothesis</data>
  <data key="d1">Aberrant PNMA2 capsids released outside the central nervous system (CNS) may cause autoantibody generation.</data>
  <data key="d3">Aberrant PNMA2 capsids released outside the central nervous system (CNS) may cause autoantibody generation.</data>
  <data key="d4">PDF_23_2024</data>
</node>
<node id="PDF_23_2024_Method_5399875870720793919">
  <data key="d0">Method</data>
  <data key="d1">Mice injected with recombinant PNMA2 capsids.</data>
  <data key="d3">Mice injected with recombinant PNMA2 capsids.</data>
  <data key="d4">PDF_23_2024</data>
</node>
<node id="PDF_23_2024_Method_-2118685823376526039">
  <data key="d0">Method</data>
  <data key="d1">Cryoelectron microscopy (cryo-EM)-derived atomic resolution structures of PNMA2 capsids.</data>
  <data key="d3">Cryoelectron microscopy (cryo-EM)-derived atomic resolution structures of PNMA2 capsids.</data>
  <data key="d4">PDF_23_2024</data>
</node>
<node id="PDF_23_2024_Method_-962667875878043483">
  <data key="d0">Method</data>
  <data key="d1">Designed PNMA2 mutants that are unable to form capsids.</data>
  <data key="d3">Designed PNMA2 mutants that are unable to form capsids.</data>
  <data key="d4">PDF_23_2024</data>
</node>
<node id="PDF_23_2024_Method_-6844345173495192814">
  <data key="d0">Method</data>
  <data key="d1">Injection of capsid mutant protein.</data>
  <data key="d3">Injection of capsid mutant protein.</data>
  <data key="d4">PDF_23_2024</data>
</node>
<node id="PDF_23_2024_Method_1387627994788856560">
  <data key="d0">Method</data>
  <data key="d1">PNMA2 autoantibodies from injected mice and CSF from patients with anti-Ma2 paraneoplastic disease.</data>
  <data key="d3">PNMA2 autoantibodies from injected mice and CSF from patients with anti-Ma2 paraneoplastic disease.</data>
  <data key="d4">PDF_23_2024</data>
</node>
<node id="PDF_23_2024_Method_-963939611664386156">
  <data key="d0">Method</data>
  <data key="d1">PNMA2 capsids are also capable of inducing maturation of dendritic cells in vitro.</data>
  <data key="d3">PNMA2 capsids are also capable of inducing maturation of dendritic cells in vitro.</data>
  <data key="d4">PDF_23_2024</data>
</node>
<node id="PDF_23_2024_Method_-8358282031659288739">
  <data key="d0">Method</data>
  <data key="d1">Mice injected with PNMA2 capsids develop significant deficits in fear learning and memory.</data>
  <data key="d3">Mice injected with PNMA2 capsids develop significant deficits in fear learning and memory.</data>
  <data key="d4">PDF_23_2024</data>
</node>
<node id="PDF_23_2024_Result_-7950454151905880499">
  <data key="d0">Result</data>
  <data key="d1">PNMA2 protein self-assembles into virus-like capsids that are released from cells as non-enveloped capsids.</data>
  <data key="d3">PNMA2 protein self-assembles into virus-like capsids that are released from cells as non-enveloped capsids.</data>
  <data key="d4">PDF_23_2024</data>
</node>
<node id="PDF_23_2024_Result_-1426847475356443601">
  <data key="d0">Result</data>
  <data key="d1">Mice injected with PNMA2 capsids produce strong autoantibody generation, even without adjuvant.</data>
  <data key="d3">Mice injected with PNMA2 capsids produce strong autoantibody generation, even without adjuvant.</data>
  <data key="d4">PDF_23_2024</data>
</node>
<node id="PDF_23_2024_Result_-6231444686870539759">
  <data key="d0">Result</data>
  <data key="d1">Injection of capsid mutant protein did not elicit autoantibody production, indicating that the fully assembled capsid is immunogenic.</data>
  <data key="d3">Injection of capsid mutant protein did not elicit autoantibody production, indicating that the fully assembled capsid is immunogenic.</data>
  <data key="d4">PDF_23_2024</data>
</node>
<node id="PDF_23_2024_Result_8331014064670918802">
  <data key="d0">Result</data>
  <data key="d1">PNMA2 autoantibodies from injected mice and CSF from patients with anti-Ma2 paraneoplastic disease preferentially bind to exterior surface spike epitopes of PNMA2 capsids.</data>
  <data key="d3">PNMA2 autoantibodies from injected mice and CSF from patients with anti-Ma2 paraneoplastic disease preferentially bind to exterior surface spike epitopes of PNMA2 capsids.</data>
  <data key="d4">PDF_23_2024</data>
</node>
<node id="PDF_23_2024_Result_-963939611664386156">
  <data key="d0">Result</data>
  <data key="d1">PNMA2 capsids are also capable of inducing maturation of dendritic cells in vitro.</data>
  <data key="d3">PNMA2 capsids are also capable of inducing maturation of dendritic cells in vitro.</data>
  <data key="d4">PDF_23_2024</data>
</node>
<node id="PDF_23_2024_Result_-8358282031659288739">
  <data key="d0">Result</data>
  <data key="d1">Mice injected with PNMA2 capsids develop significant deficits in fear learning and memory.</data>
  <data key="d3">Mice injected with PNMA2 capsids develop significant deficits in fear learning and memory.</data>
  <data key="d4">PDF_23_2024</data>
</node>
<node id="PDF_23_2024_Conclusion_4394189087389820540">
  <data key="d0">Conclusion</data>
  <data key="d1">PNMA2 is a Gag-like protein that forms endogenous virus-like capsids that are released without a membrane. These capsids can trigger a robust immune response when ectopically expressed outside the CNS, which results in neurological deficits.</data>
  <data key="d3">PNMA2 is a Gag-like protein that forms endogenous virus-like capsids that are released without a membrane. These capsids can trigger a robust immune response when ectopically expressed outside the CNS, which results in neurological deficits.</data>
  <data key="d4">PDF_23_2024</data>
</node>
<node id="PDF_23_2024_Conclusion_8378018910778163774">
  <data key="d0">Conclusion</data>
  <data key="d1">The virus-like properties of PNMA2 protein may underlie some of the neurological symptoms associated with anti-Ma2 paraneoplastic disease.</data>
  <data key="d3">The virus-like properties of PNMA2 protein may underlie some of the neurological symptoms associated with anti-Ma2 paraneoplastic disease.</data>
  <data key="d4">PDF_23_2024</data>
</node>
<node id="PDF_19_2024">
  <data key="d0">Paper</data>
  <data key="d1">nature aging
a
Resource
https://doi.org/10.1038/s43587-023-00552-5
A single-cell atlas of the aging mouse ovary
Received: 12 May 2023
Accepted: 1 December 2023
Published online: 10 January 2024
Check for updates
José V. V. Isola¹8, Sarah R. Ocañas 2,3,4,5,8, Chase R. Hubbart¹, Sunghwan Ko2,3,
Samim Ali Mondal¹, Jessica D. Hense 1,6, Hannah N. C. Carter,
Augusto Schneider, Susan Kovats, José Alberola-Ila,
Willard M. Freeman 2,5 &amp; Michael B. Stout 1,5
Ovarian aging leads to diminished fertility, d</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_19_2024_Result_-8817860122597384827">
  <data key="d0">Result</data>
  <data key="d1">scRNA-seq analysis revealed a doubling of immune cells in the aged ovary, with lymphocyte proportions increasing the most, which was confirmed by flow cytometry.</data>
  <data key="d3">scRNA-seq analysis revealed a doubling of immune cells in the aged ovary, with lymphocyte proportions increasing the most, which was confirmed by flow cytometry.</data>
  <data key="d4">PDF_19_2024</data>
</node>
<node id="PDF_19_2024_Result_-2645281073394551084">
  <data key="d0">Result</data>
  <data key="d1">age-related downregulation of collagenase pathways in stromal fibroblasts, which corresponds to rises in ovarian fibrosis.</data>
  <data key="d3">age-related downregulation of collagenase pathways in stromal fibroblasts, which corresponds to rises in ovarian fibrosis.</data>
  <data key="d4">PDF_19_2024</data>
</node>
<node id="PDF_19_2024_Result_-2074743576456389044">
  <data key="d0">Result</data>
  <data key="d1">Follicular cells displayed stress-response, immunogenic and fibrotic signaling pathway inductions with aging.</data>
  <data key="d3">Follicular cells displayed stress-response, immunogenic and fibrotic signaling pathway inductions with aging.</data>
  <data key="d4">PDF_19_2024</data>
</node>
<node id="PDF_19_2024_Result_3923832235883396720">
  <data key="d0">Result</data>
  <data key="d1">The percentage of GCs was lower in 9-month-old ovaries.</data>
  <data key="d3">The percentage of GCs was lower in 9-month-old ovaries.</data>
  <data key="d4">PDF_19_2024</data>
</node>
<node id="PDF_19_2024_Result_7123199059174422318">
  <data key="d0">Result</data>
  <data key="d1">The most marked change in ovarian cellularity with advancing age was the greater than twofold increase in immune cells.</data>
  <data key="d3">The most marked change in ovarian cellularity with advancing age was the greater than twofold increase in immune cells.</data>
  <data key="d4">PDF_19_2024</data>
</node>
<node id="PDF_19_2024_Result_515765872160966783">
  <data key="d0">Result</data>
  <data key="d1">CellChat analyses showed the most notable changes in cell signaling occurred among granulosa, stroma A and epithelium CLUs, with an overall increase in the number of interactions and interaction weights from 3 to 9 months of age.</data>
  <data key="d3">CellChat analyses showed the most notable changes in cell signaling occurred among granulosa, stroma A and epithelium CLUs, with an overall increase in the number of interactions and interaction weights from 3 to 9 months of age.</data>
  <data key="d4">PDF_19_2024</data>
</node>
<node id="PDF_19_2024_Result_-4358298089521080577">
  <data key="d0">Result</data>
  <data key="d1">The biggest difference in abundance with age was in a SCL containing Type 1 lymphoid cells, as defined by the expression of Tbx21 and Ifng.</data>
  <data key="d3">The biggest difference in abundance with age was in a SCL containing Type 1 lymphoid cells, as defined by the expression of Tbx21 and Ifng.</data>
  <data key="d4">PDF_19_2024</data>
</node>
<node id="PDF_19_2024_Result_-1156351625628116488">
  <data key="d0">Result</data>
  <data key="d1">Another SCL that significantly increased with age contained Type 17 lymphoid cells, as defined by the expression of Rorc and expression of Zbtb16.</data>
  <data key="d3">Another SCL that significantly increased with age contained Type 17 lymphoid cells, as defined by the expression of Rorc and expression of Zbtb16.</data>
  <data key="d4">PDF_19_2024</data>
</node>
<node id="PDF_19_2024_Result_1380383517768903962">
  <data key="d0">Result</data>
  <data key="d1">the percentage of CD4+ T cells was also increased within the aged ovary</data>
  <data key="d3">the percentage of CD4+ T cells was also increased within the aged ovary</data>
  <data key="d4">PDF_19_2024</data>
</node>
<node id="PDF_19_2024_Result_2989690524569484653">
  <data key="d0">Result</data>
  <data key="d1">One SCL, which was present only in the aged ovaries, was identified as monocytes that express CD300e</data>
  <data key="d3">One SCL, which was present only in the aged ovaries, was identified as monocytes that express CD300e</data>
  <data key="d4">PDF_19_2024</data>
</node>
<node id="PDF_19_2024_Result_-2658558350534186415">
  <data key="d0">Result</data>
  <data key="d1">we observed a higher percentage and number of CD90+ cells (T cells and innate lymphoid cells) in aged ovaries</data>
  <data key="d3">we observed a higher percentage and number of CD90+ cells (T cells and innate lymphoid cells) in aged ovaries</data>
  <data key="d4">PDF_19_2024</data>
</node>
<node id="PDF_19_2024_Result_2770669046705338483">
  <data key="d0">Result</data>
  <data key="d1">we observed an increase in the percentage of CD8+ T cells, 'double-negative αẞ T cells' (DNs), MAIT cells, NKT cells and y8Ts and a decrease in CD4+ αẞ T cells and innate lymphoid cells in aged ovaries</data>
  <data key="d3">we observed an increase in the percentage of CD8+ T cells, 'double-negative αẞ T cells' (DNs), MAIT cells, NKT cells and y8Ts and a decrease in CD4+ αẞ T cells and innate lymphoid cells in aged ovaries</data>
  <data key="d4">PDF_19_2024</data>
</node>
<node id="PDF_50_2022">
  <data key="d0">Paper</data>
  <data key="d1">Here is the complete text from the scientific PDF, as requested:

© 2022. Published by The Company of Biologists Ltd | Journal of Cell Science (2022) 135, jcs259807. doi:10.1242/jcs.259807
The Company of
Biologists
RESEARCH ARTICLE
The prophase oocyte nucleus is a homeostatic G-actin buffer
Kathleen Scheffler¹,*, Federica Giannini¹,*, Tom Lemonnier¹,* and Binyam Mogessie1,2,‡
ABSTRACT
Formation of healthy mammalian eggs from oocytes requires
specialised F-actin structures. F-actin disruption pro</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_50_2022_Result_9053663309313415397">
  <data key="d0">Result</data>
  <data key="d1">Mammalian oocyte nuclei contain prominent F-actin structures.</data>
  <data key="d3">Mammalian oocyte nuclei contain prominent F-actin structures.</data>
  <data key="d4">PDF_50_2022</data>
</node>
<node id="Protein_ACTIN">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">ACTIN</data>
  <data key="d7">Actin</data>
</node>
<node id="PDF_50_2022_Result_4143230277611537497">
  <data key="d0">Result</data>
  <data key="d1">Disruption of the oocyte cytoplasmic actin network by Cytochalasin D treatment triggered excessive nuclear F-actin assembly.</data>
  <data key="d3">Disruption of the oocyte cytoplasmic actin network by Cytochalasin D treatment triggered excessive nuclear F-actin assembly.</data>
  <data key="d4">PDF_50_2022</data>
</node>
<node id="Compound_CYTOCHALASIN D">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">CYTOCHALASIN D</data>
  <data key="d7">Cytochalasin D</data>
</node>
<node id="PDF_50_2022_Result_1421392516057929338">
  <data key="d0">Result</data>
  <data key="d1">High monomeric G-actin concentration is sufficient to induce F-actin polymerisation in oocytes.</data>
  <data key="d3">High monomeric G-actin concentration is sufficient to induce F-actin polymerisation in oocytes.</data>
  <data key="d4">PDF_50_2022</data>
</node>
<node id="PDF_50_2022_Result_-4352656610692023950">
  <data key="d0">Result</data>
  <data key="d1">Maintenance of oocyte cytoplasmic F-actin network organisation requires nuclear import activity</data>
  <data key="d3">Maintenance of oocyte cytoplasmic F-actin network organisation requires nuclear import activity</data>
  <data key="d4">PDF_50_2022</data>
</node>
<node id="PDF_50_2022_Result_3490528895718139935">
  <data key="d0">Result</data>
  <data key="d1">Stable nuclear actin filaments restrict chromatin mobility in oocytes</data>
  <data key="d3">Stable nuclear actin filaments restrict chromatin mobility in oocytes</data>
  <data key="d4">PDF_50_2022</data>
</node>
<node id="PDF_50_2022_Method_5663550644994586893">
  <data key="d0">Method</data>
  <data key="d1">cytoskeletal disruption tools with nuclear import inhibition and high-resolution microscopy assays</data>
  <data key="d3">cytoskeletal disruption tools with nuclear import inhibition and high-resolution microscopy assays</data>
  <data key="d4">PDF_50_2022</data>
</node>
<node id="PDF_50_2022_Result_-6540827287157967320">
  <data key="d0">Result</data>
  <data key="d1">the amount and complexity of nuclear actin filaments declines significantly with increasing reproductive age in females.</data>
  <data key="d3">the amount and complexity of nuclear actin filaments declines significantly with increasing reproductive age in females.</data>
  <data key="d4">PDF_50_2022</data>
</node>
<node id="PDF_50_2022_Result_4249280198473464805">
  <data key="d0">Result</data>
  <data key="d1">nuclei in Latrunculin B-treated oocytes were not more likely to contain actin filaments</data>
  <data key="d3">nuclei in Latrunculin B-treated oocytes were not more likely to contain actin filaments</data>
  <data key="d4">PDF_50_2022</data>
</node>
<node id="Compound_LATRUNCULIN B">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">LATRUNCULIN B</data>
  <data key="d7">Latrunculin B</data>
</node>
<node id="PDF_50_2022_Result_-1062616581953575234">
  <data key="d0">Result</data>
  <data key="d1">blocking nuclear import in oocytes not previously treated with cytoskeletal drugs significantly increases cytoplasmic actin network density</data>
  <data key="d3">blocking nuclear import in oocytes not previously treated with cytoskeletal drugs significantly increases cytoplasmic actin network density</data>
  <data key="d4">PDF_50_2022</data>
</node>
<node id="PDF_55_2023">
  <data key="d0">Paper</data>
  <data key="d1">Here's the full English text extracted from the scientific PDF:

**ARTICLE**

**Riel and Sgn1 form an RNA-binding complex that enforces the meiotic entry cell fate decision**

Alec Gaspary¹, Raphaelle Laureau, Annie Dyatel¹, Gizem Dursuk¹, Yael Simon, and Luke E. Berchowitz¹,2

¹Department of Genetics and Development, Hammer Health Sciences Center, Columbia University Irving Medical Center, New York, NY, USA; ²Taub Institute for Research on Alzheimer's and the Aging Brain, New York, NY, USA.

Co</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_55_2023_Hypothesis_-7297399529364949691">
  <data key="d0">Hypothesis</data>
  <data key="d1">We hypothesized that there may be unknown yeast RBPs that are inessential for vegetative growth but critical for meiosis.</data>
  <data key="d3">We hypothesized that there may be unknown yeast RBPs that are inessential for vegetative growth but critical for meiosis.</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="PDF_55_2023_Method_7859755160455384525">
  <data key="d0">Method</data>
  <data key="d1">We performed a forward genetic screen to determine RNA-binding proteins that affect meiotic entry at the posttranscriptional level.</data>
  <data key="d3">We performed a forward genetic screen to determine RNA-binding proteins that affect meiotic entry at the posttranscriptional level.</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="PDF_55_2023_Method_-2425396665645958323">
  <data key="d0">Method</data>
  <data key="d1">We used Zip1-GFP as a readout for meiotic entry because it is expressed, and localized to the nucleus, specifically during meiotic prophase I.</data>
  <data key="d3">We used Zip1-GFP as a readout for meiotic entry because it is expressed, and localized to the nucleus, specifically during meiotic prophase I.</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="Protein_ZIP1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">ZIP1</data>
  <data key="d7">Zip1</data>
</node>
<node id="PDF_55_2023_Method_965287074836881133">
  <data key="d0">Method</data>
  <data key="d1">We conducted an electrophoretic mobility shift assay (EMSA) using in vitro transcribed IMEI mRNA and recombinant Riel purified from Escherichia coli</data>
  <data key="d3">We conducted an electrophoretic mobility shift assay (EMSA) using in vitro transcribed IMEI mRNA and recombinant Riel purified from Escherichia coli</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="Gene_IME1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">IME1</data>
  <data key="d7">IME1</data>
</node>
<node id="Protein_RIE1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">RIE1</data>
  <data key="d7">RIE1</data>
</node>
<node id="PDF_55_2023_Method_6985826768511820878">
  <data key="d0">Method</data>
  <data key="d1">We immunoprecipified (IPed) Riel from cells in the early stages of meiosis (0, 2 h in SPO) and analyzed bound proteins by quantitative mass spectrometry.</data>
  <data key="d3">We immunoprecipified (IPed) Riel from cells in the early stages of meiosis (0, 2 h in SPO) and analyzed bound proteins by quantitative mass spectrometry.</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="PDF_55_2023_Method_4229599673691626499">
  <data key="d0">Method</data>
  <data key="d1">We performed an early meiotic RNA sequencing (RNA-seq) time course in wild type and riel∆.</data>
  <data key="d3">We performed an early meiotic RNA sequencing (RNA-seq) time course in wild type and riel∆.</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="PDF_55_2023_Method_-6275390675118843695">
  <data key="d0">Method</data>
  <data key="d1">We tested this hypothesis by performing an oligo(dT)/RNase H Northern blot assay in which meiotic mRNA extracted from wild type and rield was incubated with oligo(dT) DNA and then treated with RNase H which cleaves DNA/RNA hybrids.</data>
  <data key="d3">We tested this hypothesis by performing an oligo(dT)/RNase H Northern blot assay in which meiotic mRNA extracted from wild type and rield was incubated with oligo(dT) DNA and then treated with RNase H which cleaves DNA/RNA hybrids.</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="PDF_55_2023_Result_8446244206931902213">
  <data key="d0">Result</data>
  <data key="d1">Our screen revealed several candidates with meiotic entry phenotypes, the most significant being RIE1, which encodes an RRM-containing protein.</data>
  <data key="d3">Our screen revealed several candidates with meiotic entry phenotypes, the most significant being RIE1, which encodes an RRM-containing protein.</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="Gene_RIE1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">RIE1</data>
  <data key="d7">RIE1</data>
</node>
<node id="PDF_55_2023_Result_9141560154520856217">
  <data key="d0">Result</data>
  <data key="d1">We demonstrate that Rie1 binds RNA, is associated with the translational machinery, and acts posttranscriptionally to enhance protein levels of the master transcription factor Ime1 in sporulation conditions.</data>
  <data key="d3">We demonstrate that Rie1 binds RNA, is associated with the translational machinery, and acts posttranscriptionally to enhance protein levels of the master transcription factor Ime1 in sporulation conditions.</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="Protein_IME1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">IME1</data>
  <data key="d7">IME1</data>
</node>
<node id="PDF_55_2023_Result_5511359331068376327">
  <data key="d0">Result</data>
  <data key="d1">We also identified a physical binding partner of Rie1, Sgn1, which is another RRM-containing protein that plays a role in timely Ime1 expression.</data>
  <data key="d3">We also identified a physical binding partner of Rie1, Sgn1, which is another RRM-containing protein that plays a role in timely Ime1 expression.</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="Protein_SGN1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">SGN1</data>
  <data key="d7">Sgn1</data>
</node>
<node id="PDF_55_2023_Result_-7167181583136772137">
  <data key="d0">Result</data>
  <data key="d1">We demonstrate that these proteins act independently of cell size regulation pathways to promote meiotic entry.</data>
  <data key="d3">We demonstrate that these proteins act independently of cell size regulation pathways to promote meiotic entry.</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="PDF_55_2023_Result_-5570488036322490938">
  <data key="d0">Result</data>
  <data key="d1">The most severe entry mutant we observed was riel∆, which showed ~15% of cells entering meiotic prophase at 6 h</data>
  <data key="d3">The most severe entry mutant we observed was riel∆, which showed ~15% of cells entering meiotic prophase at 6 h</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="PDF_55_2023_Result_-2132393861908106677">
  <data key="d0">Result</data>
  <data key="d1">RIEI (also called WHI8) encodes a protein harboring three predicted RRMs and three intrinsically disordered regions.</data>
  <data key="d3">RIEI (also called WHI8) encodes a protein harboring three predicted RRMs and three intrinsically disordered regions.</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="Gene_RIEI">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">RIEI</data>
  <data key="d7">RIEI</data>
</node>
<node id="PDF_55_2023_Result_1289278742648875670">
  <data key="d0">Result</data>
  <data key="d1">We confirmed that Riel binds RNA and that point mutation of RNP motifs within RRM2 and RRM3 affected RNA binding capacity</data>
  <data key="d3">We confirmed that Riel binds RNA and that point mutation of RNP motifs within RRM2 and RRM3 affected RNA binding capacity</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="PDF_55_2023_Result_-6502481849591628661">
  <data key="d0">Result</data>
  <data key="d1">We found that Imel, Ime2, and Ime4 protein levels were all decreased in riel∆.</data>
  <data key="d3">We found that Imel, Ime2, and Ime4 protein levels were all decreased in riel∆.</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="Protein_IME2">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">IME2</data>
  <data key="d7">Ime2</data>
</node>
<node id="Protein_IME4">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">IME4</data>
  <data key="d7">Ime4</data>
</node>
<node id="PDF_55_2023_Result_-3776375590943808273">
  <data key="d0">Result</data>
  <data key="d1">We found that Riel binds IMEI mRNA compared with a control protein, bovine serum albumin (BSA), which does not bind.</data>
  <data key="d3">We found that Riel binds IMEI mRNA compared with a control protein, bovine serum albumin (BSA), which does not bind.</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="PDF_55_2023_Result_-2000097215023003340">
  <data key="d0">Result</data>
  <data key="d1">We found that the riel cln3∆ double mutant did not rescue the riel∆ meiotic entry defect</data>
  <data key="d3">We found that the riel cln3∆ double mutant did not rescue the riel∆ meiotic entry defect</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="Gene_CLN3">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CLN3</data>
  <data key="d7">CLN3</data>
</node>
<node id="PDF_55_2023_Result_8091112206004911021">
  <data key="d0">Result</data>
  <data key="d1">We observed a pronounced buildup of 80S monosome peaks in riel∆ compared to wild type cells throughout meiosis</data>
  <data key="d3">We observed a pronounced buildup of 80S monosome peaks in riel∆ compared to wild type cells throughout meiosis</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="PDF_55_2023_Result_1822898770823356325">
  <data key="d0">Result</data>
  <data key="d1">We observed increased abundance of Riel in actively translating fractions (i.e., ribosomes and polysomes) in the crosslinked samples throughout pre-meiotic S-phase.</data>
  <data key="d3">We observed increased abundance of Riel in actively translating fractions (i.e., ribosomes and polysomes) in the crosslinked samples throughout pre-meiotic S-phase.</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="PDF_55_2023_Result_6872771938282106607">
  <data key="d0">Result</data>
  <data key="d1">We found that presence or absence of Riel did not affect poly(A) tail length of IMEI</data>
  <data key="d3">We found that presence or absence of Riel did not affect poly(A) tail length of IMEI</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="PDF_55_2023_Result_154397273689384569">
  <data key="d0">Result</data>
  <data key="d1">The most highly enriched protein was another RNA-binding protein Sgnl which harbors significant similarity to the translation initiation factor eIF4B</data>
  <data key="d3">The most highly enriched protein was another RNA-binding protein Sgnl which harbors significant similarity to the translation initiation factor eIF4B</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="PDF_55_2023_Result_8406670794663616537">
  <data key="d0">Result</data>
  <data key="d1">We validated the interaction between Riel and Sgn1 by reciprocal co-IP in which FLAG-tagged Sgnl was pulled down and co-purified V5-tagged Riel abundance was measured by immunoblot</data>
  <data key="d3">We validated the interaction between Riel and Sgn1 by reciprocal co-IP in which FLAG-tagged Sgnl was pulled down and co-purified V5-tagged Riel abundance was measured by immunoblot</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="PDF_55_2023_Result_2861793387886563837">
  <data key="d0">Result</data>
  <data key="d1">We found that both riel∆ and sgnl∆ exhibited decreased Imel protein levels without corresponding downregulation of IMEI mRNA levels</data>
  <data key="d3">We found that both riel∆ and sgnl∆ exhibited decreased Imel protein levels without corresponding downregulation of IMEI mRNA levels</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="PDF_55_2023_Result_-5200047256938123750">
  <data key="d0">Result</data>
  <data key="d1">We found that Sgnl binds IME1 mRNA compared with the BSA control</data>
  <data key="d3">We found that Sgnl binds IME1 mRNA compared with the BSA control</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="PDF_55_2023_Result_-4725397333331610063">
  <data key="d0">Result</data>
  <data key="d1">In support of our model, we found that riel predicted interface mutations partially disrupted the physical interaction between Riel and Sgnl.</data>
  <data key="d3">In support of our model, we found that riel predicted interface mutations partially disrupted the physical interaction between Riel and Sgnl.</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="PDF_55_2023_Result_-9070251541271095943">
  <data key="d0">Result</data>
  <data key="d1">We found that riel D429A-S433A-S435A mutants exhibited defective Imel accumulation and delayed appearance of bi- and tetranucleate cells compared with wild type</data>
  <data key="d3">We found that riel D429A-S433A-S435A mutants exhibited defective Imel accumulation and delayed appearance of bi- and tetranucleate cells compared with wild type</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="PDF_55_2023_Conclusion_8047974710545712584">
  <data key="d0">Conclusion</data>
  <data key="d1">We propose a model explaining how constitutively expressed RNA-binding proteins, such as Rie1 and Sgn1, can act in cell fate decisions both as switch-like enforcers and as repressors of spurious cell fate activation.</data>
  <data key="d3">We propose a model explaining how constitutively expressed RNA-binding proteins, such as Rie1 and Sgn1, can act in cell fate decisions both as switch-like enforcers and as repressors of spurious cell fate activation.</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="PDF_55_2023_Conclusion_-9154970192273007236">
  <data key="d0">Conclusion</data>
  <data key="d1">Our results support a model in which Riel and Sgnl act directly to promote meiotic entry as switch-like enforcers while also playing an indirect role to repress spurious meiotic entry.</data>
  <data key="d3">Our results support a model in which Riel and Sgnl act directly to promote meiotic entry as switch-like enforcers while also playing an indirect role to repress spurious meiotic entry.</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="PDF_55_2023_Conclusion_-8764603628917911994">
  <data key="d0">Conclusion</data>
  <data key="d1">Our results support the idea that after promeiotic signaling cues, Riel and Sgn1 posttranscriptionally enhance Imel accumulation, thus contributing to timely meiotic entry.</data>
  <data key="d3">Our results support the idea that after promeiotic signaling cues, Riel and Sgn1 posttranscriptionally enhance Imel accumulation, thus contributing to timely meiotic entry.</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="PDF_55_2023_Conclusion_-5740230014961952256">
  <data key="d0">Conclusion</data>
  <data key="d1">Taken together, our results support a model in which Riel and Sgnl form a complex that acts to enforce the meiotic cell fate decision.</data>
  <data key="d3">Taken together, our results support a model in which Riel and Sgnl form a complex that acts to enforce the meiotic cell fate decision.</data>
  <data key="d4">PDF_55_2023</data>
</node>
<node id="PDF_02_2017">
  <data key="d0">Paper</data>
  <data key="d1">LTH &amp; HUMAN SERVICES-US,
Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript
HHS Public Access
Author manuscript
Trends Genet. Author manuscript; available in PMC 2018 November 01.
Published in final edited form as:
Trends Genet. 2017 November ; 33(11): 817–831. doi:10.1016/j.tig.2017.07.011.
Transposable element domestication as an adaptation to
evolutionary conflicts
Diwash Jangam¹, Cédric Feschotte2,3, and Esther Betrán¹
1Department of Biology, University of Texas at Arlin</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_02_2017_Result_-3107892441378934828">
  <data key="d0">Result</data>
  <data key="d1">the catalytic core of RAG1, the protein that is responsible for cleavage activity, is a domesticated transposase derived from an ancient lineage of DNA transposons dubbed Transib.</data>
  <data key="d3">the catalytic core of RAG1, the protein that is responsible for cleavage activity, is a domesticated transposase derived from an ancient lineage of DNA transposons dubbed Transib.</data>
  <data key="d4">PDF_02_2017</data>
</node>
<node id="Protein_RAG1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">RAG1</data>
  <data key="d7">RAG1</data>
</node>
<node id="Gene_TRANSIB">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">TRANSIB</data>
  <data key="d7">Transib</data>
</node>
<node id="PDF_02_2017_Result_-941646995600860486">
  <data key="d0">Result</data>
  <data key="d1">RAG2 also was shown to have TE origins and several lines of evidence suggested that both RAG1 and RAG2 were domesticated from the same ancestral Transib element</data>
  <data key="d3">RAG2 also was shown to have TE origins and several lines of evidence suggested that both RAG1 and RAG2 were domesticated from the same ancestral Transib element</data>
  <data key="d4">PDF_02_2017</data>
</node>
<node id="Protein_RAG2">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">RAG2</data>
  <data key="d7">RAG2</data>
</node>
<node id="PDF_02_2017_Result_-6604700396540919516">
  <data key="d0">Result</data>
  <data key="d1">Cas1, the most prominent Cas protein found in CRISPR-Cas systems, shares sequence similarity to the transposases encoded by a group of TEs called Casposons</data>
  <data key="d3">Cas1, the most prominent Cas protein found in CRISPR-Cas systems, shares sequence similarity to the transposases encoded by a group of TEs called Casposons</data>
  <data key="d4">PDF_02_2017</data>
</node>
<node id="Protein_CAS1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">CAS1</data>
  <data key="d7">Cas1</data>
</node>
<node id="Gene_CASPOSONS">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CASPOSONS</data>
  <data key="d7">Casposons</data>
</node>
<node id="PDF_02_2017_Result_-2908174313700732147">
  <data key="d0">Result</data>
  <data key="d1">Cas9-like proteins, which act as effectors in most class 2 systems, show sequence similarity to proteins called TnpB, which are poorly characterized but are commonly found in both autonomous and non-autonomous TEs</data>
  <data key="d3">Cas9-like proteins, which act as effectors in most class 2 systems, show sequence similarity to proteins called TnpB, which are poorly characterized but are commonly found in both autonomous and non-autonomous TEs</data>
  <data key="d4">PDF_02_2017</data>
</node>
<node id="Protein_TNPB">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">TNPB</data>
  <data key="d7">TnpB</data>
</node>
<node id="PDF_02_2017_Result_-3802694399909305599">
  <data key="d0">Result</data>
  <data key="d1">Several proteins derived from the Envelope (Env) gene of endogenous retroviruses are known to aid in the protection of the host cell by restricting infection of related retroviruses</data>
  <data key="d3">Several proteins derived from the Envelope (Env) gene of endogenous retroviruses are known to aid in the protection of the host cell by restricting infection of related retroviruses</data>
  <data key="d4">PDF_02_2017</data>
</node>
<node id="Protein_ENV">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">ENV</data>
  <data key="d7">Env</data>
</node>
<node id="PDF_02_2017_Result_-6156591111013576281">
  <data key="d0">Result</data>
  <data key="d1">the Gag proteins encoded by endogenous retroviruses can also be coopted for restricting retroviral infection. A classic example is the mouse Fvl gene which is derived from the Gag gene of a member of the endogenous retrovirus family ERV-L</data>
  <data key="d3">the Gag proteins encoded by endogenous retroviruses can also be coopted for restricting retroviral infection. A classic example is the mouse Fvl gene which is derived from the Gag gene of a member of the endogenous retrovirus family ERV-L</data>
  <data key="d4">PDF_02_2017</data>
</node>
<node id="Gene_FVL">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">FVL</data>
  <data key="d7">Fvl</data>
</node>
<node id="Gene_ERV-L">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ERV-L</data>
  <data key="d7">ERV-L</data>
</node>
<node id="PDF_02_2017_Result_9190923915707991205">
  <data key="d0">Result</data>
  <data key="d1">three transposase-derived proteins (Abp1, Cbh1 and Cbh2) originated from pogo transposons have taken on partially overlapping function in controlling unrelated retrotransposons called Tf2 elements. These domesticated proteins have been reported to transcriptionally silence Tf2 retrotransposons by tethering histone deacetylases to the long terminal repeats of these elements, which also prevents the chromosomal integration of Tf2 elements via homologous recombination</data>
  <data key="d3">three transposase-derived proteins (Abp1, Cbh1 and Cbh2) originated from pogo transposons have taken on partially overlapping function in controlling unrelated retrotransposons called Tf2 elements. These domesticated proteins have been reported to transcriptionally silence Tf2 retrotransposons by tethering histone deacetylases to the long terminal repeats of these elements, which also prevents the chromosomal integration of Tf2 elements via homologous recombination</data>
  <data key="d4">PDF_02_2017</data>
</node>
<node id="Protein_ABP1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">ABP1</data>
  <data key="d7">Abp1</data>
</node>
<node id="Protein_CBH1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">CBH1</data>
  <data key="d7">Cbh1</data>
</node>
<node id="Protein_CBH2">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">CBH2</data>
  <data key="d7">Cbh2</data>
</node>
<node id="PDF_02_2017_Result_-3099137440932832607">
  <data key="d0">Result</data>
  <data key="d1">In Arabidopsis, two genes MAIL1 and MAIN encode related proteins that appear to be evolutionarily derived from a subset of Ty3/gypsy retrotransposons found in angiosperms. Genetic loss of these genes resulted in impaired condensation of pericentromeric heterochromatin and upregulation of TE transcription suggesting their protein products are acting as transcriptional repressors</data>
  <data key="d3">In Arabidopsis, two genes MAIL1 and MAIN encode related proteins that appear to be evolutionarily derived from a subset of Ty3/gypsy retrotransposons found in angiosperms. Genetic loss of these genes resulted in impaired condensation of pericentromeric heterochromatin and upregulation of TE transcription suggesting their protein products are acting as transcriptional repressors</data>
  <data key="d4">PDF_02_2017</data>
</node>
<node id="Gene_MAIL1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">MAIL1</data>
  <data key="d7">MAIL1</data>
</node>
<node id="Gene_MAIN">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">MAIN</data>
  <data key="d7">MAIN</data>
</node>
<node id="PDF_02_2017_Result_-3105073551788762154">
  <data key="d0">Result</data>
  <data key="d1">ALP1 is another domesticated TE protein identified in Arabidopsis that is involved in yet another epigenetic silencing pathway. ALP1 directly derives from a PIF-like transposase and antagonizes silencing through a direct interaction with the Polycomb Repressor Complex 2 (PRC2), which is known to contribute to TE silencing in Arabidopsis</data>
  <data key="d3">ALP1 is another domesticated TE protein identified in Arabidopsis that is involved in yet another epigenetic silencing pathway. ALP1 directly derives from a PIF-like transposase and antagonizes silencing through a direct interaction with the Polycomb Repressor Complex 2 (PRC2), which is known to contribute to TE silencing in Arabidopsis</data>
  <data key="d4">PDF_02_2017</data>
</node>
<node id="Protein_ALP1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">ALP1</data>
  <data key="d7">ALP1</data>
</node>
<node id="Gene_PIF">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">PIF</data>
  <data key="d7">PIF</data>
</node>
<node id="Protein_PRC2">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">PRC2</data>
  <data key="d7">PRC2</data>
</node>
<node id="PDF_02_2017_Result_-2370930132198879483">
  <data key="d0">Result</data>
  <data key="d1">LINE-1 type Transposase Domain-containing 1 (L1TD1) was coopted in the ancestor of placental mammals from the ORF1 coding region of long interspersed nuclear elements LINE-1 (or L1s), one of the most abundant and persistent TE families in mammalian genomes</data>
  <data key="d3">LINE-1 type Transposase Domain-containing 1 (L1TD1) was coopted in the ancestor of placental mammals from the ORF1 coding region of long interspersed nuclear elements LINE-1 (or L1s), one of the most abundant and persistent TE families in mammalian genomes</data>
  <data key="d4">PDF_02_2017</data>
</node>
<node id="Protein_L1TD1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">L1TD1</data>
  <data key="d7">L1TD1</data>
</node>
<node id="Gene_LINE-1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">LINE-1</data>
  <data key="d7">LINE-1</data>
</node>
<node id="PDF_02_2017_Result_2425718710238733499">
  <data key="d0">Result</data>
  <data key="d1">Paramecium uses PiggyMac (Pgm), a domesticated transposase, while in Tetrahymena at least four other transposase-derived proteins (TPB2, TPB1, TBP6, and Lia5) are required for IES removal</data>
  <data key="d3">Paramecium uses PiggyMac (Pgm), a domesticated transposase, while in Tetrahymena at least four other transposase-derived proteins (TPB2, TPB1, TBP6, and Lia5) are required for IES removal</data>
  <data key="d4">PDF_02_2017</data>
</node>
<node id="Protein_PIGGYMAC">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">PIGGYMAC</data>
  <data key="d7">PiggyMac</data>
</node>
<node id="Protein_TPB2">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">TPB2</data>
  <data key="d7">TPB2</data>
</node>
<node id="Protein_TPB1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">TPB1</data>
  <data key="d7">TPB1</data>
</node>
<node id="Protein_TBP6">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">TBP6</data>
  <data key="d7">TBP6</data>
</node>
<node id="Protein_LIA5">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">LIA5</data>
  <data key="d7">Lia5</data>
</node>
<node id="PDF_02_2017_Result_-2598866984362038171">
  <data key="d0">Result</data>
  <data key="d1">the prp8 protein, which is an integral component of the spliceosomal complex, displays significant sequence similarity with reverse transcriptases and as such has been proposed to derive from an anciently domesticated retroelement</data>
  <data key="d3">the prp8 protein, which is an integral component of the spliceosomal complex, displays significant sequence similarity with reverse transcriptases and as such has been proposed to derive from an anciently domesticated retroelement</data>
  <data key="d4">PDF_02_2017</data>
</node>
<node id="Protein_PRP8">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">PRP8</data>
  <data key="d7">prp8</data>
</node>
<node id="PDF_02_2017_Result_-2859377263582660909">
  <data key="d0">Result</data>
  <data key="d1">Syncytins are proteins derived from the Env gene of retroviruses that have been coopted at least nine times during mammal evolution and are thought to play a role in placentation</data>
  <data key="d3">Syncytins are proteins derived from the Env gene of retroviruses that have been coopted at least nine times during mammal evolution and are thought to play a role in placentation</data>
  <data key="d4">PDF_02_2017</data>
</node>
<node id="Protein_SYNCYTINS">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">SYNCYTINS</data>
  <data key="d7">Syncytins</data>
</node>
<node id="PDF_02_2017_Hypothesis_1810271745774392349">
  <data key="d0">Hypothesis</data>
  <data key="d1">Expanding upon this idea, we propose a model in which the dimorphic nuclei system of ciliates fosters the evolution of TEs that are specifically expressed during the transition from MIC to MAC as to be excised during that transition, which would minimize their deleterious impact and lead to their eventual domestication</data>
  <data key="d3">Expanding upon this idea, we propose a model in which the dimorphic nuclei system of ciliates fosters the evolution of TEs that are specifically expressed during the transition from MIC to MAC as to be excised during that transition, which would minimize their deleterious impact and lead to their eventual domestication</data>
  <data key="d4">PDF_02_2017</data>
</node>
<node id="Gene_TES">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">TES</data>
  <data key="d7">TEs</data>
</node>
<node id="PDF_08_2021">
  <data key="d0">Paper</data>
  <data key="d1">Check for updates
Therapeutic Advances in Neurological Disorders
Autoimmune Neurology Special Collection
Review
Paraneoplastic neurological syndromes:
clinical presentations and management
Michelle F. Devine, Naga Kothapalli, Mahmoud Elkhooly and Divyanshu Dubey D
Abstract: We provide an overview of the varied presentations of paraneoplastic neurological
syndromes. We also review the onconeural antibodies and their particular oncological and
neurological associations. Recognition of these syndro</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_08_2021_Result_7408030357536987208">
  <data key="d0">Result</data>
  <data key="d1">ANNA-1 or "anti-Hu" has been described with various paraneoplastic manifestations including sensory neuronopathy, gastroparesis, and limbic encephalitis.</data>
  <data key="d3">ANNA-1 or "anti-Hu" has been described with various paraneoplastic manifestations including sensory neuronopathy, gastroparesis, and limbic encephalitis.</data>
  <data key="d4">PDF_08_2021</data>
</node>
<node id="Protein_ANNA-1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">ANNA-1</data>
  <data key="d7">ANNA-1</data>
</node>
<node id="PDF_08_2021_Result_-1323406727949833849">
  <data key="d0">Result</data>
  <data key="d1">The most common clinical syndrome associated with PCA-1 IgG is paraneoplastic cerebellar degeneration (PCD).</data>
  <data key="d3">The most common clinical syndrome associated with PCA-1 IgG is paraneoplastic cerebellar degeneration (PCD).</data>
  <data key="d4">PDF_08_2021</data>
</node>
<node id="Protein_PCA-1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">PCA-1</data>
  <data key="d7">PCA-1</data>
</node>
<node id="PDF_08_2021_Result_-5141428779280669527">
  <data key="d0">Result</data>
  <data key="d1">CRMP5 IgG has been described in association with paraneoplastic peripheral neuropathy, cranial neuropathy, gastroparesis, encephalitis, cerebellar ataxia, myelopathy, and chorea.</data>
  <data key="d3">CRMP5 IgG has been described in association with paraneoplastic peripheral neuropathy, cranial neuropathy, gastroparesis, encephalitis, cerebellar ataxia, myelopathy, and chorea.</data>
  <data key="d4">PDF_08_2021</data>
</node>
<node id="Protein_CRMP5">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">CRMP5</data>
  <data key="d7">CRMP5</data>
</node>
<node id="PDF_08_2021_Result_5145968416737818844">
  <data key="d0">Result</data>
  <data key="d1">Paraneoplastic limbic and/or diencephalic encephalitis is the typical clinical phenotype associated with Ma2 IgG.</data>
  <data key="d3">Paraneoplastic limbic and/or diencephalic encephalitis is the typical clinical phenotype associated with Ma2 IgG.</data>
  <data key="d4">PDF_08_2021</data>
</node>
<node id="Protein_MA2">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">MA2</data>
  <data key="d7">Ma2</data>
</node>
<node id="PDF_08_2021_Result_-348523210398706426">
  <data key="d0">Result</data>
  <data key="d1">Amphiphysin IgG was initially described in women with paraneoplastic stiff person syndrome and breast cancer.</data>
  <data key="d3">Amphiphysin IgG was initially described in women with paraneoplastic stiff person syndrome and breast cancer.</data>
  <data key="d4">PDF_08_2021</data>
</node>
<node id="Protein_AMPHIPHYSIN">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">AMPHIPHYSIN</data>
  <data key="d7">Amphiphysin</data>
</node>
<node id="PDF_08_2021_Result_-6934201791794996677">
  <data key="d0">Result</data>
  <data key="d1">SOX1 antibodies have been described in association with PNS and small-cell cancer, especially Lambert-Eaton myasthenic syndrome (LEMS).</data>
  <data key="d3">SOX1 antibodies have been described in association with PNS and small-cell cancer, especially Lambert-Eaton myasthenic syndrome (LEMS).</data>
  <data key="d4">PDF_08_2021</data>
</node>
<node id="Gene_SOX1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SOX1</data>
  <data key="d7">SOX1</data>
</node>
<node id="PDF_08_2021_Result_334940822866829859">
  <data key="d0">Result</data>
  <data key="d1">KLHL11 is a novel onconeural antibody associated with rhombencephalitis phenotype (brainstem and/or cerebellar involvement) and a few cases of limbic encephalitis with or without rhombencephalitis.</data>
  <data key="d3">KLHL11 is a novel onconeural antibody associated with rhombencephalitis phenotype (brainstem and/or cerebellar involvement) and a few cases of limbic encephalitis with or without rhombencephalitis.</data>
  <data key="d4">PDF_08_2021</data>
</node>
<node id="Protein_KLHL11">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">KLHL11</data>
  <data key="d7">KLHL11</data>
</node>
<node id="PDF_08_2021_Result_-3234471239190793867">
  <data key="d0">Result</data>
  <data key="d1">NFI IgG has been described among patients with PNS, with encephalopathy and/or ataxia as the predominant neurological manifestations.</data>
  <data key="d3">NFI IgG has been described among patients with PNS, with encephalopathy and/or ataxia as the predominant neurological manifestations.</data>
  <data key="d4">PDF_08_2021</data>
</node>
<node id="PDF_08_2021_Result_553740297183743922">
  <data key="d0">Result</data>
  <data key="d1">PDE10A IgG was recently described among seven patients with PNS, with movement disorders as the predominant presentation.</data>
  <data key="d3">PDE10A IgG was recently described among seven patients with PNS, with movement disorders as the predominant presentation.</data>
  <data key="d4">PDF_08_2021</data>
</node>
<node id="PDF_08_2021_Result_-2094195057826103054">
  <data key="d0">Result</data>
  <data key="d1">GABA-B-R encephalitis commonly presents with refractory non-convulsive status epilepticus and/or limbic encephalitis.</data>
  <data key="d3">GABA-B-R encephalitis commonly presents with refractory non-convulsive status epilepticus and/or limbic encephalitis.</data>
  <data key="d4">PDF_08_2021</data>
</node>
<node id="Protein_GABA-B-R">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">GABA-B-R</data>
  <data key="d7">GABA-B-R</data>
</node>
<node id="PDF_08_2021_Result_-1231270748536062013">
  <data key="d0">Result</data>
  <data key="d1">mGlur5 autoantibodies have been described in association with Ophelia syndrome which presents with encephalopathy, mood disturbances, and seizures.</data>
  <data key="d3">mGlur5 autoantibodies have been described in association with Ophelia syndrome which presents with encephalopathy, mood disturbances, and seizures.</data>
  <data key="d4">PDF_08_2021</data>
</node>
<node id="Protein_MGLUR5">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">MGLUR5</data>
  <data key="d7">mGlur5</data>
</node>
<node id="PDF_08_2021_Result_-5487901093502027533">
  <data key="d0">Result</data>
  <data key="d1">Limbic encephalitis is a common neurological presentation for AMPA-R IgG-seropositive cases, though phenotypic variability ranges from minimal symptoms to fulminant panencephalitis.</data>
  <data key="d3">Limbic encephalitis is a common neurological presentation for AMPA-R IgG-seropositive cases, though phenotypic variability ranges from minimal symptoms to fulminant panencephalitis.</data>
  <data key="d4">PDF_08_2021</data>
</node>
<node id="Protein_AMPA-R">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">AMPA-R</data>
  <data key="d7">AMPA-R</data>
</node>
<node id="PDF_08_2021_Result_483480449044224527">
  <data key="d0">Result</data>
  <data key="d1">NMDA-R encephalitis can be associated with a neoplasm in 20-40% of cases.</data>
  <data key="d3">NMDA-R encephalitis can be associated with a neoplasm in 20-40% of cases.</data>
  <data key="d4">PDF_08_2021</data>
</node>
<node id="Protein_NMDA-R">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">NMDA-R</data>
  <data key="d7">NMDA-R</data>
</node>
<node id="PDF_08_2021_Result_-1196288416550912698">
  <data key="d0">Result</data>
  <data key="d1">CASPR2-IgG is associated with thymomas in about 20% of cases, though other tumors have been reported rarely (melanomas).</data>
  <data key="d3">CASPR2-IgG is associated with thymomas in about 20% of cases, though other tumors have been reported rarely (melanomas).</data>
  <data key="d4">PDF_08_2021</data>
</node>
<node id="Protein_CASPR2">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">CASPR2</data>
  <data key="d7">CASPR2</data>
</node>
<node id="PDF_08_2021_Result_-8515337521379246039">
  <data key="d0">Result</data>
  <data key="d1">LGI1-IgG is associated with thymoma in about 5-15% of cases; rare cases of squamous cell lung cancer have also been reported.</data>
  <data key="d3">LGI1-IgG is associated with thymoma in about 5-15% of cases; rare cases of squamous cell lung cancer have also been reported.</data>
  <data key="d4">PDF_08_2021</data>
</node>
<node id="Protein_LGI1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">LGI1</data>
  <data key="d7">LGI1</data>
</node>
<node id="PDF_20_2018">
  <data key="d0">Paper</data>
  <data key="d1">Cell
Article
Retrovirus-like Gag Protein Arc1 Binds RNA and
Traffics across Synaptic Boutons
James Ashley, Benjamin Cordy,
NMJ
Diandra Lucia, Lee G. Fradkin,
Vivian Budnik, Travis Thomson
extracellular
vesicle
multivesicular
body
dArc1 capsid
Correspondence
vivian.budnik@umassmed.edu (V.B.),
travis.thomson@umassmed.edu (T.T.)
immature
synaptic bouton
postsynaptic maturation
synaptic
vesicle
In Brief
darc1 RNA
The neuronal protein Arc is evolutionarily
related to retrotransposon Gag proteins
and </data>
  <data key="d2">2024</data>
</node>
<node id="PDF_20_2018_Hypothesis_2440098807983713505">
  <data key="d0">Hypothesis</data>
  <data key="d1">dArc1 influences synaptic plasticity by utilizing a retroviral-like mechanism for transport between synaptic partners in Drosophila.</data>
  <data key="d3">dArc1 influences synaptic plasticity by utilizing a retroviral-like mechanism for transport between synaptic partners in Drosophila.</data>
  <data key="d4">PDF_20_2018</data>
</node>
<node id="Protein_DARC1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">DARC1</data>
  <data key="d7">dArc1</data>
</node>
<node id="PDF_20_2018_Method_-1955903706452186889">
  <data key="d0">Method</data>
  <data key="d1">Downregulated darc1 exclusively in motorneurons, using the Gal4 driver C380-Gal4 to express UAS-dArc1-RNAi and examined the pre-and postsynaptic levels of dArc1 mRNA via FISH.</data>
  <data key="d3">Downregulated darc1 exclusively in motorneurons, using the Gal4 driver C380-Gal4 to express UAS-dArc1-RNAi and examined the pre-and postsynaptic levels of dArc1 mRNA via FISH.</data>
  <data key="d4">PDF_20_2018</data>
</node>
<node id="Gene_DARC1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">DARC1</data>
  <data key="d7">dArc1</data>
</node>
<node id="PDF_20_2018_Method_2040376082369245937">
  <data key="d0">Method</data>
  <data key="d1">Expressed Rab11 dominant-negative (Rab11-DN) specifically in neurons and examined the levels of darc1 RNA or protein in the postsynaptic region.</data>
  <data key="d3">Expressed Rab11 dominant-negative (Rab11-DN) specifically in neurons and examined the levels of darc1 RNA or protein in the postsynaptic region.</data>
  <data key="d4">PDF_20_2018</data>
</node>
<node id="Protein_RAB11">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">RAB11</data>
  <data key="d7">Rab11</data>
</node>
<node id="PDF_20_2018_Method_-3474688735602539031">
  <data key="d0">Method</data>
  <data key="d1">Expressed a dArc1 transgene in neurons, in a darc1E8/darc1esm113 mutant background.</data>
  <data key="d3">Expressed a dArc1 transgene in neurons, in a darc1E8/darc1esm113 mutant background.</data>
  <data key="d4">PDF_20_2018</data>
</node>
<node id="PDF_20_2018_Result_659502853426524656">
  <data key="d0">Result</data>
  <data key="d1">Expressing dArc1-RNAi in motorneurons resulted in a significant decrease in darc 1 FISH signal, not only at presynaptic boutons, but also at the muscle postsynaptic region.</data>
  <data key="d3">Expressing dArc1-RNAi in motorneurons resulted in a significant decrease in darc 1 FISH signal, not only at presynaptic boutons, but also at the muscle postsynaptic region.</data>
  <data key="d4">PDF_20_2018</data>
</node>
<node id="PDF_20_2018_Result_7699402121336811946">
  <data key="d0">Result</data>
  <data key="d1">Expressing dArc1-RNAi in motorneurons resulted in a significant decrease in dArc1 protein immunoreactive signal, both in pre- and postsynaptic compartments.</data>
  <data key="d3">Expressing dArc1-RNAi in motorneurons resulted in a significant decrease in dArc1 protein immunoreactive signal, both in pre- and postsynaptic compartments.</data>
  <data key="d4">PDF_20_2018</data>
</node>
<node id="PDF_20_2018_Result_8082139644017431996">
  <data key="d0">Result</data>
  <data key="d1">Expressing Rab11 dominant-negative (Rab11-DN) specifically in neurons induced a change in the levels of darc1 RNA and protein in the postsynaptic region, resulting in a significant reduction.</data>
  <data key="d3">Expressing Rab11 dominant-negative (Rab11-DN) specifically in neurons induced a change in the levels of darc1 RNA and protein in the postsynaptic region, resulting in a significant reduction.</data>
  <data key="d4">PDF_20_2018</data>
</node>
<node id="PDF_20_2018_Result_3032866769162580276">
  <data key="d0">Result</data>
  <data key="d1">Expressing a dArc1 transgene lacking the 3' UTR resulted in accumulation of the dArc1 signal in presynaptic terminals, but virtually no signal was observed at the postsynaptic region</data>
  <data key="d3">Expressing a dArc1 transgene lacking the 3' UTR resulted in accumulation of the dArc1 signal in presynaptic terminals, but virtually no signal was observed at the postsynaptic region</data>
  <data key="d4">PDF_20_2018</data>
</node>
<node id="PDF_20_2018_Conclusion_-6414324108582099157">
  <data key="d0">Conclusion</data>
  <data key="d1">darc1 mRNA can be transferred from neurons to postsynaptic muscles in a manner dependent on its 3' UTR.</data>
  <data key="d3">darc1 mRNA can be transferred from neurons to postsynaptic muscles in a manner dependent on its 3' UTR.</data>
  <data key="d4">PDF_20_2018</data>
</node>
<node id="PDF_20_2018_Result_-1807613030103283507">
  <data key="d0">Result</data>
  <data key="d1">copia mRNA, a common Drosophila retrotransposon, was highly enriched in S2 EVs</data>
  <data key="d3">copia mRNA, a common Drosophila retrotransposon, was highly enriched in S2 EVs</data>
  <data key="d4">PDF_20_2018</data>
</node>
<node id="Gene_COPIA">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">COPIA</data>
  <data key="d7">Copia</data>
</node>
<node id="PDF_20_2018_Result_4630280045512000566">
  <data key="d0">Result</data>
  <data key="d1">the short Copia protein isoform was enriched in EVs</data>
  <data key="d3">the short Copia protein isoform was enriched in EVs</data>
  <data key="d4">PDF_20_2018</data>
</node>
<node id="Protein_COPIA">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">COPIA</data>
  <data key="d7">Copia</data>
</node>
<node id="PDF_12_2018">
  <data key="d0">Paper</data>
  <data key="d1">Resource
Molecular Cell
Transcriptome Landscape of Human
Folliculogenesis Reveals Oocyte and Granulosa Cell
Interactions
Graphical Abstract
Oocyte
Granulosa cells
Human Ovary Follicle RNA-Seq &amp; Data processing
Primordial Primary Secondary Antral Preovulatory NOTCH3
GJC1
GJA3
GJA1
GJA5
JAG2
KIT
GDF9
KITLG
BMPR2
Interaction
Dynamic gene expression
IGF2, GNRHR2
IGF2R, PRKCA, GFRA1, TSC1
NTRK2, PTEN
mTOR, Neurotrophin
Insulin, GnRH Pathway
Primordial follicle
Primary follicle
Highlights
• RNA-seq of</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_12_2018_Result_8231132027423017619">
  <data key="d0">Result</data>
  <data key="d1">RNA-seq of oocytes and granulosa cells mapped transcriptome and signature genes</data>
  <data key="d3">RNA-seq of oocytes and granulosa cells mapped transcriptome and signature genes</data>
  <data key="d4">PDF_12_2018</data>
</node>
<node id="PDF_12_2018_Result_5148420689062950713">
  <data key="d0">Result</data>
  <data key="d1">KEGG/GSEA analysis uncovered pathways involved in primordial follicle activation</data>
  <data key="d3">KEGG/GSEA analysis uncovered pathways involved in primordial follicle activation</data>
  <data key="d4">PDF_12_2018</data>
</node>
<node id="PDF_12_2018_Result_6134140273532031699">
  <data key="d0">Result</data>
  <data key="d1">Oocyte-granulosa cell interactions exhibit stage- and species-specific patterns</data>
  <data key="d3">Oocyte-granulosa cell interactions exhibit stage- and species-specific patterns</data>
  <data key="d4">PDF_12_2018</data>
</node>
<node id="PDF_12_2018_Result_-5523895506454444793">
  <data key="d0">Result</data>
  <data key="d1">RNA-seq analysis identified candidate secretory biomarkers of ovarian reserve</data>
  <data key="d3">RNA-seq analysis identified candidate secretory biomarkers of ovarian reserve</data>
  <data key="d4">PDF_12_2018</data>
</node>
<node id="PDF_12_2018_Method_-3760152990683898893">
  <data key="d0">Method</data>
  <data key="d1">RNA sequencing (RNA-seq) analysis of human oocytes and corresponding granulosa cells (GCs) spanning five follicular stages</data>
  <data key="d3">RNA sequencing (RNA-seq) analysis of human oocytes and corresponding granulosa cells (GCs) spanning five follicular stages</data>
  <data key="d4">PDF_12_2018</data>
</node>
<node id="PDF_12_2018_Result_5822347928890405041">
  <data key="d0">Result</data>
  <data key="d1">We revealed unique features in transcriptional machinery, transcription factor networks, and reciprocal interactions in human oocytes and GCs that displayed developmental-stage-specific expression patterns.</data>
  <data key="d3">We revealed unique features in transcriptional machinery, transcription factor networks, and reciprocal interactions in human oocytes and GCs that displayed developmental-stage-specific expression patterns.</data>
  <data key="d4">PDF_12_2018</data>
</node>
<node id="PDF_12_2018_Result_7747048996402230001">
  <data key="d0">Result</data>
  <data key="d1">We identified specific gene signatures of two cell types in particular developmental stage that may reflect developmental competency and ovarian reserve.</data>
  <data key="d3">We identified specific gene signatures of two cell types in particular developmental stage that may reflect developmental competency and ovarian reserve.</data>
  <data key="d4">PDF_12_2018</data>
</node>
<node id="PDF_12_2018_Result_9197870052569855966">
  <data key="d0">Result</data>
  <data key="d1">We uncovered key pathways that may concert germline-somatic interactions and drive the transition of primordial-to-primary follicle, which represents follicle activation.</data>
  <data key="d3">We uncovered key pathways that may concert germline-somatic interactions and drive the transition of primordial-to-primary follicle, which represents follicle activation.</data>
  <data key="d4">PDF_12_2018</data>
</node>
<node id="PDF_12_2018_Conclusion_6393039800423848470">
  <data key="d0">Conclusion</data>
  <data key="d1">our work provides key insights into the crucial features of the transcriptional regulation in the stepwise folliculo-genesis and offers important clues for improving follicle recruitment in vivo and restoring fully competent oocytes in vitro.</data>
  <data key="d3">our work provides key insights into the crucial features of the transcriptional regulation in the stepwise folliculo-genesis and offers important clues for improving follicle recruitment in vivo and restoring fully competent oocytes in vitro.</data>
  <data key="d4">PDF_12_2018</data>
</node>
<node id="PDF_12_2018_Result_-2607874180611961521">
  <data key="d0">Result</data>
  <data key="d1">IHC results showed that RBM24 was expressed only at the primordial and primary stages.</data>
  <data key="d3">IHC results showed that RBM24 was expressed only at the primordial and primary stages.</data>
  <data key="d4">PDF_12_2018</data>
</node>
<node id="Gene_RBM24">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">RBM24</data>
  <data key="d7">RBM24</data>
</node>
<node id="PDF_12_2018_Result_-4281626095195189638">
  <data key="d0">Result</data>
  <data key="d1">GPD1 was primarily expressed at the sec-ondary and antral stages.</data>
  <data key="d3">GPD1 was primarily expressed at the sec-ondary and antral stages.</data>
  <data key="d4">PDF_12_2018</data>
</node>
<node id="Gene_GPD1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">GPD1</data>
  <data key="d7">GPD1</data>
</node>
<node id="PDF_12_2018_Result_1420959278330774340">
  <data key="d0">Result</data>
  <data key="d1">NTF4 and LCP2 were specifically ex-pressed at antral stage</data>
  <data key="d3">NTF4 and LCP2 were specifically ex-pressed at antral stage</data>
  <data key="d4">PDF_12_2018</data>
</node>
<node id="Gene_NTF4">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">NTF4</data>
  <data key="d7">NTF4</data>
</node>
<node id="Gene_LCP2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">LCP2</data>
  <data key="d7">LCP2</data>
</node>
<node id="PDF_12_2018_Result_-858661789731053937">
  <data key="d0">Result</data>
  <data key="d1">Notably, the expression levels of ZP2, ZP3, and ZP4 re-mained stable across all stages</data>
  <data key="d3">Notably, the expression levels of ZP2, ZP3, and ZP4 re-mained stable across all stages</data>
  <data key="d4">PDF_12_2018</data>
</node>
<node id="Gene_ZP2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ZP2</data>
  <data key="d7">ZP2</data>
</node>
<node id="Gene_ZP3">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ZP3</data>
  <data key="d7">ZP3</data>
</node>
<node id="Gene_ZP4">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ZP4</data>
  <data key="d7">ZP4</data>
</node>
<node id="PDF_12_2018_Result_-9139940819274568393">
  <data key="d0">Result</data>
  <data key="d1">In contrast to the high expression levels of NANOG and POU5F1 in primordial germ cells (PGCs), the pluripo-tency markers NANOG and POU5F1 were under-expressed in most stages in oocytes</data>
  <data key="d3">In contrast to the high expression levels of NANOG and POU5F1 in primordial germ cells (PGCs), the pluripo-tency markers NANOG and POU5F1 were under-expressed in most stages in oocytes</data>
  <data key="d4">PDF_12_2018</data>
</node>
<node id="Gene_NANOG">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">NANOG</data>
  <data key="d7">NANOG</data>
</node>
<node id="Gene_POU5F1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">POU5F1</data>
  <data key="d7">POU5F1</data>
</node>
<node id="PDF_12_2018_Result_4111218568798351145">
  <data key="d0">Result</data>
  <data key="d1">Majority of genes involved in chiasma formation are expressed during human folliculogenesis</data>
  <data key="d3">Majority of genes involved in chiasma formation are expressed during human folliculogenesis</data>
  <data key="d4">PDF_12_2018</data>
</node>
<node id="PDF_12_2018_Result_-7452455469803940683">
  <data key="d0">Result</data>
  <data key="d1">Relatively high expression levels of DNMT1, DNMT3A, and DNMT3B in the oocytes of all stages with mounting abundance, indicating that the degree of DNA methylation is continually increasing with oocyte maturation</data>
  <data key="d3">Relatively high expression levels of DNMT1, DNMT3A, and DNMT3B in the oocytes of all stages with mounting abundance, indicating that the degree of DNA methylation is continually increasing with oocyte maturation</data>
  <data key="d4">PDF_12_2018</data>
</node>
<node id="Gene_DNMT1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">DNMT1</data>
  <data key="d7">DNMT1</data>
</node>
<node id="Gene_DNMT3A">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">DNMT3A</data>
  <data key="d7">DNMT3A</data>
</node>
<node id="Gene_DNMT3B">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">DNMT3B</data>
  <data key="d7">DNMT3B</data>
</node>
<node id="PDF_12_2018_Result_3918238744266758020">
  <data key="d0">Result</data>
  <data key="d1">Consistent with the results of RNA-seq, the IHC results showed a similar expression pattern of CDCA3, BNIPL, and TST on the ovarian tissues obtained from the RNA-seq sample set</data>
  <data key="d3">Consistent with the results of RNA-seq, the IHC results showed a similar expression pattern of CDCA3, BNIPL, and TST on the ovarian tissues obtained from the RNA-seq sample set</data>
  <data key="d4">PDF_12_2018</data>
</node>
<node id="Gene_CDCA3">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CDCA3</data>
  <data key="d7">CDCA3</data>
</node>
<node id="Gene_BNIPL">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">BNIPL</data>
  <data key="d7">BNIPL</data>
</node>
<node id="Gene_TST">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">TST</data>
  <data key="d7">TST</data>
</node>
<node id="PDF_12_2018_Result_-8986841771365759825">
  <data key="d0">Result</data>
  <data key="d1">Several genes that encode steroidogenic enzymes, including CYP11A1, CYP19A1, HSD17B1, and HSD3B2, were upregu-lated in the antral follicles, with a peak expression level in the pre-ovulatory follicles</data>
  <data key="d3">Several genes that encode steroidogenic enzymes, including CYP11A1, CYP19A1, HSD17B1, and HSD3B2, were upregu-lated in the antral follicles, with a peak expression level in the pre-ovulatory follicles</data>
  <data key="d4">PDF_12_2018</data>
</node>
<node id="Gene_CYP11A1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CYP11A1</data>
  <data key="d7">CYP11A1</data>
</node>
<node id="Gene_CYP19A1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CYP19A1</data>
  <data key="d7">CYP19A1</data>
</node>
<node id="Gene_HSD17B1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">HSD17B1</data>
  <data key="d7">HSD17B1</data>
</node>
<node id="Gene_HSD3B2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">HSD3B2</data>
  <data key="d7">HSD3B2</data>
</node>
<node id="PDF_12_2018_Result_5956478383114071180">
  <data key="d0">Result</data>
  <data key="d1">NR5A1, a key regulator of the steroidogenic enzyme-encoding genes that has been previously described in sheep GCs exhibited an upregulation with the progression of follicular growth</data>
  <data key="d3">NR5A1, a key regulator of the steroidogenic enzyme-encoding genes that has been previously described in sheep GCs exhibited an upregulation with the progression of follicular growth</data>
  <data key="d4">PDF_12_2018</data>
</node>
<node id="Gene_NR5A1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">NR5A1</data>
  <data key="d7">NR5A1</data>
</node>
<node id="PDF_12_2018_Result_2020864101128395712">
  <data key="d0">Result</data>
  <data key="d1">AR, ESR (ESR1 and ESR2), and PGR, encoding for androgen, estrogen, and progesterone hormone receptors, respectively, were expressed in GCs from primary follicles, with the highest expression level in antral follicles.</data>
  <data key="d3">AR, ESR (ESR1 and ESR2), and PGR, encoding for androgen, estrogen, and progesterone hormone receptors, respectively, were expressed in GCs from primary follicles, with the highest expression level in antral follicles.</data>
  <data key="d4">PDF_12_2018</data>
</node>
<node id="Gene_AR">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">AR</data>
  <data key="d7">AR</data>
</node>
<node id="Gene_ESR1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ESR1</data>
  <data key="d7">ESR1</data>
</node>
<node id="Gene_ESR2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ESR2</data>
  <data key="d7">ESR2</data>
</node>
<node id="Gene_PGR">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">PGR</data>
  <data key="d7">PGR</data>
</node>
<node id="PDF_10_2013">
  <data key="d0">Paper</data>
  <data key="d1">Cell Reports
Resource
Cellular Source and Mechanisms
of High Transcriptome Complexity
in the Mammalian Testis
Magali Soumillon,1,2,9,10,* Anamaria Necsulea, 1,2,11 Manuela Weier,¹ David Brawand, 1,2 Xiaolan Zhang, Hongcang Gu, 3
Pauline Barthès, 4 Maria Kokkinaki, 5 Serge Nef, Andreas Gnirke, Martin Dym,5 Bernard de Massy, 4
Tarjei S. Mikkelsen, 3,7,8 and Henrik Kaessmann1,2,*
1Center for Integrative Genomics, University of Lausanne
2Swiss Institute of Bioinformatics
Génopode, CH-1015, Lausanne,</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_10_2013_Result_7660639465545493236">
  <data key="d0">Result</data>
  <data key="d1">Transcription of the genome is substantially more widespread in the testis than in other organs across representative mammals.</data>
  <data key="d3">Transcription of the genome is substantially more widespread in the testis than in other organs across representative mammals.</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_10_2013_Result_-6227014357902030541">
  <data key="d0">Result</data>
  <data key="d1">Meiotic spermatocytes and especially postmeiotic round spermatids have remarkably diverse transcriptomes, which explains the high transcriptome complexity of the testis as a whole.</data>
  <data key="d3">Meiotic spermatocytes and especially postmeiotic round spermatids have remarkably diverse transcriptomes, which explains the high transcriptome complexity of the testis as a whole.</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_10_2013_Result_2989983545862870772">
  <data key="d0">Result</data>
  <data key="d1">Widespread transcriptional activity in spermatocytes and spermatids encompasses protein-coding and long noncoding RNA genes but also poorly conserved intergenic sequences.</data>
  <data key="d3">Widespread transcriptional activity in spermatocytes and spermatids encompasses protein-coding and long noncoding RNA genes but also poorly conserved intergenic sequences.</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_10_2013_Result_8264196092172785362">
  <data key="d0">Result</data>
  <data key="d1">Prevalent transcription is facilitated by an overall permissive chromatin in these germ cells that results from extensive chromatin remodeling.</data>
  <data key="d3">Prevalent transcription is facilitated by an overall permissive chromatin in these germ cells that results from extensive chromatin remodeling.</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_10_2013_Result_7389490728307779516">
  <data key="d0">Result</data>
  <data key="d1">Autosomal protein-coding genes are more frequently transcribed in testis than in other organs.</data>
  <data key="d3">Autosomal protein-coding genes are more frequently transcribed in testis than in other organs.</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_10_2013_Result_5283225216925315128">
  <data key="d0">Result</data>
  <data key="d1">The skew toward testis was even more pronounced for predicted long noncoding RNA genes and the intergenic remainder of the genome, which includes pseudogenes, transposable elements, and other intergenic sequences.</data>
  <data key="d3">The skew toward testis was even more pronounced for predicted long noncoding RNA genes and the intergenic remainder of the genome, which includes pseudogenes, transposable elements, and other intergenic sequences.</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_10_2013_Result_420236917476400032">
  <data key="d0">Result</data>
  <data key="d1">A significantly larger number of autosomal protein-coding genes are transcribed in testis (~18,700) than in brain (~18,000) and liver (~15,500).</data>
  <data key="d3">A significantly larger number of autosomal protein-coding genes are transcribed in testis (~18,700) than in brain (~18,000) and liver (~15,500).</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_10_2013_Result_7996577112299451193">
  <data key="d0">Result</data>
  <data key="d1">Germ cell transcriptomes are also characterized by complex alternative splicing patterns.</data>
  <data key="d3">Germ cell transcriptomes are also characterized by complex alternative splicing patterns.</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_10_2013_Result_-2332817142182407515">
  <data key="d0">Result</data>
  <data key="d1">The difference between testis and other organs in terms of transcript diversity is pronounced for noncoding transcripts.</data>
  <data key="d3">The difference between testis and other organs in terms of transcript diversity is pronounced for noncoding transcripts.</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_10_2013_Result_-4668032360149998449">
  <data key="d0">Result</data>
  <data key="d1">The testis also transcribes larger numbers of intergenic elements compared with other tissues.</data>
  <data key="d3">The testis also transcribes larger numbers of intergenic elements compared with other tissues.</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_10_2013_Result_2987051478517357551">
  <data key="d0">Result</data>
  <data key="d1">Expression-level patterns are strikingly similar between spermatocytes and testis, and between spermatids and testis.</data>
  <data key="d3">Expression-level patterns are strikingly similar between spermatocytes and testis, and between spermatids and testis.</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_10_2013_Result_-6065915869636728351">
  <data key="d0">Result</data>
  <data key="d1">Protein-coding genes located in chromosomal regions that recently experienced segmental duplications in the mouse were more highly expressed in spermatids and spermatocytes (and total testis) relative to the other tissues, when compared with genes in the rest of the genome.</data>
  <data key="d3">Protein-coding genes located in chromosomal regions that recently experienced segmental duplications in the mouse were more highly expressed in spermatids and spermatocytes (and total testis) relative to the other tissues, when compared with genes in the rest of the genome.</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_10_2013_Result_2142565753247946721">
  <data key="d0">Result</data>
  <data key="d1">Retrocopies with truncated open reading frames (retropseudogenes) are transcribed at significantly higher levels in spermatids than in the other tissues.</data>
  <data key="d3">Retrocopies with truncated open reading frames (retropseudogenes) are transcribed at significantly higher levels in spermatids than in the other tissues.</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_10_2013_Result_-8161811732862639655">
  <data key="d0">Result</data>
  <data key="d1">Functional retrocopies (retrogenes) show a striking upregulation in both spermatids and spermatocytes.</data>
  <data key="d3">Functional retrocopies (retrogenes) show a striking upregulation in both spermatids and spermatocytes.</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_10_2013_Result_2613013752129771342">
  <data key="d0">Result</data>
  <data key="d1">Our analyses revealed reduced expression levels of protein-coding genes on the X chromosome in spermatocytes and spermatids, consistent with the action of meiotic sex chromosome inactivation (MSCI).</data>
  <data key="d3">Our analyses revealed reduced expression levels of protein-coding genes on the X chromosome in spermatocytes and spermatids, consistent with the action of meiotic sex chromosome inactivation (MSCI).</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_10_2013_Result_3525795321615417002">
  <data key="d0">Result</data>
  <data key="d1">Genes with Sertoli-cell-specific expression are also significantly enriched on the X for the ancient gene set.</data>
  <data key="d3">Genes with Sertoli-cell-specific expression are also significantly enriched on the X for the ancient gene set.</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_10_2013_Result_406078476358270010">
  <data key="d0">Result</data>
  <data key="d1">Potentially functional IncRNAs, retrogenes, and pseudogenes also show significantly lower promoter CpG methylation levels in the germline (in particular in spermatids) than in brain and liver.</data>
  <data key="d3">Potentially functional IncRNAs, retrogenes, and pseudogenes also show significantly lower promoter CpG methylation levels in the germline (in particular in spermatids) than in brain and liver.</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_10_2013_Result_-1602343731690292095">
  <data key="d0">Result</data>
  <data key="d1">Our analyses revealed significantly higher levels of H3K4me2 around the TSS of protein-coding genes compared with nearby upstream DNA.</data>
  <data key="d3">Our analyses revealed significantly higher levels of H3K4me2 around the TSS of protein-coding genes compared with nearby upstream DNA.</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_10_2013_Conclusion_-7817475420056821586">
  <data key="d0">Conclusion</data>
  <data key="d1">Promiscuous transcriptional activity in the testis is common to amniotes.</data>
  <data key="d3">Promiscuous transcriptional activity in the testis is common to amniotes.</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_10_2013_Conclusion_-5114861423823520268">
  <data key="d0">Conclusion</data>
  <data key="d1">The high transcriptome complexity of the amniote testis stems largely from extensive transcriptional activity in round spermatids and pachytene spermatocytes.</data>
  <data key="d3">The high transcriptome complexity of the amniote testis stems largely from extensive transcriptional activity in round spermatids and pachytene spermatocytes.</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_10_2013_Method_-1154998830364791936">
  <data key="d0">Method</data>
  <data key="d1">Using extensive RNA-seq data</data>
  <data key="d3">Using extensive RNA-seq data</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_10_2013_Method_-6635551054193205326">
  <data key="d0">Method</data>
  <data key="d1">Using mouse as a model system</data>
  <data key="d3">Using mouse as a model system</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_10_2013_Method_2873418557632259137">
  <data key="d0">Method</data>
  <data key="d1">deep-coverage, strand-specific RNA-seq data for the polyadenylated RNA fraction</data>
  <data key="d3">deep-coverage, strand-specific RNA-seq data for the polyadenylated RNA fraction</data>
  <data key="d4">PDF_10_2013</data>
</node>
<node id="PDF_27_2021">
  <data key="d0">Paper</data>
  <data key="d1">Published online 12 October 2020
Nucleic Acids Research, 2021, Vol. 49, Database issue D1311-D1320
doi: 10.1093/nar/gkaa840
Open Targets Genetics: systematic identification of
trait-associated genes using large-scale genetics and
functional genomics
Maya Ghoussaini¹,2, Edward Mountjoy1,2, Miguel Carmona 2,3, Gareth Peat2,3,
Ellen M. Schmidt1,2, Andrew Hercules2,3, Luca Fumis2,3, Alfredo Miranda2,3,
Denise Carvalho-Silva2,3, Annalisa Buniello 2,3, Tony Burdett 2,3, James Hayhurst2,3,
Jarrod Baker</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_27_2021_Result_-1406664229123110075">
  <data key="d0">Result</data>
  <data key="d1">Open Targets Genetics (https://genetics.opentargets.org) is an open-access integrative resource that aggregates human GWAS and functional genomics data including gene expression, protein abundance, chromatin interaction and conformation data from a wide range of cell types and tissues to make robust connections between GWAS-associated loci, variants and likely causal genes.</data>
  <data key="d3">Open Targets Genetics (https://genetics.opentargets.org) is an open-access integrative resource that aggregates human GWAS and functional genomics data including gene expression, protein abundance, chromatin interaction and conformation data from a wide range of cell types and tissues to make robust connections between GWAS-associated loci, variants and likely causal genes.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Result_2449857216096601196">
  <data key="d0">Result</data>
  <data key="d1">Open Targets Genetics can be searched by variant, gene or study/phenotype.</data>
  <data key="d3">Open Targets Genetics can be searched by variant, gene or study/phenotype.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Result_-4530820129589716056">
  <data key="d0">Result</data>
  <data key="d1">It offers tools that enable users to prioritise causal variants and genes at disease-associated loci and access systematic cross-disease and disease-molecular trait colocalization analysis across 92 cell types and tissues including the eQTL Catalogue.</data>
  <data key="d3">It offers tools that enable users to prioritise causal variants and genes at disease-associated loci and access systematic cross-disease and disease-molecular trait colocalization analysis across 92 cell types and tissues including the eQTL Catalogue.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Result_6733583506875309280">
  <data key="d0">Result</data>
  <data key="d1">Data visualizations such as Manhattan-like plots, regional plots, credible sets overlap between studies and PheWAS plots enable users to explore GWAS signals in depth.</data>
  <data key="d3">Data visualizations such as Manhattan-like plots, regional plots, credible sets overlap between studies and PheWAS plots enable users to explore GWAS signals in depth.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Result_-8602808043301586197">
  <data key="d0">Result</data>
  <data key="d1">The integrated data is made available through the web portal, for bulk download and via a GraphQL API, and the software is open source.</data>
  <data key="d3">The integrated data is made available through the web portal, for bulk download and via a GraphQL API, and the software is open source.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Result_2301375868642044250">
  <data key="d0">Result</data>
  <data key="d1">Applications of this integrated data include identification of novel targets for drug discovery and drug repurposing.</data>
  <data key="d3">Applications of this integrated data include identification of novel targets for drug discovery and drug repurposing.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Result_-3381954708418817692">
  <data key="d0">Result</data>
  <data key="d1">Drugs with targets that have underlying genetic evidence for disease association have been shown to be twice as likely to succeed in clinical development.</data>
  <data key="d3">Drugs with targets that have underlying genetic evidence for disease association have been shown to be twice as likely to succeed in clinical development.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Method_-8976447147640461678">
  <data key="d0">Method</data>
  <data key="d1">We developed Open Targets Genetics (https://genetics.opentargets.org), an open-access integrative resource that enables statistical genetics and functional genomics scientists to translate signals from Genome Wide Association Studies (GWAS) and Biobank data into target gene(s) across thousands of traits genome-wide using a workflow suited to their needs.</data>
  <data key="d3">We developed Open Targets Genetics (https://genetics.opentargets.org), an open-access integrative resource that enables statistical genetics and functional genomics scientists to translate signals from Genome Wide Association Studies (GWAS) and Biobank data into target gene(s) across thousands of traits genome-wide using a workflow suited to their needs.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Result_2880652585661967698">
  <data key="d0">Result</data>
  <data key="d1">The portal contains genetic and functional genomics data from a wide range of repositories and datasets, as well as additional data analyses generated internally using robust statistical methods.</data>
  <data key="d3">The portal contains genetic and functional genomics data from a wide range of repositories and datasets, as well as additional data analyses generated internally using robust statistical methods.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Result_2438720786959728430">
  <data key="d0">Result</data>
  <data key="d1">The data integrated into Open Targets Genetics can be searched by gene, variant or trait/disease.</data>
  <data key="d3">The data integrated into Open Targets Genetics can be searched by gene, variant or trait/disease.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Result_3841224437418375056">
  <data key="d0">Result</data>
  <data key="d1">It offers several features that are fundamental for refining GWAS signals and identifying the likely causal variant(s) and target gene(s) at trait-associated loci.</data>
  <data key="d3">It offers several features that are fundamental for refining GWAS signals and identifying the likely causal variant(s) and target gene(s) at trait-associated loci.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Result_5898260031081342840">
  <data key="d0">Result</data>
  <data key="d1">These include: (i) systematic statistical fine-mapping across thousands of trait-associated loci to resolve association signals, (ii) cross-trait/disease disease colocalisation analysis and disease-molecular trait colocalisation analysis across 92 tissues and cell types, (iii) linking each variant to its likely target gene(s), using a single evidence score aggregating across a range of functional genomics datasets (disease agnostic), (iv) prediction of the likely causal gene(s) for all GWAS-associated loci using a machine learning model combining genetics and functional genomics information in a single ‘locus to gene’ (L2G) score, (v) Phenome Wide Association Study (PheWAS) analysis across a wide range of diseases and traits, (vi) enriched trait––gene evidence with orthogonal evidence including clinical trials that might support therapeutic hypothesis by linking with the Open Targets Platform.</data>
  <data key="d3">These include: (i) systematic statistical fine-mapping across thousands of trait-associated loci to resolve association signals, (ii) cross-trait/disease disease colocalisation analysis and disease-molecular trait colocalisation analysis across 92 tissues and cell types, (iii) linking each variant to its likely target gene(s), using a single evidence score aggregating across a range of functional genomics datasets (disease agnostic), (iv) prediction of the likely causal gene(s) for all GWAS-associated loci using a machine learning model combining genetics and functional genomics information in a single ‘locus to gene’ (L2G) score, (v) Phenome Wide Association Study (PheWAS) analysis across a wide range of diseases and traits, (vi) enriched trait––gene evidence with orthogonal evidence including clinical trials that might support therapeutic hypothesis by linking with the Open Targets Platform.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Result_-8239913640821835535">
  <data key="d0">Result</data>
  <data key="d1">This stand-alone genetics resource within the Open Targets ecosystem complements the existing Open Targets Platform and provides underlying genetic evidence to aid drug target identification and prioritisation.</data>
  <data key="d3">This stand-alone genetics resource within the Open Targets ecosystem complements the existing Open Targets Platform and provides underlying genetic evidence to aid drug target identification and prioritisation.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Result_-844600880480320235">
  <data key="d0">Result</data>
  <data key="d1">Molecular phenotype quantitative trait loci data (QTLs) includes protein QTL (pQTL) data of 2994 plasma proteins assessed in 3301 individuals of European descent.</data>
  <data key="d3">Molecular phenotype quantitative trait loci data (QTLs) includes protein QTL (pQTL) data of 2994 plasma proteins assessed in 3301 individuals of European descent.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Result_4214243624179199811">
  <data key="d0">Result</data>
  <data key="d1">Gene expression QTLs (eQTLs) are integrated from the eQTL Catalogue, eQTLGen and GTEx.</data>
  <data key="d3">Gene expression QTLs (eQTLs) are integrated from the eQTL Catalogue, eQTLGen and GTEx.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Result_853693060358169077">
  <data key="d0">Result</data>
  <data key="d1">Other datasets that provide evidence for variant to gene (V2G) association include epigenetics chromatin conformation and interaction experiments with promoter capture hiC (PCHI-C) from 27 different cell types, enhancer-TSS pairwise cap analysis of gene expression (CAGE) correlation, and DNase I hypersensitive site (DHS)-gene promoter correlation.</data>
  <data key="d3">Other datasets that provide evidence for variant to gene (V2G) association include epigenetics chromatin conformation and interaction experiments with promoter capture hiC (PCHI-C) from 27 different cell types, enhancer-TSS pairwise cap analysis of gene expression (CAGE) correlation, and DNase I hypersensitive site (DHS)-gene promoter correlation.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Method_-3512103989150941167">
  <data key="d0">Method</data>
  <data key="d1">Lead variant annotation, and lead variant to tag variant expansion methods, which include fine-mapping/credible set analysis and linkage-disequilibrium expansion are described in full here.</data>
  <data key="d3">Lead variant annotation, and lead variant to tag variant expansion methods, which include fine-mapping/credible set analysis and linkage-disequilibrium expansion are described in full here.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Method_1800362366101282462">
  <data key="d0">Method</data>
  <data key="d1">Disease-molecular trait colocalisation analysis for studies with full summary statistics is explained in more detail here.</data>
  <data key="d3">Disease-molecular trait colocalisation analysis for studies with full summary statistics is explained in more detail here.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Method_-912887596059014410">
  <data key="d0">Method</data>
  <data key="d1">Similar analyses have been conducted for GWAS studies without full summary statistics, using an approximate colocalisation heuristic based on variant probabilities from the PICS method.</data>
  <data key="d3">Similar analyses have been conducted for GWAS studies without full summary statistics, using an approximate colocalisation heuristic based on variant probabilities from the PICS method.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Method_1946689005624197172">
  <data key="d0">Method</data>
  <data key="d1">These analyses then feed into the causal inference L2G analysis pipeline to connect the associated loci to genes, utilising underlying evidence in order to ultimately rank the genes most likely to be underlying the associated trait/disease.</data>
  <data key="d3">These analyses then feed into the causal inference L2G analysis pipeline to connect the associated loci to genes, utilising underlying evidence in order to ultimately rank the genes most likely to be underlying the associated trait/disease.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Result_-4906500001861674686">
  <data key="d0">Result</data>
  <data key="d1">The public availability and wide applicability of the genetics-trait association data provided can serve a wide range of users with different expertise.</data>
  <data key="d3">The public availability and wide applicability of the genetics-trait association data provided can serve a wide range of users with different expertise.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Result_3635515074531159089">
  <data key="d0">Result</data>
  <data key="d1">The gene prioritisation data using the L2G score from the Open Targets Genetics Portal feeds into the genetic association evidence to support target - disease associations in the Open Targets Platform.</data>
  <data key="d3">The gene prioritisation data using the L2G score from the Open Targets Genetics Portal feeds into the genetic association evidence to support target - disease associations in the Open Targets Platform.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Method_-8577085393107265036">
  <data key="d0">Method</data>
  <data key="d1">We have built an integrated system for incorporating GWAS, EQTL, pQTL and epigenetics data resources together and provide statistical genetics analysis of this data within an easy-to-navigate portal, which requires compatibility of data features (for example genes are mapped to Ensembl gene IDs and variants to chromosomal position on genome build GRCh38).</data>
  <data key="d3">We have built an integrated system for incorporating GWAS, EQTL, pQTL and epigenetics data resources together and provide statistical genetics analysis of this data within an easy-to-navigate portal, which requires compatibility of data features (for example genes are mapped to Ensembl gene IDs and variants to chromosomal position on genome build GRCh38).</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_27_2021_Method_7274297947901528281">
  <data key="d0">Method</data>
  <data key="d1">We have used the Experimental Factor Ontology (EFO) to map disease terms across data resources and have added new EFO terms where required.</data>
  <data key="d3">We have used the Experimental Factor Ontology (EFO) to map disease terms across data resources and have added new EFO terms where required.</data>
  <data key="d4">PDF_27_2021</data>
</node>
<node id="PDF_09_2017">
  <data key="d0">Paper</data>
  <data key="d1">www.impactjournals.com/oncotarget/
Oncotarget, 2017, Vol. 8, (No. 57), pp: 96809-96825
Research Paper
Pnma5 is essential to the progression of meiosis in mouse
oocytes through a chain of phosphorylation
Xiao-Lan Zhang¹,*, Peng Liu1*, Zhi-Xia Yang¹*, Jing-Jing Zhao³, Lei-Lei Gao¹, Bo
Yuan, Li-Ya Shi¹, Chun-Xiang Zhou¹, Hai-Feng Qiao5, Ya-Hong Liu, Xiao-Yan
Ying, Jun-Qiang Zhang², Xiu-Feng Ling² and Dong Zhang¹
1State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, Ji</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_09_2017_Hypothesis_-823536038409716850">
  <data key="d0">Hypothesis</data>
  <data key="d1">Pnma5 might play important roles in meiosis.</data>
  <data key="d3">Pnma5 might play important roles in meiosis.</data>
  <data key="d4">PDF_09_2017</data>
</node>
<node id="PDF_09_2017_Method_-5916248252771113392">
  <data key="d0">Method</data>
  <data key="d1">Pnma5 was knocked down in in-vitro maturated (IVM) mouse oocytes by specific siRNA.</data>
  <data key="d3">Pnma5 was knocked down in in-vitro maturated (IVM) mouse oocytes by specific siRNA.</data>
  <data key="d4">PDF_09_2017</data>
</node>
<node id="PDF_09_2017_Result_2918064835761663307">
  <data key="d0">Result</data>
  <data key="d1">Loss of Pnma5 significantly delayed the progression of meiosis I and increased chromosome segregation errors during anaphase I.</data>
  <data key="d3">Loss of Pnma5 significantly delayed the progression of meiosis I and increased chromosome segregation errors during anaphase I.</data>
  <data key="d4">PDF_09_2017</data>
</node>
<node id="PDF_09_2017_Result_-6899339675324614913">
  <data key="d0">Result</data>
  <data key="d1">Pnma5 knockdown caused significantly lower fertilization in in-vitro fertilization (IVF).</data>
  <data key="d3">Pnma5 knockdown caused significantly lower fertilization in in-vitro fertilization (IVF).</data>
  <data key="d4">PDF_09_2017</data>
</node>
<node id="PDF_09_2017_Result_-4894716366255718112">
  <data key="d0">Result</data>
  <data key="d1">Pnma5 knockdown was found to significantly decrease the stability of spindle microtubules and altered F-actin organization within actin cap regions, cause significantly abnormal mitochondria aggregation and lower ATP concentration.</data>
  <data key="d3">Pnma5 knockdown was found to significantly decrease the stability of spindle microtubules and altered F-actin organization within actin cap regions, cause significantly abnormal mitochondria aggregation and lower ATP concentration.</data>
  <data key="d4">PDF_09_2017</data>
</node>
<node id="PDF_09_2017_Result_-4284888244655995464">
  <data key="d0">Result</data>
  <data key="d1">Phosphorylation at Thr533 re-located Pnma5 strongly to spindles &amp; cortex and was required for the phosphorylation of Akt and Gsk3ẞ, while Src and Erk1/2 phosphorylation was required for the phosphorylation of Pnma5, indicating that phosphorylated Pnma5 is the active form and subsequently activates Akt and Gsk3ẞ.</data>
  <data key="d3">Phosphorylation at Thr533 re-located Pnma5 strongly to spindles &amp; cortex and was required for the phosphorylation of Akt and Gsk3ẞ, while Src and Erk1/2 phosphorylation was required for the phosphorylation of Pnma5, indicating that phosphorylated Pnma5 is the active form and subsequently activates Akt and Gsk3ẞ.</data>
  <data key="d4">PDF_09_2017</data>
</node>
<node id="Protein_AKT1">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">AKT1</data>
  <data key="d7">AKT1</data>
</node>
<node id="Protein_GSK3B">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">GSK3B</data>
  <data key="d7">GSK3B</data>
</node>
<node id="Gene_SRC">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SRC</data>
  <data key="d7">Src</data>
</node>
<node id="Protein_ERK1/2">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">ERK1/2</data>
  <data key="d7">Erk1/2</data>
</node>
<node id="PDF_09_2017_Conclusion_-6511780672371724639">
  <data key="d0">Conclusion</data>
  <data key="d1">Pnma5 is important for meiosis and is the pivot of Src→Erk1/2→Pnma5→Akt→Gsk3ẞ pathway.</data>
  <data key="d3">Pnma5 is important for meiosis and is the pivot of Src→Erk1/2→Pnma5→Akt→Gsk3ẞ pathway.</data>
  <data key="d4">PDF_09_2017</data>
</node>
<node id="PDF_09_2017_Result_-6261464948747278153">
  <data key="d0">Result</data>
  <data key="d1">Pnma5 is much more prominent in oocytes than in GCs and is the most abundant among PNMAs in oocytes, suggesting that compared with the others, Pnma5 is the selected Pnma family member particularly important in oocytes.</data>
  <data key="d3">Pnma5 is much more prominent in oocytes than in GCs and is the most abundant among PNMAs in oocytes, suggesting that compared with the others, Pnma5 is the selected Pnma family member particularly important in oocytes.</data>
  <data key="d4">PDF_09_2017</data>
</node>
<node id="PDF_09_2017_Result_5312661458836239154">
  <data key="d0">Result</data>
  <data key="d1">Pnma5 knockdown was found to cause significant meiotic defects, which was manifested mainly through delayed meiotic resumption, disturbed meiosis I, abnormal anaphase I with lagging chromosomes.</data>
  <data key="d3">Pnma5 knockdown was found to cause significant meiotic defects, which was manifested mainly through delayed meiotic resumption, disturbed meiosis I, abnormal anaphase I with lagging chromosomes.</data>
  <data key="d4">PDF_09_2017</data>
</node>
<node id="PDF_09_2017_Result_-4283512138045495103">
  <data key="d0">Result</data>
  <data key="d1">Pnma5 knockdown also significantly decreased the level of acetylated tubulin, a major form of stable microtubules within spindles, which were also closely related to the meiotic defects.</data>
  <data key="d3">Pnma5 knockdown also significantly decreased the level of acetylated tubulin, a major form of stable microtubules within spindles, which were also closely related to the meiotic defects.</data>
  <data key="d4">PDF_09_2017</data>
</node>
<node id="PDF_09_2017_Result_-3556133635542159306">
  <data key="d0">Result</data>
  <data key="d1">Pnma5 knockdown significantly affected the translocation of MI spindles and the organization of F-actin at actin cap region.</data>
  <data key="d3">Pnma5 knockdown significantly affected the translocation of MI spindles and the organization of F-actin at actin cap region.</data>
  <data key="d4">PDF_09_2017</data>
</node>
<node id="PDF_09_2017_Result_7013219452746291712">
  <data key="d0">Result</data>
  <data key="d1">Pnma5 knockdown dramatically increased abnormal MII oocytes with less congressed chromosomes.</data>
  <data key="d3">Pnma5 knockdown dramatically increased abnormal MII oocytes with less congressed chromosomes.</data>
  <data key="d4">PDF_09_2017</data>
</node>
<node id="PDF_09_2017_Result_4678989147869615074">
  <data key="d0">Result</data>
  <data key="d1">Pnma5 knockdown also dramatically disrupted mitochondrial distribution and significantly decreased ATP levels in maturated MII oocytes.</data>
  <data key="d3">Pnma5 knockdown also dramatically disrupted mitochondrial distribution and significantly decreased ATP levels in maturated MII oocytes.</data>
  <data key="d4">PDF_09_2017</data>
</node>
<node id="PDF_09_2017_Result_7887175685820429368">
  <data key="d0">Result</data>
  <data key="d1">Pnma5 phosphorylation is controlled by upstream phosphorylation of Src→Erk1/2, since it's well-known that Src Erk1/2 is activatied by phosphorylation, so probably the phosphorylated Pnma5 is the active form of total Pnma5.</data>
  <data key="d3">Pnma5 phosphorylation is controlled by upstream phosphorylation of Src→Erk1/2, since it's well-known that Src Erk1/2 is activatied by phosphorylation, so probably the phosphorylated Pnma5 is the active form of total Pnma5.</data>
  <data key="d4">PDF_09_2017</data>
</node>
<node id="PDF_09_2017_Result_-3423247757071777685">
  <data key="d0">Result</data>
  <data key="d1">Pnma5 could phosphorylate downstream Akt→Gsk3ẞ.</data>
  <data key="d3">Pnma5 could phosphorylate downstream Akt→Gsk3ẞ.</data>
  <data key="d4">PDF_09_2017</data>
</node>
<node id="PDF_09_2017_Conclusion_2714058693539317562">
  <data key="d0">Conclusion</data>
  <data key="d1">The signal pathway for Pnma5 appears to be Src Erk1/2→Pnma5→Akt→Gsk3ẞ, where Pnma5 is at a pivotal position.</data>
  <data key="d3">The signal pathway for Pnma5 appears to be Src Erk1/2→Pnma5→Akt→Gsk3ẞ, where Pnma5 is at a pivotal position.</data>
  <data key="d4">PDF_09_2017</data>
</node>
<node id="PDF_41_2007">
  <data key="d0">Paper</data>
  <data key="d1">Inhibition of ubiquitin-mediated degradation
of MOAP-1 by apoptotic stimuli promotes
Bax function in mitochondria
Nai Yang Fu, Sunil K. Sukumaran, and Victor C. Yu*
Institute of Molecular and Cell Biology, 61 Biopolis Drive (Proteos), Singapore 138673
Edited by Xiaodong Wang, University of Texas Southwestern Medical Center,
The multidomain proapoptotic protein Bax of the Bcl-2 family is a
central regulator for controlling the release of apoptogenic factors
from mitochondria. Recent evidence sugg</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_41_2007_Hypothesis_1845554087649987154">
  <data key="d0">Hypothesis</data>
  <data key="d1">apoptotic stimuli can facilitate the proapoptotic function of Bax in mitochondria through stabilization of MOAP-1</data>
  <data key="d3">apoptotic stimuli can facilitate the proapoptotic function of Bax in mitochondria through stabilization of MOAP-1</data>
  <data key="d4">PDF_41_2007</data>
</node>
<node id="PDF_41_2007_Method_4932639676826302701">
  <data key="d0">Method</data>
  <data key="d1">Using a combined immunoprecipitation (IP)/Western blot analysis</data>
  <data key="d3">Using a combined immunoprecipitation (IP)/Western blot analysis</data>
  <data key="d4">PDF_41_2007</data>
</node>
<node id="PDF_41_2007_Method_1326454549095164944">
  <data key="d0">Method</data>
  <data key="d1">MOAP-1 mRNA levels by real-time PCR</data>
  <data key="d3">MOAP-1 mRNA levels by real-time PCR</data>
  <data key="d4">PDF_41_2007</data>
</node>
<node id="PDF_41_2007_Method_-6634265973247530439">
  <data key="d0">Method</data>
  <data key="d1">cells were transiently transfected with a HA-tagged MOAP-1-expressing plasmid</data>
  <data key="d3">cells were transiently transfected with a HA-tagged MOAP-1-expressing plasmid</data>
  <data key="d4">PDF_41_2007</data>
</node>
<node id="PDF_41_2007_Method_4907608771826218470">
  <data key="d0">Method</data>
  <data key="d1">protein synthesis inhibitor CHX was added to the 293T cells to block the de novo protein synthesis</data>
  <data key="d3">protein synthesis inhibitor CHX was added to the 293T cells to block the de novo protein synthesis</data>
  <data key="d4">PDF_41_2007</data>
</node>
<node id="PDF_41_2007_Method_9218436023312221288">
  <data key="d0">Method</data>
  <data key="d1">293T cells were also sub- jected to pulse-chase analysis</data>
  <data key="d3">293T cells were also sub- jected to pulse-chase analysis</data>
  <data key="d4">PDF_41_2007</data>
</node>
<node id="PDF_41_2007_Method_-8368613888239113054">
  <data key="d0">Method</data>
  <data key="d1">293T cells were subjected to treatment with diverse protease inhibitors</data>
  <data key="d3">293T cells were subjected to treatment with diverse protease inhibitors</data>
  <data key="d4">PDF_41_2007</data>
</node>
<node id="PDF_41_2007_Result_-4440267453667459716">
  <data key="d0">Result</data>
  <data key="d1">MOAP-1 protein levels were first found to be rapidly up-regulated in HCT116, H1299, SY5Y, and HeLa cells upon tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) treatment</data>
  <data key="d3">MOAP-1 protein levels were first found to be rapidly up-regulated in HCT116, H1299, SY5Y, and HeLa cells upon tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) treatment</data>
  <data key="d4">PDF_41_2007</data>
</node>
<node id="Protein_TRAIL">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">TRAIL</data>
  <data key="d7">TRAIL</data>
</node>
<node id="PDF_41_2007_Result_875328654420229611">
  <data key="d0">Result</data>
  <data key="d1">the induction of MOAP-1 by TRAIL displayed a fast kinetics similar to Bax activation in the HCT116, H1299 and HeLa cells</data>
  <data key="d3">the induction of MOAP-1 by TRAIL displayed a fast kinetics similar to Bax activation in the HCT116, H1299 and HeLa cells</data>
  <data key="d4">PDF_41_2007</data>
</node>
<node id="PDF_41_2007_Result_5235726866360229377">
  <data key="d0">Result</data>
  <data key="d1">TRAIL failed to induce Bax activation and apoptosis in SY5Y cells, it was effective in triggering up-regulation of MOAP-1 protein in these cells</data>
  <data key="d3">TRAIL failed to induce Bax activation and apoptosis in SY5Y cells, it was effective in triggering up-regulation of MOAP-1 protein in these cells</data>
  <data key="d4">PDF_41_2007</data>
</node>
<node id="PDF_41_2007_Result_4840550149737968855">
  <data key="d0">Result</data>
  <data key="d1">all apoptotic stimuli tested were able to rapidly enhance MOAP-1 levels in mammalian cell lines, including SY5Y, HCT116, HepG2, 293T, H1299, and HeLa cells</data>
  <data key="d3">all apoptotic stimuli tested were able to rapidly enhance MOAP-1 levels in mammalian cell lines, including SY5Y, HCT116, HepG2, 293T, H1299, and HeLa cells</data>
  <data key="d4">PDF_41_2007</data>
</node>
<node id="PDF_41_2007_Result_7968539060733958719">
  <data key="d0">Result</data>
  <data key="d1">The broad spectrum caspase inhibitor z-VAD failed to inhibit MOAP-1 up-regulation by ETOP and TRAIL, whereas it effectively blocked DNA fragmentation</data>
  <data key="d3">The broad spectrum caspase inhibitor z-VAD failed to inhibit MOAP-1 up-regulation by ETOP and TRAIL, whereas it effectively blocked DNA fragmentation</data>
  <data key="d4">PDF_41_2007</data>
</node>
<node id="Compound_ETOP">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">ETOP</data>
  <data key="d7">ETOP</data>
</node>
<node id="PDF_41_2007_Result_3554482876249373722">
  <data key="d0">Result</data>
  <data key="d1">Similar to the endogenous MOAP-1 protein, the levels of HA-tagged MOAP-1 protein were rapidly increased by treatment with TRAIL or ETOP</data>
  <data key="d3">Similar to the endogenous MOAP-1 protein, the levels of HA-tagged MOAP-1 protein were rapidly increased by treatment with TRAIL or ETOP</data>
  <data key="d4">PDF_41_2007</data>
</node>
<node id="PDF_41_2007_Result_-3382147042930824034">
  <data key="d0">Result</data>
  <data key="d1">TRAIL or ETOP treatment led to a pronounced extension of MOAP-1 half-life compared with the untreated control</data>
  <data key="d3">TRAIL or ETOP treatment led to a pronounced extension of MOAP-1 half-life compared with the untreated control</data>
  <data key="d4">PDF_41_2007</data>
</node>
<node id="PDF_41_2007_Result_5909327930269608857">
  <data key="d0">Result</data>
  <data key="d1">only the proteasome inhibitors (i.e., MG132, LLnL, epoxomycin and lactacystin) were found to dramatically elevate endogenous MOAP-1 protein levels through extension of its half-life</data>
  <data key="d3">only the proteasome inhibitors (i.e., MG132, LLnL, epoxomycin and lactacystin) were found to dramatically elevate endogenous MOAP-1 protein levels through extension of its half-life</data>
  <data key="d4">PDF_41_2007</data>
</node>
<node id="PDF_41_2007_Result_-7980773298399431532">
  <data key="d0">Result</data>
  <data key="d1">MOAP-1 knockdown by RNAi has been shown to attenuate recombinant Bax- and tBid- mediated Cyto c release</data>
  <data key="d3">MOAP-1 knockdown by RNAi has been shown to attenuate recombinant Bax- and tBid- mediated Cyto c release</data>
  <data key="d4">PDF_41_2007</data>
</node>
<node id="PDF_41_2007_Conclusion_-6269182097353802293">
  <data key="d0">Conclusion</data>
  <data key="d1">We propose that apoptotic stimuli can facilitate the proapoptotic function of Bax in mitochondria through stabilization of MOAP-1.</data>
  <data key="d3">We propose that apoptotic stimuli can facilitate the proapoptotic function of Bax in mitochondria through stabilization of MOAP-1.</data>
  <data key="d4">PDF_41_2007</data>
</node>
<node id="PDF_17_2020">
  <data key="d0">Paper</data>
  <data key="d1">nature
COMMUNICATIONS

ARTICLE
Check for updates
https://doi.org/10.1038/s41467-020-15209-9 OPEN

The RNA-binding protein DAZL functions as
repressor and activator of mRNA translation during
oocyte maturation

Cai-Rong Yang 1,2,3, Gabriel Rajkovic1,2,3, Enrico Maria Daldello 1,2,3, Xuan G. Luong1,2,3, Jing Chen1,2,3 &amp;
Marco Conti 1,2,3

Deleted in azoospermia-like (DAZL) is an RNA-binding protein critical for gamete develop-
ment. In full-grown oocytes, the DAZL protein increases 4-fold during r</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_17_2020_Result_-980599211666020308">
  <data key="d0">Result</data>
  <data key="d1">DAZL depletion causes a block in maturation and widespread disruption in the pattern of ribosome loading on maternal transcripts.</data>
  <data key="d3">DAZL depletion causes a block in maturation and widespread disruption in the pattern of ribosome loading on maternal transcripts.</data>
  <data key="d4">PDF_17_2020</data>
</node>
<node id="PDF_17_2020_Result_-6168667314122613882">
  <data key="d0">Result</data>
  <data key="d1">DAZL depletion also causes translational activation of a distinct subset of mRNAs both in quiescent and maturing oocytes.</data>
  <data key="d3">DAZL depletion also causes translational activation of a distinct subset of mRNAs both in quiescent and maturing oocytes.</data>
  <data key="d4">PDF_17_2020</data>
</node>
<node id="PDF_17_2020_Result_-7733120735039512864">
  <data key="d0">Result</data>
  <data key="d1">DAZL binds to mRNAs whose translation is both repressed and activated during maturation.</data>
  <data key="d3">DAZL binds to mRNAs whose translation is both repressed and activated during maturation.</data>
  <data key="d4">PDF_17_2020</data>
</node>
<node id="Gene_MRNAS">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">MRNAS</data>
  <data key="d7">mRNAs</data>
</node>
<node id="PDF_17_2020_Result_4232220067037490103">
  <data key="d0">Result</data>
  <data key="d1">Injection of recombinant DAZL protein in DAZL-depleted oocytes rescues the translation and maturation to MII.</data>
  <data key="d3">Injection of recombinant DAZL protein in DAZL-depleted oocytes rescues the translation and maturation to MII.</data>
  <data key="d4">PDF_17_2020</data>
</node>
<node id="PDF_17_2020_Conclusion_7910753888088406109">
  <data key="d0">Conclusion</data>
  <data key="d1">DAZL regulates translation of maternal mRNAs, functioning both as the translational repressor and activator during oocyte maturation.</data>
  <data key="d3">DAZL regulates translation of maternal mRNAs, functioning both as the translational repressor and activator during oocyte maturation.</data>
  <data key="d4">PDF_17_2020</data>
</node>
<node id="PDF_17_2020_Result_-8982414712985685890">
  <data key="d0">Result</data>
  <data key="d1">Blockage of Dazl mRNA translation by this specific MO markedly reduces the endogenous DAZL protein expression compared to a CON-MO.</data>
  <data key="d3">Blockage of Dazl mRNA translation by this specific MO markedly reduces the endogenous DAZL protein expression compared to a CON-MO.</data>
  <data key="d4">PDF_17_2020</data>
</node>
<node id="PDF_17_2020_Result_4657786812539322725">
  <data key="d0">Result</data>
  <data key="d1">mRNA loading onto ribosomes of Tex19.1 is significantly decreased after injection of DAZL-MO at the MI stage.</data>
  <data key="d3">mRNA loading onto ribosomes of Tex19.1 is significantly decreased after injection of DAZL-MO at the MI stage.</data>
  <data key="d4">PDF_17_2020</data>
</node>
<node id="PDF_17_2020_Result_-8139204930781012277">
  <data key="d0">Result</data>
  <data key="d1">Knockdown of DAZL had no effect on ribosome loading onto the non-target CcnB1.</data>
  <data key="d3">Knockdown of DAZL had no effect on ribosome loading onto the non-target CcnB1.</data>
  <data key="d4">PDF_17_2020</data>
</node>
<node id="PDF_17_2020_Result_-4104397398872225064">
  <data key="d0">Result</data>
  <data key="d1">DAZL depletion disrupts oocyte maturation to MII.</data>
  <data key="d3">DAZL depletion disrupts oocyte maturation to MII.</data>
  <data key="d4">PDF_17_2020</data>
</node>
<node id="PDF_17_2020_Result_-3525531358675821859">
  <data key="d0">Result</data>
  <data key="d1">DAZL depletion causes increases and decreases in translational efficiency of a wide range of transcripts expressed in the oocyte.</data>
  <data key="d3">DAZL depletion causes increases and decreases in translational efficiency of a wide range of transcripts expressed in the oocyte.</data>
  <data key="d4">PDF_17_2020</data>
</node>
<node id="PDF_17_2020_Result_-7563912959373531681">
  <data key="d0">Result</data>
  <data key="d1">Ribosome loading onto a group of transcripts decreases after DAZL depletion.</data>
  <data key="d3">Ribosome loading onto a group of transcripts decreases after DAZL depletion.</data>
  <data key="d4">PDF_17_2020</data>
</node>
<node id="PDF_17_2020_Result_8103721274521775049">
  <data key="d0">Result</data>
  <data key="d1">A group of transcripts whose translation increases after DAZL removal was identified.</data>
  <data key="d3">A group of transcripts whose translation increases after DAZL removal was identified.</data>
  <data key="d4">PDF_17_2020</data>
</node>
<node id="PDF_17_2020_Result_-3316046931134377020">
  <data key="d0">Result</data>
  <data key="d1">RiboTag IP/RNA-Seq shows an increase in ribosome loading for transcripts Tex19.1 and Txnip during maturation in CON-MO injected oocytes, whereas the recruitment is blunted after DAZL KD in MI stage.</data>
  <data key="d3">RiboTag IP/RNA-Seq shows an increase in ribosome loading for transcripts Tex19.1 and Txnip during maturation in CON-MO injected oocytes, whereas the recruitment is blunted after DAZL KD in MI stage.</data>
  <data key="d4">PDF_17_2020</data>
</node>
<node id="Gene_TXNIP">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">TXNIP</data>
  <data key="d7">Txnip</data>
</node>
<node id="PDF_17_2020_Result_-6722892752945433645">
  <data key="d0">Result</data>
  <data key="d1">Ribosome loading onto Akap10 and Nsf mRNAs is increased after DAZL depletion.</data>
  <data key="d3">Ribosome loading onto Akap10 and Nsf mRNAs is increased after DAZL depletion.</data>
  <data key="d4">PDF_17_2020</data>
</node>
<node id="Gene_AKAP10">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">AKAP10</data>
  <data key="d7">Akap10</data>
</node>
<node id="Gene_NSF">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">NSF</data>
  <data key="d7">Nsf</data>
</node>
<node id="PDF_17_2020_Result_2889273631862273294">
  <data key="d0">Result</data>
  <data key="d1">RiboTag IP/qPCR shows a decrease in translation for Dazl, Tex19.1, Txnip, Rad51C, Btg4, Erol, Oosp1, Obox5, Ireb2, and Tcll after DAZL removal.</data>
  <data key="d3">RiboTag IP/qPCR shows a decrease in translation for Dazl, Tex19.1, Txnip, Rad51C, Btg4, Erol, Oosp1, Obox5, Ireb2, and Tcll after DAZL removal.</data>
  <data key="d4">PDF_17_2020</data>
</node>
<node id="Gene_RAD51C">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">RAD51C</data>
  <data key="d7">Rad51C</data>
</node>
<node id="Gene_BTG4">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">BTG4</data>
  <data key="d7">Btg4</data>
</node>
<node id="Gene_EROL">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">EROL</data>
  <data key="d7">Erol</data>
</node>
<node id="Gene_OOSP1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">OOSP1</data>
  <data key="d7">Oosp1</data>
</node>
<node id="Gene_OBOX5">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">OBOX5</data>
  <data key="d7">Obox5</data>
</node>
<node id="Gene_IREB2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">IREB2</data>
  <data key="d7">Ireb2</data>
</node>
<node id="Gene_TCLL">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">TCLL</data>
  <data key="d7">Tcll</data>
</node>
<node id="PDF_17_2020_Result_-4520606036701953389">
  <data key="d0">Result</data>
  <data key="d1">Translation of transcripts coding for Akap10, Cenpe, Nsf, Ywhaz, Nin, and YTHDF3 is upregulated after DAZL removal.</data>
  <data key="d3">Translation of transcripts coding for Akap10, Cenpe, Nsf, Ywhaz, Nin, and YTHDF3 is upregulated after DAZL removal.</data>
  <data key="d4">PDF_17_2020</data>
</node>
<node id="Gene_CENPE">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CENPE</data>
  <data key="d7">Cenpe</data>
</node>
<node id="Gene_YWHAZ">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">YWHAZ</data>
  <data key="d7">Ywhaz</data>
</node>
<node id="Gene_NIN">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">NIN</data>
  <data key="d7">Nin</data>
</node>
<node id="Gene_YTHDF3">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">YTHDF3</data>
  <data key="d7">YTHDF3</data>
</node>
<node id="PDF_17_2020_Conclusion_9156115554715097118">
  <data key="d0">Conclusion</data>
  <data key="d1">DAZL may play a dual function (both translational activator and repressor) during oocyte maturation.</data>
  <data key="d3">DAZL may play a dual function (both translational activator and repressor) during oocyte maturation.</data>
  <data key="d4">PDF_17_2020</data>
</node>
<node id="PDF_17_2020_Result_5606996305972567241">
  <data key="d0">Result</data>
  <data key="d1">DAZL binding to maternal mRNA leads to an increase and decrease in translation.</data>
  <data key="d3">DAZL binding to maternal mRNA leads to an increase and decrease in translation.</data>
  <data key="d4">PDF_17_2020</data>
</node>
<node id="PDF_13_2018">
  <data key="d0">Paper</data>
  <data key="d1">Cell Stem Cell
Resource
Single-Cell RNA Sequencing Analysis Reveals
Sequential Cell Fate Transition during Human
Spermatogenesis
Mei Wang, 1,8,9 Xixi Liu, 2,5,9 Gang Chang, 3,9 Yidong Chen, 2,5,7,9 Geng An, 4,9 Liying Yan, 2,5 Shuai Gao, 2,5 Yanwen Xu, 1,8
Yueli Cui, 2,5 Ji Dong, 2,5 Yuhan Chen, 1,8 Xiaoying Fan, 2,5 Yuqiong Hu, 2,5,7 Ke Song, 1,8 Xiaohui Zhu, 2,5 Yun Gao, 2,5
Zhaokai Yao, 1,8 Shuhui Bian, 2,5,7 Yu Hou, 2,5 Jiahao Lu, 1,8 Rui Wang, 2,5 Yong Fan, 4 Ying Lian, 2,5 Wenhao Tang, 2,5</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_13_2018_Result_-2585656780267943343">
  <data key="d0">Result</data>
  <data key="d1">scRNA-seq analysis identified stage-specific marker genes of human germ cells, such as HMGA1, PIWIL4, TEX29, SCML1, and CCDC112.</data>
  <data key="d3">scRNA-seq analysis identified stage-specific marker genes of human germ cells, such as HMGA1, PIWIL4, TEX29, SCML1, and CCDC112.</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_HMGA1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">HMGA1</data>
  <data key="d7">HMGA1</data>
</node>
<node id="Gene_PIWIL4">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">PIWIL4</data>
  <data key="d7">PIWIL4</data>
</node>
<node id="Gene_TEX29">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">TEX29</data>
  <data key="d7">TEX29</data>
</node>
<node id="Gene_SCML1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SCML1</data>
  <data key="d7">SCML1</data>
</node>
<node id="Gene_CCDC112">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CCDC112</data>
  <data key="d7">CCDC112</data>
</node>
<node id="PDF_13_2018_Method_-1631782468720367454">
  <data key="d0">Method</data>
  <data key="d1">single-cell RNA sequencing (scRNA-seq) analysis for 2,854 testicular cells from donors with normal spermatogenesis and 174 testicular cells from one nonobstructive azoospermia (NOA) donor.</data>
  <data key="d3">single-cell RNA sequencing (scRNA-seq) analysis for 2,854 testicular cells from donors with normal spermatogenesis and 174 testicular cells from one nonobstructive azoospermia (NOA) donor.</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="PDF_13_2018_Result_-2325768832848065975">
  <data key="d0">Result</data>
  <data key="d1">GFRA1, UTF1, KIT, MKI67, and STRA8 were specifically expressed in clusters 1, 2, and 3, respectively.</data>
  <data key="d3">GFRA1, UTF1, KIT, MKI67, and STRA8 were specifically expressed in clusters 1, 2, and 3, respectively.</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_GFRA1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">GFRA1</data>
  <data key="d7">GFRA1</data>
</node>
<node id="Gene_UTF1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">UTF1</data>
  <data key="d7">UTF1</data>
</node>
<node id="Gene_KIT">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">KIT</data>
  <data key="d7">KIT</data>
</node>
<node id="Gene_MKI67">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">MKI67</data>
  <data key="d7">MKI67</data>
</node>
<node id="PDF_13_2018_Result_233866424154959566">
  <data key="d0">Result</data>
  <data key="d1">SPO11 and SYCP1, markers of meiotic-specific double-strand breaks and synapsis, respectively, were expressed in clusters 4-7.</data>
  <data key="d3">SPO11 and SYCP1, markers of meiotic-specific double-strand breaks and synapsis, respectively, were expressed in clusters 4-7.</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_SPO11">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SPO11</data>
  <data key="d7">SPO11</data>
</node>
<node id="Gene_SYCP1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SYCP1</data>
  <data key="d7">SYCP1</data>
</node>
<node id="PDF_13_2018_Result_240066150997085673">
  <data key="d0">Result</data>
  <data key="d1">TEX19, a regulator of SPO11-dependent meiotic recombination in leptotene, was mainly expressed in clusters 3-6.</data>
  <data key="d3">TEX19, a regulator of SPO11-dependent meiotic recombination in leptotene, was mainly expressed in clusters 3-6.</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="PDF_13_2018_Result_-5201337009747604388">
  <data key="d0">Result</data>
  <data key="d1">OVOL1 and OVOL2, which are localized in the XY body of and human spermatocytes at the pachytene and diplotene stages, were exclusively highly expressed in clusters 8 and 9.</data>
  <data key="d3">OVOL1 and OVOL2, which are localized in the XY body of and human spermatocytes at the pachytene and diplotene stages, were exclusively highly expressed in clusters 8 and 9.</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_OVOL1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">OVOL1</data>
  <data key="d7">OVOL1</data>
</node>
<node id="Gene_OVOL2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">OVOL2</data>
  <data key="d7">OVOL2</data>
</node>
<node id="PDF_13_2018_Result_6834090465481552738">
  <data key="d0">Result</data>
  <data key="d1">NME8, which is expressed from pachytene spermatocytes to the early stage of spermatids, was expressed from cluster 8 to cluster 11.</data>
  <data key="d3">NME8, which is expressed from pachytene spermatocytes to the early stage of spermatids, was expressed from cluster 8 to cluster 11.</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_NME8">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">NME8</data>
  <data key="d7">NME8</data>
</node>
<node id="PDF_13_2018_Result_1698627113773803473">
  <data key="d0">Result</data>
  <data key="d1">TXNDC2, the marker gene of round spermatids and elongated spermatids, was highly expressed in clusters 11 and 12</data>
  <data key="d3">TXNDC2, the marker gene of round spermatids and elongated spermatids, was highly expressed in clusters 11 and 12</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_TXNDC2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">TXNDC2</data>
  <data key="d7">TXNDC2</data>
</node>
<node id="PDF_13_2018_Result_5125497776235445436">
  <data key="d0">Result</data>
  <data key="d1">TNP1 and PRM1, two markers of spermatids or spermatozoa, clusters 11, 12, 13, and 14 were the four stages of spermatids</data>
  <data key="d3">TNP1 and PRM1, two markers of spermatids or spermatozoa, clusters 11, 12, 13, and 14 were the four stages of spermatids</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_TNP1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">TNP1</data>
  <data key="d7">TNP1</data>
</node>
<node id="Gene_PRM1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">PRM1</data>
  <data key="d7">PRM1</data>
</node>
<node id="PDF_13_2018_Result_-6827799273926872532">
  <data key="d0">Result</data>
  <data key="d1">AMH and SOX9 specifically expressed by Sertoli cells</data>
  <data key="d3">AMH and SOX9 specifically expressed by Sertoli cells</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_AMH">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">AMH</data>
  <data key="d7">AMH</data>
</node>
<node id="Gene_SOX9">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SOX9</data>
  <data key="d7">SOX9</data>
</node>
<node id="PDF_13_2018_Result_4797238506809767795">
  <data key="d0">Result</data>
  <data key="d1">MYH11 and DLK1 were particularly expressed in peritubular myoid cells (PMCs) and Leydig cells</data>
  <data key="d3">MYH11 and DLK1 were particularly expressed in peritubular myoid cells (PMCs) and Leydig cells</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_MYH11">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">MYH11</data>
  <data key="d7">MYH11</data>
</node>
<node id="Gene_DLK1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">DLK1</data>
  <data key="d7">DLK1</data>
</node>
<node id="PDF_13_2018_Result_-3520867239035683269">
  <data key="d0">Result</data>
  <data key="d1">CD68 and CD163 exclusively expressed by testicular macrophages (tMφ)</data>
  <data key="d3">CD68 and CD163 exclusively expressed by testicular macrophages (tMφ)</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_CD68">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CD68</data>
  <data key="d7">CD68</data>
</node>
<node id="Gene_CD163">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CD163</data>
  <data key="d7">CD163</data>
</node>
<node id="PDF_13_2018_Result_-5731736455124499248">
  <data key="d0">Result</data>
  <data key="d1">HMGA1 was actively transcribed in the spermatogonia located near the basal layer of seminiferous epithelium</data>
  <data key="d3">HMGA1 was actively transcribed in the spermatogonia located near the basal layer of seminiferous epithelium</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="PDF_13_2018_Result_-6837675869442569123">
  <data key="d0">Result</data>
  <data key="d1">SCML1 exhibited similar expression pattern to that of DMC1 in spermatocytes</data>
  <data key="d3">SCML1 exhibited similar expression pattern to that of DMC1 in spermatocytes</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_DMC1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">DMC1</data>
  <data key="d7">DMC1</data>
</node>
<node id="PDF_13_2018_Result_-2168887568482952382">
  <data key="d0">Result</data>
  <data key="d1">CCDC112 was highly expressed in both pachytene and diplotene spermatocytes</data>
  <data key="d3">CCDC112 was highly expressed in both pachytene and diplotene spermatocytes</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="PDF_13_2018_Result_418644541576375920">
  <data key="d0">Result</data>
  <data key="d1">intense signal of the TEX29 transcript was observed in the early stage of spermatids</data>
  <data key="d3">intense signal of the TEX29 transcript was observed in the early stage of spermatids</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="PDF_13_2018_Result_7147866663107401983">
  <data key="d0">Result</data>
  <data key="d1">GFRA1 and RET were highly enriched in cluster 1</data>
  <data key="d3">GFRA1 and RET were highly enriched in cluster 1</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_RET">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">RET</data>
  <data key="d7">RET</data>
</node>
<node id="PDF_13_2018_Result_1132378231311873623">
  <data key="d0">Result</data>
  <data key="d1">NANOS2, ZBTB16, SALL4, POU3F1, UTF1, and NANOS3 were all highly expressed in cluster 1</data>
  <data key="d3">NANOS2, ZBTB16, SALL4, POU3F1, UTF1, and NANOS3 were all highly expressed in cluster 1</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_NANOS2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">NANOS2</data>
  <data key="d7">NANOS2</data>
</node>
<node id="Gene_ZBTB16">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ZBTB16</data>
  <data key="d7">ZBTB16</data>
</node>
<node id="Gene_SALL4">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SALL4</data>
  <data key="d7">SALL4</data>
</node>
<node id="Gene_POU3F1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">POU3F1</data>
  <data key="d7">POU3F1</data>
</node>
<node id="Gene_NANOS3">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">NANOS3</data>
  <data key="d7">NANOS3</data>
</node>
<node id="PDF_13_2018_Result_-4558964390352668683">
  <data key="d0">Result</data>
  <data key="d1">FGFR3 and BMPR1B were predominantly co-expressed in cluster 1</data>
  <data key="d3">FGFR3 and BMPR1B were predominantly co-expressed in cluster 1</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_FGFR3">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">FGFR3</data>
  <data key="d7">FGFR3</data>
</node>
<node id="Gene_BMPR1B">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">BMPR1B</data>
  <data key="d7">BMPR1B</data>
</node>
<node id="PDF_13_2018_Result_4538883070159406809">
  <data key="d0">Result</data>
  <data key="d1">KIT had a relatively intense expression in cluster 2</data>
  <data key="d3">KIT had a relatively intense expression in cluster 2</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="PDF_13_2018_Result_7098111269807349278">
  <data key="d0">Result</data>
  <data key="d1">MKI67 exhibited an expression pattern similar to that of KIT</data>
  <data key="d3">MKI67 exhibited an expression pattern similar to that of KIT</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="PDF_13_2018_Result_-7548059631000195813">
  <data key="d0">Result</data>
  <data key="d1">The expression of STRA8 initiated at cluster 2 and culminated in cluster 3.</data>
  <data key="d3">The expression of STRA8 initiated at cluster 2 and culminated in cluster 3.</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="PDF_13_2018_Result_8218078299226839869">
  <data key="d0">Result</data>
  <data key="d1">DMRT1 was highly expressed in GFRA1highUTF1low cells but downregulated in GFRA1lowUTF1high cells</data>
  <data key="d3">DMRT1 was highly expressed in GFRA1highUTF1low cells but downregulated in GFRA1lowUTF1high cells</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_DMRT1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">DMRT1</data>
  <data key="d7">DMRT1</data>
</node>
<node id="PDF_13_2018_Result_-603430371271684152">
  <data key="d0">Result</data>
  <data key="d1">PIWIL4 was highly expressed in a proportion of FGFR3high SSCs</data>
  <data key="d3">PIWIL4 was highly expressed in a proportion of FGFR3high SSCs</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="PDF_13_2018_Result_-3106995970904756223">
  <data key="d0">Result</data>
  <data key="d1">ALDH1A1 highly expressed by Sertoli cells</data>
  <data key="d3">ALDH1A1 highly expressed by Sertoli cells</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_ALDH1A1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ALDH1A1</data>
  <data key="d7">ALDH1A1</data>
</node>
<node id="PDF_13_2018_Result_-8265794064548944133">
  <data key="d0">Result</data>
  <data key="d1">MIX exhibited upregulated expression of ALDH1A1 and CYP26B1</data>
  <data key="d3">MIX exhibited upregulated expression of ALDH1A1 and CYP26B1</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_CYP26B1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CYP26B1</data>
  <data key="d7">CYP26B1</data>
</node>
<node id="PDF_13_2018_Result_-2116837359288474551">
  <data key="d0">Result</data>
  <data key="d1">ALDH1A2 was highly expressed at the pachytene, diplotene, and SPC7 stages, and ALDH1A3 was highly expressed in pachytene spermatocytes</data>
  <data key="d3">ALDH1A2 was highly expressed at the pachytene, diplotene, and SPC7 stages, and ALDH1A3 was highly expressed in pachytene spermatocytes</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_ALDH1A2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ALDH1A2</data>
  <data key="d7">ALDH1A2</data>
</node>
<node id="Gene_ALDH1A3">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ALDH1A3</data>
  <data key="d7">ALDH1A3</data>
</node>
<node id="PDF_13_2018_Result_2575703314355210802">
  <data key="d0">Result</data>
  <data key="d1">DMRT1 and SOHLH1 were highly expressed in SSCs and differentiating spermatogonia</data>
  <data key="d3">DMRT1 and SOHLH1 were highly expressed in SSCs and differentiating spermatogonia</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_SOHLH1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SOHLH1</data>
  <data key="d7">SOHLH1</data>
</node>
<node id="PDF_13_2018_Result_-2361164632489912218">
  <data key="d0">Result</data>
  <data key="d1">FGFR1 and FGFR2, FGFR3, KRAS, MAP2K2, ΜΑPK1, and MAPK3 were highly expressed in SSCs.</data>
  <data key="d3">FGFR1 and FGFR2, FGFR3, KRAS, MAP2K2, ΜΑPK1, and MAPK3 were highly expressed in SSCs.</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_FGFR1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">FGFR1</data>
  <data key="d7">FGFR1</data>
</node>
<node id="Gene_FGFR2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">FGFR2</data>
  <data key="d7">FGFR2</data>
</node>
<node id="Gene_KRAS">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">KRAS</data>
  <data key="d7">KRAS</data>
</node>
<node id="Gene_MAP2K2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">MAP2K2</data>
  <data key="d7">MAP2K2</data>
</node>
<node id="Gene_ΜΑPK1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ΜΑPK1</data>
  <data key="d7">ΜΑPK1</data>
</node>
<node id="Gene_MAPK3">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">MAPK3</data>
  <data key="d7">MAPK3</data>
</node>
<node id="PDF_13_2018_Result_-6354715977465030224">
  <data key="d0">Result</data>
  <data key="d1">FGF1 was specifically expressed in Sertoli cells, whereas FGF2 and FGF9 were expressed in SSCs and other-stage germ cells</data>
  <data key="d3">FGF1 was specifically expressed in Sertoli cells, whereas FGF2 and FGF9 were expressed in SSCs and other-stage germ cells</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_FGF1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">FGF1</data>
  <data key="d7">FGF1</data>
</node>
<node id="Gene_FGF2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">FGF2</data>
  <data key="d7">FGF2</data>
</node>
<node id="Gene_FGF9">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">FGF9</data>
  <data key="d7">FGF9</data>
</node>
<node id="PDF_13_2018_Result_-8766377227572290641">
  <data key="d0">Result</data>
  <data key="d1">BMPR1B was exclusively enriched in SSCs</data>
  <data key="d3">BMPR1B was exclusively enriched in SSCs</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="PDF_13_2018_Result_-738583257906051561">
  <data key="d0">Result</data>
  <data key="d1">BMP7, BMPR2, SMAD1, SMAD5, SMAD9, ID1, ID2, and ID4 were all clearly expressed in SSCs</data>
  <data key="d3">BMP7, BMPR2, SMAD1, SMAD5, SMAD9, ID1, ID2, and ID4 were all clearly expressed in SSCs</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_BMP7">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">BMP7</data>
  <data key="d7">BMP7</data>
</node>
<node id="Gene_BMPR2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">BMPR2</data>
  <data key="d7">BMPR2</data>
</node>
<node id="Gene_SMAD1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SMAD1</data>
  <data key="d7">SMAD1</data>
</node>
<node id="Gene_SMAD5">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SMAD5</data>
  <data key="d7">SMAD5</data>
</node>
<node id="Gene_SMAD9">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SMAD9</data>
  <data key="d7">SMAD9</data>
</node>
<node id="Gene_ID1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ID1</data>
  <data key="d7">ID1</data>
</node>
<node id="Gene_ID2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ID2</data>
  <data key="d7">ID2</data>
</node>
<node id="Gene_ID4">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ID4</data>
  <data key="d7">ID4</data>
</node>
<node id="PDF_13_2018_Result_4332550590543243693">
  <data key="d0">Result</data>
  <data key="d1">large fraction of BMPR1B+ SSCs were also positive for phosphorylated SMAD1/5/9 (P-SMAD1/5/9), ID1, and ID4</data>
  <data key="d3">large fraction of BMPR1B+ SSCs were also positive for phosphorylated SMAD1/5/9 (P-SMAD1/5/9), ID1, and ID4</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="PDF_13_2018_Result_-967102195879578252">
  <data key="d0">Result</data>
  <data key="d1">SPO11, DMC1, and RAD51AP2, were especially expressed in spermatocytes in the leptotene and zygotene stages</data>
  <data key="d3">SPO11, DMC1, and RAD51AP2, were especially expressed in spermatocytes in the leptotene and zygotene stages</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_RAD51AP2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">RAD51AP2</data>
  <data key="d7">RAD51AP2</data>
</node>
<node id="PDF_13_2018_Result_-478275195892596815">
  <data key="d0">Result</data>
  <data key="d1">SC components, such as SYCP3, SYCP1, SYCP2, SYCE1, and TEX12 were also upregulated from the leptotene to the zygotene stage</data>
  <data key="d3">SC components, such as SYCP3, SYCP1, SYCP2, SYCE1, and TEX12 were also upregulated from the leptotene to the zygotene stage</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_SYCP2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SYCP2</data>
  <data key="d7">SYCP2</data>
</node>
<node id="Gene_SYCE1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SYCE1</data>
  <data key="d7">SYCE1</data>
</node>
<node id="Gene_TEX12">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">TEX12</data>
  <data key="d7">TEX12</data>
</node>
<node id="PDF_13_2018_Result_7278440245603404407">
  <data key="d0">Result</data>
  <data key="d1">OVOL1 and OVOL2 were found to be highly expressed from the pachytene to the diplotene stage</data>
  <data key="d3">OVOL1 and OVOL2 were found to be highly expressed from the pachytene to the diplotene stage</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="PDF_13_2018_Result_1100926031557611908">
  <data key="d0">Result</data>
  <data key="d1">both CCNA1 and CCNA2 were highly enriched from pachytene to SPC7</data>
  <data key="d3">both CCNA1 and CCNA2 were highly enriched from pachytene to SPC7</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_CCNA1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CCNA1</data>
  <data key="d7">CCNA1</data>
</node>
<node id="Gene_CCNA2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CCNA2</data>
  <data key="d7">CCNA2</data>
</node>
<node id="PDF_13_2018_Result_6419039013111316253">
  <data key="d0">Result</data>
  <data key="d1">SPC7, which consisted of diakinesis, metaphase, anaphase, telophase, and secondary spermatocytes, exhibited upregulation of CCNA1, CCNA2, TJP3, SLC26A3, and SIRPG</data>
  <data key="d3">SPC7, which consisted of diakinesis, metaphase, anaphase, telophase, and secondary spermatocytes, exhibited upregulation of CCNA1, CCNA2, TJP3, SLC26A3, and SIRPG</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_TJP3">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">TJP3</data>
  <data key="d7">TJP3</data>
</node>
<node id="Gene_SLC26A3">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SLC26A3</data>
  <data key="d7">SLC26A3</data>
</node>
<node id="Gene_SIRPG">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SIRPG</data>
  <data key="d7">SIRPG</data>
</node>
<node id="PDF_13_2018_Result_739995519673443118">
  <data key="d0">Result</data>
  <data key="d1">ACR was highly expressed in the stages from pachytene to S4</data>
  <data key="d3">ACR was highly expressed in the stages from pachytene to S4</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="Gene_ACR">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ACR</data>
  <data key="d7">ACR</data>
</node>
<node id="PDF_13_2018_Result_8015836603834141161">
  <data key="d0">Result</data>
  <data key="d1">DMC1 protein was highly expressed in the stages from leptotene to zygotene and retained in pachytene spermatocytes</data>
  <data key="d3">DMC1 protein was highly expressed in the stages from leptotene to zygotene and retained in pachytene spermatocytes</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="PDF_13_2018_Result_3390424010982936346">
  <data key="d0">Result</data>
  <data key="d1">SYCP2, SYCP3, and SYCE1 were also upregulated from the leptotene to the pachytene stage. Especially, SYCP3 protein was expressed from the leptotene to the pachytene stage</data>
  <data key="d3">SYCP2, SYCP3, and SYCE1 were also upregulated from the leptotene to the pachytene stage. Especially, SYCP3 protein was expressed from the leptotene to the pachytene stage</data>
  <data key="d4">PDF_13_2018</data>
</node>
<node id="PDF_29_2021">
  <data key="d0">Paper</data>
  <data key="d1">LTH &amp; HUMAN SERVICES-US,
Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript
HHS Public Access
Author manuscript
Nat Genet. Author manuscript; available in PMC 2021 July 18.
Published in final edited form as:
Nat Genet. 2021 February ; 53(2): 185–194. doi:10.1038/s41588-020-00757-z.
Genetics of 35 blood and urine biomarkers in the UK Biobank
Nasa Sinnott- Armstrong1,2,3,*,†, Yosuke Tanigawa4,*,+, David Amar4,5, Nina Mars2, Christian
Benner2, Matthew Aguirre, Guhan Ram Venkata</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_29_2021_Hypothesis_-2505351006953661186">
  <data key="d0">Hypothesis</data>
  <data key="d1">the 35 biomarker PRSs may improve the prediction of higher-level traits and diseases in combination with the PRS for the trait or disease itself</data>
  <data key="d3">the 35 biomarker PRSs may improve the prediction of higher-level traits and diseases in combination with the PRS for the trait or disease itself</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="PDF_29_2021_Method_-3810266808512889234">
  <data key="d0">Method</data>
  <data key="d1">systematic analysis of the genetic architecture and detailed fine-mapping of biomarker-associated loci in 363,228 individuals including protein-altering, protein-truncating (PTV), non-coding, human leukocyte antigen (HLA), and copy number variants</data>
  <data key="d3">systematic analysis of the genetic architecture and detailed fine-mapping of biomarker-associated loci in 363,228 individuals including protein-altering, protein-truncating (PTV), non-coding, human leukocyte antigen (HLA), and copy number variants</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="PDF_29_2021_Method_7622518009099704019">
  <data key="d0">Method</data>
  <data key="d1">building phenome-wide associations for implicated genetic variants</data>
  <data key="d3">building phenome-wide associations for implicated genetic variants</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="PDF_29_2021_Method_3582097726647072040">
  <data key="d0">Method</data>
  <data key="d1">evaluating causal relationships between biomarkers and 40 medically relevant phenotypes</data>
  <data key="d3">evaluating causal relationships between biomarkers and 40 medically relevant phenotypes</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="PDF_29_2021_Method_1675248724131067389">
  <data key="d0">Method</data>
  <data key="d1">constructing polygenic prediction models</data>
  <data key="d3">constructing polygenic prediction models</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="PDF_29_2021_Result_4261585918296958017">
  <data key="d0">Result</data>
  <data key="d1">identified 1,857 loci associated with at least one trait, containing 3,374 fine-mapped associations</data>
  <data key="d3">identified 1,857 loci associated with at least one trait, containing 3,374 fine-mapped associations</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="PDF_29_2021_Result_8444100787297833661">
  <data key="d0">Result</data>
  <data key="d1">discovery of 51 causal relationships, including previously known agonistic effects of urate on gout and cystatin C on stroke</data>
  <data key="d3">discovery of 51 causal relationships, including previously known agonistic effects of urate on gout and cystatin C on stroke</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Compound_URATE">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">URATE</data>
  <data key="d7">urate</data>
</node>
<node id="Disease_GOUT">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">GOUT</data>
  <data key="d7">gout</data>
</node>
<node id="Protein_CYSTATIN C">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">CYSTATIN C</data>
  <data key="d7">Cystatin C</data>
</node>
<node id="Disease_STROKE">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">STROKE</data>
  <data key="d7">stroke</data>
</node>
<node id="PDF_29_2021_Result_-1940611298464184448">
  <data key="d0">Result</data>
  <data key="d1">development of polygenic risk scores for each biomarker and built "multi-PRS" models for diseases using 35 PRSs simultaneously, which improved chronic kidney disease, type 2 diabetes, gout, and alcoholic cirrhosis genetic risk stratification in an independent dataset (FinnGen; n=135,500) relative to single-disease PRSs</data>
  <data key="d3">development of polygenic risk scores for each biomarker and built "multi-PRS" models for diseases using 35 PRSs simultaneously, which improved chronic kidney disease, type 2 diabetes, gout, and alcoholic cirrhosis genetic risk stratification in an independent dataset (FinnGen; n=135,500) relative to single-disease PRSs</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Disease_KIDNEY DISEASE">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">KIDNEY DISEASE</data>
  <data key="d7">kidney disease</data>
</node>
<node id="Disease_ALCOHOLIC CIRRHOSIS">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">ALCOHOLIC CIRRHOSIS</data>
  <data key="d7">alcoholic cirrhosis</data>
</node>
<node id="PDF_29_2021_Result_-654978772005704754">
  <data key="d0">Result</data>
  <data key="d1">identified a stop-gain variant in PDE3B with documented protection against high cholesterol and a range of effects on increasing HDL cholesterol and Apolipoprotein A (0.40, 0.27 sd) and decreasing triglycerides and Apolipoprotein B (0.43, 0.27 sd)</data>
  <data key="d3">identified a stop-gain variant in PDE3B with documented protection against high cholesterol and a range of effects on increasing HDL cholesterol and Apolipoprotein A (0.40, 0.27 sd) and decreasing triglycerides and Apolipoprotein B (0.43, 0.27 sd)</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Compound_HDL CHOLESTEROL">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">HDL CHOLESTEROL</data>
  <data key="d7">HDL cholesterol</data>
</node>
<node id="Protein_APOLIPOPROTEIN A">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">APOLIPOPROTEIN A</data>
  <data key="d7">Apolipoprotein A</data>
</node>
<node id="Compound_TRIGLYCERIDE">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">TRIGLYCERIDE</data>
  <data key="d7">triglyceride</data>
</node>
<node id="Protein_APOLIPOPROTEIN B">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">APOLIPOPROTEIN B</data>
  <data key="d7">Apolipoprotein B</data>
</node>
<node id="Compound_CHOLESTEROL">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">CHOLESTEROL</data>
  <data key="d7">cholesterol</data>
</node>
<node id="PDF_29_2021_Result_-2113211573748693212">
  <data key="d0">Result</data>
  <data key="d1">a stop gain variant in ANGPTL8, where we replicated a previously-reported effect on HDL cholesterol (0.06 sd in our dataset) and discovered a triglyceride-lowering effect (0.06 sd)</data>
  <data key="d3">a stop gain variant in ANGPTL8, where we replicated a previously-reported effect on HDL cholesterol (0.06 sd in our dataset) and discovered a triglyceride-lowering effect (0.06 sd)</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_ANGPTL8">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ANGPTL8</data>
  <data key="d7">ANGPTL8</data>
</node>
<node id="PDF_29_2021_Result_-509827256225457201">
  <data key="d0">Result</data>
  <data key="d1">two PTVs in LPA with lowering effects on Lipoprotein A levels (0.37, 0.42 sd), of which one is known to be associated with decreased risk of coronary artery disease (p = 3 × 10-11; OR = 0.89 [95% CI 0.86, 0.92])</data>
  <data key="d3">two PTVs in LPA with lowering effects on Lipoprotein A levels (0.37, 0.42 sd), of which one is known to be associated with decreased risk of coronary artery disease (p = 3 × 10-11; OR = 0.89 [95% CI 0.86, 0.92])</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_LIPOPROTEIN A">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">LIPOPROTEIN A</data>
  <data key="d7">Lipoprotein A</data>
</node>
<node id="Protein_LIPOPROTEIN A">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">LIPOPROTEIN A</data>
  <data key="d7">Lipoprotein A</data>
</node>
<node id="Disease_CORONARY ARTERY DISEASE">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">CORONARY ARTERY DISEASE</data>
  <data key="d7">coronary artery disease</data>
</node>
<node id="PDF_29_2021_Result_4586619883533712137">
  <data key="d0">Result</data>
  <data key="d1">a 0.2% MAF missense allele in ACACB associated with LDL, triglyceride, ApoB, and alkaline phosphatase</data>
  <data key="d3">a 0.2% MAF missense allele in ACACB associated with LDL, triglyceride, ApoB, and alkaline phosphatase</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_ACACB">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ACACB</data>
  <data key="d7">ACACB</data>
</node>
<node id="Compound_LDL">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">LDL</data>
  <data key="d7">LDL</data>
</node>
<node id="Protein_ALKALINE PHOSPHATASE">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">ALKALINE PHOSPHATASE</data>
  <data key="d7">alkaline phosphatase</data>
</node>
<node id="PDF_29_2021_Result_-5445114003000852953">
  <data key="d0">Result</data>
  <data key="d1">two independent missense alleles in PLA2G12A with increasing effects on triglycerides, sex-hormone binding globulin (SHBG), and testosterone, and lowering effects on HDL cholesterol, ApoA, and HbA1c levels</data>
  <data key="d3">two independent missense alleles in PLA2G12A with increasing effects on triglycerides, sex-hormone binding globulin (SHBG), and testosterone, and lowering effects on HDL cholesterol, ApoA, and HbA1c levels</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Protein_HBA1C">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">HBA1C</data>
  <data key="d7">HbA1c</data>
</node>
<node id="PDF_29_2021_Result_-5249027082067024832">
  <data key="d0">Result</data>
  <data key="d1">a splice region variant in CPTIA, with lowering effects on triglycerides</data>
  <data key="d3">a splice region variant in CPTIA, with lowering effects on triglycerides</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_CPTIA">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CPTIA</data>
  <data key="d7">CPTIA</data>
</node>
<node id="PDF_29_2021_Result_-5368129289754909413">
  <data key="d0">Result</data>
  <data key="d1">a missense variant in PCSK6 with ApoB- and LDL-lowering effects</data>
  <data key="d3">a missense variant in PCSK6 with ApoB- and LDL-lowering effects</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_PCSK6">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">PCSK6</data>
  <data key="d7">PCSK6</data>
</node>
<node id="PDF_29_2021_Result_-2832035924117954040">
  <data key="d0">Result</data>
  <data key="d1">a 0.05% MAF inframe deletion in GOT1 with a lowering effect on aspartate aminotransferase (2.6 sd)</data>
  <data key="d3">a 0.05% MAF inframe deletion in GOT1 with a lowering effect on aspartate aminotransferase (2.6 sd)</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_ASPARTATE AMINOTRANSFERASE">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ASPARTATE AMINOTRANSFERASE</data>
  <data key="d7">aspartate aminotransferase</data>
</node>
<node id="Protein_ASPARTATE AMINOTRANSFERASE">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">ASPARTATE AMINOTRANSFERASE</data>
  <data key="d7">aspartate aminotransferase</data>
</node>
<node id="PDF_29_2021_Result_-8976027927423428532">
  <data key="d0">Result</data>
  <data key="d1">a 0.1% MAF missense allele in SLC30A10 with increasing effects on alanine and aspartate aminotransferases</data>
  <data key="d3">a 0.1% MAF missense allele in SLC30A10 with increasing effects on alanine and aspartate aminotransferases</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_SLC30A10">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SLC30A10</data>
  <data key="d7">SLC30A10</data>
</node>
<node id="Protein_ALANINE AMINOTRANSFERASE">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">ALANINE AMINOTRANSFERASE</data>
  <data key="d7">alanine aminotransferase</data>
</node>
<node id="PDF_29_2021_Result_-8889034665994520849">
  <data key="d0">Result</data>
  <data key="d1">four missense alleles in GPT with alanine aminotransferase lowering effects</data>
  <data key="d3">four missense alleles in GPT with alanine aminotransferase lowering effects</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_ALANINE AMINOTRANSFERASE">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ALANINE AMINOTRANSFERASE</data>
  <data key="d7">alanine aminotransferase</data>
</node>
<node id="PDF_29_2021_Result_5071185389621275607">
  <data key="d0">Result</data>
  <data key="d1">a missense variant in ABCB4 with increasing effect on alanine aminotransferase and increased risk of gallstones in UK Biobank (p = 1.2 × 10−8, OR = 1.38 [95% CI: 1.23, 1.38])</data>
  <data key="d3">a missense variant in ABCB4 with increasing effect on alanine aminotransferase and increased risk of gallstones in UK Biobank (p = 1.2 × 10−8, OR = 1.38 [95% CI: 1.23, 1.38])</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_ABCB4">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ABCB4</data>
  <data key="d7">ABCB4</data>
</node>
<node id="Disease_GALLSTONES">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">GALLSTONES</data>
  <data key="d7">gallstones</data>
</node>
<node id="PDF_29_2021_Result_-5877346504939176835">
  <data key="d0">Result</data>
  <data key="d1">an allelic series of 3 missense variants in SERPINA1 with pleiotropic increasing effects on albumin, aspartate aminotransferase, direct bilirubin, and gamma glutamyltransferase, and lowering effects on AST to ALT ratio, with one of these missense alleles associated with increased risk of gallstones (p = 8.1 × 10–17, OR = 1.36 [95% CI:
1.27, 1.47]) and cholecystitis (p = 1.6 × 10~8, OR = 1.26 [95% CI: 1.16, 1.37]) in UK
Biobank</data>
  <data key="d3">an allelic series of 3 missense variants in SERPINA1 with pleiotropic increasing effects on albumin, aspartate aminotransferase, direct bilirubin, and gamma glutamyltransferase, and lowering effects on AST to ALT ratio, with one of these missense alleles associated with increased risk of gallstones (p = 8.1 × 10–17, OR = 1.36 [95% CI:
1.27, 1.47]) and cholecystitis (p = 1.6 × 10~8, OR = 1.26 [95% CI: 1.16, 1.37]) in UK
Biobank</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_SERPINA1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SERPINA1</data>
  <data key="d7">SERPINA1</data>
</node>
<node id="Protein_ALBUMIN">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">ALBUMIN</data>
  <data key="d7">albumin</data>
</node>
<node id="Compound_DIRECT BILIRUBIN">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">DIRECT BILIRUBIN</data>
  <data key="d7">direct bilirubin</data>
</node>
<node id="Protein_GAMMA GLUTAMYLTRANSFERASE">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">GAMMA GLUTAMYLTRANSFERASE</data>
  <data key="d7">gamma glutamyltransferase</data>
</node>
<node id="Disease_CHOLECYSTITIS">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">CHOLECYSTITIS</data>
  <data key="d7">cholecystitis</data>
</node>
<node id="PDF_29_2021_Result_-4221729511752295252">
  <data key="d0">Result</data>
  <data key="d1">two missense alleles in DGKD, with raising and lowering effects, respectively, on direct and total bilirubin</data>
  <data key="d3">two missense alleles in DGKD, with raising and lowering effects, respectively, on direct and total bilirubin</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_DGKD">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">DGKD</data>
  <data key="d7">DGKD</data>
</node>
<node id="Compound_TOTAL BILIRUBIN">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">TOTAL BILIRUBIN</data>
  <data key="d7">total bilirubin</data>
</node>
<node id="PDF_29_2021_Result_2977106505218234330">
  <data key="d0">Result</data>
  <data key="d1">a PTV in COL4A4 associated with an increasing effect on microalbumin in urine (0.77 sd) and an increased risk of kidney disease (p = 6.7 × 10-13, OR = 6.9 [95% CI: 4.06, 11.6]) in UK Biobank</data>
  <data key="d3">a PTV in COL4A4 associated with an increasing effect on microalbumin in urine (0.77 sd) and an increased risk of kidney disease (p = 6.7 × 10-13, OR = 6.9 [95% CI: 4.06, 11.6]) in UK Biobank</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_COL4A4">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">COL4A4</data>
  <data key="d7">COL4A4</data>
</node>
<node id="Protein_MICROALBUMIN">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">MICROALBUMIN</data>
  <data key="d7">microalbumin</data>
</node>
<node id="PDF_29_2021_Result_2428702352743802929">
  <data key="d0">Result</data>
  <data key="d1">a frame-shift variant in SLC22A2 with strong lowering effects on eGFR (0.52 sd) and increasing effect on creatinine (0.52 sd)</data>
  <data key="d3">a frame-shift variant in SLC22A2 with strong lowering effects on eGFR (0.52 sd) and increasing effect on creatinine (0.52 sd)</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_SLC22A2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SLC22A2</data>
  <data key="d7">SLC22A2</data>
</node>
<node id="Protein_EGFR">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">EGFR</data>
  <data key="d7">eGFR</data>
</node>
<node id="Compound_CREATININE">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">CREATININE</data>
  <data key="d7">creatinine</data>
</node>
<node id="PDF_29_2021_Result_-5380714902332756007">
  <data key="d0">Result</data>
  <data key="d1">a stop-gain variant in SLC22A11 with raising effects on urate (0.14 sd)</data>
  <data key="d3">a stop-gain variant in SLC22A11 with raising effects on urate (0.14 sd)</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_SLC22A11">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SLC22A11</data>
  <data key="d7">SLC22A11</data>
</node>
<node id="PDF_29_2021_Result_4039113898606538160">
  <data key="d0">Result</data>
  <data key="d1">a 0.1% rare missense allele in SLC34A3 with strong eGFR and phosphate lowering and serum creatinine, Cystatin C, and urea raising effects</data>
  <data key="d3">a 0.1% rare missense allele in SLC34A3 with strong eGFR and phosphate lowering and serum creatinine, Cystatin C, and urea raising effects</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_SLC34A3">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SLC34A3</data>
  <data key="d7">SLC34A3</data>
</node>
<node id="Compound_PHOSPHATE">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">PHOSPHATE</data>
  <data key="d7">phosphate</data>
</node>
<node id="Compound_UREA">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">UREA</data>
  <data key="d7">urea</data>
</node>
<node id="PDF_29_2021_Result_9153768662042259724">
  <data key="d0">Result</data>
  <data key="d1">missense alleles in SLC6A19, LRP2, ALDOB, and SLC7A9, and two missense variants in
SLC25A45, all associated with creatinine lowering and eGFR raising</data>
  <data key="d3">missense alleles in SLC6A19, LRP2, ALDOB, and SLC7A9, and two missense variants in
SLC25A45, all associated with creatinine lowering and eGFR raising</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_SLC6A19">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SLC6A19</data>
  <data key="d7">SLC6A19</data>
</node>
<node id="Gene_LRP2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">LRP2</data>
  <data key="d7">LRP2</data>
</node>
<node id="Gene_ALDOB">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ALDOB</data>
  <data key="d7">ALDOB</data>
</node>
<node id="Gene_SLC7A9">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SLC7A9</data>
  <data key="d7">SLC7A9</data>
</node>
<node id="Gene_SLC25A45">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">SLC25A45</data>
  <data key="d7">SLC25A45</data>
</node>
<node id="PDF_29_2021_Result_-592902069678588903">
  <data key="d0">Result</data>
  <data key="d1">an allelic series of two frame-shift variants and a missense variant in GPLD1</data>
  <data key="d3">an allelic series of two frame-shift variants and a missense variant in GPLD1</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_GPLD1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">GPLD1</data>
  <data key="d7">GPLD1</data>
</node>
<node id="PDF_29_2021_Result_-710225815859847602">
  <data key="d0">Result</data>
  <data key="d1">an allelic series of missense variants in ALPL</data>
  <data key="d3">an allelic series of missense variants in ALPL</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="PDF_29_2021_Result_-73008443620360455">
  <data key="d0">Result</data>
  <data key="d1">an allelic series in CASR that is associated with both calcium increasing and lowering effects</data>
  <data key="d3">an allelic series in CASR that is associated with both calcium increasing and lowering effects</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_CASR">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CASR</data>
  <data key="d7">CASR</data>
</node>
<node id="Compound_CALCIUM">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">CALCIUM</data>
  <data key="d7">calcium</data>
</node>
<node id="PDF_29_2021_Result_646666475697248923">
  <data key="d0">Result</data>
  <data key="d1">a known missense variant association in ANKH(-0.11 and −0.17 sd for glucose and HbA1C,
respectively), which we also replicated the documented protective effects to diabetes (p = 1.2
× 10-8, OR = 0.66 [95% CI: 0.57, 0.76])</data>
  <data key="d3">a known missense variant association in ANKH(-0.11 and −0.17 sd for glucose and HbA1C,
respectively), which we also replicated the documented protective effects to diabetes (p = 1.2
× 10-8, OR = 0.66 [95% CI: 0.57, 0.76])</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_ANKH">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ANKH</data>
  <data key="d7">ANKH</data>
</node>
<node id="Compound_GLUCOSE">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">GLUCOSE</data>
  <data key="d7">glucose</data>
</node>
<node id="Disease_DIABETES">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">DIABETES</data>
  <data key="d7">diabetes</data>
</node>
<node id="PDF_29_2021_Result_-6615300606113970582">
  <data key="d0">Result</data>
  <data key="d1">a splice-donor variant in RHAG that is strongly associated with lower HbA1c (0.80 sd) and allelic series containing 4 missense variants each in G6PC2 and TMC8</data>
  <data key="d3">a splice-donor variant in RHAG that is strongly associated with lower HbA1c (0.80 sd) and allelic series containing 4 missense variants each in G6PC2 and TMC8</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_RHAG">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">RHAG</data>
  <data key="d7">RHAG</data>
</node>
<node id="Gene_G6PC2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">G6PC2</data>
  <data key="d7">G6PC2</data>
</node>
<node id="Gene_TMC8">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">TMC8</data>
  <data key="d7">TMC8</data>
</node>
<node id="PDF_29_2021_Result_-8638093714097755657">
  <data key="d0">Result</data>
  <data key="d1">a PTV in ADH1C, MSR1, and NUBP2 affecting serum IGF-1 levels, and an allelic series including the
hepatocyte growth factor genes HGFAC, HGF, and HNF4A with effects on SHBG</data>
  <data key="d3">a PTV in ADH1C, MSR1, and NUBP2 affecting serum IGF-1 levels, and an allelic series including the
hepatocyte growth factor genes HGFAC, HGF, and HNF4A with effects on SHBG</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_ADH1C">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ADH1C</data>
  <data key="d7">ADH1C</data>
</node>
<node id="Gene_MSR1">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">MSR1</data>
  <data key="d7">MSR1</data>
</node>
<node id="Gene_NUBP2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">NUBP2</data>
  <data key="d7">NUBP2</data>
</node>
<node id="Gene_HEPATOCYTE GROWTH FACTOR ACTIVATOR">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">HEPATOCYTE GROWTH FACTOR ACTIVATOR</data>
  <data key="d7">hepatocyte growth factor activator</data>
</node>
<node id="Gene_HEPATOCYTE GROWTH FACTOR">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">HEPATOCYTE GROWTH FACTOR</data>
  <data key="d7">hepatocyte growth factor</data>
</node>
<node id="Gene_HNF4A">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">HNF4A</data>
  <data key="d7">HNF4A</data>
</node>
<node id="PDF_29_2021_Result_-3755063657638932584">
  <data key="d0">Result</data>
  <data key="d1">a missense variant with MAF 0.02% was associated with increased risk for diabetic eye disorders (p = 3.1 × 10−8, OR =
9.60 ]95% CI: 4.30, 21.4]) and diabetes (p = 4.7 × 108־, OR = 3.8 [95% CI: 2.34, 6.09])</data>
  <data key="d3">a missense variant with MAF 0.02% was associated with increased risk for diabetic eye disorders (p = 3.1 × 10−8, OR =
9.60 ]95% CI: 4.30, 21.4]) and diabetes (p = 4.7 × 108־, OR = 3.8 [95% CI: 2.34, 6.09])</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="PDF_29_2021_Result_-7552275888856269627">
  <data key="d0">Result</data>
  <data key="d1">a missense variant (MAF 3.1%) was associated with increased risk for cholecystitis (p
= 2.2 × 10-13, OR = 1.27 [95% CI: 1.22, 1.38] in UK Biobank, and also replicated in
FinnGen R2, p = 2.9 × 10-17, OR = 1.46 [95% CI: 1.34, 1.60])</data>
  <data key="d3">a missense variant (MAF 3.1%) was associated with increased risk for cholecystitis (p
= 2.2 × 10-13, OR = 1.27 [95% CI: 1.22, 1.38] in UK Biobank, and also replicated in
FinnGen R2, p = 2.9 × 10-17, OR = 1.46 [95% CI: 1.34, 1.60])</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="PDF_29_2021_Result_-4201111930626082783">
  <data key="d0">Result</data>
  <data key="d1">rare CNVs overlapping HNF1B associated with serum urea, eGFR, creatinine, and cystatin C</data>
  <data key="d3">rare CNVs overlapping HNF1B associated with serum urea, eGFR, creatinine, and cystatin C</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_HNF1B">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">HNF1B</data>
  <data key="d7">HNF1B</data>
</node>
<node id="PDF_29_2021_Result_2729564798083139075">
  <data key="d0">Result</data>
  <data key="d1">mutations in HNF1B with maturity onset diabetes of the young (MODY5) and altered
kidney function</data>
  <data key="d3">mutations in HNF1B with maturity onset diabetes of the young (MODY5) and altered
kidney function</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Disease_MATURITY ONSET DIABETES OF THE YOUNG">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">MATURITY ONSET DIABETES OF THE YOUNG</data>
  <data key="d7">maturity onset diabetes of the young</data>
</node>
<node id="Process_KIDNEY FUNCTION">
  <data key="d0">Entity</data>
  <data key="d5">Process</data>
  <data key="d6">KIDNEY FUNCTION</data>
  <data key="d7">kidney function</data>
</node>
<node id="PDF_29_2021_Result_-3349541591639341791">
  <data key="d0">Result</data>
  <data key="d1">rare CNVs overlapping HNF1B were associated with chronic kidney
disease (p = 1 × 10–7; OR = 4.94, SE = 0.30</data>
  <data key="d3">rare CNVs overlapping HNF1B were associated with chronic kidney
disease (p = 1 × 10–7; OR = 4.94, SE = 0.30</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="PDF_29_2021_Result_4001098613197549686">
  <data key="d0">Result</data>
  <data key="d1">rare duplication in the CST3 gene associated with increased levels of cystatin C, the protein it encodes, of opposite effect
to a rare PTV at the same locus</data>
  <data key="d3">rare duplication in the CST3 gene associated with increased levels of cystatin C, the protein it encodes, of opposite effect
to a rare PTV at the same locus</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_CYSTATIN C">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">CYSTATIN C</data>
  <data key="d7">Cystatin C</data>
</node>
<node id="PDF_29_2021_Result_6142937756838132795">
  <data key="d0">Result</data>
  <data key="d1">HGFAC, the gene encoding hepatocyte growth factor activator, variants show significant associations with a number of diverse biomarker traits, including lipids, IGF-1, albumin, and calcium</data>
  <data key="d3">HGFAC, the gene encoding hepatocyte growth factor activator, variants show significant associations with a number of diverse biomarker traits, including lipids, IGF-1, albumin, and calcium</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Protein_HEPATOCYTE GROWTH FACTOR ACTIVATOR">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">HEPATOCYTE GROWTH FACTOR ACTIVATOR</data>
  <data key="d7">hepatocyte growth factor activator</data>
</node>
<node id="Compound_LIPIDS">
  <data key="d0">Entity</data>
  <data key="d5">Compound</data>
  <data key="d6">LIPIDS</data>
  <data key="d7">lipids</data>
</node>
<node id="PDF_29_2021_Result_-8007171609199782149">
  <data key="d0">Result</data>
  <data key="d1">rs114303452 has been previously associated with serum HGF levels47, supporting the role of HGFAC in control of a number of other serum biomarkers through regulation of hepatocyte growth factor</data>
  <data key="d3">rs114303452 has been previously associated with serum HGF levels47, supporting the role of HGFAC in control of a number of other serum biomarkers through regulation of hepatocyte growth factor</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Protein_HEPATOCYTE GROWTH FACTOR">
  <data key="d0">Entity</data>
  <data key="d5">Protein</data>
  <data key="d6">HEPATOCYTE GROWTH FACTOR</data>
  <data key="d7">hepatocyte growth factor</data>
</node>
<node id="PDF_29_2021_Result_-8639879267144360643">
  <data key="d0">Result</data>
  <data key="d1">common (MAF = 33%) intronic
variant in DPEPI has protective effects against skin cancers (OR = 0.88 [95% CI: 0.86,
0.90], 0.81 [0.77, 0.84], and 0.89 [0.87, 0.91] for skin cancer, malignant melanoma, and
non-melanoma skin cancer, respectively), with replication in FinnGen R2 (p = 3.1 × 10~5,
OR = 0.81 [95% CI: 0.74, 0.90] for malignant neoplasm of skin)</data>
  <data key="d3">common (MAF = 33%) intronic
variant in DPEPI has protective effects against skin cancers (OR = 0.88 [95% CI: 0.86,
0.90], 0.81 [0.77, 0.84], and 0.89 [0.87, 0.91] for skin cancer, malignant melanoma, and
non-melanoma skin cancer, respectively), with replication in FinnGen R2 (p = 3.1 × 10~5,
OR = 0.81 [95% CI: 0.74, 0.90] for malignant neoplasm of skin)</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_DPEPI">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">DPEPI</data>
  <data key="d7">DPEPI</data>
</node>
<node id="Disease_SKIN CANCERS">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">SKIN CANCERS</data>
  <data key="d7">skin cancers</data>
</node>
<node id="Disease_MALIGNANT MELANOMA">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">MALIGNANT MELANOMA</data>
  <data key="d7">malignant melanoma</data>
</node>
<node id="Disease_NON-MELANOMA SKIN CANCER">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">NON-MELANOMA SKIN CANCER</data>
  <data key="d7">non-melanoma skin cancer</data>
</node>
<node id="PDF_29_2021_Result_8465833011909455292">
  <data key="d0">Result</data>
  <data key="d1">allelic series of two
intronic variants in ABCG2 identified with increasing and lowering urate level associations
that have risk-increasing (p = 2.8 × 10–67, OR = 1.38 [95% CI: 1.33, 1.44]) and protective
(OR = 0.72 [95% CI: 0.69, 0.74]) associations with gout, respectively</data>
  <data key="d3">allelic series of two
intronic variants in ABCG2 identified with increasing and lowering urate level associations
that have risk-increasing (p = 2.8 × 10–67, OR = 1.38 [95% CI: 1.33, 1.44]) and protective
(OR = 0.72 [95% CI: 0.69, 0.74]) associations with gout, respectively</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Gene_ABCG2">
  <data key="d0">Entity</data>
  <data key="d5">Gene</data>
  <data key="d6">ABCG2</data>
  <data key="d7">ABCG2</data>
</node>
<node id="PDF_29_2021_Result_-6867944860966669618">
  <data key="d0">Result</data>
  <data key="d1">genetic evidence supporting the protective effect of sex hormone binding globulin on diabetes (0.7 OR/SD) consistent with existing reports</data>
  <data key="d3">genetic evidence supporting the protective effect of sex hormone binding globulin on diabetes (0.7 OR/SD) consistent with existing reports</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="PDF_29_2021_Result_1446722532634649339">
  <data key="d0">Result</data>
  <data key="d1">ApoA on fasting glucose (0.84 OR/SD, FDR-adjusted p = 0.02)</data>
  <data key="d3">ApoA on fasting glucose (0.84 OR/SD, FDR-adjusted p = 0.02)</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="PDF_29_2021_Result_-4997994686314589138">
  <data key="d0">Result</data>
  <data key="d1">increasing effect of alanine
aminotransferase levels on diabetes (1.53 OR/SD, FDR-adjusted p = 0.0018)</data>
  <data key="d3">increasing effect of alanine
aminotransferase levels on diabetes (1.53 OR/SD, FDR-adjusted p = 0.0018)</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="PDF_29_2021_Result_4786714691298363183">
  <data key="d0">Result</data>
  <data key="d1">consistent effect of cystatin C on stroke (1.2 OR/SD, FDR-adjusted p = 8.7×10−4 for any
stroke and 1.21 OR/SD, FDR-adjusted p = 2.8×10−3 for ischemic stroke)</data>
  <data key="d3">consistent effect of cystatin C on stroke (1.2 OR/SD, FDR-adjusted p = 8.7×10−4 for any
stroke and 1.21 OR/SD, FDR-adjusted p = 2.8×10−3 for ischemic stroke)</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="PDF_29_2021_Result_-7248453938590399397">
  <data key="d0">Result</data>
  <data key="d1">HDL and ApoA were associated with increased risk of age-related macular degeneration</data>
  <data key="d3">HDL and ApoA were associated with increased risk of age-related macular degeneration</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Disease_AGE-RELATED MACULAR DEGENERATION">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">AGE-RELATED MACULAR DEGENERATION</data>
  <data key="d7">age-related macular degeneration</data>
</node>
<node id="PDF_29_2021_Result_-242860860274716819">
  <data key="d0">Result</data>
  <data key="d1">cystatin C on age-related macular degeneration</data>
  <data key="d3">cystatin C on age-related macular degeneration</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="PDF_29_2021_Result_5865510701742958866">
  <data key="d0">Result</data>
  <data key="d1">causal protective effect of testosterone on inflammatory bowel disease (0.70
OR/SD, FDR-adjusted p = 3.86×10−3)</data>
  <data key="d3">causal protective effect of testosterone on inflammatory bowel disease (0.70
OR/SD, FDR-adjusted p = 3.86×10−3)</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="Disease_INFLAMMATORY BOWEL DISEASE">
  <data key="d0">Entity</data>
  <data key="d5">Disease</data>
  <data key="d6">INFLAMMATORY BOWEL DISEASE</data>
  <data key="d7">inflammatory bowel disease</data>
</node>
<node id="PDF_29_2021_Result_2926063715828468877">
  <data key="d0">Result</data>
  <data key="d1">protective effect of urate on breast cancer
risk (0.87 OR/SD, FDR-adjusted p = 0.033)</data>
  <data key="d3">protective effect of urate on breast cancer
risk (0.87 OR/SD, FDR-adjusted p = 0.033)</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="PDF_29_2021_Conclusion_-6275312812223095918">
  <data key="d0">Conclusion</data>
  <data key="d1">Together, our results delineate the genetic
basis of biomarkers, their causal influences on diseases, and improve genetic risk stratification for
common diseases.</data>
  <data key="d3">Together, our results delineate the genetic
basis of biomarkers, their causal influences on diseases, and improve genetic risk stratification for
common diseases.</data>
  <data key="d4">PDF_29_2021</data>
</node>
<node id="PDF_03_2016">
  <data key="d0">Paper</data>
  <data key="d1">REVIEW
Not so bad after all: retroviruses and long terminal repeat
retrotransposons as a source of new genes in vertebrates
M. Naville', I. A. Warren, Z. Haftek-Terreau', D. Chalopin 12, F. Brunet', P. Levin', D. Galiana and J.-N. Volff
1) Institut de Génomique Fonctionnelle de Lyon, Ecole Normale Supérieure de Lyon, CNRS UMR5242, Université Lyon I, Lyon, France and 2) Department of
Genetics, University of Georgia, Athens, GA, USA

Abstract
Viruses and transposable elements, once considered as p</data>
  <data key="d2">2024</data>
</node>
<node id="PDF_03_2016_Conclusion_-643451381044668031">
  <data key="d0">Conclusion</data>
  <data key="d1">Retroviruses and LTR retrotransposons have repeatedly contributed their coding sequences for the formation of new protein-coding genes in vertebrates.</data>
  <data key="d3">Retroviruses and LTR retrotransposons have repeatedly contributed their coding sequences for the formation of new protein-coding genes in vertebrates.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Conclusion_145202335114919830">
  <data key="d0">Conclusion</data>
  <data key="d1">LTR retroelements have played an important role in the evolution and diversification of the vertebrate lineage.</data>
  <data key="d3">LTR retroelements have played an important role in the evolution and diversification of the vertebrate lineage.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Conclusion_3575593707632110593">
  <data key="d0">Conclusion</data>
  <data key="d1">This is particularly true for the mammalian lineage, where many gag- and env-derived genes have been identified.</data>
  <data key="d3">This is particularly true for the mammalian lineage, where many gag- and env-derived genes have been identified.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Conclusion_-532478394493600253">
  <data key="d0">Conclusion</data>
  <data key="d1">Some domestication events might have been crucial for the emergence and evolution of new structures leading to major evolutionary transitions within vertebrates.</data>
  <data key="d3">Some domestication events might have been crucial for the emergence and evolution of new structures leading to major evolutionary transitions within vertebrates.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_2611395328384755538">
  <data key="d0">Result</data>
  <data key="d1">At least 85 genes derived from the gag gene of LTR retrotransposons have been identified in the human genome.</data>
  <data key="d3">At least 85 genes derived from the gag gene of LTR retrotransposons have been identified in the human genome.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-6506083880635425266">
  <data key="d0">Result</data>
  <data key="d1">These retrotransposons belong to diverse families, with a particular involvement of Ty3/Gypsy elements.</data>
  <data key="d3">These retrotransposons belong to diverse families, with a particular involvement of Ty3/Gypsy elements.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-1338665336501691604">
  <data key="d0">Result</data>
  <data key="d1">Many of these domesticated genes are also conserved in other mammalian species.</data>
  <data key="d3">Many of these domesticated genes are also conserved in other mammalian species.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_5237846299816503068">
  <data key="d0">Result</data>
  <data key="d1">According to their evolutionary origin, these genes have been grouped into different major families including the Mart, Pnma and SCAN gene families.</data>
  <data key="d3">According to their evolutionary origin, these genes have been grouped into different major families including the Mart, Pnma and SCAN gene families.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_1090941322669377502">
  <data key="d0">Result</data>
  <data key="d1">The Mart gene family contains at least 11 genes in placental mammals.</data>
  <data key="d3">The Mart gene family contains at least 11 genes in placental mammals.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-7097743009099374394">
  <data key="d0">Result</data>
  <data key="d1">The Mart gene family is probably derived from a vertebrate Ty3/Gypsy retrotransposon family called Sushi, which has been lost in mammals but is still active in fish.</data>
  <data key="d3">The Mart gene family is probably derived from a vertebrate Ty3/Gypsy retrotransposon family called Sushi, which has been lost in mammals but is still active in fish.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-4855797592693601594">
  <data key="d0">Result</data>
  <data key="d1">After an initial event of molecular domestication in an ancestor of mammals, the family has been probably expanded through serial segmental duplication events.</data>
  <data key="d3">After an initial event of molecular domestication in an ancestor of mammals, the family has been probably expanded through serial segmental duplication events.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_6516712969677708757">
  <data key="d0">Result</data>
  <data key="d1">Most copies of the gene are located on the X chromosome, suggesting that the formation of the ancestral Mart gene occurred on this chromosome.</data>
  <data key="d3">Most copies of the gene are located on the X chromosome, suggesting that the formation of the ancestral Mart gene occurred on this chromosome.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-192296634193942865">
  <data key="d0">Result</data>
  <data key="d1">None of the Mart genes remain capable of transposition, and all have lost structural features such as LTRs, which are essential for mobilization.</data>
  <data key="d3">None of the Mart genes remain capable of transposition, and all have lost structural features such as LTRs, which are essential for mobilization.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_6316432437868048452">
  <data key="d0">Result</data>
  <data key="d1">However, all Mart genes have retained a protein-coding potential, which is conserved between species for a particular gene but can vary between genes.</data>
  <data key="d3">However, all Mart genes have retained a protein-coding potential, which is conserved between species for a particular gene but can vary between genes.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_1016911348703401768">
  <data key="d0">Result</data>
  <data key="d1">Particularly, the pol region is completely or partially deleted to differing degrees in different Mart genes.</data>
  <data key="d3">Particularly, the pol region is completely or partially deleted to differing degrees in different Mart genes.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_6182808461083643693">
  <data key="d0">Result</data>
  <data key="d1">Strikingly, all Mart genes carry a protein-coding region that is derived from the gag region of the ancestral Sushi retrotransposon.</data>
  <data key="d3">Strikingly, all Mart genes carry a protein-coding region that is derived from the gag region of the ancestral Sushi retrotransposon.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-6260615307188953613">
  <data key="d0">Result</data>
  <data key="d1">However, only four Mart proteins have conserved the nucleic acid-binding zinc finger from the original Gag nucleocapsid protein.</data>
  <data key="d3">However, only four Mart proteins have conserved the nucleic acid-binding zinc finger from the original Gag nucleocapsid protein.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_2452383165856283543">
  <data key="d0">Result</data>
  <data key="d1">Two Mart genes have a partial pol sequence with protease domain; they still use the programmed ribosomal frameshift present in the ancestral retrotransposon to produce a Gag-Pol precursor polyprotein.</data>
  <data key="d3">Two Mart genes have a partial pol sequence with protease domain; they still use the programmed ribosomal frameshift present in the ancestral retrotransposon to produce a Gag-Pol precursor polyprotein.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_1243368607826909004">
  <data key="d0">Result</data>
  <data key="d1">At least two autosomal Mart genes, Peg10 (Mart2) and Peg11/Rtl (Mart1), are subject to genomic imprinting and are located in imprinted clusters.</data>
  <data key="d3">At least two autosomal Mart genes, Peg10 (Mart2) and Peg11/Rtl (Mart1), are subject to genomic imprinting and are located in imprinted clusters.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-626512274622576483">
  <data key="d0">Result</data>
  <data key="d1">Both are exclusively expressed by the paternal allele, with their expression being under the control of differentially methylated regions.</data>
  <data key="d3">Both are exclusively expressed by the paternal allele, with their expression being under the control of differentially methylated regions.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_8204497841698412773">
  <data key="d0">Result</data>
  <data key="d1">A maternally expressed microRNA (miRNA) processed from a Peg|1/Rtl antisense transcript induces RNA interference</data>
  <data key="d3">A maternally expressed microRNA (miRNA) processed from a Peg|1/Rtl antisense transcript induces RNA interference</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-5405089879357394740">
  <data key="d0">Result</data>
  <data key="d1">Strikingly, as many as eight out of 11 Mart genes are expressed in the placenta</data>
  <data key="d3">Strikingly, as many as eight out of 11 Mart genes are expressed in the placenta</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_4819660478751447880">
  <data key="d0">Result</data>
  <data key="d1">Peg 10/Mart2 knockout mice display defects in placenta formation leading to early embryonic lethality</data>
  <data key="d3">Peg 10/Mart2 knockout mice display defects in placenta formation leading to early embryonic lethality</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-1765181065565569119">
  <data key="d0">Result</data>
  <data key="d1">Placental expression of Peg10 has also been reported in human and pig, suggesting a conserved function</data>
  <data key="d3">Placental expression of Peg10 has also been reported in human and pig, suggesting a conserved function</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-4742793393373640942">
  <data key="d0">Result</data>
  <data key="d1">Modification of Peg 11/Rtl//Mart/ expression (knockout and overexpression) causes late-foetal and/or neonatal lethality in mouse</data>
  <data key="d3">Modification of Peg 11/Rtl//Mart/ expression (knockout and overexpression) causes late-foetal and/or neonatal lethality in mouse</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-8022210761480170780">
  <data key="d0">Result</data>
  <data key="d1">Expression of the gene is detected in the mouse labyrinth zone of the placenta (the exchange region of the placenta, analogous to the villous placenta in human).</data>
  <data key="d3">Expression of the gene is detected in the mouse labyrinth zone of the placenta (the exchange region of the placenta, analogous to the villous placenta in human).</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-1707995260394507711">
  <data key="d0">Result</data>
  <data key="d1">Peg// is essential for the maintenance of foetal capillaries at the foeto-maternal interface during the late-foetal stage</data>
  <data key="d3">Peg// is essential for the maintenance of foetal capillaries at the foeto-maternal interface during the late-foetal stage</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_8130796514709054219">
  <data key="d0">Result</data>
  <data key="d1">In human paternal uniparental disomy for chromosome 14, overexpression of Peg/1, due to the presence of two paternal genes, is associated with an abnormally large placenta (placentomegaly)</data>
  <data key="d3">In human paternal uniparental disomy for chromosome 14, overexpression of Peg/1, due to the presence of two paternal genes, is associated with an abnormally large placenta (placentomegaly)</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-2298838677054812738">
  <data key="d0">Result</data>
  <data key="d1">Maternal disomy of mouse chromosome 12, which carries Peg/1, results in placental hypoplasia</data>
  <data key="d3">Maternal disomy of mouse chromosome 12, which carries Peg/1, results in placental hypoplasia</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_2768816900533462166">
  <data key="d0">Result</data>
  <data key="d1">Peg|| expression is regulated by an miRNA, miR-127, which is processed from a maternally expressed antisense Peg// transcript</data>
  <data key="d3">Peg|| expression is regulated by an miRNA, miR-127, which is processed from a maternally expressed antisense Peg// transcript</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-218620009308765095">
  <data key="d0">Result</data>
  <data key="d1">Finally, knock-out mice for LdocI/Sirh7/Mart7 show abnormal placental cell differentiation and maturation, with an overproduction of placental progesterone and placental lactogen I from trophoblast giant cells</data>
  <data key="d3">Finally, knock-out mice for LdocI/Sirh7/Mart7 show abnormal placental cell differentiation and maturation, with an overproduction of placental progesterone and placental lactogen I from trophoblast giant cells</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_6966711558591681604">
  <data key="d0">Result</data>
  <data key="d1">Pregnant Ldocl knockout mice display delayed parturition</data>
  <data key="d3">Pregnant Ldocl knockout mice display delayed parturition</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_3591124625376200672">
  <data key="d0">Result</data>
  <data key="d1">Beside placenta, Mart genes including Peg10 and Peg/l are expressed in other embryonic and adult organs and tissues with frequent expression in brain, suggesting other functions in development and physiology</data>
  <data key="d3">Beside placenta, Mart genes including Peg10 and Peg/l are expressed in other embryonic and adult organs and tissues with frequent expression in brain, suggesting other functions in development and physiology</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_7195033068660679754">
  <data key="d0">Result</data>
  <data key="d1">Peg10 has also been proposed to work as a transcription factor binding to DNA to regulate the transcription of the myelin basic protein gene.</data>
  <data key="d3">Peg10 has also been proposed to work as a transcription factor binding to DNA to regulate the transcription of the myelin basic protein gene.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-3356635196631907474">
  <data key="d0">Result</data>
  <data key="d1">PegII has been shown to contribute to muscular hypertrophy of callipyge sheep</data>
  <data key="d3">PegII has been shown to contribute to muscular hypertrophy of callipyge sheep</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_6041168224285911215">
  <data key="d0">Result</data>
  <data key="d1">Interestingly, a recent analysis has shown that disruption of the Zcchc16/Mart4/Sirhll gene in the mouse causes abnormal behaviours related to cognition, including attention, impulsivity and working memory.</data>
  <data key="d3">Interestingly, a recent analysis has shown that disruption of the Zcchc16/Mart4/Sirhll gene in the mouse causes abnormal behaviours related to cognition, including attention, impulsivity and working memory.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-4752682912734643746">
  <data key="d0">Result</data>
  <data key="d1">This indicated that Zcchc16 is involved in cognitive function in the brain, possibly via the noradrenergic system</data>
  <data key="d3">This indicated that Zcchc16 is involved in cognitive function in the brain, possibly via the noradrenergic system</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_3170009576357379118">
  <data key="d0">Result</data>
  <data key="d1">Several Mart genes show an aberrant expression in human cancers</data>
  <data key="d3">Several Mart genes show an aberrant expression in human cancers</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-8525835524271274561">
  <data key="d0">Result</data>
  <data key="d1">Peg10 is overexpressed in human hepatocellular carcinoma and other types of tumours and might itself promote cancer formation through the suppression of apoptosis and the stimulation of cell proliferation</data>
  <data key="d3">Peg10 is overexpressed in human hepatocellular carcinoma and other types of tumours and might itself promote cancer formation through the suppression of apoptosis and the stimulation of cell proliferation</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_8326470630231534351">
  <data key="d0">Result</data>
  <data key="d1">Overexpression of Peg11/Rtll in the liver of adult mice results in highly penetrant tumour formation, suggesting a role as a driver of hepatocarcinogenesis</data>
  <data key="d3">Overexpression of Peg11/Rtll in the liver of adult mice results in highly penetrant tumour formation, suggesting a role as a driver of hepatocarcinogenesis</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_6514576396171389801">
  <data key="d0">Result</data>
  <data key="d1">Ldocl, considered as a tumour suppressor down-regulated in human pancreatic cancer cell lines, inhibits nuclear factor-KB activation and induces apoptosis</data>
  <data key="d3">Ldocl, considered as a tumour suppressor down-regulated in human pancreatic cancer cell lines, inhibits nuclear factor-KB activation and induces apoptosis</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_6729994292218247921">
  <data key="d0">Result</data>
  <data key="d1">Ldocl mRNA is differentially expressed in chronic lymphocytic leukaemia and predicts overall survival in untreated patients</data>
  <data key="d3">Ldocl mRNA is differentially expressed in chronic lymphocytic leukaemia and predicts overall survival in untreated patients</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_5231125941815717684">
  <data key="d0">Result</data>
  <data key="d1">Loss of Ldoc/ expression occurs by promoter methylation in cervical cancer cells</data>
  <data key="d3">Loss of Ldoc/ expression occurs by promoter methylation in cervical cancer cells</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_484880477693735595">
  <data key="d0">Result</data>
  <data key="d1">The Ma/Pnma gene family is a second mammalian gene family that originated from a Gypsy/Ty3 LTR retrotransposon.</data>
  <data key="d3">The Ma/Pnma gene family is a second mammalian gene family that originated from a Gypsy/Ty3 LTR retrotransposon.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_5807435356745159919">
  <data key="d0">Result</data>
  <data key="d1">This family was formed independently from the Mart gene family through the domestication of a single Gypsy 12_DR-related retrotransposon copy</data>
  <data key="d3">This family was formed independently from the Mart gene family through the domestication of a single Gypsy 12_DR-related retrotransposon copy</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_2879939869721617914">
  <data key="d0">Result</data>
  <data key="d1">Subsequent duplication events expanded the family, with at least 15 Pnma genes present in human and 12 in mouse, most of them located on the X chromosome like the Mart genes</data>
  <data key="d3">Subsequent duplication events expanded the family, with at least 15 Pnma genes present in human and 12 in mouse, most of them located on the X chromosome like the Mart genes</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_4181264621298161287">
  <data key="d0">Result</data>
  <data key="d1">Pnma proteins are called 'paraneoplastic Ma antigens' because antibodies against some of them have been identified in serum from patients with paraneoplastic neurological disorders</data>
  <data key="d3">Pnma proteins are called 'paraneoplastic Ma antigens' because antibodies against some of them have been identified in serum from patients with paraneoplastic neurological disorders</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_187317135494929868">
  <data key="d0">Result</data>
  <data key="d1">Some Pnma proteins expressed in tumours of patients with paraneoplastic neurological disorders might be targeted by the autoimmune response, leading to neurological disorder</data>
  <data key="d3">Some Pnma proteins expressed in tumours of patients with paraneoplastic neurological disorders might be targeted by the autoimmune response, leading to neurological disorder</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-5912592020987490968">
  <data key="d0">Result</data>
  <data key="d1">As observed for the Mart genes, there is a link between Pnma gene functions and cell proliferation, apoptosis and cancer.</data>
  <data key="d3">As observed for the Mart genes, there is a link between Pnma gene functions and cell proliferation, apoptosis and cancer.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_2776163156402196038">
  <data key="d0">Result</data>
  <data key="d1">Pnma4 (Ma4/Map1/Maop1) is a pro-apoptotic protein that can bind the pro-apoptotic Bax (Bcl2-associated X) protein and the pro-survival Bcl-2 and Bcl-X(L) proteins</data>
  <data key="d3">Pnma4 (Ma4/Map1/Maop1) is a pro-apoptotic protein that can bind the pro-apoptotic Bax (Bcl2-associated X) protein and the pro-survival Bcl-2 and Bcl-X(L) proteins</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-6615997024763038732">
  <data key="d0">Result</data>
  <data key="d1">The stimulation of death receptors induces the formation of a complex between Pnma4 and the tumour suppressor protein RASSFIA, allowing the binding of Pnma4 to Bax.</data>
  <data key="d3">The stimulation of death receptors induces the formation of a complex between Pnma4 and the tumour suppressor protein RASSFIA, allowing the binding of Pnma4 to Bax.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-7904140944362345877">
  <data key="d0">Result</data>
  <data key="d1">Bax conformational change and induction of apoptosis in response to death receptor stimulation require interaction between RASSFIA and Pnma4</data>
  <data key="d3">Bax conformational change and induction of apoptosis in response to death receptor stimulation require interaction between RASSFIA and Pnma4</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-4065146560459111244">
  <data key="d0">Result</data>
  <data key="d1">A second Pnma protein, Pnmal/Mal, is a pro-apoptotic protein in neurons: Pnmal overexpression may contribute to neurodegenerative disorders</data>
  <data key="d3">A second Pnma protein, Pnmal/Mal, is a pro-apoptotic protein in neurons: Pnmal overexpression may contribute to neurodegenerative disorders</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-5484845071041109114">
  <data key="d0">Result</data>
  <data key="d1">Pnmal also promotes cell growth in human pancreatic ductal adenocarcinoma</data>
  <data key="d3">Pnmal also promotes cell growth in human pancreatic ductal adenocarcinoma</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_7927968620823455195">
  <data key="d0">Result</data>
  <data key="d1">Finally, Pnma10/SIZNI is expressed in the mouse ventral embryonic forebrain. It contributes to Bone Morphogenetic Protein (BMP)-dependent cholinergic-neuron-specific gene expression, and is a candidate gene for X-linked mental retardation in human</data>
  <data key="d3">Finally, Pnma10/SIZNI is expressed in the mouse ventral embryonic forebrain. It contributes to Bone Morphogenetic Protein (BMP)-dependent cholinergic-neuron-specific gene expression, and is a candidate gene for X-linked mental retardation in human</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_4860711557052946174">
  <data key="d0">Result</data>
  <data key="d1">The SCAN family of transcription factors includes C2H2 zinc finger proteins with a vertebrate-specific domain called SCAN in their N-terminus region</data>
  <data key="d3">The SCAN family of transcription factors includes C2H2 zinc finger proteins with a vertebrate-specific domain called SCAN in their N-terminus region</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-8019904981425352654">
  <data key="d0">Result</data>
  <data key="d1">This domain is a conserved 84-residue leucine-rich motif mediating interactions with other proteins; it presents structural homologies to the C-terminal domain of retroviral capsids</data>
  <data key="d3">This domain is a conserved 84-residue leucine-rich motif mediating interactions with other proteins; it presents structural homologies to the C-terminal domain of retroviral capsids</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_435226949226979638">
  <data key="d0">Result</data>
  <data key="d1">The SCAN gene family has probably been formed through the molecular domestication of a Gmr/-like LTR retrotransposon in an early tetrapod ancestor about 300 MYA</data>
  <data key="d3">The SCAN gene family has probably been formed through the molecular domestication of a Gmr/-like LTR retrotransposon in an early tetrapod ancestor about 300 MYA</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_4948576322101467019">
  <data key="d0">Result</data>
  <data key="d1">Subsequent duplication events have led to the presence of around 70 and 40 genes in human and mouse, respectively</data>
  <data key="d3">Subsequent duplication events have led to the presence of around 70 and 40 genes in human and mouse, respectively</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-6605973537982548892">
  <data key="d0">Result</data>
  <data key="d1">SCAN domain genes have also been identified in birds and reptiles</data>
  <data key="d3">SCAN domain genes have also been identified in birds and reptiles</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-7273747954525077845">
  <data key="d0">Result</data>
  <data key="d1">SCAN domain transcription factors are involved in biological processes as diverse as haematopoiesis (Myeloid zinc finger | MZFI), regulation of pluripotency of embryonic stem cells (ZNF20688), control of lipid metabolism (ZNF202), regulation of hippocampal neuronal cholesterol biosynthesis (NRIF), chondrogenesis (ZNF449), as well as in muscle stem cell behaviour, core body temperature, body fat and maternal behaviour (PWI/Peg3)</data>
  <data key="d3">SCAN domain transcription factors are involved in biological processes as diverse as haematopoiesis (Myeloid zinc finger | MZFI), regulation of pluripotency of embryonic stem cells (ZNF20688), control of lipid metabolism (ZNF202), regulation of hippocampal neuronal cholesterol biosynthesis (NRIF), chondrogenesis (ZNF449), as well as in muscle stem cell behaviour, core body temperature, body fat and maternal behaviour (PWI/Peg3)</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_8665009682326536185">
  <data key="d0">Result</data>
  <data key="d1">As observed in other Gag-related genes, SCAN domain genes play a role in the control of cell survival, proliferation and apoptosis, therefore having a possible involvement in cancer</data>
  <data key="d3">As observed in other Gag-related genes, SCAN domain genes play a role in the control of cell survival, proliferation and apoptosis, therefore having a possible involvement in cancer</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_8997888408379898657">
  <data key="d0">Result</data>
  <data key="d1">NRIF is a mediator of neuronal apoptosis</data>
  <data key="d3">NRIF is a mediator of neuronal apoptosis</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-4249170324546643797">
  <data key="d0">Result</data>
  <data key="d1">ZNF307 suppresses the p53-p21 pathway possibly through p53 degradation</data>
  <data key="d3">ZNF307 suppresses the p53-p21 pathway possibly through p53 degradation</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-4674289829848126397">
  <data key="d0">Result</data>
  <data key="d1">Mzfl is involved in the aetiology of major solid tumours such as lung, cervical, breast and colorectal cancers</data>
  <data key="d3">Mzfl is involved in the aetiology of major solid tumours such as lung, cervical, breast and colorectal cancers</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_8604739485804645421">
  <data key="d0">Result</data>
  <data key="d1">SCAN domain proteins are able to interact with many other proteins including the von Hippel-Lindau tumour suppressor protein (ZnF197), the E3 ubiquitin ligase Siahla (PwI/Peg3), the neurotrophin receptor p75 (NRIF), the peroxisome proliferator-activated receptors (SDPI and PGC-2), the glucocorticoid receptor (Znf307), the transcriptional repressor Jumonij/Jarid2 (Zfp496), the NSDI histone lysine methyltransferase (Nizpl) and the tumour necrosis factor mediator TRAF2 (Pwl/Peg3)</data>
  <data key="d3">SCAN domain proteins are able to interact with many other proteins including the von Hippel-Lindau tumour suppressor protein (ZnF197), the E3 ubiquitin ligase Siahla (PwI/Peg3), the neurotrophin receptor p75 (NRIF), the peroxisome proliferator-activated receptors (SDPI and PGC-2), the glucocorticoid receptor (Znf307), the transcriptional repressor Jumonij/Jarid2 (Zfp496), the NSDI histone lysine methyltransferase (Nizpl) and the tumour necrosis factor mediator TRAF2 (Pwl/Peg3)</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-8149516773716739703">
  <data key="d0">Result</data>
  <data key="d1">Some Gag-derived proteins play a role in the defence of organisms against infections by retroviruses</data>
  <data key="d3">Some Gag-derived proteins play a role in the defence of organisms against infections by retroviruses</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_6138912185392396335">
  <data key="d0">Result</data>
  <data key="d1">This is exemplified in the mouse by the Friend-virus-susceptibility-1 (Fvl) gene, which protects against infection by the murine leukaemia virus and other types of retroviruses</data>
  <data key="d3">This is exemplified in the mouse by the Friend-virus-susceptibility-1 (Fvl) gene, which protects against infection by the murine leukaemia virus and other types of retroviruses</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-5248946010868100813">
  <data key="d0">Result</data>
  <data key="d1">Fvl was formed about 7 MYA from the gag gene of an endogenous retrovirus family, MERV-L</data>
  <data key="d3">Fvl was formed about 7 MYA from the gag gene of an endogenous retrovirus family, MERV-L</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_3842845297345155070">
  <data key="d0">Result</data>
  <data key="d1">FvI blocks infection through interaction with the capsid protein of the restricted murine leukaemia virus</data>
  <data key="d3">FvI blocks infection through interaction with the capsid protein of the restricted murine leukaemia virus</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-2769329775037719334">
  <data key="d0">Result</data>
  <data key="d1">Fvl appears to control replication of the murine leukaemia virus after entry into the target cell but before integration and formation of the provirus</data>
  <data key="d3">Fvl appears to control replication of the murine leukaemia virus after entry into the target cell but before integration and formation of the provirus</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_4368022153806193586">
  <data key="d0">Result</data>
  <data key="d1">In mouse, Fvl is able to prevent or delay spontaneous or experimentally induced viral tumours</data>
  <data key="d3">In mouse, Fvl is able to prevent or delay spontaneous or experimentally induced viral tumours</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_6394915112418864867">
  <data key="d0">Result</data>
  <data key="d1">In sheep, two independent genes called enJS56A1 and enJSRV-20 have been derived from enJSRV Jaagsiekte endogenous betaretroviruses</data>
  <data key="d3">In sheep, two independent genes called enJS56A1 and enJSRV-20 have been derived from enJSRV Jaagsiekte endogenous betaretroviruses</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_7751973788691617524">
  <data key="d0">Result</data>
  <data key="d1">The proteins encoded by these genes can block the replication of related exogenous retroviruses</data>
  <data key="d3">The proteins encoded by these genes can block the replication of related exogenous retroviruses</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_4046510346252145046">
  <data key="d0">Result</data>
  <data key="d1">The activity-regulated cytoskeleton-associated protein (Arc) gene (aka Arg3.1) is a neuron-specific gene that works at excitatory synapses and is required for learning and memory in the mammalian brain</data>
  <data key="d3">The activity-regulated cytoskeleton-associated protein (Arc) gene (aka Arg3.1) is a neuron-specific gene that works at excitatory synapses and is required for learning and memory in the mammalian brain</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_8943811499915257727">
  <data key="d0">Result</data>
  <data key="d1">Arc has been derived from the gag gene of a Gypsy-26-I_DR retrotransposon before the divergence between mammals and amphibians</data>
  <data key="d3">Arc has been derived from the gag gene of a Gypsy-26-I_DR retrotransposon before the divergence between mammals and amphibians</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-7798959133294810114">
  <data key="d0">Result</data>
  <data key="d1">Among them, a gag-like gene called Ens-1/Erni is involved in the timing of neural plate emergence during embryonic development through the control of the expression of the Sox2 transcription factor</data>
  <data key="d3">Among them, a gag-like gene called Ens-1/Erni is involved in the timing of neural plate emergence during embryonic development through the control of the expression of the Sox2 transcription factor</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_2147677484367228702">
  <data key="d0">Result</data>
  <data key="d1">Compared with gag-derived genes, genes derived from integrases of retroviruses and LTR retrotransposons are not numerous in vertebrate genomes</data>
  <data key="d3">Compared with gag-derived genes, genes derived from integrases of retroviruses and LTR retrotransposons are not numerous in vertebrate genomes</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_4689609401511785160">
  <data key="d0">Result</data>
  <data key="d1">Two genes related to integrases, called Gin-1 and Gin-2, have been identified in vertebrates</data>
  <data key="d3">Two genes related to integrases, called Gin-1 and Gin-2, have been identified in vertebrates</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-2733308991801400711">
  <data key="d0">Result</data>
  <data key="d1">Gin-2 is present in cartilaginous and ray-finned fish, amphibians, birds and reptiles, suggesting a molecular domestication event approximately 500 MYA.</data>
  <data key="d3">Gin-2 is present in cartilaginous and ray-finned fish, amphibians, birds and reptiles, suggesting a molecular domestication event approximately 500 MYA.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-6363912091192157552">
  <data key="d0">Result</data>
  <data key="d1">However, this gene has been lost in placental mammals</data>
  <data key="d3">However, this gene has been lost in placental mammals</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_2291854045400655013">
  <data key="d0">Result</data>
  <data key="d1">Gin-1 is more recent and has been formed independently of Gin-2 in a common ancestor of birds/reptiles and mammals.</data>
  <data key="d3">Gin-1 is more recent and has been formed independently of Gin-2 in a common ancestor of birds/reptiles and mammals.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-349997672573353110">
  <data key="d0">Result</data>
  <data key="d1">Nothing is known of the functions of both genes, but the expression pattern of Gin-2 in zebrafish embryos suggests a role during gastrulation</data>
  <data key="d3">Nothing is known of the functions of both genes, but the expression pattern of Gin-2 in zebrafish embryos suggests a role during gastrulation</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-4862312033229545929">
  <data key="d0">Result</data>
  <data key="d1">Additional analyses have demonstrated that Gin genes have been formed from particular DNA transposons that have themselves recruited an integrase from LTR retrotransposons to use as a transposase.</data>
  <data key="d3">Additional analyses have demonstrated that Gin genes have been formed from particular DNA transposons that have themselves recruited an integrase from LTR retrotransposons to use as a transposase.</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-1082889079323691771">
  <data key="d0">Result</data>
  <data key="d1">Hence, the Gin genes are only indirectly derived from LTR retroelement integrases</data>
  <data key="d3">Hence, the Gin genes are only indirectly derived from LTR retroelement integrases</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-7934512523283457974">
  <data key="d0">Result</data>
  <data key="d1">In mammals, a gene called CGINI has been formed through the fusion of an endogenous retroviral sequence (integrase and RNase H) and a duplicated copy of the cellular gene KIAA0323</data>
  <data key="d3">In mammals, a gene called CGINI has been formed through the fusion of an endogenous retroviral sequence (integrase and RNase H) and a duplicated copy of the cellular gene KIAA0323</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_5242860508786423365">
  <data key="d0">Result</data>
  <data key="d1">This domestication event took place c. 125-180 MYA in a common ancestor of marsupials and Eutherians</data>
  <data key="d3">This domestication event took place c. 125-180 MYA in a common ancestor of marsupials and Eutherians</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-7866323607528034826">
  <data key="d0">Result</data>
  <data key="d1">The CGINI integrase-like domain has been inactivated by mutations but might have retained the three-dimensional folding observed in retroviral integrases</data>
  <data key="d3">The CGINI integrase-like domain has been inactivated by mutations but might have retained the three-dimensional folding observed in retroviral integrases</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-1410001266504977847">
  <data key="d0">Result</data>
  <data key="d1">A role in the resistance to retroviruses through regulation of viral protein ubiquitination has been proposed</data>
  <data key="d3">A role in the resistance to retroviruses through regulation of viral protein ubiquitination has been proposed</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_782228815989570679">
  <data key="d0">Result</data>
  <data key="d1">Retroviral-like aspartic protease genes that are not embedded within endogenous retroviral elements have been identified in vertebrate genomes</data>
  <data key="d3">Retroviral-like aspartic protease genes that are not embedded within endogenous retroviral elements have been identified in vertebrate genomes</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_1309553967301455561">
  <data key="d0">Result</data>
  <data key="d1">One of them, SASPase (ASPRVI), which is possibly derived from a retroviral/retrotransposon aspartic protease, is expressed in human and mouse epidermis</data>
  <data key="d3">One of them, SASPase (ASPRVI), which is possibly derived from a retroviral/retrotransposon aspartic protease, is expressed in human and mouse epidermis</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_4708305334563415109">
  <data key="d0">Result</data>
  <data key="d1">In mouse, SASPase is involved in wrinkle formation and is necessary for the maintenance of the texture and hydration of the stratum corneum, the outermost layer of the epidermis</data>
  <data key="d3">In mouse, SASPase is involved in wrinkle formation and is necessary for the maintenance of the texture and hydration of the stratum corneum, the outermost layer of the epidermis</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-2180706313580158849">
  <data key="d0">Result</data>
  <data key="d1">In addition to the protease domain, SASPase also shows homology with the capsid domain of Gag proteins from LTR retroelements</data>
  <data key="d3">In addition to the protease domain, SASPase also shows homology with the capsid domain of Gag proteins from LTR retroelements</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_5513406597114021216">
  <data key="d0">Result</data>
  <data key="d1">In human, two genes called DDII and NIXI encode predicted products with similarities to aspartyl proteases from LTR retroelements</data>
  <data key="d3">In human, two genes called DDII and NIXI encode predicted products with similarities to aspartyl proteases from LTR retroelements</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-8716936521240148936">
  <data key="d0">Result</data>
  <data key="d1">Both proteins are related to the yeast Ddilp protein and have homologues in a- and y-Proteobacteria, suggesting horizontal transfer between eukaryotes and Proteobacteria</data>
  <data key="d3">Both proteins are related to the yeast Ddilp protein and have homologues in a- and y-Proteobacteria, suggesting horizontal transfer between eukaryotes and Proteobacteria</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-8770586852948316027">
  <data key="d0">Result</data>
  <data key="d1">In the mouse, NIXI is expressed only in specific neurons of the central nervous system; NIXI binds ligand-activated/constitutively active nuclear receptors and down-regulates transcription</data>
  <data key="d3">In the mouse, NIXI is expressed only in specific neurons of the central nervous system; NIXI binds ligand-activated/constitutively active nuclear receptors and down-regulates transcription</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-1265511982591255889">
  <data key="d0">Result</data>
  <data key="d1">One of the most intriguing examples of convergent exaptation of LTR retroelement genes is provided by the Syncytins, which are genes derived from endogenous retrovirus envelope genes</data>
  <data key="d3">One of the most intriguing examples of convergent exaptation of LTR retroelement genes is provided by the Syncytins, which are genes derived from endogenous retrovirus envelope genes</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-8557359170346303004">
  <data key="d0">Result</data>
  <data key="d1">Syncytins have been recruited several times independently in different sublineages in mammals, and are involved in the formation of the placenta, which forms the nutritional and protective interface between the mother and the developing foetus</data>
  <data key="d3">Syncytins have been recruited several times independently in different sublineages in mammals, and are involved in the formation of the placenta, which forms the nutritional and protective interface between the mother and the developing foetus</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-5471715600935533770">
  <data key="d0">Result</data>
  <data key="d1">Syncytins are expressed in the syncytiotrophoblast layer, a continuous structure with microvillar surfaces forming the outermost foetal component of the placenta</data>
  <data key="d3">Syncytins are expressed in the syncytiotrophoblast layer, a continuous structure with microvillar surfaces forming the outermost foetal component of the placenta</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_1099131292023905312">
  <data key="d0">Result</data>
  <data key="d1">This layer is important for exchanges between mother and foetus</data>
  <data key="d3">This layer is important for exchanges between mother and foetus</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_7344316095245262954">
  <data key="d0">Result</data>
  <data key="d1">Syncytins promote the fusion of trophoblast cells, which leads to the formation of the syncytiotrophoblast</data>
  <data key="d3">Syncytins promote the fusion of trophoblast cells, which leads to the formation of the syncytiotrophoblast</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-5437192387775896707">
  <data key="d0">Result</data>
  <data key="d1">Some Syncytins-but not all-also possess immunosuppressive properties, which might help to protect foetal tissues from the maternal immune system</data>
  <data key="d3">Some Syncytins-but not all-also possess immunosuppressive properties, which might help to protect foetal tissues from the maternal immune system</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-6306807145602007753">
  <data key="d0">Result</data>
  <data key="d1">The first Syncytin to be discovered was Syncytin-I in human, which corresponds to an envelope-like protein encoded by a defective HERV-W provirus</data>
  <data key="d3">The first Syncytin to be discovered was Syncytin-I in human, which corresponds to an envelope-like protein encoded by a defective HERV-W provirus</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_6968961274516821675">
  <data key="d0">Result</data>
  <data key="d1">Beside placenta formation, Syncytin-I might also be involved in osteoclast fusion and bone resorption and may also regulate neuro-inflammation in multiple sclerosis</data>
  <data key="d3">Beside placenta formation, Syncytin-I might also be involved in osteoclast fusion and bone resorption and may also regulate neuro-inflammation in multiple sclerosis</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-4443640459229702546">
  <data key="d0">Result</data>
  <data key="d1">Subsequently, Syncytin-2, a second placental Syncytin with fusogenic properties, derived from a HERV-FRD endogenous retrovirus, has been found in human</data>
  <data key="d3">Subsequently, Syncytin-2, a second placental Syncytin with fusogenic properties, derived from a HERV-FRD endogenous retrovirus, has been found in human</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-7981679838125482304">
  <data key="d0">Result</data>
  <data key="d1">Both Syncytin-1 and -2 genes are conserved in simians, where other potentially intact retroviral env genes have been detected, but with no hint of their functions</data>
  <data key="d3">Both Syncytin-1 and -2 genes are conserved in simians, where other potentially intact retroviral env genes have been detected, but with no hint of their functions</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-4221535811612929792">
  <data key="d0">Result</data>
  <data key="d1">Genes for Syncytin-1 (apes) and Syncytin-2 (apes and monkeys) have been acquired through independent infection events</data>
  <data key="d3">Genes for Syncytin-1 (apes) and Syncytin-2 (apes and monkeys) have been acquired through independent infection events</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-5407220415233439904">
  <data key="d0">Result</data>
  <data key="d1">Syncytin-1 cell-cell fusion requires interaction with the human sodium-dependent neutral amino acid transporter type 2 hASCT2</data>
  <data key="d3">Syncytin-1 cell-cell fusion requires interaction with the human sodium-dependent neutral amino acid transporter type 2 hASCT2</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_5209383823554195311">
  <data key="d0">Result</data>
  <data key="d1">The Syncytin-2 receptor, MFSD2, is a presumptive carbohydrate transporter with 10-12 membrane-spanning domains</data>
  <data key="d3">The Syncytin-2 receptor, MFSD2, is a presumptive carbohydrate transporter with 10-12 membrane-spanning domains</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_8993459347457690362">
  <data key="d0">Result</data>
  <data key="d1">This receptor, which is placenta-specific and expressed at the level of the syncytiotrophoblast, is important for trophoblast fusion</data>
  <data key="d3">This receptor, which is placenta-specific and expressed at the level of the syncytiotrophoblast, is important for trophoblast fusion</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_6375875421462555005">
  <data key="d0">Result</data>
  <data key="d1">Another human placenta-specific HERV-derived protein called Suppressyn inhibits cell fusion</data>
  <data key="d3">Another human placenta-specific HERV-derived protein called Suppressyn inhibits cell fusion</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_9125790733851897827">
  <data key="d0">Result</data>
  <data key="d1">Through its binding to hASCT2, this protein might compete with Syncytin-1 to modulate its function in placenta</data>
  <data key="d3">Through its binding to hASCT2, this protein might compete with Syncytin-1 to modulate its function in placenta</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_1963783371072672739">
  <data key="d0">Result</data>
  <data key="d1">Two Syncytin genes of independent origins, called Syncytin-A and Syncytin-B, have also been identified in the mouse and other Muroidea species</data>
  <data key="d3">Two Syncytin genes of independent origins, called Syncytin-A and Syncytin-B, have also been identified in the mouse and other Muroidea species</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-4389366504757811525">
  <data key="d0">Result</data>
  <data key="d1">Both exhibit placenta-specific expression and cell-cell fusogenic properties</data>
  <data key="d3">Both exhibit placenta-specific expression and cell-cell fusogenic properties</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_2800497317580016243">
  <data key="d0">Result</data>
  <data key="d1">Homozygous Syncytin-A knock-out mouse embryos die in utero between 11.5 and 13.5 days of gestation, demonstrating the critical function of this gene in development</data>
  <data key="d3">Homozygous Syncytin-A knock-out mouse embryos die in utero between 11.5 and 13.5 days of gestation, demonstrating the critical function of this gene in development</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_458064007711797466">
  <data key="d0">Result</data>
  <data key="d1">In these embryos, absence of trophoblast cell fusion and defect in the formation of one of the two syncytiotrophoblast layers are associated with decreased vascularization, inhibition of placental transport and foetal growth retardation</data>
  <data key="d3">In these embryos, absence of trophoblast cell fusion and defect in the formation of one of the two syncytiotrophoblast layers are associated with decreased vascularization, inhibition of placental transport and foetal growth retardation</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_7082090687118344914">
  <data key="d0">Result</data>
  <data key="d1">Syncytin-B null embryos are viable, but Syncytin-A null embryos die prematurely when Syncytin-B is also inactivated</data>
  <data key="d3">Syncytin-B null embryos are viable, but Syncytin-A null embryos die prematurely when Syncytin-B is also inactivated</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-4867061353284130689">
  <data key="d0">Result</data>
  <data key="d1">In addition to simians and mouse-related rodents, Syncytin-like genes have also been identified in squirrel-related rodents, lagomorphs, guinea pig, ruminants, including Fematrin-1, Afrotherian tenrecs and Carnivora, the latter being the oldest Syncytin gene identified to date with an age of 60-85 million years</data>
  <data key="d3">In addition to simians and mouse-related rodents, Syncytin-like genes have also been identified in squirrel-related rodents, lagomorphs, guinea pig, ruminants, including Fematrin-1, Afrotherian tenrecs and Carnivora, the latter being the oldest Syncytin gene identified to date with an age of 60-85 million years</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_5051524760802359573">
  <data key="d0">Result</data>
  <data key="d1">Expression of an env-derived Syncytin gene with cell-cell fusogenic properties has also been found in the short-lived marsupial placenta of the South American marsupial opossum</data>
  <data key="d3">Expression of an env-derived Syncytin gene with cell-cell fusogenic properties has also been found in the short-lived marsupial placenta of the South American marsupial opossum</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-4205445665452748532">
  <data key="d0">Result</data>
  <data key="d1">All of these Syncytin genes have been introduced in the germ line of their hosts through independent retrovirus infections, indicating recurrent convergent domestication of env sequences into Syncytin genes in mammals</data>
  <data key="d3">All of these Syncytin genes have been introduced in the germ line of their hosts through independent retrovirus infections, indicating recurrent convergent domestication of env sequences into Syncytin genes in mammals</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_7101319638586571796">
  <data key="d0">Result</data>
  <data key="d1">Other env-derived genes possess functions independent of placenta formation, including the restriction of infection by other viruses</data>
  <data key="d3">Other env-derived genes possess functions independent of placenta formation, including the restriction of infection by other viruses</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-1531191695952572802">
  <data key="d0">Result</data>
  <data key="d1">For instance, the Fv-4 (Friend virus susceptibility protein 4, aka Akvrl for AKR virus restriction 1) locus in the mouse controls the susceptibility to infection by ecotropic murine leukaemia virus</data>
  <data key="d3">For instance, the Fv-4 (Friend virus susceptibility protein 4, aka Akvrl for AKR virus restriction 1) locus in the mouse controls the susceptibility to infection by ecotropic murine leukaemia virus</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-280540192320232240">
  <data key="d0">Result</data>
  <data key="d1">This locus corresponds to a gene constituted by an entire murine leukaemia virus env gene flanked by a partial pol sequence and a 3' murine leukaemia virus LTR</data>
  <data key="d3">This locus corresponds to a gene constituted by an entire murine leukaemia virus env gene flanked by a partial pol sequence and a 3' murine leukaemia virus LTR</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_-7590497477455818820">
  <data key="d0">Result</data>
  <data key="d1">Expression of the Env protein confers resistance to virus infection</data>
  <data key="d3">Expression of the Env protein confers resistance to virus infection</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_1702324324304191159">
  <data key="d0">Result</data>
  <data key="d1">In domestic chicken, several env-derived genes that originated from endogenous avian leucosis viruses confer protection against exogenous avian leucosis viruses by blocking their entry into the cell</data>
  <data key="d3">In domestic chicken, several env-derived genes that originated from endogenous avian leucosis viruses confer protection against exogenous avian leucosis viruses by blocking their entry into the cell</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_1068733771608301059">
  <data key="d0">Result</data>
  <data key="d1">In domestic sheep, one copy of an endogenous Jaagsiekte sheep retrovirus expresses an env gene that restricts infection by exogenous Jaagsiekte sheep retroviruses</data>
  <data key="d3">In domestic sheep, one copy of an endogenous Jaagsiekte sheep retrovirus expresses an env gene that restricts infection by exogenous Jaagsiekte sheep retroviruses</data>
  <data key="d4">PDF_03_2016</data>
</node>
<node id="PDF_03_2016_Result_6166757899220619831">
  <data key="d0">Result</data>
  <data key="d1">Other examples of env-derived genes involved in resistance to infection are known from domestic mouse (Rmcf and Rmcf2) and cat (Refrex-1)</data>
  <data key="d3">Other examples of env-derived genes involved in resistance to infection are known from domestic mouse (Rmcf and Rmcf2) and cat (Refrex-1)</data>
  <data key="d4">PDF_03_2016</data>
</node>
<edge source="PDF_35_2018" target="PDF_35_2018_Hypothesis_6607342765796793125">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_35_2018" target="PDF_35_2018_Method_-4022510037365219681">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_35_2018" target="PDF_35_2018_Result_6372364759180780684">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_35_2018" target="PDF_35_2018_Result_2505657037585826409">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_35_2018" target="PDF_35_2018_Conclusion_168680280078598681">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_35_2018_Result_6372364759180780684" target="Protein_KITL">
  <data key="d8">MENTIONS</data>
  <data key="d9">KITL produced by the granulosa cells in the primordial follicle triggers growth of the enclosed oocyte.</data>
</edge>
<edge source="PDF_06_2021" target="PDF_06_2021_Conclusion_-3571697265012646536">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_06_2021" target="PDF_06_2021_Result_-8293907984342820785">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_06_2021" target="PDF_06_2021_Result_6580076833441545751">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_06_2021" target="PDF_06_2021_Result_1886473363624640680">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_06_2021_Result_-8293907984342820785" target="Protein_NDT80">
  <data key="d8">MENTIONS</data>
  <data key="d9">We show that budding yeast Ty3/Gypsy co-opts binding sites of the essential meiotic transcription factor Ndt80 upstream of the integration site, thereby tightly linking its transcriptional activation to meiotic progression.</data>
</edge>
<edge source="PDF_06_2021_Result_-8293907984342820785" target="Gene_TY3/GYPSY">
  <data key="d8">MENTIONS</data>
  <data key="d9">We show that budding yeast Ty3/Gypsy co-opts binding sites of the essential meiotic transcription factor Ndt80 upstream of the integration site, thereby tightly linking its transcriptional activation to meiotic progression.</data>
</edge>
<edge source="PDF_06_2021_Result_6580076833441545751" target="Protein_RIM4">
  <data key="d8">MENTIONS</data>
  <data key="d9">We also elucidate how yeast cells thwart Ty3/Gypsy proliferation by blocking translation of the retrotransposon mRNA using amyloid-like assemblies of the RNA-binding protein Rim4.</data>
</edge>
<edge source="PDF_06_2021_Result_6580076833441545751" target="Gene_TY3/GYPSY">
  <data key="d8">MENTIONS</data>
  <data key="d9">We also elucidate how yeast cells thwart Ty3/Gypsy proliferation by blocking translation of the retrotransposon mRNA using amyloid-like assemblies of the RNA-binding protein Rim4.</data>
</edge>
<edge source="PDF_06_2021_Result_1886473363624640680" target="Gene_STRA8">
  <data key="d8">MENTIONS</data>
  <data key="d9">We show that mammals utilize equivalent master meiotic regulators (Stra8, Mybl1, Dazl) to regulate Ty3/Gypsy-derived genes in developing gametes.</data>
</edge>
<edge source="PDF_06_2021_Result_1886473363624640680" target="Gene_MYBL1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We show that mammals utilize equivalent master meiotic regulators (Stra8, Mybl1, Dazl) to regulate Ty3/Gypsy-derived genes in developing gametes.</data>
</edge>
<edge source="PDF_06_2021_Result_1886473363624640680" target="Gene_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">We show that mammals utilize equivalent master meiotic regulators (Stra8, Mybl1, Dazl) to regulate Ty3/Gypsy-derived genes in developing gametes.</data>
</edge>
<edge source="PDF_06_2021_Result_1886473363624640680" target="Gene_TY3/GYPSY">
  <data key="d8">MENTIONS</data>
  <data key="d9">We show that mammals utilize equivalent master meiotic regulators (Stra8, Mybl1, Dazl) to regulate Ty3/Gypsy-derived genes in developing gametes.</data>
</edge>
<edge source="PDF_49_2017" target="PDF_49_2017_Result_-996224747342952721">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_49_2017" target="PDF_49_2017_Result_5555692958255038668">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_49_2017" target="PDF_49_2017_Result_-4649153068088334797">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_49_2017" target="PDF_49_2017_Result_-891350384711302256">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_49_2017_Result_-996224747342952721" target="Protein_CD3">
  <data key="d8">MENTIONS</data>
  <data key="d9">a statistically significant association between disease-specific survival and positive cell density scores was demonstrated for both CD3 and CD8</data>
</edge>
<edge source="PDF_49_2017_Result_-996224747342952721" target="Protein_CD8">
  <data key="d8">MENTIONS</data>
  <data key="d9">a statistically significant association between disease-specific survival and positive cell density scores was demonstrated for both CD3 and CD8</data>
</edge>
<edge source="PDF_49_2017_Result_5555692958255038668" target="Protein_TP53">
  <data key="d8">MENTIONS</data>
  <data key="d9">aberrant p53 expression is associated with significantly poorer unadjusted disease-specific survival when compared with intermediate, 'wild-type' expression</data>
</edge>
<edge source="PDF_49_2017_Result_5555692958255038668" target="Gene_TP53">
  <data key="d8">MENTIONS</data>
  <data key="d9">aberrant p53 expression is associated with significantly poorer unadjusted disease-specific survival when compared with intermediate, 'wild-type' expression</data>
</edge>
<edge source="PDF_49_2017_Result_-4649153068088334797" target="Protein_PD-L1">
  <data key="d8">MENTIONS</data>
  <data key="d9">higher PD-L1 expression to be significantly associated with improved disease-specific survival in unadjusted analysis</data>
</edge>
<edge source="PDF_04_2013" target="PDF_04_2013_Hypothesis_-552669748670766290">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_04_2013" target="PDF_04_2013_Method_2235178835756339331">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_04_2013" target="PDF_04_2013_Method_-7138270917738499825">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_04_2013" target="PDF_04_2013_Method_-8868282894336236895">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_04_2013" target="PDF_04_2013_Result_-7584703077616507795">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_04_2013" target="PDF_04_2013_Result_8531639358069998615">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_04_2013" target="PDF_04_2013_Result_-1132446246714849278">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_04_2013" target="PDF_04_2013_Result_444563630561013278">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_04_2013" target="PDF_04_2013_Conclusion_-5562496876107181190">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_18_2013" target="PDF_18_2013_Hypothesis_1698064238978234472">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_18_2013" target="PDF_18_2013_Method_7340696956969420060">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_18_2013" target="PDF_18_2013_Method_-1981325593318475646">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_18_2013" target="PDF_18_2013_Method_10165599989779262">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_18_2013" target="PDF_18_2013_Method_1833730253347585872">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_18_2013" target="PDF_18_2013_Method_7975679540487905188">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_18_2013" target="PDF_18_2013_Method_3696440658537175570">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_18_2013" target="PDF_18_2013_Method_2515045453521819794">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_18_2013" target="PDF_18_2013_Result_-9161646209441668556">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_18_2013" target="PDF_18_2013_Conclusion_-1276811915882357539">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_18_2013" target="PDF_18_2013_Conclusion_-520697566531489822">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_18_2013" target="PDF_18_2013_Conclusion_-5162339154313744163">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_18_2013_Hypothesis_1698064238978234472" target="Disease_DISEASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">Polymorphisms in regulatory regions probably contribute to many disease phenotypes.</data>
</edge>
<edge source="PDF_18_2013_Conclusion_-520697566531489822" target="Disease_DISEASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">The GTEx project will aid in the interpretation of GWAS findings for translational research by providing data and resources on eQTLs in a wide range of tissues of relevance to many diseases.</data>
</edge>
<edge source="PDF_39_2016" target="PDF_39_2016_Result_-318989661465928678">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_39_2016" target="PDF_39_2016_Result_2154384502965408521">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_39_2016" target="PDF_39_2016_Result_-667261254184653789">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_39_2016" target="PDF_39_2016_Result_-2160432020041116881">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_39_2016" target="PDF_39_2016_Conclusion_-6214686346960481988">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_39_2016_Result_-318989661465928678" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1-deficient mice are markedly resistant to Fas-induced hepatocellular apoptosis and lethality.</data>
</edge>
<edge source="PDF_39_2016_Result_-318989661465928678" target="Protein_FAS">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1-deficient mice are markedly resistant to Fas-induced hepatocellular apoptosis and lethality.</data>
</edge>
<edge source="PDF_39_2016_Result_-318989661465928678" target="Process_APOPTOSIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1-deficient mice are markedly resistant to Fas-induced hepatocellular apoptosis and lethality.</data>
</edge>
<edge source="PDF_39_2016_Result_2154384502965408521" target="Protein_TBID">
  <data key="d8">MENTIONS</data>
  <data key="d9">tBid is unable to associate with MTCH2 and fails to accumulate at mitochondria in the absence of MOAP-1.</data>
</edge>
<edge source="PDF_39_2016_Result_2154384502965408521" target="Protein_MTCH2">
  <data key="d8">MENTIONS</data>
  <data key="d9">tBid is unable to associate with MTCH2 and fails to accumulate at mitochondria in the absence of MOAP-1.</data>
</edge>
<edge source="PDF_39_2016_Result_2154384502965408521" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">tBid is unable to associate with MTCH2 and fails to accumulate at mitochondria in the absence of MOAP-1.</data>
</edge>
<edge source="PDF_39_2016_Result_2154384502965408521" target="Process_MITOCHONDRIA">
  <data key="d8">MENTIONS</data>
  <data key="d9">tBid is unable to associate with MTCH2 and fails to accumulate at mitochondria in the absence of MOAP-1.</data>
</edge>
<edge source="PDF_39_2016_Result_-667261254184653789" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1 associates with MTCH2, but not tBid.</data>
</edge>
<edge source="PDF_39_2016_Result_-667261254184653789" target="Protein_MTCH2">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1 associates with MTCH2, but not tBid.</data>
</edge>
<edge source="PDF_39_2016_Result_-667261254184653789" target="Protein_TBID">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1 associates with MTCH2, but not tBid.</data>
</edge>
<edge source="PDF_39_2016_Result_-2160432020041116881" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Re-expression of MOAP-1, but not the MOAP-1 mutant defective in binding MTCH, restores the binding of tBid to MTCH2 and hepatocellular apoptosis upon Fas activation.</data>
</edge>
<edge source="PDF_39_2016_Result_-2160432020041116881" target="Gene_MTCH2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Re-expression of MOAP-1, but not the MOAP-1 mutant defective in binding MTCH, restores the binding of tBid to MTCH2 and hepatocellular apoptosis upon Fas activation.</data>
</edge>
<edge source="PDF_39_2016_Result_-2160432020041116881" target="Protein_TBID">
  <data key="d8">MENTIONS</data>
  <data key="d9">Re-expression of MOAP-1, but not the MOAP-1 mutant defective in binding MTCH, restores the binding of tBid to MTCH2 and hepatocellular apoptosis upon Fas activation.</data>
</edge>
<edge source="PDF_39_2016_Result_-2160432020041116881" target="Protein_MTCH2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Re-expression of MOAP-1, but not the MOAP-1 mutant defective in binding MTCH, restores the binding of tBid to MTCH2 and hepatocellular apoptosis upon Fas activation.</data>
</edge>
<edge source="PDF_39_2016_Result_-2160432020041116881" target="Process_APOPTOSIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">Re-expression of MOAP-1, but not the MOAP-1 mutant defective in binding MTCH, restores the binding of tBid to MTCH2 and hepatocellular apoptosis upon Fas activation.</data>
</edge>
<edge source="PDF_39_2016_Result_-2160432020041116881" target="Protein_FAS">
  <data key="d8">MENTIONS</data>
  <data key="d9">Re-expression of MOAP-1, but not the MOAP-1 mutant defective in binding MTCH, restores the binding of tBid to MTCH2 and hepatocellular apoptosis upon Fas activation.</data>
</edge>
<edge source="PDF_39_2016_Conclusion_-6214686346960481988" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1 serves as a critical component of the Fas signaling in liver by promoting the mitochondrial receptor function of MTCH2 for tBid.</data>
</edge>
<edge source="PDF_39_2016_Conclusion_-6214686346960481988" target="Protein_FAS">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1 serves as a critical component of the Fas signaling in liver by promoting the mitochondrial receptor function of MTCH2 for tBid.</data>
</edge>
<edge source="PDF_39_2016_Conclusion_-6214686346960481988" target="Protein_MTCH2">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1 serves as a critical component of the Fas signaling in liver by promoting the mitochondrial receptor function of MTCH2 for tBid.</data>
</edge>
<edge source="PDF_39_2016_Conclusion_-6214686346960481988" target="Protein_TBID">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1 serves as a critical component of the Fas signaling in liver by promoting the mitochondrial receptor function of MTCH2 for tBid.</data>
</edge>
<edge source="PDF_58_2023" target="PDF_58_2023_Hypothesis_4931475269163258933">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_58_2023" target="PDF_58_2023_Method_4078968727892392345">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_58_2023" target="PDF_58_2023_Method_2813433265140845269">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_58_2023" target="PDF_58_2023_Method_6495057347155501077">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_58_2023" target="PDF_58_2023_Result_3345746782032400808">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_58_2023" target="PDF_58_2023_Result_533722152885788374">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_58_2023" target="PDF_58_2023_Result_3460477371086700921">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_58_2023" target="PDF_58_2023_Result_7550864938787887815">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_58_2023" target="PDF_58_2023_Conclusion_9069111716801773710">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_58_2023" target="PDF_58_2023_Conclusion_-7061615767234987994">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_58_2023_Hypothesis_4931475269163258933" target="Protein_RIM4">
  <data key="d8">MENTIONS</data>
  <data key="d9">Rim4 assembly stimulates RRM-mediated binding of its target RNAs, a requisite for its function as a translational repressor.</data>
</edge>
<edge source="PDF_58_2023_Hypothesis_4931475269163258933" target="Compound_RNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">Rim4 assembly stimulates RRM-mediated binding of its target RNAs, a requisite for its function as a translational repressor.</data>
</edge>
<edge source="PDF_58_2023_Result_3345746782032400808" target="Protein_RIM4">
  <data key="d8">MENTIONS</data>
  <data key="d9">assembled Rim4 binds RNA more efficiently than its monomeric form, a requirement for effective translational repression</data>
</edge>
<edge source="PDF_58_2023_Result_3345746782032400808" target="Compound_RNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">assembled Rim4 binds RNA more efficiently than its monomeric form, a requirement for effective translational repression</data>
</edge>
<edge source="PDF_58_2023_Result_533722152885788374" target="Protein_RIM4">
  <data key="d8">MENTIONS</data>
  <data key="d9">Rim4 represses translation when it binds the transcripts at their 5' end, while it does not have any effect when it binds their 3' end</data>
</edge>
<edge source="PDF_58_2023_Result_3460477371086700921" target="Protein_RIM4">
  <data key="d8">MENTIONS</data>
  <data key="d9">Rim4 assembly depends exclusively on its intrinsically disordered region (IDR)</data>
</edge>
<edge source="PDF_58_2023_Result_7550864938787887815" target="Protein_PKA">
  <data key="d8">MENTIONS</data>
  <data key="d9">Assembly is prevented by protein kinase A (PKA) which promotes growth and suppresses meiotic entry</data>
</edge>
<edge source="PDF_58_2023_Conclusion_9069111716801773710" target="Protein_PKA">
  <data key="d8">MENTIONS</data>
  <data key="d9">the PKA signaling pathway transduces the carbon source input into Rim4 assembly</data>
</edge>
<edge source="PDF_58_2023_Conclusion_9069111716801773710" target="Protein_RIM4">
  <data key="d8">MENTIONS</data>
  <data key="d9">the PKA signaling pathway transduces the carbon source input into Rim4 assembly</data>
</edge>
<edge source="PDF_25_2015" target="PDF_25_2015_Method_1266927071867598665">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_25_2015" target="PDF_25_2015_Method_5370093709698939040">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_25_2015" target="PDF_25_2015_Result_5911189686826317284">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_25_2015" target="PDF_25_2015_Result_8421603819451325932">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_25_2015" target="PDF_25_2015_Result_8052546391498430882">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_25_2015" target="PDF_25_2015_Conclusion_-3211183483896047280">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_25_2015_Method_5370093709698939040" target="Protein_VLP">
  <data key="d8">MENTIONS</data>
  <data key="d9">The protocol described here is suitable for determining whether VLPs are formed after recombinant protein expression in plants, using sucrose cushion and Nycodenz gradient.</data>
</edge>
<edge source="PDF_25_2015_Result_8421603819451325932" target="Protein_VLP">
  <data key="d8">MENTIONS</data>
  <data key="d9">VLPs are detectable in the 70% sucrose fraction as well as in the interface, although the 70% fraction will normally look cleaner</data>
</edge>
<edge source="PDF_25_2015_Result_8052546391498430882" target="Protein_VLP">
  <data key="d8">MENTIONS</data>
  <data key="d9">TEM analysis of Nycodenz gradient fractions containing VLPs will appear cleaner than fractions obtained from the sucrose cushion</data>
</edge>
<edge source="PDF_25_2015_Conclusion_-3211183483896047280" target="Protein_VLP">
  <data key="d8">MENTIONS</data>
  <data key="d9">Every correctly assembled virion or VLP should fulfil this assumption that the protein forms particulate material which will migrate through a sucrose cushion and Nycodenz gradient.</data>
</edge>
<edge source="PDF_44_2021" target="PDF_44_2021_Hypothesis_-2890070289513742288">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_44_2021" target="PDF_44_2021_Method_7331792267970534220">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_44_2021" target="PDF_44_2021_Result_8778780853808610518">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_44_2021" target="PDF_44_2021_Result_4207171578410820690">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_44_2021" target="PDF_44_2021_Result_1999710543803669641">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_44_2021" target="PDF_44_2021_Result_-7207908545179264720">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_44_2021" target="PDF_44_2021_Result_2489551907130943990">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_44_2021" target="PDF_44_2021_Result_-7836916781230135730">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_44_2021" target="PDF_44_2021_Conclusion_-3795922340976508904">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_44_2021_Hypothesis_-2890070289513742288" target="Gene_NORAD">
  <data key="d8">MENTIONS</data>
  <data key="d9">NORAD is able to negatively regulate PUM proteins by nucleating the formation of phase-separated cytoplasmic PUM condensates, which we termed NORAD-PUM (NP) bodies.</data>
</edge>
<edge source="PDF_44_2021_Hypothesis_-2890070289513742288" target="Protein_PUMILIO">
  <data key="d8">MENTIONS</data>
  <data key="d9">NORAD is able to negatively regulate PUM proteins by nucleating the formation of phase-separated cytoplasmic PUM condensates, which we termed NORAD-PUM (NP) bodies.</data>
</edge>
<edge source="PDF_44_2021_Method_7331792267970534220" target="Protein_PUMILIO">
  <data key="d8">MENTIONS</data>
  <data key="d9">We synthesized a series of fluorescently-labeled RNA oligonucleotides containing varying numbers of PREs to test whether the multivalent binding of PUM to a PRE-containing transcript is sufficient to promote phase separation</data>
</edge>
<edge source="PDF_44_2021_Result_8778780853808610518" target="Gene_NORAD">
  <data key="d8">MENTIONS</data>
  <data key="d9">NORAD and PUM co-localize in NP bodies</data>
</edge>
<edge source="PDF_44_2021_Result_8778780853808610518" target="Protein_PUMILIO">
  <data key="d8">MENTIONS</data>
  <data key="d9">NORAD and PUM co-localize in NP bodies</data>
</edge>
<edge source="PDF_44_2021_Result_4207171578410820690" target="Gene_NORAD">
  <data key="d8">MENTIONS</data>
  <data key="d9">NORAD promotes PUM phase separation</data>
</edge>
<edge source="PDF_44_2021_Result_4207171578410820690" target="Protein_PUMILIO">
  <data key="d8">MENTIONS</data>
  <data key="d9">NORAD promotes PUM phase separation</data>
</edge>
<edge source="PDF_44_2021_Result_1999710543803669641" target="Protein_PUMILIO">
  <data key="d8">MENTIONS</data>
  <data key="d9">RNA valency and abundance drive PUM LLPS</data>
</edge>
<edge source="PDF_44_2021_Result_-7207908545179264720" target="Protein_PUMILIO">
  <data key="d8">MENTIONS</data>
  <data key="d9">LLPS enables competitive PUM recruitment</data>
</edge>
<edge source="PDF_44_2021_Result_2489551907130943990" target="Protein_PUMILIO">
  <data key="d8">MENTIONS</data>
  <data key="d9">Dual mechanisms of PUM recruitment</data>
</edge>
<edge source="PDF_44_2021_Result_-7836916781230135730" target="Protein_PUMILIO">
  <data key="d8">MENTIONS</data>
  <data key="d9">PUM LLPS maintains genome stability</data>
</edge>
<edge source="PDF_44_2021_Conclusion_-3795922340976508904" target="Gene_NORAD">
  <data key="d8">MENTIONS</data>
  <data key="d9">NORAD drives the highly efficient condensation and sequestration of PUM proteins in NP bodies through at least two complementary mechanisms: multivalent PUM-NORAD RNA binding interactions and IDR-driven PUM-PUM interactions.</data>
</edge>
<edge source="PDF_44_2021_Conclusion_-3795922340976508904" target="Protein_PUMILIO">
  <data key="d8">MENTIONS</data>
  <data key="d9">NORAD drives the highly efficient condensation and sequestration of PUM proteins in NP bodies through at least two complementary mechanisms: multivalent PUM-NORAD RNA binding interactions and IDR-driven PUM-PUM interactions.</data>
</edge>
<edge source="PDF_51_2019" target="PDF_51_2019_Result_-3569765945771674079">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_51_2019" target="PDF_51_2019_Method_-3039018007016841882">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_51_2019_Result_-3569765945771674079" target="Gene_ACTIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">actin filaments embedded inside the spindle help to organize microtubules into functional bundles that can accurately separate the chromosomes</data>
</edge>
<edge source="PDF_51_2019_Result_-3569765945771674079" target="Gene_MICROTUBULES">
  <data key="d8">MENTIONS</data>
  <data key="d9">actin filaments embedded inside the spindle help to organize microtubules into functional bundles that can accurately separate the chromosomes</data>
</edge>
<edge source="PDF_51_2019_Result_-3569765945771674079" target="Gene_CHROMOSOMES">
  <data key="d8">MENTIONS</data>
  <data key="d9">actin filaments embedded inside the spindle help to organize microtubules into functional bundles that can accurately separate the chromosomes</data>
</edge>
<edge source="PDF_51_2019_Method_-3039018007016841882" target="Gene_ACTIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">live and immunofluorescence microscopy assays</data>
</edge>
<edge source="PDF_57_2014" target="PDF_57_2014_Method_6712150288663736186">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_57_2014" target="PDF_57_2014_Method_4009134471863954483">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_57_2014" target="PDF_57_2014_Method_-4196302596036995745">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_57_2014" target="PDF_57_2014_Method_3041812272966518866">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_57_2014" target="PDF_57_2014_Method_-5385669441163379192">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_57_2014" target="PDF_57_2014_Method_-3449099108385238925">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_57_2014" target="PDF_57_2014_Method_-4632433267646643152">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_57_2014" target="PDF_57_2014_Method_-6766091978779411187">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_57_2014" target="PDF_57_2014_Method_6308390223147394036">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_57_2014" target="PDF_57_2014_Method_-2836767369846950065">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_11_2021" target="PDF_11_2021_Result_4545149482106579378">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_11_2021" target="PDF_11_2021_Result_747923047402519578">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_11_2021" target="PDF_11_2021_Result_-4471648538808608262">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_11_2021" target="PDF_11_2021_Result_9155848952570057070">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_11_2021" target="PDF_11_2021_Method_2711460924351622335">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_11_2021" target="PDF_11_2021_Method_6759470100232400240">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_11_2021" target="PDF_11_2021_Method_1495249140752136449">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_11_2021_Result_747923047402519578" target="Gene_UBE2C">
  <data key="d8">MENTIONS</data>
  <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
</edge>
<edge source="PDF_11_2021_Result_747923047402519578" target="Gene_UBC">
  <data key="d8">MENTIONS</data>
  <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
</edge>
<edge source="PDF_11_2021_Result_747923047402519578" target="Gene_CDC34">
  <data key="d8">MENTIONS</data>
  <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
</edge>
<edge source="PDF_11_2021_Result_747923047402519578" target="Gene_UBR1">
  <data key="d8">MENTIONS</data>
  <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
</edge>
<edge source="PDF_11_2021_Result_747923047402519578" target="Gene_KIF11">
  <data key="d8">MENTIONS</data>
  <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
</edge>
<edge source="PDF_11_2021_Result_747923047402519578" target="Gene_ASF1B">
  <data key="d8">MENTIONS</data>
  <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
</edge>
<edge source="PDF_11_2021_Result_747923047402519578" target="Gene_PRC1">
  <data key="d8">MENTIONS</data>
  <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
</edge>
<edge source="PDF_11_2021_Result_747923047402519578" target="Gene_ESPL1">
  <data key="d8">MENTIONS</data>
  <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
</edge>
<edge source="PDF_11_2021_Result_747923047402519578" target="Gene_GTSE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
</edge>
<edge source="PDF_11_2021_Result_747923047402519578" target="Gene_EXO1">
  <data key="d8">MENTIONS</data>
  <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
</edge>
<edge source="PDF_11_2021_Result_747923047402519578" target="Gene_UBA1">
  <data key="d8">MENTIONS</data>
  <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
</edge>
<edge source="PDF_11_2021_Result_747923047402519578" target="Gene_KIF4A">
  <data key="d8">MENTIONS</data>
  <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
</edge>
<edge source="PDF_11_2021_Result_747923047402519578" target="Gene_UBA52">
  <data key="d8">MENTIONS</data>
  <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
</edge>
<edge source="PDF_11_2021_Result_747923047402519578" target="Gene_UBE2V2">
  <data key="d8">MENTIONS</data>
  <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
</edge>
<edge source="PDF_11_2021_Result_747923047402519578" target="Gene_SKP1">
  <data key="d8">MENTIONS</data>
  <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
</edge>
<edge source="PDF_11_2021_Result_747923047402519578" target="Gene_CCNB1">
  <data key="d8">MENTIONS</data>
  <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
</edge>
<edge source="PDF_11_2021_Result_747923047402519578" target="Gene_MAD2L1">
  <data key="d8">MENTIONS</data>
  <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
</edge>
<edge source="PDF_11_2021_Result_-4471648538808608262" target="Process_UBIQUITINATION-RELATED PATHWAYS">
  <data key="d8">MENTIONS</data>
  <data key="d9">significant key biological processes that are associated with these hub genes include ubiquitin-mediated proteolysis, ubiquitination-related pathways, oocyte meiosis, and cell cycle</data>
</edge>
<edge source="PDF_11_2021_Result_-4471648538808608262" target="Process_MEIOSIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">significant key biological processes that are associated with these hub genes include ubiquitin-mediated proteolysis, ubiquitination-related pathways, oocyte meiosis, and cell cycle</data>
</edge>
<edge source="PDF_11_2021_Result_-4471648538808608262" target="Process_CELL CYCLE">
  <data key="d8">MENTIONS</data>
  <data key="d9">significant key biological processes that are associated with these hub genes include ubiquitin-mediated proteolysis, ubiquitination-related pathways, oocyte meiosis, and cell cycle</data>
</edge>
<edge source="PDF_11_2021_Result_9155848952570057070" target="Gene_UBE2C">
  <data key="d8">MENTIONS</data>
  <data key="d9">UBE2C may play a crucial role in human oocyte ageing</data>
</edge>
<edge source="PDF_28_2020" target="PDF_28_2020_Result_-3506536314743552721">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_28_2020" target="PDF_28_2020_Result_4029085613184699148">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_28_2020" target="PDF_28_2020_Result_4276858518438925913">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_28_2020" target="PDF_28_2020_Result_-1763742948628417109">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_28_2020" target="PDF_28_2020_Result_-6615976712426358734">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_28_2020" target="PDF_28_2020_Result_-3557385827310005528">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_28_2020" target="PDF_28_2020_Result_-260840842823475328">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_28_2020" target="PDF_28_2020_Result_-8203877554228120262">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_28_2020" target="PDF_28_2020_Result_4472470031596683723">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_28_2020" target="PDF_28_2020_Method_-2589034834822375471">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_28_2020" target="PDF_28_2020_Method_3976456801352914638">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_28_2020_Result_-3506536314743552721" target="Compound_TESTOSTERONE">
  <data key="d8">MENTIONS</data>
  <data key="d9">Genetic determinants of testosterone levels are substantially different between sexes.</data>
</edge>
<edge source="PDF_28_2020_Result_4029085613184699148" target="Compound_TESTOSTERONE">
  <data key="d8">MENTIONS</data>
  <data key="d9">Genetically higher testosterone is harmful for metabolic diseases in women but beneficial in men.</data>
</edge>
<edge source="PDF_28_2020_Result_4276858518438925913" target="Compound_TESTOSTERONE">
  <data key="d8">MENTIONS</data>
  <data key="d9">A genetically determined 1-standard deviation higher testosterone increases the risks of Type 2 diabetes (T2D) and polycystic ovary syndrome in women, but reduces T2D risk in men.</data>
</edge>
<edge source="PDF_28_2020_Result_4276858518438925913" target="Disease_TYPE 2 DIABETES">
  <data key="d8">MENTIONS</data>
  <data key="d9">A genetically determined 1-standard deviation higher testosterone increases the risks of Type 2 diabetes (T2D) and polycystic ovary syndrome in women, but reduces T2D risk in men.</data>
</edge>
<edge source="PDF_28_2020_Result_4276858518438925913" target="Disease_POLYCYSTIC OVARY SYNDROME">
  <data key="d8">MENTIONS</data>
  <data key="d9">A genetically determined 1-standard deviation higher testosterone increases the risks of Type 2 diabetes (T2D) and polycystic ovary syndrome in women, but reduces T2D risk in men.</data>
</edge>
<edge source="PDF_28_2020_Result_-1763742948628417109" target="Compound_TESTOSTERONE">
  <data key="d8">MENTIONS</data>
  <data key="d9">Adverse effects of higher testosterone on breast and endometrial cancers in women, and prostate cancer in men.</data>
</edge>
<edge source="PDF_28_2020_Result_-1763742948628417109" target="Disease_BREAST CANCER">
  <data key="d8">MENTIONS</data>
  <data key="d9">Adverse effects of higher testosterone on breast and endometrial cancers in women, and prostate cancer in men.</data>
</edge>
<edge source="PDF_28_2020_Result_-1763742948628417109" target="Disease_ENDOMETRIAL CANCER">
  <data key="d8">MENTIONS</data>
  <data key="d9">Adverse effects of higher testosterone on breast and endometrial cancers in women, and prostate cancer in men.</data>
</edge>
<edge source="PDF_28_2020_Result_-1763742948628417109" target="Disease_PROSTATE CANCER">
  <data key="d8">MENTIONS</data>
  <data key="d9">Adverse effects of higher testosterone on breast and endometrial cancers in women, and prostate cancer in men.</data>
</edge>
<edge source="PDF_28_2020_Result_-6615976712426358734" target="Compound_TESTOSTERONE">
  <data key="d8">MENTIONS</data>
  <data key="d9">Higher testosterone increases the risk of PCOS in women.</data>
</edge>
<edge source="PDF_28_2020_Result_-6615976712426358734" target="Disease_PCOS">
  <data key="d8">MENTIONS</data>
  <data key="d9">Higher testosterone increases the risk of PCOS in women.</data>
</edge>
<edge source="PDF_28_2020_Result_-3557385827310005528" target="Compound_TESTOSTERONE">
  <data key="d8">MENTIONS</data>
  <data key="d9">Testosterone increases the risk of ER+ breast cancer.</data>
</edge>
<edge source="PDF_28_2020_Result_-3557385827310005528" target="Disease_BREAST CANCER">
  <data key="d8">MENTIONS</data>
  <data key="d9">Testosterone increases the risk of ER+ breast cancer.</data>
</edge>
<edge source="PDF_28_2020_Result_-260840842823475328" target="Compound_TESTOSTERONE">
  <data key="d8">MENTIONS</data>
  <data key="d9">Testosterone increased the risk of endometrial cancer but reduced the risk of ovarian cancer.</data>
</edge>
<edge source="PDF_28_2020_Result_-260840842823475328" target="Disease_ENDOMETRIAL CANCER">
  <data key="d8">MENTIONS</data>
  <data key="d9">Testosterone increased the risk of endometrial cancer but reduced the risk of ovarian cancer.</data>
</edge>
<edge source="PDF_28_2020_Result_-260840842823475328" target="Disease_OVARIAN CANCER">
  <data key="d8">MENTIONS</data>
  <data key="d9">Testosterone increased the risk of endometrial cancer but reduced the risk of ovarian cancer.</data>
</edge>
<edge source="PDF_28_2020_Result_-8203877554228120262" target="Compound_TESTOSTERONE">
  <data key="d8">MENTIONS</data>
  <data key="d9">Higher testosterone, independent of SHBG, conferred lower T2D risk and lower fasting glucose in men.</data>
</edge>
<edge source="PDF_28_2020_Result_-8203877554228120262" target="Protein_SEX HORMONE BINDING GLOBULIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">Higher testosterone, independent of SHBG, conferred lower T2D risk and lower fasting glucose in men.</data>
</edge>
<edge source="PDF_28_2020_Result_-8203877554228120262" target="Disease_TYPE 2 DIABETES">
  <data key="d8">MENTIONS</data>
  <data key="d9">Higher testosterone, independent of SHBG, conferred lower T2D risk and lower fasting glucose in men.</data>
</edge>
<edge source="PDF_28_2020_Result_4472470031596683723" target="Compound_TESTOSTERONE">
  <data key="d8">MENTIONS</data>
  <data key="d9">Testosterone increases prostate cancer risk in men.</data>
</edge>
<edge source="PDF_28_2020_Result_4472470031596683723" target="Disease_PROSTATE CANCER">
  <data key="d8">MENTIONS</data>
  <data key="d9">Testosterone increases prostate cancer risk in men.</data>
</edge>
<edge source="PDF_28_2020_Method_3976456801352914638" target="Compound_TESTOSTERONE">
  <data key="d8">MENTIONS</data>
  <data key="d9">Genome wide association studies (GWAS) are needed to identify additional genetic variants that can be used to test the effects of testosterone.</data>
</edge>
<edge source="PDF_56_2013" target="PDF_56_2013_Method_-476371590765220008">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_56_2013" target="PDF_56_2013_Method_-3123513686382491932">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_56_2013" target="PDF_56_2013_Method_994679622489463835">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_56_2013" target="PDF_56_2013_Result_-2843952847225168039">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_56_2013" target="PDF_56_2013_Result_-5653130319489697596">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_56_2013" target="PDF_56_2013_Result_-387495421321406550">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_56_2013" target="PDF_56_2013_Result_-133007962228439525">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_56_2013" target="PDF_56_2013_Result_-7166499766531524492">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_56_2013" target="PDF_56_2013_Result_5624013977863266128">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_56_2013_Result_-7166499766531524492" target="Gene_CASP8">
  <data key="d8">MENTIONS</data>
  <data key="d9">a 6 bp indel in the promoter region of gene Casp8 was identified to be associated with susceptibility to multiple cancers</data>
</edge>
<edge source="PDF_56_2013_Result_-7166499766531524492" target="Disease_CANCER">
  <data key="d8">MENTIONS</data>
  <data key="d9">a 6 bp indel in the promoter region of gene Casp8 was identified to be associated with susceptibility to multiple cancers</data>
</edge>
<edge source="PDF_56_2013_Result_5624013977863266128" target="Gene_NCX1">
  <data key="d8">MENTIONS</data>
  <data key="d9">A 14 bp indel in the gene Ncx1 was found to modulate the age at onset in late-onset Alzheimer's disease</data>
</edge>
<edge source="PDF_56_2013_Result_5624013977863266128" target="Disease_ALZHEIMER'S DISEASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">A 14 bp indel in the gene Ncx1 was found to modulate the age at onset in late-onset Alzheimer's disease</data>
</edge>
<edge source="PDF_60_2012" target="PDF_60_2012_Result_-3460396310477957540">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_60_2012" target="PDF_60_2012_Result_8151029886933108466">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_60_2012" target="PDF_60_2012_Result_9113303972890400832">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_60_2012" target="PDF_60_2012_Result_6931986617788441699">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_60_2012" target="PDF_60_2012_Method_6399464483961650502">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_60_2012" target="PDF_60_2012_Method_105083118773543844">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_60_2012" target="PDF_60_2012_Method_78287496728053011">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_60_2012_Result_-3460396310477957540" target="Gene_SHANK3">
  <data key="d8">MENTIONS</data>
  <data key="d9">Both homozygous and heterozygous mice showed reduced glutamatergic transmission and long-term potentiation in the hippocampus with more severe deficits detected in the homozygous mice.</data>
</edge>
<edge source="PDF_60_2012_Result_8151029886933108466" target="Gene_SHANK3">
  <data key="d8">MENTIONS</data>
  <data key="d9">Mild social impairments were detected, primarily in juveniles during reciprocal interactions, while all genotypes displayed normal adult sociability on the three-chambered task.</data>
</edge>
<edge source="PDF_60_2012_Result_9113303972890400832" target="Gene_SHANK3">
  <data key="d8">MENTIONS</data>
  <data key="d9">Impaired novel object recognition and rotarod performance were consistent across cohorts of null mutants.</data>
</edge>
<edge source="PDF_60_2012_Result_6931986617788441699" target="Gene_SHANK3">
  <data key="d8">MENTIONS</data>
  <data key="d9">Repetitive self-grooming, reduced ultrasonic vocalizations, and deficits in reversal of water maze learning were detected only in some cohorts, emphasizing the importance of replication analyses.</data>
</edge>
<edge source="PDF_60_2012_Method_6399464483961650502" target="Gene_SHANK3">
  <data key="d8">MENTIONS</data>
  <data key="d9">Mice with mutations in the gene coding for the Shank3 protein were generated at the Mount Sinai School of Medicine as previously described (Bozdagi et al., 2010).</data>
</edge>
<edge source="PDF_16_2017" target="PDF_16_2017_Hypothesis_1314856865614482660">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_16_2017" target="PDF_16_2017_Method_-2993343221340655616">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_16_2017" target="PDF_16_2017_Method_2376836183844078075">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_16_2017" target="PDF_16_2017_Method_-6167142702891750207">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_16_2017" target="PDF_16_2017_Result_-1739999805386391909">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_16_2017" target="PDF_16_2017_Result_6131539558149926170">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_16_2017" target="PDF_16_2017_Conclusion_-1239221863231033063">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_16_2017_Hypothesis_1314856865614482660" target="Gene_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">Can novel meiotic RNA targets of DAZL (deleted in azoospermia-like) be identified in the human foetal ovary?</data>
</edge>
<edge source="PDF_16_2017_Method_-2993343221340655616" target="Gene_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">We carried out RNA sequencing after immunoprecipitation of endogenous DAZL from human foetal ovarian tissue to identify novel DAZL targets involved in meiosis.</data>
</edge>
<edge source="PDF_16_2017_Method_2376836183844078075" target="Protein_SMCIB">
  <data key="d8">MENTIONS</data>
  <data key="d9">Using quantitative RT-PCR, we examined the expression of selected RNAs identified by our immunoprecipitation across gestation, and visualised the expression of potential target SMCIB in relation to DAZL, with a combination of in situ hybridisation and immunohistochemistry.</data>
</edge>
<edge source="PDF_16_2017_Method_2376836183844078075" target="Gene_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">Using quantitative RT-PCR, we examined the expression of selected RNAs identified by our immunoprecipitation across gestation, and visualised the expression of potential target SMCIB in relation to DAZL, with a combination of in situ hybridisation and immunohistochemistry.</data>
</edge>
<edge source="PDF_16_2017_Method_-6167142702891750207" target="Gene_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">3' untranslated region (3'UTR)-luciferase reporter assays and polysome profile analysis were used to investigate the regulation of three RNA targets by DAZL, representing key functionalities: SYCPI, TEXII and SMCIB.</data>
</edge>
<edge source="PDF_16_2017_Method_-6167142702891750207" target="Protein_SYCP1">
  <data key="d8">MENTIONS</data>
  <data key="d9">3' untranslated region (3'UTR)-luciferase reporter assays and polysome profile analysis were used to investigate the regulation of three RNA targets by DAZL, representing key functionalities: SYCPI, TEXII and SMCIB.</data>
</edge>
<edge source="PDF_16_2017_Method_-6167142702891750207" target="Protein_TEX12">
  <data key="d8">MENTIONS</data>
  <data key="d9">3' untranslated region (3'UTR)-luciferase reporter assays and polysome profile analysis were used to investigate the regulation of three RNA targets by DAZL, representing key functionalities: SYCPI, TEXII and SMCIB.</data>
</edge>
<edge source="PDF_16_2017_Method_-6167142702891750207" target="Protein_SMCIB">
  <data key="d8">MENTIONS</data>
  <data key="d9">3' untranslated region (3'UTR)-luciferase reporter assays and polysome profile analysis were used to investigate the regulation of three RNA targets by DAZL, representing key functionalities: SYCPI, TEXII and SMCIB.</data>
</edge>
<edge source="PDF_16_2017_Result_-1739999805386391909" target="Gene_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">We identified 764 potential RNA targets of DAZL in the human foetal ovary, with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13), and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
</edge>
<edge source="PDF_16_2017_Result_-1739999805386391909" target="Protein_SYCP1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We identified 764 potential RNA targets of DAZL in the human foetal ovary, with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13), and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
</edge>
<edge source="PDF_16_2017_Result_-1739999805386391909" target="Protein_SYCP3">
  <data key="d8">MENTIONS</data>
  <data key="d9">We identified 764 potential RNA targets of DAZL in the human foetal ovary, with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13), and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
</edge>
<edge source="PDF_16_2017_Result_-1739999805386391909" target="Protein_SMCIB">
  <data key="d8">MENTIONS</data>
  <data key="d9">We identified 764 potential RNA targets of DAZL in the human foetal ovary, with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13), and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
</edge>
<edge source="PDF_16_2017_Result_-1739999805386391909" target="Gene_RAD21">
  <data key="d8">MENTIONS</data>
  <data key="d9">We identified 764 potential RNA targets of DAZL in the human foetal ovary, with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13), and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
</edge>
<edge source="PDF_16_2017_Result_-1739999805386391909" target="Gene_MAD2L1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We identified 764 potential RNA targets of DAZL in the human foetal ovary, with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13), and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
</edge>
<edge source="PDF_16_2017_Result_-1739999805386391909" target="Gene_TRIP13">
  <data key="d8">MENTIONS</data>
  <data key="d9">We identified 764 potential RNA targets of DAZL in the human foetal ovary, with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13), and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
</edge>
<edge source="PDF_16_2017_Result_-1739999805386391909" target="Gene_HORMAD1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We identified 764 potential RNA targets of DAZL in the human foetal ovary, with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13), and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
</edge>
<edge source="PDF_16_2017_Result_-1739999805386391909" target="Protein_TEX12">
  <data key="d8">MENTIONS</data>
  <data key="d9">We identified 764 potential RNA targets of DAZL in the human foetal ovary, with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13), and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
</edge>
<edge source="PDF_16_2017_Result_-1739999805386391909" target="Gene_RAD18">
  <data key="d8">MENTIONS</data>
  <data key="d9">We identified 764 potential RNA targets of DAZL in the human foetal ovary, with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13), and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
</edge>
<edge source="PDF_16_2017_Result_-1739999805386391909" target="Gene_RAD51">
  <data key="d8">MENTIONS</data>
  <data key="d9">We identified 764 potential RNA targets of DAZL in the human foetal ovary, with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13), and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
</edge>
<edge source="PDF_16_2017_Result_6131539558149926170" target="Protein_SYCP1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We demonstrated that the translation of novel targets SYCPI, TEXII and SMCIB is stimulated by the presence of DAZL but not by a mutant DAZL with impaired RNA-binding activity.</data>
</edge>
<edge source="PDF_16_2017_Result_6131539558149926170" target="Protein_TEX12">
  <data key="d8">MENTIONS</data>
  <data key="d9">We demonstrated that the translation of novel targets SYCPI, TEXII and SMCIB is stimulated by the presence of DAZL but not by a mutant DAZL with impaired RNA-binding activity.</data>
</edge>
<edge source="PDF_16_2017_Result_6131539558149926170" target="Protein_SMCIB">
  <data key="d8">MENTIONS</data>
  <data key="d9">We demonstrated that the translation of novel targets SYCPI, TEXII and SMCIB is stimulated by the presence of DAZL but not by a mutant DAZL with impaired RNA-binding activity.</data>
</edge>
<edge source="PDF_16_2017_Result_6131539558149926170" target="Gene_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">We demonstrated that the translation of novel targets SYCPI, TEXII and SMCIB is stimulated by the presence of DAZL but not by a mutant DAZL with impaired RNA-binding activity.</data>
</edge>
<edge source="PDF_16_2017_Conclusion_-1239221863231033063" target="Protein_SMCIB">
  <data key="d8">MENTIONS</data>
  <data key="d9">Through the translational regulation of novel RNA targets SMCIB and TEXII, DAZL may have a key role in regulating chromosome cohesion and DNA recombination; two processes fundamental in determining oocyte quality and whose establishment in foetal life may support lifelong fertility.</data>
</edge>
<edge source="PDF_16_2017_Conclusion_-1239221863231033063" target="Protein_TEX12">
  <data key="d8">MENTIONS</data>
  <data key="d9">Through the translational regulation of novel RNA targets SMCIB and TEXII, DAZL may have a key role in regulating chromosome cohesion and DNA recombination; two processes fundamental in determining oocyte quality and whose establishment in foetal life may support lifelong fertility.</data>
</edge>
<edge source="PDF_16_2017_Conclusion_-1239221863231033063" target="Gene_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">Through the translational regulation of novel RNA targets SMCIB and TEXII, DAZL may have a key role in regulating chromosome cohesion and DNA recombination; two processes fundamental in determining oocyte quality and whose establishment in foetal life may support lifelong fertility.</data>
</edge>
<edge source="PDF_42_2001" target="PDF_42_2001_Hypothesis_8948168157081769195">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_42_2001" target="PDF_42_2001_Method_-5350663781838135745">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_42_2001" target="PDF_42_2001_Method_1633846816564335947">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_42_2001" target="PDF_42_2001_Method_3074820796691479520">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_42_2001" target="PDF_42_2001_Method_3104162734557743250">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_42_2001" target="PDF_42_2001_Result_8649051848906610438">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_42_2001" target="PDF_42_2001_Result_8108291916909211586">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_42_2001" target="PDF_42_2001_Result_-2720474815089682321">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_42_2001" target="PDF_42_2001_Result_-7672314093551496806">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_42_2001" target="PDF_42_2001_Conclusion_6533134157357704615">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_42_2001_Hypothesis_8948168157081769195" target="Protein_MAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">MAP-1 mediates apoptosis through a mechanism that involves binding to Bax.</data>
</edge>
<edge source="PDF_42_2001_Hypothesis_8948168157081769195" target="Process_APOPTOSIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">MAP-1 mediates apoptosis through a mechanism that involves binding to Bax.</data>
</edge>
<edge source="PDF_42_2001_Hypothesis_8948168157081769195" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">MAP-1 mediates apoptosis through a mechanism that involves binding to Bax.</data>
</edge>
<edge source="PDF_42_2001_Method_-5350663781838135745" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">Yeast two-hybrid screen was used to identify Bax-associating proteins.</data>
</edge>
<edge source="PDF_42_2001_Method_3104162734557743250" target="Process_APOPTOSIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">Apoptosis assay was performed to assess cell death.</data>
</edge>
<edge source="PDF_42_2001_Result_8649051848906610438" target="Protein_MAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">MAP-1 homodimerizes and associates with Bax, Bcl-2, and Bcl-X₁ in vitro and in vivo in mammalian cells.</data>
</edge>
<edge source="PDF_42_2001_Result_8649051848906610438" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">MAP-1 homodimerizes and associates with Bax, Bcl-2, and Bcl-X₁ in vitro and in vivo in mammalian cells.</data>
</edge>
<edge source="PDF_42_2001_Result_8649051848906610438" target="Protein_BCL-2">
  <data key="d8">MENTIONS</data>
  <data key="d9">MAP-1 homodimerizes and associates with Bax, Bcl-2, and Bcl-X₁ in vitro and in vivo in mammalian cells.</data>
</edge>
<edge source="PDF_42_2001_Result_8649051848906610438" target="Protein_BCL-XL">
  <data key="d8">MENTIONS</data>
  <data key="d9">MAP-1 homodimerizes and associates with Bax, Bcl-2, and Bcl-X₁ in vitro and in vivo in mammalian cells.</data>
</edge>
<edge source="PDF_42_2001_Result_8108291916909211586" target="Protein_MAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">MAP-1 induces caspase-dependent apoptosis in mammalian cells when overexpressed.</data>
</edge>
<edge source="PDF_42_2001_Result_8108291916909211586" target="Protein_CASPASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">MAP-1 induces caspase-dependent apoptosis in mammalian cells when overexpressed.</data>
</edge>
<edge source="PDF_42_2001_Result_8108291916909211586" target="Process_APOPTOSIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">MAP-1 induces caspase-dependent apoptosis in mammalian cells when overexpressed.</data>
</edge>
<edge source="PDF_42_2001_Result_-2720474815089682321" target="Protein_MAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">The BH3-like domain in MAP-1 is required for mediating apoptosis and its binding to Bax, but not Bcl-XL.</data>
</edge>
<edge source="PDF_42_2001_Result_-2720474815089682321" target="Protein_BH3">
  <data key="d8">MENTIONS</data>
  <data key="d9">The BH3-like domain in MAP-1 is required for mediating apoptosis and its binding to Bax, but not Bcl-XL.</data>
</edge>
<edge source="PDF_42_2001_Result_-2720474815089682321" target="Process_APOPTOSIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">The BH3-like domain in MAP-1 is required for mediating apoptosis and its binding to Bax, but not Bcl-XL.</data>
</edge>
<edge source="PDF_42_2001_Result_-2720474815089682321" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">The BH3-like domain in MAP-1 is required for mediating apoptosis and its binding to Bax, but not Bcl-XL.</data>
</edge>
<edge source="PDF_42_2001_Result_-2720474815089682321" target="Protein_BCL-XL">
  <data key="d8">MENTIONS</data>
  <data key="d9">The BH3-like domain in MAP-1 is required for mediating apoptosis and its binding to Bax, but not Bcl-XL.</data>
</edge>
<edge source="PDF_42_2001_Result_-7672314093551496806" target="Protein_MAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">The binding of MAP-1 to Bax requires all three BH (BH1, BH2, and BH3) domains of Bax.</data>
</edge>
<edge source="PDF_42_2001_Result_-7672314093551496806" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">The binding of MAP-1 to Bax requires all three BH (BH1, BH2, and BH3) domains of Bax.</data>
</edge>
<edge source="PDF_42_2001_Result_-7672314093551496806" target="Protein_BH1">
  <data key="d8">MENTIONS</data>
  <data key="d9">The binding of MAP-1 to Bax requires all three BH (BH1, BH2, and BH3) domains of Bax.</data>
</edge>
<edge source="PDF_42_2001_Result_-7672314093551496806" target="Protein_BH2">
  <data key="d8">MENTIONS</data>
  <data key="d9">The binding of MAP-1 to Bax requires all three BH (BH1, BH2, and BH3) domains of Bax.</data>
</edge>
<edge source="PDF_42_2001_Result_-7672314093551496806" target="Protein_BH3">
  <data key="d8">MENTIONS</data>
  <data key="d9">The binding of MAP-1 to Bax requires all three BH (BH1, BH2, and BH3) domains of Bax.</data>
</edge>
<edge source="PDF_42_2001_Conclusion_6533134157357704615" target="Protein_MAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">MAP-1 represents a novel Bax-associating protein that may mediate apoptosis through binding to Bax.</data>
</edge>
<edge source="PDF_42_2001_Conclusion_6533134157357704615" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">MAP-1 represents a novel Bax-associating protein that may mediate apoptosis through binding to Bax.</data>
</edge>
<edge source="PDF_42_2001_Conclusion_6533134157357704615" target="Process_APOPTOSIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">MAP-1 represents a novel Bax-associating protein that may mediate apoptosis through binding to Bax.</data>
</edge>
<edge source="PDF_01_2012" target="PDF_01_2012_Result_6847604029630155249">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_01_2012" target="PDF_01_2012_Result_9005381443327010603">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_01_2012" target="PDF_01_2012_Result_-8247913670897431649">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_01_2012" target="PDF_01_2012_Result_-8179251931439498498">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_01_2012" target="PDF_01_2012_Result_2743507154434502038">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_01_2012" target="PDF_01_2012_Result_-3711517568656442077">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_01_2012" target="PDF_01_2012_Result_6661844184217701909">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_01_2012" target="PDF_01_2012_Result_-4662230457726497710">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_01_2012" target="PDF_01_2012_Result_-5302554718486720449">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_01_2012" target="PDF_01_2012_Conclusion_2860140093006074194">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_01_2012" target="PDF_01_2012_Conclusion_1390741747946254137">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_01_2012" target="PDF_01_2012_Conclusion_-1817902315861890616">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_01_2012_Result_6847604029630155249" target="Gene_MMPEG10">
  <data key="d8">MENTIONS</data>
  <data key="d9">PEG10 and PEG11/RTL1 play essential roles in early placenta formation and maintenance of the placenta in the mid-to-late stages of gestation, respectively.</data>
</edge>
<edge source="PDF_01_2012_Result_6847604029630155249" target="Gene_PEG11/RTL1">
  <data key="d8">MENTIONS</data>
  <data key="d9">PEG10 and PEG11/RTL1 play essential roles in early placenta formation and maintenance of the placenta in the mid-to-late stages of gestation, respectively.</data>
</edge>
<edge source="PDF_01_2012_Result_9005381443327010603" target="Protein_MMPEG10">
  <data key="d8">MENTIONS</data>
  <data key="d9">PEG10 protein is reportedly associated with a member of the "seven in absentia homolog" family (SIAH1 protein) that acts as a mediator of apoptosis.</data>
</edge>
<edge source="PDF_01_2012_Result_9005381443327010603" target="Protein_SIAH1">
  <data key="d8">MENTIONS</data>
  <data key="d9">PEG10 protein is reportedly associated with a member of the "seven in absentia homolog" family (SIAH1 protein) that acts as a mediator of apoptosis.</data>
</edge>
<edge source="PDF_01_2012_Result_9005381443327010603" target="Process_APOPTOSIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">PEG10 protein is reportedly associated with a member of the "seven in absentia homolog" family (SIAH1 protein) that acts as a mediator of apoptosis.</data>
</edge>
<edge source="PDF_01_2012_Result_-8247913670897431649" target="Gene_PEG11/RTL1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Loss and overexpression of PEG11/RTL1 are thought to attribute to the etiology of two different human imprinted diseases, maternal and paternal disomies of human chromosome 14 (matUPD14 and patUPD14).</data>
</edge>
<edge source="PDF_01_2012_Result_-8247913670897431649" target="Disease_MATUPD14">
  <data key="d8">MENTIONS</data>
  <data key="d9">Loss and overexpression of PEG11/RTL1 are thought to attribute to the etiology of two different human imprinted diseases, maternal and paternal disomies of human chromosome 14 (matUPD14 and patUPD14).</data>
</edge>
<edge source="PDF_01_2012_Result_-8247913670897431649" target="Disease_PATUPD14">
  <data key="d8">MENTIONS</data>
  <data key="d9">Loss and overexpression of PEG11/RTL1 are thought to attribute to the etiology of two different human imprinted diseases, maternal and paternal disomies of human chromosome 14 (matUPD14 and patUPD14).</data>
</edge>
<edge source="PDF_01_2012_Result_-8179251931439498498" target="Gene_PNMA4">
  <data key="d8">MENTIONS</data>
  <data key="d9">PNMA4-deficient cells exhibit aggressive anchorage-independent growth, suggesting that PNMA4 has an important role in regulating apoptosis signaling in a strict temporal manner in mammalian cells</data>
</edge>
<edge source="PDF_01_2012_Result_-8179251931439498498" target="Process_APOPTOSIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">PNMA4-deficient cells exhibit aggressive anchorage-independent growth, suggesting that PNMA4 has an important role in regulating apoptosis signaling in a strict temporal manner in mammalian cells</data>
</edge>
<edge source="PDF_01_2012_Result_2743507154434502038" target="Gene_PNMA10">
  <data key="d8">MENTIONS</data>
  <data key="d9">PNMA10 is related to the evolution of brain function in mammals.</data>
</edge>
<edge source="PDF_01_2012_Result_-3711517568656442077" target="Gene_PNMA14/CCDC8">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma14/CCDC8 was suggested to be one of the genes responsible for 3-M syndrome.</data>
</edge>
<edge source="PDF_01_2012_Result_-3711517568656442077" target="Disease_3-M SYNDROME">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma14/CCDC8 was suggested to be one of the genes responsible for 3-M syndrome.</data>
</edge>
<edge source="PDF_01_2012_Result_6661844184217701909" target="Gene_FILAGGRIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">Filaggrin gene has recently been identified to be etiologically responsible for atopic dermatitis</data>
</edge>
<edge source="PDF_01_2012_Result_6661844184217701909" target="Disease_ATOPIC DERMATITIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">Filaggrin gene has recently been identified to be etiologically responsible for atopic dermatitis</data>
</edge>
<edge source="PDF_01_2012_Result_-4662230457726497710" target="Gene_PEG3">
  <data key="d8">MENTIONS</data>
  <data key="d9">Peg3 KO offspring are approximately 20% smaller at birth, with markedly reduced nursing behavior and a reduced number of oxytocin-positive neurons in the hypothalamus of Peg3 KO females</data>
</edge>
<edge source="PDF_01_2012_Result_-5302554718486720449" target="Gene_PEG3">
  <data key="d8">MENTIONS</data>
  <data key="d9">Human PEG3 has tumor-suppressing activity in glioma cell lines by its capacity to inhibit Wnt signaling, and the loss of its expression is reportedly observed in gliomas.</data>
</edge>
<edge source="PDF_01_2012_Result_-5302554718486720449" target="Process_WNT SIGNALING">
  <data key="d8">MENTIONS</data>
  <data key="d9">Human PEG3 has tumor-suppressing activity in glioma cell lines by its capacity to inhibit Wnt signaling, and the loss of its expression is reportedly observed in gliomas.</data>
</edge>
<edge source="PDF_01_2012_Result_-5302554718486720449" target="Disease_GLIOMAS">
  <data key="d8">MENTIONS</data>
  <data key="d9">Human PEG3 has tumor-suppressing activity in glioma cell lines by its capacity to inhibit Wnt signaling, and the loss of its expression is reportedly observed in gliomas.</data>
</edge>
<edge source="PDF_01_2012_Conclusion_1390741747946254137" target="Gene_MMPEG10">
  <data key="d8">MENTIONS</data>
  <data key="d9">PEG10 contributed to the establishment of the current developmental systems of viviparous mammalian groups as a positively selected gene</data>
</edge>
<edge source="PDF_01_2012_Conclusion_-1817902315861890616" target="Gene_PEG11/RTL1">
  <data key="d8">MENTIONS</data>
  <data key="d9">PEG11/RTL1 has a role in the reproduction system of eutherians, which have the chorioallantoic placenta and that it thus contributed to the diversification of these two viviparous mammalian groups.</data>
</edge>
<edge source="PDF_45_2016" target="PDF_45_2016_Hypothesis_-1553147097003440318">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_45_2016" target="PDF_45_2016_Method_-8915966741790558701">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_45_2016" target="PDF_45_2016_Method_-3480396298746657110">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_45_2016" target="PDF_45_2016_Result_-4589350216914818784">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_45_2016" target="PDF_45_2016_Result_-908377324346105843">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_45_2016" target="PDF_45_2016_Result_-7153334455177507801">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_45_2016" target="PDF_45_2016_Result_8209822599145596674">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_45_2016" target="PDF_45_2016_Result_-1006441427067008625">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_45_2016" target="PDF_45_2016_Result_-1485383280183728608">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_45_2016" target="PDF_45_2016_Result_-3730996765766011008">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_45_2016" target="PDF_45_2016_Result_-649955863056853271">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_45_2016" target="PDF_45_2016_Result_5085690336790710673">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_45_2016" target="PDF_45_2016_Result_-2279688250594086410">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_45_2016" target="PDF_45_2016_Result_-8868307895684558241">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_45_2016" target="PDF_45_2016_Conclusion_3085968706911168016">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_45_2016" target="PDF_45_2016_Conclusion_7530143935422672266">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_45_2016" target="PDF_45_2016_Conclusion_-3805813853744680934">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_45_2016_Hypothesis_-1553147097003440318" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">DAZL cooperates with CPEB1 to regulate maternal mRNA translation.</data>
</edge>
<edge source="PDF_45_2016_Hypothesis_-1553147097003440318" target="Protein_CPEB1">
  <data key="d8">MENTIONS</data>
  <data key="d9">DAZL cooperates with CPEB1 to regulate maternal mRNA translation.</data>
</edge>
<edge source="PDF_45_2016_Hypothesis_-1553147097003440318" target="Compound_MRNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">DAZL cooperates with CPEB1 to regulate maternal mRNA translation.</data>
</edge>
<edge source="PDF_45_2016_Method_-8915966741790558701" target="Compound_RIBOTAG">
  <data key="d8">MENTIONS</data>
  <data key="d9">Using a mouse line expressing an epitope-tagged ribosomal protein (RiboTag), which is activated by the tissue-specific cre recombinase, we recovered transcripts that are associated with ribosomes by using immunoprecipitation.</data>
</edge>
<edge source="PDF_45_2016_Result_-4589350216914818784" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">ribosome loading is induced in a DAZL- and CPEB1-dependent manner, as the oocyte reenters meiosis.</data>
</edge>
<edge source="PDF_45_2016_Result_-4589350216914818784" target="Protein_CPEB1">
  <data key="d8">MENTIONS</data>
  <data key="d9">ribosome loading is induced in a DAZL- and CPEB1-dependent manner, as the oocyte reenters meiosis.</data>
</edge>
<edge source="PDF_45_2016_Result_-908377324346105843" target="Gene_TEX19">
  <data key="d8">MENTIONS</data>
  <data key="d9">Depletion of the two RBPs from oocytes and mutagenesis of the 3' untranslated regions (UTRs) demonstrate that both RBPs interact with the Tex19.1 3' UTR and cooperate in translation activation of this mRNA.</data>
</edge>
<edge source="PDF_45_2016_Result_-7153334455177507801" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">We observed a synergism between DAZL and cytoplasmic polyadenylation elements (CPEs) in the translation pattern of maternal mRNAs when using a genome-wide analysis.</data>
</edge>
<edge source="PDF_45_2016_Result_-7153334455177507801" target="Compound_MRNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">We observed a synergism between DAZL and cytoplasmic polyadenylation elements (CPEs) in the translation pattern of maternal mRNAs when using a genome-wide analysis.</data>
</edge>
<edge source="PDF_45_2016_Result_8209822599145596674" target="Protein_CPEB1">
  <data key="d8">MENTIONS</data>
  <data key="d9">The knockdown of CPEB1 was associated with a reduction in the number of oocytes that reached MII after 17 h of in vitro maturation, whereas depletion in DAZL resulted in an almost complete block of progression into MII</data>
</edge>
<edge source="PDF_45_2016_Result_8209822599145596674" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">The knockdown of CPEB1 was associated with a reduction in the number of oocytes that reached MII after 17 h of in vitro maturation, whereas depletion in DAZL resulted in an almost complete block of progression into MII</data>
</edge>
<edge source="PDF_45_2016_Result_-1006441427067008625" target="Gene_TEX19">
  <data key="d8">MENTIONS</data>
  <data key="d9">We observed a significant decrease in ribosome recruitment to the Tex19.1 and Ccnbl mRNAs after injection of the morpholino targeting CPEВ1 (СРЕВ1-MO).</data>
</edge>
<edge source="PDF_45_2016_Result_-1006441427067008625" target="Gene_CCNB1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We observed a significant decrease in ribosome recruitment to the Tex19.1 and Ccnbl mRNAs after injection of the morpholino targeting CPEВ1 (СРЕВ1-MO).</data>
</edge>
<edge source="PDF_45_2016_Result_-1006441427067008625" target="Protein_CPEB1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We observed a significant decrease in ribosome recruitment to the Tex19.1 and Ccnbl mRNAs after injection of the morpholino targeting CPEВ1 (СРЕВ1-MO).</data>
</edge>
<edge source="PDF_45_2016_Result_-1485383280183728608" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">A DAZL concentration-dependent decrease in ribosome loading onto Tex19.1 mRNA was proportional to the depletion of DAZL</data>
</edge>
<edge source="PDF_45_2016_Result_-1485383280183728608" target="Gene_TEX19">
  <data key="d8">MENTIONS</data>
  <data key="d9">A DAZL concentration-dependent decrease in ribosome loading onto Tex19.1 mRNA was proportional to the depletion of DAZL</data>
</edge>
<edge source="PDF_45_2016_Result_5085690336790710673" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">Combined mutation of DAZL sites 1 and 3 (41+3) further decreased the translation of the reporter to minimal levels.</data>
</edge>
<edge source="PDF_45_2016_Result_-2279688250594086410" target="Protein_CPEB1">
  <data key="d8">MENTIONS</data>
  <data key="d9">CPEB1 and DAZL interact with the same RNA targets, but possibly not through a direct interaction between both proteins.</data>
</edge>
<edge source="PDF_45_2016_Result_-2279688250594086410" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">CPEB1 and DAZL interact with the same RNA targets, but possibly not through a direct interaction between both proteins.</data>
</edge>
<edge source="PDF_45_2016_Result_-8868307895684558241" target="Protein_CPEB1">
  <data key="d8">MENTIONS</data>
  <data key="d9">A decrease in CPEB1 binding could be detected for both mutants compared to the wild-type reporter</data>
</edge>
<edge source="PDF_45_2016_Conclusion_3085968706911168016" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">Mechanistically, the number of DAZL proteins loaded onto the mRNA and the characteristics of the CPE might define the degree of cooperation between the two RBPs in activating translation and meiotic progression.</data>
</edge>
<edge source="PDF_45_2016_Conclusion_7530143935422672266" target="Gene_TEX19">
  <data key="d8">MENTIONS</data>
  <data key="d9">These findings confirm the weaker activity of the non-consensus CPE found in the 3' UTR of Tex19.1.</data>
</edge>
<edge source="PDF_45_2016_Conclusion_-3805813853744680934" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">This experiment shows that only the non-consensus CPE allows CРЕВ1 and DAZL to act synergistically.</data>
</edge>
<edge source="PDF_45_2016_Conclusion_-3805813853744680934" target="Protein_CPEB1">
  <data key="d8">MENTIONS</data>
  <data key="d9">This experiment shows that only the non-consensus CPE allows CРЕВ1 and DAZL to act synergistically.</data>
</edge>
<edge source="PDF_47_2015" target="PDF_47_2015_Method_-54781574078941181">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_47_2015" target="PDF_47_2015_Result_4893860246615182674">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_47_2015" target="PDF_47_2015_Result_1783835243512145812">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_47_2015" target="PDF_47_2015_Result_1488196317240352265">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_47_2015" target="PDF_47_2015_Result_2165500294956861730">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_47_2015" target="PDF_47_2015_Result_2332962644881182286">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_47_2015" target="PDF_47_2015_Result_-2718079740960111134">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_47_2015" target="PDF_47_2015_Result_1959305655694642448">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_47_2015" target="PDF_47_2015_Result_-181533159906841637">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_47_2015" target="PDF_47_2015_Conclusion_7439052657272579615">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_47_2015_Method_-54781574078941181" target="Protein_GAG">
  <data key="d8">MENTIONS</data>
  <data key="d9">Chimeric VLPs were prepared using gag and M1 capsid proteins.</data>
</edge>
<edge source="PDF_47_2015_Method_-54781574078941181" target="Protein_M1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Chimeric VLPs were prepared using gag and M1 capsid proteins.</data>
</edge>
<edge source="PDF_47_2015_Result_1783835243512145812" target="Protein_GAG">
  <data key="d8">MENTIONS</data>
  <data key="d9">Chimeric VLPs were composed of gag (61 kDa), M1 (28 kDa), glycoprotein 64 GP64 (64 kDa), and rscFvs (32 kDa), and the presence of all proteins was confirmed by Western blotting.</data>
</edge>
<edge source="PDF_47_2015_Result_1783835243512145812" target="Protein_M1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Chimeric VLPs were composed of gag (61 kDa), M1 (28 kDa), glycoprotein 64 GP64 (64 kDa), and rscFvs (32 kDa), and the presence of all proteins was confirmed by Western blotting.</data>
</edge>
<edge source="PDF_47_2015_Result_1783835243512145812" target="Protein_GP64">
  <data key="d8">MENTIONS</data>
  <data key="d9">Chimeric VLPs were composed of gag (61 kDa), M1 (28 kDa), glycoprotein 64 GP64 (64 kDa), and rscFvs (32 kDa), and the presence of all proteins was confirmed by Western blotting.</data>
</edge>
<edge source="PDF_47_2015_Result_1488196317240352265" target="Protein_M1">
  <data key="d8">MENTIONS</data>
  <data key="d9">The amount of M1 present on the chimeric VLPs per microgram was estimated to be 305 ng, which was about 30.5% of total chimera protein.</data>
</edge>
<edge source="PDF_47_2015_Result_1959305655694642448" target="Compound_DOXORUBICIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">The delivery of doxorubicin to spheroids was confirmed (red channel) along with the presence of rscFvs fluorescence (green channel).</data>
</edge>
<edge source="PDF_47_2015_Result_-181533159906841637" target="Disease_SWINE FLU-INFLUENZA A VIRUS (H1N1)">
  <data key="d8">MENTIONS</data>
  <data key="d9">The serum showed specificity for chimera as well as swine flu-influenza A virus (H1N1).</data>
</edge>
<edge source="PDF_47_2015_Conclusion_7439052657272579615" target="Protein_GAG">
  <data key="d8">MENTIONS</data>
  <data key="d9">We prepared a nanobiomaterial with dual function of DDS and vaccination using two capsid proteins, gag-577 and M1, to target tumors and provide immunity against influenza virus</data>
</edge>
<edge source="PDF_47_2015_Conclusion_7439052657272579615" target="Protein_M1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We prepared a nanobiomaterial with dual function of DDS and vaccination using two capsid proteins, gag-577 and M1, to target tumors and provide immunity against influenza virus</data>
</edge>
<edge source="PDF_47_2015_Conclusion_7439052657272579615" target="Disease_INFLUENZA VIRUS">
  <data key="d8">MENTIONS</data>
  <data key="d9">We prepared a nanobiomaterial with dual function of DDS and vaccination using two capsid proteins, gag-577 and M1, to target tumors and provide immunity against influenza virus</data>
</edge>
<edge source="PDF_59_2021" target="PDF_59_2021_Method_8084785180202623832">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_59_2021" target="PDF_59_2021_Method_8884767966340028883">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_59_2021" target="PDF_59_2021_Method_9000689309584930492">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_59_2021" target="PDF_59_2021_Method_6134842963143498965">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_59_2021" target="PDF_59_2021_Method_9164412909000990652">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_59_2021" target="PDF_59_2021_Result_5263780920456016974">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_59_2021" target="PDF_59_2021_Result_8331701323369931557">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_59_2021" target="PDF_59_2021_Result_-1877269811622938180">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_59_2021" target="PDF_59_2021_Result_-4511610816675086746">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_59_2021" target="PDF_59_2021_Result_235750629806043123">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_59_2021" target="PDF_59_2021_Result_8321466901512663758">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_59_2021" target="PDF_59_2021_Result_-822497605866246829">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_59_2021" target="PDF_59_2021_Result_-8722289623207287559">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_59_2021" target="PDF_59_2021_Result_-5834581784832178746">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_59_2021" target="PDF_59_2021_Result_-8563409432147183205">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_59_2021" target="PDF_59_2021_Result_-5676837304885577544">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_59_2021" target="PDF_59_2021_Conclusion_761728912910396060">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_59_2021_Result_5263780920456016974" target="Gene_CD8">
  <data key="d8">MENTIONS</data>
  <data key="d9">For example, CD8+ and CD4+ T cells were partially blended together when analyzing the transcrip- tome but separated clearly in the protein data.</data>
</edge>
<edge source="PDF_59_2021_Result_5263780920456016974" target="Gene_CD4">
  <data key="d8">MENTIONS</data>
  <data key="d9">For example, CD8+ and CD4+ T cells were partially blended together when analyzing the transcrip- tome but separated clearly in the protein data.</data>
</edge>
<edge source="PDF_59_2021_Result_5263780920456016974" target="Process_T CELL">
  <data key="d8">MENTIONS</data>
  <data key="d9">For example, CD8+ and CD4+ T cells were partially blended together when analyzing the transcrip- tome but separated clearly in the protein data.</data>
</edge>
<edge source="PDF_59_2021_Result_-1877269811622938180" target="Gene_CD8">
  <data key="d8">MENTIONS</data>
  <data key="d9">For CD8+ T cells, protein KNN-based predictions were more accurate compared to RNA KNN-based predictions</data>
</edge>
<edge source="PDF_59_2021_Result_-1877269811622938180" target="Process_T CELL">
  <data key="d8">MENTIONS</data>
  <data key="d9">For CD8+ T cells, protein KNN-based predictions were more accurate compared to RNA KNN-based predictions</data>
</edge>
<edge source="PDF_59_2021_Result_-4511610816675086746" target="Gene_CD8">
  <data key="d8">MENTIONS</data>
  <data key="d9">cells classified as CD8+ T cells were assigned higher protein modality weights, whereas DCs were assigned higher RNA modality weights</data>
</edge>
<edge source="PDF_59_2021_Result_-4511610816675086746" target="Process_T CELL">
  <data key="d8">MENTIONS</data>
  <data key="d9">cells classified as CD8+ T cells were assigned higher protein modality weights, whereas DCs were assigned higher RNA modality weights</data>
</edge>
<edge source="PDF_59_2021_Result_8321466901512663758" target="Process_T CELL">
  <data key="d8">MENTIONS</data>
  <data key="d9">T cell groups-and in particular, populations that were masked in scRNA-seq analyses-all received higher protein modality weights</data>
</edge>
<edge source="PDF_59_2021_Result_-8722289623207287559" target="Gene_CD8">
  <data key="d8">MENTIONS</data>
  <data key="d9">ATAC-seq data were more capable of separating naive CD8+ and CD4+ T cell states due to reliable detection of cell-type-spe- cific open chromatin regions</data>
</edge>
<edge source="PDF_59_2021_Result_-8722289623207287559" target="Gene_CD4">
  <data key="d8">MENTIONS</data>
  <data key="d9">ATAC-seq data were more capable of separating naive CD8+ and CD4+ T cell states due to reliable detection of cell-type-spe- cific open chromatin regions</data>
</edge>
<edge source="PDF_59_2021_Result_-8722289623207287559" target="Process_T CELL">
  <data key="d8">MENTIONS</data>
  <data key="d9">ATAC-seq data were more capable of separating naive CD8+ and CD4+ T cell states due to reliable detection of cell-type-spe- cific open chromatin regions</data>
</edge>
<edge source="PDF_40_2006" target="PDF_40_2006_Hypothesis_3683953763906390933">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_40_2006" target="PDF_40_2006_Method_-683990889861317871">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_40_2006" target="PDF_40_2006_Method_-1587955044789052164">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_40_2006" target="PDF_40_2006_Method_-7160951234920139849">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_40_2006" target="PDF_40_2006_Method_-7144305972820793422">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_40_2006" target="PDF_40_2006_Method_-9082245207375802968">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_40_2006" target="PDF_40_2006_Method_-1136047486022654854">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_40_2006" target="PDF_40_2006_Result_16013246130922863">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_40_2006" target="PDF_40_2006_Result_5606897750963540037">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_40_2006" target="PDF_40_2006_Result_5883488902810301376">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_40_2006" target="PDF_40_2006_Result_1679627554638903512">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_40_2006" target="PDF_40_2006_Result_8308012542702244040">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_40_2006" target="PDF_40_2006_Conclusion_-3781462944046668637">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_40_2006" target="PDF_40_2006_Conclusion_6779262816191981106">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_40_2006_Hypothesis_3683953763906390933" target="Protein_RASSF">
  <data key="d8">MENTIONS</data>
  <data key="d9">We have hypothesized that RASSF family proteins may serve as effectors that mediate some of the growth inhibitory aspects of Ras, including Ras-induced apoptosis</data>
</edge>
<edge source="PDF_40_2006_Hypothesis_3683953763906390933" target="Protein_RAS">
  <data key="d8">MENTIONS</data>
  <data key="d9">We have hypothesized that RASSF family proteins may serve as effectors that mediate some of the growth inhibitory aspects of Ras, including Ras-induced apoptosis</data>
</edge>
<edge source="PDF_40_2006_Method_-683990889861317871" target="Gene_RASSF1A">
  <data key="d8">MENTIONS</data>
  <data key="d9">Yeast two-hybrid analysis was performed using a full-length RASSF1A clone</data>
</edge>
<edge source="PDF_40_2006_Method_-1587955044789052164" target="Gene_RASSF1A">
  <data key="d8">MENTIONS</data>
  <data key="d9">co-transfected RFP-RASSF1A and GFP-MOAP-1 into 293-T cells and examined expressing cells by fluorescence microscopy</data>
</edge>
<edge source="PDF_40_2006_Method_-1587955044789052164" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">co-transfected RFP-RASSF1A and GFP-MOAP-1 into 293-T cells and examined expressing cells by fluorescence microscopy</data>
</edge>
<edge source="PDF_40_2006_Method_-7160951234920139849" target="Gene_RASSF1A">
  <data key="d8">MENTIONS</data>
  <data key="d9">immunoprecipitated liver lysates with a mouse monoclonal RASSF1A antibody and detected the presence of endogenous MOAP-1</data>
</edge>
<edge source="PDF_40_2006_Method_-7160951234920139849" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">immunoprecipitated liver lysates with a mouse monoclonal RASSF1A antibody and detected the presence of endogenous MOAP-1</data>
</edge>
<edge source="PDF_40_2006_Method_-9082245207375802968" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">co-transfected GFP-Bax and RFP-RASSF1A into H1299 human lung tumor cells</data>
</edge>
<edge source="PDF_40_2006_Method_-9082245207375802968" target="Gene_RASSF1A">
  <data key="d8">MENTIONS</data>
  <data key="d9">co-transfected GFP-Bax and RFP-RASSF1A into H1299 human lung tumor cells</data>
</edge>
<edge source="PDF_40_2006_Method_-1136047486022654854" target="Gene_RASSF1A">
  <data key="d8">MENTIONS</data>
  <data key="d9">transfected H1792 cells with an shRNA construct designed against RASSF1A</data>
</edge>
<edge source="PDF_40_2006_Result_16013246130922863" target="Gene_RASSF1A">
  <data key="d8">MENTIONS</data>
  <data key="d9">the C65R mutant of RASSF1A is defective for MOAP-1 binding and does not exhibit enhanced MOAP-1 binding in the presence of activated K-Ras</data>
</edge>
<edge source="PDF_40_2006_Result_16013246130922863" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">the C65R mutant of RASSF1A is defective for MOAP-1 binding and does not exhibit enhanced MOAP-1 binding in the presence of activated K-Ras</data>
</edge>
<edge source="PDF_40_2006_Result_16013246130922863" target="Protein_K-RAS">
  <data key="d8">MENTIONS</data>
  <data key="d9">the C65R mutant of RASSF1A is defective for MOAP-1 binding and does not exhibit enhanced MOAP-1 binding in the presence of activated K-Ras</data>
</edge>
<edge source="PDF_40_2006_Result_5606897750963540037" target="Gene_RASSF1A">
  <data key="d8">MENTIONS</data>
  <data key="d9">RASSF1A induces the relocalization and clustering of Bax</data>
</edge>
<edge source="PDF_40_2006_Result_5606897750963540037" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">RASSF1A induces the relocalization and clustering of Bax</data>
</edge>
<edge source="PDF_40_2006_Result_5883488902810301376" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Co-transfection of the BH3 domain of MOAP-1 blocked the ability of RASSF1A to activate Bax</data>
</edge>
<edge source="PDF_40_2006_Result_5883488902810301376" target="Gene_RASSF1A">
  <data key="d8">MENTIONS</data>
  <data key="d9">Co-transfection of the BH3 domain of MOAP-1 blocked the ability of RASSF1A to activate Bax</data>
</edge>
<edge source="PDF_40_2006_Result_5883488902810301376" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">Co-transfection of the BH3 domain of MOAP-1 blocked the ability of RASSF1A to activate Bax</data>
</edge>
<edge source="PDF_40_2006_Result_1679627554638903512" target="Gene_RASSF1A">
  <data key="d8">MENTIONS</data>
  <data key="d9">RASSF1A C65R is defective for Bax activation in H1299 lung tumor cells</data>
</edge>
<edge source="PDF_40_2006_Result_1679627554638903512" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">RASSF1A C65R is defective for Bax activation in H1299 lung tumor cells</data>
</edge>
<edge source="PDF_40_2006_Result_8308012542702244040" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">A strong activation of Bax by K-Ras12v was only detected in the cells expressing RASSF1A</data>
</edge>
<edge source="PDF_40_2006_Result_8308012542702244040" target="Protein_K-RAS">
  <data key="d8">MENTIONS</data>
  <data key="d9">A strong activation of Bax by K-Ras12v was only detected in the cells expressing RASSF1A</data>
</edge>
<edge source="PDF_40_2006_Result_8308012542702244040" target="Gene_RASSF1A">
  <data key="d8">MENTIONS</data>
  <data key="d9">A strong activation of Bax by K-Ras12v was only detected in the cells expressing RASSF1A</data>
</edge>
<edge source="PDF_40_2006_Conclusion_-3781462944046668637" target="Protein_K-RAS">
  <data key="d8">MENTIONS</data>
  <data key="d9">Thus, we identify a novel pro-apoptotic pathway linking K-Ras, RASSF1A and Bax that is specifically impaired in some human tumors.</data>
</edge>
<edge source="PDF_40_2006_Conclusion_-3781462944046668637" target="Gene_RASSF1A">
  <data key="d8">MENTIONS</data>
  <data key="d9">Thus, we identify a novel pro-apoptotic pathway linking K-Ras, RASSF1A and Bax that is specifically impaired in some human tumors.</data>
</edge>
<edge source="PDF_40_2006_Conclusion_-3781462944046668637" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">Thus, we identify a novel pro-apoptotic pathway linking K-Ras, RASSF1A and Bax that is specifically impaired in some human tumors.</data>
</edge>
<edge source="PDF_40_2006_Conclusion_-3781462944046668637" target="Disease_DISEASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">Thus, we identify a novel pro-apoptotic pathway linking K-Ras, RASSF1A and Bax that is specifically impaired in some human tumors.</data>
</edge>
<edge source="PDF_40_2006_Conclusion_6779262816191981106" target="Gene_RASSF1A">
  <data key="d8">MENTIONS</data>
  <data key="d9">Our determination that the tumor-derived C65R mutant of RASSF1A is defective for MOAP-1 association and Bax activation suggests the interaction of RASSF1A with MOAP-1 is a significant component of its tumor suppressor function.</data>
</edge>
<edge source="PDF_40_2006_Conclusion_6779262816191981106" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Our determination that the tumor-derived C65R mutant of RASSF1A is defective for MOAP-1 association and Bax activation suggests the interaction of RASSF1A with MOAP-1 is a significant component of its tumor suppressor function.</data>
</edge>
<edge source="PDF_40_2006_Conclusion_6779262816191981106" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">Our determination that the tumor-derived C65R mutant of RASSF1A is defective for MOAP-1 association and Bax activation suggests the interaction of RASSF1A with MOAP-1 is a significant component of its tumor suppressor function.</data>
</edge>
<edge source="PDF_26_2021" target="PDF_26_2021_Hypothesis_-5082930849196607872">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_26_2021" target="PDF_26_2021_Method_2151172292187832547">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_26_2021" target="PDF_26_2021_Method_-8691077547092582639">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_26_2021" target="PDF_26_2021_Method_-5594211197849721181">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_26_2021" target="PDF_26_2021_Result_6192805185311629188">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_26_2021" target="PDF_26_2021_Result_4920982137656896410">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_26_2021" target="PDF_26_2021_Result_-3117426508078294293">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_26_2021" target="PDF_26_2021_Conclusion_-5294938487575171592">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_26_2021_Result_4920982137656896410" target="Gene_PHLDA3">
  <data key="d8">MENTIONS</data>
  <data key="d9">rs35383942, associated with breast cancer, is a predicted deleterious missense variant in PHLDA3.</data>
</edge>
<edge source="PDF_26_2021_Result_4920982137656896410" target="Gene_TP53">
  <data key="d8">MENTIONS</data>
  <data key="d9">rs35383942, associated with breast cancer, is a predicted deleterious missense variant in PHLDA3.</data>
</edge>
<edge source="PDF_26_2021_Result_4920982137656896410" target="Gene_AKT1">
  <data key="d8">MENTIONS</data>
  <data key="d9">rs35383942, associated with breast cancer, is a predicted deleterious missense variant in PHLDA3.</data>
</edge>
<edge source="PDF_26_2021_Result_4920982137656896410" target="Disease_BREAST CANCER">
  <data key="d8">MENTIONS</data>
  <data key="d9">rs35383942, associated with breast cancer, is a predicted deleterious missense variant in PHLDA3.</data>
</edge>
<edge source="PDF_26_2021_Result_-3117426508078294293" target="Gene_ADAM15">
  <data key="d8">MENTIONS</data>
  <data key="d9">splice region variant rs11589479, which causes increase in ADAM15 expression in several monocytes states and also colocalizes (H4 = 0.99) with Crohn's disease</data>
</edge>
<edge source="PDF_26_2021_Result_-3117426508078294293" target="Disease_CROHN'S DISEASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">splice region variant rs11589479, which causes increase in ADAM15 expression in several monocytes states and also colocalizes (H4 = 0.99) with Crohn's disease</data>
</edge>
<edge source="PDF_31_2019" target="PDF_31_2019_Hypothesis_-1056833595134377367">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_31_2019" target="PDF_31_2019_Method_-1439198623860928750">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_31_2019" target="PDF_31_2019_Method_-7244849363223085226">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_31_2019" target="PDF_31_2019_Method_-3471959365747463789">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_31_2019" target="PDF_31_2019_Method_7023445881201550886">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_31_2019" target="PDF_31_2019_Result_-119217658207850139">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_31_2019" target="PDF_31_2019_Result_5633783855499589783">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_31_2019" target="PDF_31_2019_Result_-7315920823835259182">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_31_2019" target="PDF_31_2019_Conclusion_-1911165917813386521">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_46_2010" target="PDF_46_2010_Hypothesis_701123404578016755">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_46_2010" target="PDF_46_2010_Method_-441247898462120587">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_46_2010" target="PDF_46_2010_Method_2696937838462256372">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_46_2010" target="PDF_46_2010_Result_5563776965883224748">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_46_2010" target="PDF_46_2010_Result_-1436724849490238434">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_46_2010" target="PDF_46_2010_Result_-3076783188810283608">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_46_2010" target="PDF_46_2010_Result_4291168305466479502">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_46_2010" target="PDF_46_2010_Result_4635522752032459763">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_46_2010" target="PDF_46_2010_Result_-7601699126870717197">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_46_2010" target="PDF_46_2010_Result_-7694673687348091914">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_46_2010" target="PDF_46_2010_Result_-734895794085640200">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_46_2010" target="PDF_46_2010_Result_-4724971973414181120">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_46_2010" target="PDF_46_2010_Result_1824116455646388372">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_46_2010" target="PDF_46_2010_Conclusion_-571866029861193511">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_46_2010" target="PDF_46_2010_Conclusion_4127119109142202898">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_46_2010_Hypothesis_701123404578016755" target="Protein_PUM2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pum2 can repress translation by blocking the assembly of the essential initiation complex on the cap.</data>
</edge>
<edge source="PDF_46_2010_Hypothesis_701123404578016755" target="Protein_EIF4E">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pum2 can repress translation by blocking the assembly of the essential initiation complex on the cap.</data>
</edge>
<edge source="PDF_46_2010_Method_-441247898462120587" target="Protein_PUM2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Using deletion analysis, we have mapped the cap interaction domain of Pum2 to the amino terminus of the protein and identified a conserved tryptophan residue that mediates this specific interaction.</data>
</edge>
<edge source="PDF_46_2010_Method_2696937838462256372" target="Protein_PUM2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Reporter mRNA-based assays demonstrate that Pum2 requires the conserved tryptophan to repress translation in injected Xenopus oocytes.</data>
</edge>
<edge source="PDF_46_2010_Result_5563776965883224748" target="Protein_PUM2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pum2 binds directly to the 5' 7mG cap structure; in so doing, it precludes eIF4E from binding the cap.</data>
</edge>
<edge source="PDF_46_2010_Result_5563776965883224748" target="Protein_EIF4E">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pum2 binds directly to the 5' 7mG cap structure; in so doing, it precludes eIF4E from binding the cap.</data>
</edge>
<edge source="PDF_46_2010_Result_-1436724849490238434" target="Protein_PUM2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pum2, like Maskin, was retained on the affinity matrix and that it was competed off by excess cap analog.</data>
</edge>
<edge source="PDF_46_2010_Result_-1436724849490238434" target="Protein_MASKIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pum2, like Maskin, was retained on the affinity matrix and that it was competed off by excess cap analog.</data>
</edge>
<edge source="PDF_46_2010_Result_-3076783188810283608" target="Protein_PUM2">
  <data key="d8">MENTIONS</data>
  <data key="d9">progressively more Pum2 was retained on the cap analog matrix as the cell cycle progressed</data>
</edge>
<edge source="PDF_46_2010_Result_4291168305466479502" target="Protein_PUM2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pum2, as well as eIF4E, were both retained on the m'G-Sepharose matrix, but not on the GDP matrix</data>
</edge>
<edge source="PDF_46_2010_Result_4291168305466479502" target="Protein_EIF4E">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pum2, as well as eIF4E, were both retained on the m'G-Sepharose matrix, but not on the GDP matrix</data>
</edge>
<edge source="PDF_46_2010_Result_4635522752032459763" target="Protein_PUM2">
  <data key="d8">MENTIONS</data>
  <data key="d9">In the presence of excess free cap analog, but not free GTP, both Pum2 and eIF4E failed to be retained on the m'G-Sepharose matrix</data>
</edge>
<edge source="PDF_46_2010_Result_4635522752032459763" target="Protein_EIF4E">
  <data key="d8">MENTIONS</data>
  <data key="d9">In the presence of excess free cap analog, but not free GTP, both Pum2 and eIF4E failed to be retained on the m'G-Sepharose matrix</data>
</edge>
<edge source="PDF_46_2010_Result_-7601699126870717197" target="Protein_PUM2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pum2 bound the m G-Sepharose in the presence of GTP, but not the free cap analog.</data>
</edge>
<edge source="PDF_46_2010_Result_-7694673687348091914" target="Protein_PUM2">
  <data key="d8">MENTIONS</data>
  <data key="d9">both recombinant Pum2 and eIF4E were retained on cap analog, but not GDP Sepharose.</data>
</edge>
<edge source="PDF_46_2010_Result_-7694673687348091914" target="Protein_EIF4E">
  <data key="d8">MENTIONS</data>
  <data key="d9">both recombinant Pum2 and eIF4E were retained on cap analog, but not GDP Sepharose.</data>
</edge>
<edge source="PDF_46_2010_Result_-734895794085640200" target="Protein_EIF4E">
  <data key="d8">MENTIONS</data>
  <data key="d9">As more eIF4E was retained on the matrix, progressively less Pum2 was retained. However, increased Pum2 retention caused no detectable decrease in eIF4E retention</data>
</edge>
<edge source="PDF_46_2010_Result_-734895794085640200" target="Protein_PUM2">
  <data key="d8">MENTIONS</data>
  <data key="d9">As more eIF4E was retained on the matrix, progressively less Pum2 was retained. However, increased Pum2 retention caused no detectable decrease in eIF4E retention</data>
</edge>
<edge source="PDF_46_2010_Result_-4724971973414181120" target="Protein_PUM2">
  <data key="d8">MENTIONS</data>
  <data key="d9">the preponderance of Pum2 binding activity resided in residues 334-689.</data>
</edge>
<edge source="PDF_46_2010_Result_1824116455646388372" target="Protein_PUM2">
  <data key="d8">MENTIONS</data>
  <data key="d9">the substitution of W344, which is conserved among Pum2 proteins from several vertebrate species, consistently abrogated cap binding</data>
</edge>
<edge source="PDF_46_2010_Conclusion_-571866029861193511" target="Protein_PUMILIO">
  <data key="d8">MENTIONS</data>
  <data key="d9">vertebrate Pumilio can repress translation by blocking the assembly of the essential initiation complex on the cap.</data>
</edge>
<edge source="PDF_46_2010_Conclusion_4127119109142202898" target="Protein_PUM2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pum2 combines two binding specificities, with the cap and the 3' UTR PBE, to repress translation.</data>
</edge>
<edge source="PDF_53_2019" target="PDF_53_2019_Method_-1599774961034013939">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_53_2019" target="PDF_53_2019_Method_4462753343622714275">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_53_2019" target="PDF_53_2019_Result_-2904868856983182395">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_53_2019" target="PDF_53_2019_Result_-1666800357086250499">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_53_2019" target="PDF_53_2019_Result_-3025535816794254610">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_53_2019" target="PDF_53_2019_Method_-5787164148879896390">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_53_2019_Method_4462753343622714275" target="Protein_HEMAGGLUTININ">
  <data key="d8">MENTIONS</data>
  <data key="d9">Using uranyl acetate stained molecular com- plexes of influenza hemagglutinin bound to Fab 441D6, we describe a simple and efficient means to collect several hundred micrographs with SerialEM.</data>
</edge>
<edge source="PDF_53_2019_Result_-2904868856983182395" target="Protein_HEMAGGLUTININ">
  <data key="d8">MENTIONS</data>
  <data key="d9">Using RELION, we illustrate how tens of thousands of complexes can be auto-picked and classified to accurately describe the domain level topology of this unconventional hemagglutinin head-domain epitope.</data>
</edge>
<edge source="PDF_53_2019_Method_-5787164148879896390" target="Protein_HEMAGGLUTININ">
  <data key="d8">MENTIONS</data>
  <data key="d9">As an example for this article, we use the molecular complex of the antibody fragment antigen-binding (Fab) 441D6 in complex with influenza hemagglutinin (HA) A/New York/653/1996.</data>
</edge>
<edge source="PDF_30_2021" target="PDF_30_2021_Hypothesis_-8818541740068170277">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_30_2021" target="PDF_30_2021_Method_6290913108374888870">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_30_2021" target="PDF_30_2021_Method_1795151608853513841">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_30_2021" target="PDF_30_2021_Method_2261030653331385831">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_30_2021" target="PDF_30_2021_Method_2063425435594633472">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_30_2021" target="PDF_30_2021_Result_-6073832681468716012">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_30_2021" target="PDF_30_2021_Result_915134545367537338">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_30_2021" target="PDF_30_2021_Result_-8878043653176464976">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_30_2021" target="PDF_30_2021_Result_7694964158821428791">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_30_2021" target="PDF_30_2021_Result_-4011479752700675712">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_30_2021" target="PDF_30_2021_Result_7287794434995970486">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_30_2021" target="PDF_30_2021_Result_-6309994986059093048">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_30_2021" target="PDF_30_2021_Result_6731876750101381095">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_30_2021" target="PDF_30_2021_Result_1686584626329549693">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_30_2021" target="PDF_30_2021_Result_5072087701384916043">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_30_2021" target="PDF_30_2021_Result_8635076780095329992">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_30_2021" target="PDF_30_2021_Conclusion_2061329940680074376">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_30_2021" target="PDF_30_2021_Conclusion_2274660399732934383">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_30_2021" target="PDF_30_2021_Conclusion_-8226118059089604154">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_30_2021_Result_-8878043653176464976" target="Gene_ALKALINE PHOSPHATASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">In the longest allelic series, 45 rare coding variants in ALPL independently associated with serum alkaline phosphatase levels, all with negative effect directions for the rare minor allele.</data>
</edge>
<edge source="PDF_30_2021_Result_7694964158821428791" target="Gene_IFRD2">
  <data key="d8">MENTIONS</data>
  <data key="d9">At IFRD2 (interferon-related developmental regulator 2, which has an unknown function), 24 rare coding variants independently associated with high light scatter reticulocyte count</data>
</edge>
<edge source="PDF_30_2021_Result_-4011479752700675712" target="Gene_NPR2">
  <data key="d8">MENTIONS</data>
  <data key="d9">At NPR2, which encodes a natriuretic peptide receptor involved in bone growth regulation35, 11 rare coding variants independently associated with height</data>
</edge>
<edge source="PDF_30_2021_Result_7287794434995970486" target="Gene_PLA2G12A">
  <data key="d8">MENTIONS</data>
  <data key="d9">At PLA2G12A and PLINI, allelic series containing up to seven rare coding variants in PLA2G12A and eight in PLINI associated with serum lipid levels</data>
</edge>
<edge source="PDF_30_2021_Result_7287794434995970486" target="Gene_PLINI">
  <data key="d8">MENTIONS</data>
  <data key="d9">At PLA2G12A and PLINI, allelic series containing up to seven rare coding variants in PLA2G12A and eight in PLINI associated with serum lipid levels</data>
</edge>
<edge source="PDF_30_2021_Result_-6309994986059093048" target="Gene_CHEK2">
  <data key="d8">MENTIONS</data>
  <data key="d9">the cell cycle regulators CHEK2 and JAK2 both contained likely-causal variants associated with white blood cell, red blood cell and platelet traits; a JAK2 missense variant also associated with IGF-1 measurements</data>
</edge>
<edge source="PDF_30_2021_Result_-6309994986059093048" target="Gene_JAK2">
  <data key="d8">MENTIONS</data>
  <data key="d9">the cell cycle regulators CHEK2 and JAK2 both contained likely-causal variants associated with white blood cell, red blood cell and platelet traits; a JAK2 missense variant also associated with IGF-1 measurements</data>
</edge>
<edge source="PDF_30_2021_Result_-6309994986059093048" target="Protein_IGF-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">the cell cycle regulators CHEK2 and JAK2 both contained likely-causal variants associated with white blood cell, red blood cell and platelet traits; a JAK2 missense variant also associated with IGF-1 measurements</data>
</edge>
<edge source="PDF_30_2021_Result_6731876750101381095" target="Gene_DENND2C">
  <data key="d8">MENTIONS</data>
  <data key="d9">three genes that regulate Rho GTPases (DENND2C, DOCK8, and KALRN) contained likely-causal variants associated with multiple platelet traits</data>
</edge>
<edge source="PDF_30_2021_Result_6731876750101381095" target="Gene_DOCK8">
  <data key="d8">MENTIONS</data>
  <data key="d9">three genes that regulate Rho GTPases (DENND2C, DOCK8, and KALRN) contained likely-causal variants associated with multiple platelet traits</data>
</edge>
<edge source="PDF_30_2021_Result_6731876750101381095" target="Gene_KALRN">
  <data key="d8">MENTIONS</data>
  <data key="d9">three genes that regulate Rho GTPases (DENND2C, DOCK8, and KALRN) contained likely-causal variants associated with multiple platelet traits</data>
</edge>
<edge source="PDF_30_2021_Result_1686584626329549693" target="Gene_APOC3">
  <data key="d8">MENTIONS</data>
  <data key="d9">APOC3 exhibited the widest variety of likely-causal associations, with the splice donor variant rs138326449 associating with 13 distinct traits including lipid levels, white blood cell and red blood cell traits, and kidney biomarkers.</data>
</edge>
<edge source="PDF_30_2021_Result_5072087701384916043" target="Gene_PDE3B">
  <data key="d8">MENTIONS</data>
  <data key="d9">In PDE3B, the stop gain variant rs150090666 associated likely-causally with 10 distinct traits, including expected associations with waist-hip-ratio and lipid measurements38, but also associations with red blood cell traits, SHBG levels, and height.</data>
</edge>
<edge source="PDF_30_2021_Result_8635076780095329992" target="Gene_MC4R">
  <data key="d8">MENTIONS</data>
  <data key="d9">We also detected one very-large-effect variant for BMI in MC4R (+0.62 (0.12) s.d.; Supplementary Table 10); this variant had previously been associated with obesity in a Mendelian fashion41.</data>
</edge>
<edge source="PDF_30_2021_Result_8635076780095329992" target="Disease_OBESITY">
  <data key="d8">MENTIONS</data>
  <data key="d9">We also detected one very-large-effect variant for BMI in MC4R (+0.62 (0.12) s.d.; Supplementary Table 10); this variant had previously been associated with obesity in a Mendelian fashion41.</data>
</edge>
<edge source="PDF_21_2018" target="PDF_21_2018_Hypothesis_-3563607693496270283">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_21_2018" target="PDF_21_2018_Method_-8783716829984003002">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_21_2018" target="PDF_21_2018_Method_-4106576273646245627">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_21_2018" target="PDF_21_2018_Method_-6184085133573977298">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_21_2018" target="PDF_21_2018_Result_-6159745445870016260">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_21_2018" target="PDF_21_2018_Result_-4579426345443929590">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_21_2018" target="PDF_21_2018_Result_-2721047602620332017">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_21_2018" target="PDF_21_2018_Conclusion_2143140091600789523">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_21_2018_Hypothesis_-3563607693496270283" target="Gene_ARC">
  <data key="d8">MENTIONS</data>
  <data key="d9">Arc might bind and encapsulate RNA.</data>
</edge>
<edge source="PDF_21_2018_Hypothesis_-3563607693496270283" target="Compound_RNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">Arc might bind and encapsulate RNA.</data>
</edge>
<edge source="PDF_21_2018_Method_-8783716829984003002" target="Gene_ARC">
  <data key="d8">MENTIONS</data>
  <data key="d9">Expressed rat Arc in bacteria as a glutathione S-transferase (GST) fusion protein.</data>
</edge>
<edge source="PDF_21_2018_Method_-4106576273646245627" target="Gene_ARC">
  <data key="d8">MENTIONS</data>
  <data key="d9">Performed phylogenomic analyses.</data>
</edge>
<edge source="PDF_21_2018_Method_-6184085133573977298" target="Compound_ARC">
  <data key="d8">MENTIONS</data>
  <data key="d9">Used RT-PCR to show that Arc mRNA is also present in EVs purified from neurons.</data>
</edge>
<edge source="PDF_21_2018_Result_-6159745445870016260" target="Protein_ARC">
  <data key="d8">MENTIONS</data>
  <data key="d9">prArc spontaneously forms oligomeric structures that resemble virus-like capsids.</data>
</edge>
<edge source="PDF_21_2018_Result_-4579426345443929590" target="Gene_ARC">
  <data key="d8">MENTIONS</data>
  <data key="d9">Arc is released from neurons in EVs and is able to transfer its own mRNA into neurons.</data>
</edge>
<edge source="PDF_21_2018_Result_-4579426345443929590" target="Compound_MRNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">Arc is released from neurons in EVs and is able to transfer its own mRNA into neurons.</data>
</edge>
<edge source="PDF_21_2018_Result_-4579426345443929590" target="Process_NEURONS">
  <data key="d8">MENTIONS</data>
  <data key="d9">Arc is released from neurons in EVs and is able to transfer its own mRNA into neurons.</data>
</edge>
<edge source="PDF_21_2018_Result_-2721047602620332017" target="Compound_RNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">Stripping RNA resulted in significantly fewer fully formed capsids, suggesting that Arc capsids require RNA for normal assembly.</data>
</edge>
<edge source="PDF_21_2018_Result_-2721047602620332017" target="Protein_ARC">
  <data key="d8">MENTIONS</data>
  <data key="d9">Stripping RNA resulted in significantly fewer fully formed capsids, suggesting that Arc capsids require RNA for normal assembly.</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Hypothesis_4164567301117783779">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Method_7297217210385788847">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_-6553612527542556915">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_7475989343544700684">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_-4004399965614423551">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Hypothesis_-5316617838561894012">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Method_-1673455566313239752">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_6064804342065993759">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_-1397549757452382402">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_8000450620091172683">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_-9071224477929579481">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Conclusion_-2630366916512089137">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_3177759640078138706">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_1470432972548654560">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_-3379324757801553436">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_9182419568005416721">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_-7548824776608565829">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_1752204976944477647">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_-4811669220701434189">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_-8472024034684665930">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_-7248658781969017657">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_-9190880975557393590">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_4733603008324162908">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_-1205846018493210175">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_-1858247962095125921">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_3552208912935154417">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_-7396469426040130416">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Result_-3238329267919947274">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_38_2024" target="PDF_38_2024_Conclusion_-6789794902732702756">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_36_2014" target="PDF_36_2014_Hypothesis_4972182180303622502">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_36_2014" target="PDF_36_2014_Method_-2295714312279089060">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_36_2014" target="PDF_36_2014_Method_-7972339232864600486">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_36_2014" target="PDF_36_2014_Result_-389420263346194733">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_36_2014" target="PDF_36_2014_Result_2699379388307985870">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_36_2014" target="PDF_36_2014_Result_8662810041692786578">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_36_2014" target="PDF_36_2014_Result_-7182093143440056343">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_36_2014" target="PDF_36_2014_Result_2878733584736117557">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_36_2014" target="PDF_36_2014_Result_-1531446935205058615">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_36_2014" target="PDF_36_2014_Conclusion_-3705689529277907024">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_36_2014_Hypothesis_4972182180303622502" target="Compound_MRNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">We hypothesized that the cumulus cells transfer mRNAs benefitting oocyte maturation in an orchestrated fashion.</data>
</edge>
<edge source="PDF_36_2014_Result_-389420263346194733" target="Compound_RNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">Nascent RNA was detected within the TZPs of treated cumulus oocyte complexes (COCs).</data>
</edge>
<edge source="PDF_36_2014_Result_8662810041692786578" target="Compound_RNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">Evidence of active transfer of RNA from the cumulus cells to the oocyte was found by comparing signal distribution of labeled nascent RNA within a fully enclosed oocyte to the signal detected in a partially denuded oocyte.</data>
</edge>
<edge source="PDF_36_2014_Result_-7182093143440056343" target="Compound_MRNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">Comparing this list to those found associated with the polyribosomes, 1,226 transcripts intersected.</data>
</edge>
<edge source="PDF_36_2014_Result_-1531446935205058615" target="Compound_RNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">Oocytes demonstrated an increasing number of RNA bearing TZPs over time, significantly increasing between 0 h, 2 h and 4 h post slaughter and appearing to plateau by 6 h</data>
</edge>
<edge source="PDF_36_2014_Conclusion_-3705689529277907024" target="Compound_RNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">The presented results highlight the additional contribution of the cumulus cells to the oocyte in the form of large cargo transfer. We focused on RNA transfer from the cumulus cells, and its importance for gamete maturation.</data>
</edge>
<edge source="PDF_52_2013" target="PDF_52_2013_Hypothesis_-3618604179736161483">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_52_2013" target="PDF_52_2013_Method_5558943803450188274">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_52_2013" target="PDF_52_2013_Method_7459385719516688739">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_52_2013" target="PDF_52_2013_Method_-5827387973616987370">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_52_2013" target="PDF_52_2013_Method_-878961672549594553">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_52_2013" target="PDF_52_2013_Result_4997911498934269511">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_52_2013" target="PDF_52_2013_Result_7490315703337305613">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_52_2013" target="PDF_52_2013_Result_-3597215061576887774">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_52_2013" target="PDF_52_2013_Result_6878228180634941732">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_52_2013" target="PDF_52_2013_Conclusion_1635221794646452479">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_52_2013" target="PDF_52_2013_Conclusion_8337539805626380235">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_52_2013_Hypothesis_-3618604179736161483" target="Protein_ARNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">We designed a new E. coli expression strain named LOBSTR (low-background-strain), which features genomic modifications in arnA and slyD based on surface engineering to address the problem of co-purification of histidine-rich host proteins ArnA and SlyD during His-tag affinity purification.</data>
</edge>
<edge source="PDF_52_2013_Hypothesis_-3618604179736161483" target="Protein_SLYD">
  <data key="d8">MENTIONS</data>
  <data key="d9">We designed a new E. coli expression strain named LOBSTR (low-background-strain), which features genomic modifications in arnA and slyD based on surface engineering to address the problem of co-purification of histidine-rich host proteins ArnA and SlyD during His-tag affinity purification.</data>
</edge>
<edge source="PDF_52_2013_Method_5558943803450188274" target="Gene_ARNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">Genomic copies of arnA and slyD in the host strain BL21(DE3) were replaced with mutant versions to create LOBSTR using a modified recombineering approach.</data>
</edge>
<edge source="PDF_52_2013_Method_5558943803450188274" target="Gene_SLYD">
  <data key="d8">MENTIONS</data>
  <data key="d9">Genomic copies of arnA and slyD in the host strain BL21(DE3) were replaced with mutant versions to create LOBSTR using a modified recombineering approach.</data>
</edge>
<edge source="PDF_52_2013_Method_7459385719516688739" target="Protein_ARNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">Wild-type and mutant ArnA binding affinity was assessed by immobilizing purified protein onto a His-Trap FF column and eluting with a linear imidazole gradient.</data>
</edge>
<edge source="PDF_52_2013_Method_7459385719516688739" target="Compound_IMIDAZOLE">
  <data key="d8">MENTIONS</data>
  <data key="d9">Wild-type and mutant ArnA binding affinity was assessed by immobilizing purified protein onto a His-Trap FF column and eluting with a linear imidazole gradient.</data>
</edge>
<edge source="PDF_52_2013_Result_4997911498934269511" target="Protein_ARNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">Mutating four histidine residues to serines in ArnA lowers the Ni-affinity to a level comparable to non-specific binding.</data>
</edge>
<edge source="PDF_52_2013_Result_4997911498934269511" target="Compound_SERINE">
  <data key="d8">MENTIONS</data>
  <data key="d9">Mutating four histidine residues to serines in ArnA lowers the Ni-affinity to a level comparable to non-specific binding.</data>
</edge>
<edge source="PDF_52_2013_Result_4997911498934269511" target="Compound_HISTIDINE">
  <data key="d8">MENTIONS</data>
  <data key="d9">Mutating four histidine residues to serines in ArnA lowers the Ni-affinity to a level comparable to non-specific binding.</data>
</edge>
<edge source="PDF_52_2013_Result_7490315703337305613" target="Protein_SLYD">
  <data key="d8">MENTIONS</data>
  <data key="d9">Truncating SlyD at residue 150 maintains the structural integrity of the catalytic N-terminal domain while removing the entire unstructured tail.</data>
</edge>
<edge source="PDF_52_2013_Result_6878228180634941732" target="Protein_ARNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">In LOBSTR, the vast majority of contaminants ArnA and SlyD are eliminated, with the target protein now being the most prominent protein.</data>
</edge>
<edge source="PDF_52_2013_Result_6878228180634941732" target="Protein_SLYD">
  <data key="d8">MENTIONS</data>
  <data key="d9">In LOBSTR, the vast majority of contaminants ArnA and SlyD are eliminated, with the target protein now being the most prominent protein.</data>
</edge>
<edge source="PDF_52_2013_Conclusion_1635221794646452479" target="Protein_ARNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">LOBSTR enables the pursuit of poorly expressed protein targets in E. coli by lowering the background contamination of ArnA and SlyD.</data>
</edge>
<edge source="PDF_52_2013_Conclusion_1635221794646452479" target="Protein_SLYD">
  <data key="d8">MENTIONS</data>
  <data key="d9">LOBSTR enables the pursuit of poorly expressed protein targets in E. coli by lowering the background contamination of ArnA and SlyD.</data>
</edge>
<edge source="PDF_52_2013_Conclusion_8337539805626380235" target="Gene_ARNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">LOBSTR incorporates genomic modifications to arnA and slyD in order to reduce the affinity of their gene products for metal affinity resins, eliminating them from co-purification with recombinant proteins of interest.</data>
</edge>
<edge source="PDF_52_2013_Conclusion_8337539805626380235" target="Gene_SLYD">
  <data key="d8">MENTIONS</data>
  <data key="d9">LOBSTR incorporates genomic modifications to arnA and slyD in order to reduce the affinity of their gene products for metal affinity resins, eliminating them from co-purification with recombinant proteins of interest.</data>
</edge>
<edge source="PDF_07_2018_u" target="PDF_07_2018_u_Hypothesis_5873392826698736435">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_07_2018_u" target="PDF_07_2018_u_Method_-55218238772028976">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_701153642943013160">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_-4708202846778036675">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_-7433035212583584034">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_-2954653150365098046">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_6132546014739191182">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_8851558357898745440">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_1240758421043641278">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_-2916064496208044032">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_3607880444052199621">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_07_2018_u" target="PDF_07_2018_u_Conclusion_-7261463142285962439">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_07_2018_u" target="PDF_07_2018_u_Conclusion_-7051281338107796056">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_07_2018_u_Hypothesis_5873392826698736435" target="Protein_PNMA FAMILY">
  <data key="d8">MENTIONS</data>
  <data key="d9">PNMA family represents a novel set of proteins that are involved in regulation of cell growth, apoptosis, or cell fate determination in different cell types</data>
</edge>
<edge source="PDF_07_2018_u_Hypothesis_5873392826698736435" target="Process_APOPTOSIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">PNMA family represents a novel set of proteins that are involved in regulation of cell growth, apoptosis, or cell fate determination in different cell types</data>
</edge>
<edge source="PDF_07_2018_u_Method_-55218238772028976" target="Protein_PNMA">
  <data key="d8">MENTIONS</data>
  <data key="d9">Molecular diagnostic methodologies are often used to diagnose PND, including detection of auto- antibodies against PNMA proteins as well as identification of aberrantly expressed PNMA 1, 2 or 3 in the tumor tissues</data>
</edge>
<edge source="PDF_07_2018_u_Method_-55218238772028976" target="Protein_PNMA1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Molecular diagnostic methodologies are often used to diagnose PND, including detection of auto- antibodies against PNMA proteins as well as identification of aberrantly expressed PNMA 1, 2 or 3 in the tumor tissues</data>
</edge>
<edge source="PDF_07_2018_u_Method_-55218238772028976" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Molecular diagnostic methodologies are often used to diagnose PND, including detection of auto- antibodies against PNMA proteins as well as identification of aberrantly expressed PNMA 1, 2 or 3 in the tumor tissues</data>
</edge>
<edge source="PDF_07_2018_u_Method_-55218238772028976" target="Protein_PNMA3">
  <data key="d8">MENTIONS</data>
  <data key="d9">Molecular diagnostic methodologies are often used to diagnose PND, including detection of auto- antibodies against PNMA proteins as well as identification of aberrantly expressed PNMA 1, 2 or 3 in the tumor tissues</data>
</edge>
<edge source="PDF_07_2018_u_Result_701153642943013160" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1 was reported to mediate apoptotic signalling by interacting with Bax, a pro-apoptotic member of Bcl-2 family</data>
</edge>
<edge source="PDF_07_2018_u_Result_701153642943013160" target="Process_APOPTOSIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1 was reported to mediate apoptotic signalling by interacting with Bax, a pro-apoptotic member of Bcl-2 family</data>
</edge>
<edge source="PDF_07_2018_u_Result_701153642943013160" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1 was reported to mediate apoptotic signalling by interacting with Bax, a pro-apoptotic member of Bcl-2 family</data>
</edge>
<edge source="PDF_07_2018_u_Result_701153642943013160" target="Protein_BCL-2">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1 was reported to mediate apoptotic signalling by interacting with Bax, a pro-apoptotic member of Bcl-2 family</data>
</edge>
<edge source="PDF_07_2018_u_Result_-4708202846778036675" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1 was shown to interact with RASSF1A tumor suppressor through TNF receptor mediated signalling upon activation of the TNF receptor by TNF ligand</data>
</edge>
<edge source="PDF_07_2018_u_Result_-4708202846778036675" target="Protein_RASSF1A">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1 was shown to interact with RASSF1A tumor suppressor through TNF receptor mediated signalling upon activation of the TNF receptor by TNF ligand</data>
</edge>
<edge source="PDF_07_2018_u_Result_-4708202846778036675" target="Protein_TNF">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1 was shown to interact with RASSF1A tumor suppressor through TNF receptor mediated signalling upon activation of the TNF receptor by TNF ligand</data>
</edge>
<edge source="PDF_07_2018_u_Result_-7433035212583584034" target="Protein_PNMA7A">
  <data key="d8">MENTIONS</data>
  <data key="d9">PNMA7A was reported to function as transcriptional co-activator and participate in Bone Morphogenic Protein (BMP) signalling by interacting with Smad1 and CBP</data>
</edge>
<edge source="PDF_07_2018_u_Result_-7433035212583584034" target="Protein_SMAD1">
  <data key="d8">MENTIONS</data>
  <data key="d9">PNMA7A was reported to function as transcriptional co-activator and participate in Bone Morphogenic Protein (BMP) signalling by interacting with Smad1 and CBP</data>
</edge>
<edge source="PDF_07_2018_u_Result_-7433035212583584034" target="Protein_BMP">
  <data key="d8">MENTIONS</data>
  <data key="d9">PNMA7A was reported to function as transcriptional co-activator and participate in Bone Morphogenic Protein (BMP) signalling by interacting with Smad1 and CBP</data>
</edge>
<edge source="PDF_07_2018_u_Result_-2954653150365098046" target="Gene_CCDC8">
  <data key="d8">MENTIONS</data>
  <data key="d9">Mutations of CCDC8 gene were associated with post-natal growth restriction, one of the well described features of 3M-syndrome</data>
</edge>
<edge source="PDF_07_2018_u_Result_-2954653150365098046" target="Disease_3-M SYNDROME">
  <data key="d8">MENTIONS</data>
  <data key="d9">Mutations of CCDC8 gene were associated with post-natal growth restriction, one of the well described features of 3M-syndrome</data>
</edge>
<edge source="PDF_07_2018_u_Result_6132546014739191182" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1 interacts with poly-glutamic acid residues of RASSF1A</data>
</edge>
<edge source="PDF_07_2018_u_Result_6132546014739191182" target="Protein_RASSF1A">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1 interacts with poly-glutamic acid residues of RASSF1A</data>
</edge>
<edge source="PDF_07_2018_u_Result_8851558357898745440" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Interaction with PNMA2 leads to inhibition of pro-apoptotic function of MOAP-1. In contrast, interaction with PNMA5 enhances pro-apoptotic function of MOAP-1</data>
</edge>
<edge source="PDF_07_2018_u_Result_8851558357898745440" target="Process_APOPTOSIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">Interaction with PNMA2 leads to inhibition of pro-apoptotic function of MOAP-1. In contrast, interaction with PNMA5 enhances pro-apoptotic function of MOAP-1</data>
</edge>
<edge source="PDF_07_2018_u_Result_8851558357898745440" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Interaction with PNMA2 leads to inhibition of pro-apoptotic function of MOAP-1. In contrast, interaction with PNMA5 enhances pro-apoptotic function of MOAP-1</data>
</edge>
<edge source="PDF_07_2018_u_Result_8851558357898745440" target="Protein_PNMA5">
  <data key="d8">MENTIONS</data>
  <data key="d9">Interaction with PNMA2 leads to inhibition of pro-apoptotic function of MOAP-1. In contrast, interaction with PNMA5 enhances pro-apoptotic function of MOAP-1</data>
</edge>
<edge source="PDF_07_2018_u_Result_1240758421043641278" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Activation of MOAP-1 requires death stimuli, RASSF1A or RASSF6, in the presence of K-RAS to promote or enhance apoptotic signalling through change of MOAP-1 conformation, leading to exposure of MOAP-1 BH3-like domain, which interacts with the pro-apoptotic Bax, resulting in activation of apoptotic cell death</data>
</edge>
<edge source="PDF_07_2018_u_Result_1240758421043641278" target="Protein_RASSF1A">
  <data key="d8">MENTIONS</data>
  <data key="d9">Activation of MOAP-1 requires death stimuli, RASSF1A or RASSF6, in the presence of K-RAS to promote or enhance apoptotic signalling through change of MOAP-1 conformation, leading to exposure of MOAP-1 BH3-like domain, which interacts with the pro-apoptotic Bax, resulting in activation of apoptotic cell death</data>
</edge>
<edge source="PDF_07_2018_u_Result_1240758421043641278" target="Protein_RASSF6">
  <data key="d8">MENTIONS</data>
  <data key="d9">Activation of MOAP-1 requires death stimuli, RASSF1A or RASSF6, in the presence of K-RAS to promote or enhance apoptotic signalling through change of MOAP-1 conformation, leading to exposure of MOAP-1 BH3-like domain, which interacts with the pro-apoptotic Bax, resulting in activation of apoptotic cell death</data>
</edge>
<edge source="PDF_07_2018_u_Result_1240758421043641278" target="Protein_KRAS">
  <data key="d8">MENTIONS</data>
  <data key="d9">Activation of MOAP-1 requires death stimuli, RASSF1A or RASSF6, in the presence of K-RAS to promote or enhance apoptotic signalling through change of MOAP-1 conformation, leading to exposure of MOAP-1 BH3-like domain, which interacts with the pro-apoptotic Bax, resulting in activation of apoptotic cell death</data>
</edge>
<edge source="PDF_07_2018_u_Result_1240758421043641278" target="Process_APOPTOSIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">Activation of MOAP-1 requires death stimuli, RASSF1A or RASSF6, in the presence of K-RAS to promote or enhance apoptotic signalling through change of MOAP-1 conformation, leading to exposure of MOAP-1 BH3-like domain, which interacts with the pro-apoptotic Bax, resulting in activation of apoptotic cell death</data>
</edge>
<edge source="PDF_07_2018_u_Result_1240758421043641278" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">Activation of MOAP-1 requires death stimuli, RASSF1A or RASSF6, in the presence of K-RAS to promote or enhance apoptotic signalling through change of MOAP-1 conformation, leading to exposure of MOAP-1 BH3-like domain, which interacts with the pro-apoptotic Bax, resulting in activation of apoptotic cell death</data>
</edge>
<edge source="PDF_07_2018_u_Result_-2916064496208044032" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">PNMA2 antagonized the pro-apoptotic function of both MOAP-1 and PNMA1</data>
</edge>
<edge source="PDF_07_2018_u_Result_-2916064496208044032" target="Process_APOPTOSIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">PNMA2 antagonized the pro-apoptotic function of both MOAP-1 and PNMA1</data>
</edge>
<edge source="PDF_07_2018_u_Result_-2916064496208044032" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">PNMA2 antagonized the pro-apoptotic function of both MOAP-1 and PNMA1</data>
</edge>
<edge source="PDF_07_2018_u_Result_-2916064496208044032" target="Protein_PNMA1">
  <data key="d8">MENTIONS</data>
  <data key="d9">PNMA2 antagonized the pro-apoptotic function of both MOAP-1 and PNMA1</data>
</edge>
<edge source="PDF_07_2018_u_Result_3607880444052199621" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Trim39 ubiquitin ligase interacts with MOAP-1 and promotes stability of MOAP-1 by inhibiting the activity of APC/CCdh1-mediated ubiquitination and degradation</data>
</edge>
<edge source="PDF_07_2018_u_Conclusion_-7261463142285962439" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">PNMA2, an onconeuronal antigen, was reported to be aberrantly expressed in a number of tumors, and its over-expression is likely to be closely associated with tumorigenesis</data>
</edge>
<edge source="PDF_07_2018_u_Conclusion_-7261463142285962439" target="Disease_TUMOR">
  <data key="d8">MENTIONS</data>
  <data key="d9">PNMA2, an onconeuronal antigen, was reported to be aberrantly expressed in a number of tumors, and its over-expression is likely to be closely associated with tumorigenesis</data>
</edge>
<edge source="PDF_07_2018_u_Conclusion_-7051281338107796056" target="Protein_ZCCHC12">
  <data key="d8">MENTIONS</data>
  <data key="d9">ZCCHC12 was found over-expressed in papillary thyroid tumours and ZCCHC12 knocked downed thyroid cancer cell lines exhibited reduced number of colonies formed in the colony formation assay, providing further evidence to support that ZCCHC12 functioned as an oncogene in papillary thyroid cancer</data>
</edge>
<edge source="PDF_07_2018_u_Conclusion_-7051281338107796056" target="Disease_THYROID CANCER">
  <data key="d8">MENTIONS</data>
  <data key="d9">ZCCHC12 was found over-expressed in papillary thyroid tumours and ZCCHC12 knocked downed thyroid cancer cell lines exhibited reduced number of colonies formed in the colony formation assay, providing further evidence to support that ZCCHC12 functioned as an oncogene in papillary thyroid cancer</data>
</edge>
<edge source="PDF_48_2024" target="PDF_48_2024_Hypothesis_-8097966962975211921">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_48_2024" target="PDF_48_2024_Method_-4408217750595003763">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_48_2024" target="PDF_48_2024_Method_487949912162685570">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_48_2024" target="PDF_48_2024_Method_5001480191516639294">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_48_2024" target="PDF_48_2024_Result_3930217898354713551">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_48_2024" target="PDF_48_2024_Result_-4142428845467348943">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_48_2024" target="PDF_48_2024_Result_4035520068157967964">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_48_2024" target="PDF_48_2024_Result_4470377117851099983">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_48_2024" target="PDF_48_2024_Result_5994432042651290295">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_48_2024" target="PDF_48_2024_Result_-8892711395869718090">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_48_2024" target="PDF_48_2024_Conclusion_-3066554939127887280">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_48_2024" target="PDF_48_2024_Conclusion_2419552112454791478">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_48_2024_Hypothesis_-8097966962975211921" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">orchestrating PNMA2 disassembly and reassembly around RNA might facilitate RNA packaging</data>
</edge>
<edge source="PDF_48_2024_Hypothesis_-8097966962975211921" target="Compound_RNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">orchestrating PNMA2 disassembly and reassembly around RNA might facilitate RNA packaging</data>
</edge>
<edge source="PDF_48_2024_Method_-4408217750595003763" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">We used cryoelectron microscopy (cryo-EM) to resolve the structure of recombinant human PNMA2 expressed in E. coli at 3.1 Å resolution</data>
</edge>
<edge source="PDF_48_2024_Method_487949912162685570" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">structure-guided engineering to modify the PNMA2 protein capsid to package mRNA</data>
</edge>
<edge source="PDF_48_2024_Method_487949912162685570" target="Compound_MRNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">structure-guided engineering to modify the PNMA2 protein capsid to package mRNA</data>
</edge>
<edge source="PDF_48_2024_Method_5001480191516639294" target="Compound_RNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">replacing the C-terminal disordered region with an RNA-binding motif, cowpea chlorotic mottle virus N-terminal 30 residues (CCMV1-30)</data>
</edge>
<edge source="PDF_48_2024_Result_3930217898354713551" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">PNMA2 forms icosahedral capsids efficiently but does not naturally encapsidate nucleic acids</data>
</edge>
<edge source="PDF_48_2024_Result_-4142428845467348943" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">PNMA2 is robustly secreted as an icosahedral capsid from human cells and can self-assemble in vitro from recombinant protein.</data>
</edge>
<edge source="PDF_48_2024_Result_4035520068157967964" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">self-assembled PNMA2 did not protect Cre mRNA from nuclease degradation</data>
</edge>
<edge source="PDF_48_2024_Result_4035520068157967964" target="Compound_CRE MRNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">self-assembled PNMA2 did not protect Cre mRNA from nuclease degradation</data>
</edge>
<edge source="PDF_48_2024_Result_5994432042651290295" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">ePNMA2 exhibited more efficient recombinant protein expression and capsid assembly</data>
</edge>
<edge source="PDF_48_2024_Result_-8892711395869718090" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">LAH4 treatment of ePNMA2 before addition to cells increased the cytosolic localization of ePNMA2</data>
</edge>
<edge source="PDF_48_2024_Conclusion_-3066554939127887280" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">engineered PNMA2 capsids can functionally deliver mRNA into recipient cells, demonstrating promise as a therapeutic mRNA delivery vehicle</data>
</edge>
<edge source="PDF_48_2024_Conclusion_-3066554939127887280" target="Compound_MRNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">engineered PNMA2 capsids can functionally deliver mRNA into recipient cells, demonstrating promise as a therapeutic mRNA delivery vehicle</data>
</edge>
<edge source="PDF_48_2024_Conclusion_2419552112454791478" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">our work with PNMA2 may be extended to other PNMA family members, some of which also form capsids</data>
</edge>
<edge source="PDF_32_2020" target="PDF_32_2020_Result_-5138253738568548245">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_32_2020" target="PDF_32_2020_Result_-3995889984062233605">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_32_2020" target="PDF_32_2020_Method_6719759838008404595">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_32_2020" target="PDF_32_2020_Result_601226181796264073">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_32_2020" target="PDF_32_2020_Result_-5033775488700588586">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_32_2020" target="PDF_32_2020_Result_-3744215661890310000">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_32_2020" target="PDF_32_2020_Result_-4672051410336722934">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_32_2020" target="PDF_32_2020_Result_4351999353499056023">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_32_2020" target="PDF_32_2020_Result_7342408560306002389">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_32_2020" target="PDF_32_2020_Result_4915610234547273028">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_32_2020" target="PDF_32_2020_Result_1439348016575724462">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_32_2020" target="PDF_32_2020_Result_-4765660050882933824">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_32_2020" target="PDF_32_2020_Result_-5527902416486625596">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_32_2020_Result_601226181796264073" target="Gene_LIN28B">
  <data key="d8">MENTIONS</data>
  <data key="d9">The most significantly associated variant (rs11156429,GWAS-P = 3.5 × 10-52) was located in/near LIN28B</data>
</edge>
<edge source="PDF_32_2020_Result_4915610234547273028" target="Gene_KDM4C">
  <data key="d8">MENTIONS</data>
  <data key="d9">Two of the 76 lead variants associated with male pubertal timing were non-synonymous: a previously reported AAM signal in KDM4C (rs913588), encoding a lysine-specific demethylase, and a male-specific signal in ALX4 (rs3824915), encoding a homeobox gene involved in fibroblast growth factor (FGF) signalling that is mutated in rare disorders of cranium/central neural system (CNS) development with male-specific hypogonadism</data>
</edge>
<edge source="PDF_32_2020_Result_4915610234547273028" target="Gene_ALX4">
  <data key="d8">MENTIONS</data>
  <data key="d9">Two of the 76 lead variants associated with male pubertal timing were non-synonymous: a previously reported AAM signal in KDM4C (rs913588), encoding a lysine-specific demethylase, and a male-specific signal in ALX4 (rs3824915), encoding a homeobox gene involved in fibroblast growth factor (FGF) signalling that is mutated in rare disorders of cranium/central neural system (CNS) development with male-specific hypogonadism</data>
</edge>
<edge source="PDF_32_2020_Result_4915610234547273028" target="Protein_FIBROBLAST GROWTH FACTOR">
  <data key="d8">MENTIONS</data>
  <data key="d9">Two of the 76 lead variants associated with male pubertal timing were non-synonymous: a previously reported AAM signal in KDM4C (rs913588), encoding a lysine-specific demethylase, and a male-specific signal in ALX4 (rs3824915), encoding a homeobox gene involved in fibroblast growth factor (FGF) signalling that is mutated in rare disorders of cranium/central neural system (CNS) development with male-specific hypogonadism</data>
</edge>
<edge source="PDF_32_2020_Result_4915610234547273028" target="Disease_HYPOGONADISM">
  <data key="d8">MENTIONS</data>
  <data key="d9">Two of the 76 lead variants associated with male pubertal timing were non-synonymous: a previously reported AAM signal in KDM4C (rs913588), encoding a lysine-specific demethylase, and a male-specific signal in ALX4 (rs3824915), encoding a homeobox gene involved in fibroblast growth factor (FGF) signalling that is mutated in rare disorders of cranium/central neural system (CNS) development with male-specific hypogonadism</data>
</edge>
<edge source="PDF_43_2015" target="PDF_43_2015_Result_-8665501615026760998">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_43_2015" target="PDF_43_2015_Result_167825607920829172">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_43_2015" target="PDF_43_2015_Result_2705350459434224624">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_43_2015" target="PDF_43_2015_Result_-3029878178375161098">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_43_2015" target="PDF_43_2015_Result_1380003361575204495">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_43_2015" target="PDF_43_2015_Result_-3818900363804058031">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_43_2015" target="PDF_43_2015_Result_-1883080806691592796">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_43_2015" target="PDF_43_2015_Result_-7775875949945022870">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_43_2015" target="PDF_43_2015_Result_-8881202664970378798">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_43_2015" target="PDF_43_2015_Result_-6987735620508999491">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_43_2015" target="PDF_43_2015_Result_7681704928127343375">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_43_2015" target="PDF_43_2015_Conclusion_-8844063316195757453">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_43_2015_Result_-8665501615026760998" target="Protein_RIM4">
  <data key="d8">MENTIONS</data>
  <data key="d9">Rim4 forms amyloid-like aggregates and that it is the amyloid-like form of Rim4 that is the active, translationally repressive form of the protein.</data>
</edge>
<edge source="PDF_43_2015_Result_167825607920829172" target="Protein_RIM4">
  <data key="d8">MENTIONS</data>
  <data key="d9">Rim4 aggregation is a developmentally regulated process.</data>
</edge>
<edge source="PDF_43_2015_Result_2705350459434224624" target="Protein_RIM4">
  <data key="d8">MENTIONS</data>
  <data key="d9">Starvation induces the conversion of monomeric Rim4 into amyloid-like aggregates, thereby activating the protein to bring about repression of translation.</data>
</edge>
<edge source="PDF_43_2015_Result_-3029878178375161098" target="Protein_RIM4">
  <data key="d8">MENTIONS</data>
  <data key="d9">At the onset of meiosis II, Rim4 aggregates are abruptly degraded allowing translation to commence.</data>
</edge>
<edge source="PDF_43_2015_Result_1380003361575204495" target="Protein_RIM4">
  <data key="d8">MENTIONS</data>
  <data key="d9">Rim4, like prions and other proteins with amyloid-like properties, binds to b-isox and does so during the stages of meiosis when the protein actively inhibits CLB3 translation.</data>
</edge>
<edge source="PDF_43_2015_Result_1380003361575204495" target="Gene_CLB3">
  <data key="d8">MENTIONS</data>
  <data key="d9">Rim4, like prions and other proteins with amyloid-like properties, binds to b-isox and does so during the stages of meiosis when the protein actively inhibits CLB3 translation.</data>
</edge>
<edge source="PDF_43_2015_Result_-3818900363804058031" target="Protein_RIM4">
  <data key="d8">MENTIONS</data>
  <data key="d9">Rim4 forms fibrillar helical structures with a fixed width of ~15 nm and length up to 15 µm</data>
</edge>
<edge source="PDF_43_2015_Result_-7775875949945022870" target="Protein_RIM4">
  <data key="d8">MENTIONS</data>
  <data key="d9">Rim4 fibers are composed of β sheets, a hallmark of amyloid.</data>
</edge>
<edge source="PDF_43_2015_Result_-8881202664970378798" target="Protein_RIM4">
  <data key="d8">MENTIONS</data>
  <data key="d9">Rim4 structures within the cell are largely static.</data>
</edge>
<edge source="PDF_43_2015_Result_-6987735620508999491" target="Protein_RIM4">
  <data key="d8">MENTIONS</data>
  <data key="d9">The localization pattern of Rim4 is also consistent with the protein forming aggregates in cells during stages of meiosis when the protein inhibits translation.</data>
</edge>
<edge source="PDF_43_2015_Result_7681704928127343375" target="Protein_RIM4">
  <data key="d8">MENTIONS</data>
  <data key="d9">C-terminal 204 amino acids are important for Rim4 aggregation in vivo and contain elements necessary for proper Rim4 clearance at the onset of meiosis II.</data>
</edge>
<edge source="PDF_14_2024" target="PDF_14_2024_Result_-3109408136348264968">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_14_2024" target="PDF_14_2024_Result_-6305622922967172267">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_14_2024" target="PDF_14_2024_Result_8951654089548728117">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_14_2024" target="PDF_14_2024_Result_-3788353734610438696">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_14_2024" target="PDF_14_2024_Result_3270171566214665174">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_14_2024" target="PDF_14_2024_Result_-3950855886175765830">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_14_2024" target="PDF_14_2024_Result_1727081612218890504">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_14_2024" target="PDF_14_2024_Result_-1903928770928789546">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_14_2024" target="PDF_14_2024_Result_-6880153114975964996">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_14_2024" target="PDF_14_2024_Result_8245876933059396761">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_14_2024" target="PDF_14_2024_Result_6329313869831559455">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_14_2024" target="PDF_14_2024_Result_-1965139603633213800">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_14_2024" target="PDF_14_2024_Result_8553078647428444333">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_14_2024" target="PDF_14_2024_Result_-3635699810532714596">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_14_2024" target="PDF_14_2024_Conclusion_23683077128086401">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_14_2024_Result_-3109408136348264968" target="Protein_MTOR">
  <data key="d8">MENTIONS</data>
  <data key="d9">Our analyses reveal coordinated changes in transcriptomes and chromatin accessibilities across cell types in the ovary during aging, notably mTOR signaling being a prominent ovary-specific aging pathway.</data>
</edge>
<edge source="PDF_14_2024_Result_-6305622922967172267" target="Gene_CEBPD">
  <data key="d8">MENTIONS</data>
  <data key="d9">Cell-type-specific regulatory networks reveal enhanced activity of the transcription factor CEBPD across cell types in the aged ovary.</data>
</edge>
<edge source="PDF_14_2024_Result_-1903928770928789546" target="Gene_RICTOR">
  <data key="d8">MENTIONS</data>
  <data key="d9">Common DEGs include known aging-related genes such as RICTOR, IGF1R, MAP3K5 and APOE</data>
</edge>
<edge source="PDF_14_2024_Result_-1903928770928789546" target="Gene_IGF1R">
  <data key="d8">MENTIONS</data>
  <data key="d9">Common DEGs include known aging-related genes such as RICTOR, IGF1R, MAP3K5 and APOE</data>
</edge>
<edge source="PDF_14_2024_Result_-1903928770928789546" target="Gene_MAP3K5">
  <data key="d8">MENTIONS</data>
  <data key="d9">Common DEGs include known aging-related genes such as RICTOR, IGF1R, MAP3K5 and APOE</data>
</edge>
<edge source="PDF_14_2024_Result_-1903928770928789546" target="Gene_APOE">
  <data key="d8">MENTIONS</data>
  <data key="d9">Common DEGs include known aging-related genes such as RICTOR, IGF1R, MAP3K5 and APOE</data>
</edge>
<edge source="PDF_14_2024_Result_-6880153114975964996" target="Protein_MTOR">
  <data key="d8">MENTIONS</data>
  <data key="d9">Gene expression in histone modification, cellular senescence and nutrient-sensing signaling pathways, including mTOR and insulin pathways, increased in aged ovaries across cell types</data>
</edge>
<edge source="PDF_14_2024_Result_6329313869831559455" target="Protein_MTOR">
  <data key="d8">MENTIONS</data>
  <data key="d9">We validated these age-related changes using in situ hybridization assays, confirming increased expression of the mTOR signaling gene RICTOR and decreased expression of the oxidative phosphorylation gene MT-ATP6 in aged ovaries</data>
</edge>
<edge source="PDF_14_2024_Result_6329313869831559455" target="Gene_RICTOR">
  <data key="d8">MENTIONS</data>
  <data key="d9">We validated these age-related changes using in situ hybridization assays, confirming increased expression of the mTOR signaling gene RICTOR and decreased expression of the oxidative phosphorylation gene MT-ATP6 in aged ovaries</data>
</edge>
<edge source="PDF_14_2024_Result_6329313869831559455" target="Gene_MT-ATP6">
  <data key="d8">MENTIONS</data>
  <data key="d9">We validated these age-related changes using in situ hybridization assays, confirming increased expression of the mTOR signaling gene RICTOR and decreased expression of the oxidative phosphorylation gene MT-ATP6 in aged ovaries</data>
</edge>
<edge source="PDF_14_2024_Result_-1965139603633213800" target="Protein_MTOR">
  <data key="d8">MENTIONS</data>
  <data key="d9">mTOR signaling emerged as an ovary-specific aging-prevalent pathway</data>
</edge>
<edge source="PDF_14_2024_Result_-3635699810532714596" target="Gene_CDKN1A">
  <data key="d8">MENTIONS</data>
  <data key="d9">We found significant increases in CDKN1A+ cells with age in several cell types</data>
</edge>
<edge source="PDF_14_2024_Conclusion_23683077128086401" target="Protein_MTOR">
  <data key="d8">MENTIONS</data>
  <data key="d9">our comprehensive analysis reveals the distinct and accelerated nature of ovarian aging, characterized by high transcriptomic coordination and distinct pathway activity changes. Notably, we identify mTOR signaling as a unique factor in ovarian aging, offering potential insights into sex-specific longevity responses.</data>
</edge>
<edge source="PDF_24_2019" target="PDF_24_2019_Hypothesis_-3453584697838837682">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_24_2019" target="PDF_24_2019_Method_7351416614653181741">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_24_2019" target="PDF_24_2019_Method_2739485742662363291">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_24_2019" target="PDF_24_2019_Method_-6925621107195890312">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_24_2019" target="PDF_24_2019_Result_-643056528189324795">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_24_2019" target="PDF_24_2019_Result_-4659394613518505422">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_24_2019" target="PDF_24_2019_Result_-6546740736136143929">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_24_2019" target="PDF_24_2019_Result_-987783024772160422">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_24_2019" target="PDF_24_2019_Result_-1686070901914360345">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_24_2019" target="PDF_24_2019_Result_2884434579122930344">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_24_2019" target="PDF_24_2019_Result_-9132036320385733918">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_24_2019" target="PDF_24_2019_Conclusion_-5480258274516350032">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_24_2019_Result_-4659394613518505422" target="Disease_HIV-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Tertiary and quaternary arrangement of the capsid (CA) C-terminal domain within the assembled capsid is conserved with mature HIV-1.</data>
</edge>
<edge source="PDF_24_2019_Result_-987783024772160422" target="Disease_HIV-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Ty3 capsid structure shows striking similarity to mature HIV-1 capsids.</data>
</edge>
<edge source="PDF_22_2021" target="PDF_22_2021_Hypothesis_-1403530705624508273">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_22_2021" target="PDF_22_2021_Method_7612153954739874289">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_22_2021" target="PDF_22_2021_Method_-3540572276885414593">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_22_2021" target="PDF_22_2021_Method_-4719631070988160495">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_22_2021" target="PDF_22_2021_Method_4081601807065825882">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_22_2021" target="PDF_22_2021_Result_5590334583102740542">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_22_2021" target="PDF_22_2021_Result_-982050469218463871">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_22_2021" target="PDF_22_2021_Result_8226100373075108923">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_22_2021" target="PDF_22_2021_Method_1979361156444858157">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_22_2021" target="PDF_22_2021_Result_8631218194293664135">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_22_2021" target="PDF_22_2021_Result_5557861515758995316">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_22_2021" target="PDF_22_2021_Result_-6573448921126278675">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_22_2021" target="PDF_22_2021_Result_-6942168829170947879">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_22_2021" target="PDF_22_2021_Method_992049933037111916">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_22_2021" target="PDF_22_2021_Result_2612807020811944606">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_22_2021" target="PDF_22_2021_Result_1284482544037727418">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_22_2021" target="PDF_22_2021_Result_4018866932238782064">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_22_2021" target="PDF_22_2021_Result_-7744660373325422857">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_22_2021" target="PDF_22_2021_Conclusion_-3093210777716935094">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_22_2021" target="PDF_22_2021_Conclusion_-5636708818920378132">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_22_2021" target="PDF_22_2021_Conclusion_6281965894368531425">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_22_2021_Method_7612153954739874289" target="Gene_GAG">
  <data key="d8">MENTIONS</data>
  <data key="d9">We searched the human and mouse genomes for gag homologs to identify genes with the potential to transfer specific nucleic acids.</data>
</edge>
<edge source="PDF_22_2021_Method_-3540572276885414593" target="Protein_CA">
  <data key="d8">MENTIONS</data>
  <data key="d9">We produced mouse versions of the selected CA-containing proteins in E. coli and found that a number of these formed higher molecular weight oligomers identified by size exclusion.</data>
</edge>
<edge source="PDF_22_2021_Method_-4719631070988160495" target="Gene_CA">
  <data key="d8">MENTIONS</data>
  <data key="d9">We overexpressed an epitope tagged mouse ortholog of each CA-containing gene in HEK293FT cells and harvested both the whole cell lysate and the virus-like particle (VLP) fraction by clarification and ultracentrifugation of the culture media.</data>
</edge>
<edge source="PDF_22_2021_Method_4081601807065825882" target="Process_CRISPR">
  <data key="d8">MENTIONS</data>
  <data key="d9">We used CRISPR activation to induce expression of endogenous genes in mouse N2a cells.</data>
</edge>
<edge source="PDF_22_2021_Result_5590334583102740542" target="Gene_MMPEG10">
  <data key="d8">MENTIONS</data>
  <data key="d9">MmPeg10 transcriptional activation led to accumulation of significant amounts of full length MmPeg10 mRNA transcripts in the VLP fraction.</data>
</edge>
<edge source="PDF_22_2021_Result_-982050469218463871" target="Protein_MMPEG10">
  <data key="d8">MENTIONS</data>
  <data key="d9">MmPEG10 binds and secretes its own mRNA into the VLP fraction.</data>
</edge>
<edge source="PDF_22_2021_Result_8226100373075108923" target="Protein_MMPEG10">
  <data key="d8">MENTIONS</data>
  <data key="d9">mRNA export depends on the MmPEG10 NC, as loss of the nucleic acid-binding zinc finger CCHC motif (residues 416-429) from the MmPEG10 NC substantially reduced export of its mRNA.</data>
</edge>
<edge source="PDF_22_2021_Method_1979361156444858157" target="Gene_MMPEG10">
  <data key="d8">MENTIONS</data>
  <data key="d9">We performed eCLIP in N2a cells after transient transfection with HA-tagged MmPeg10 as well as the NC and RT mutants.</data>
</edge>
<edge source="PDF_22_2021_Result_8631218194293664135" target="Protein_MMPEG10">
  <data key="d8">MENTIONS</data>
  <data key="d9">Compared to the control, MmPEG10 strongly bound a number of mRNAs in N2a cells including its own mRNA.</data>
</edge>
<edge source="PDF_22_2021_Result_5557861515758995316" target="Protein_MMPEG10">
  <data key="d8">MENTIONS</data>
  <data key="d9">Both the NC and the RT domains are required for the binding of these mRNAs by MmPEG10.</data>
</edge>
<edge source="PDF_22_2021_Result_-6573448921126278675" target="Protein_MMPEG10">
  <data key="d8">MENTIONS</data>
  <data key="d9">Endogenous MmPEG10 was also found to bind its own mRNA as well as other transcripts abundant in neurons.</data>
</edge>
<edge source="PDF_22_2021_Result_-6942168829170947879" target="Gene_MMPEG10">
  <data key="d8">MENTIONS</data>
  <data key="d9">The mRNAs of 49 genes downregulated in the brain upon MmPeg10 knockout are bound to MmPEG10 in the age-matched mouse brain, suggesting that one of the functions of MmPEG10 is to bind and stabilize mRNAs with fundamental roles in neurodevelopment.</data>
</edge>
<edge source="PDF_22_2021_Method_992049933037111916" target="Gene_MMPEG10">
  <data key="d8">MENTIONS</data>
  <data key="d9">We tested whether a cargo mRNA consisting of both the 5' and 3' UTR of MmPeg10 flanking a gene of interest would be efficiently packaged, exported, delivered, and translated in recipient cells.</data>
</edge>
<edge source="PDF_22_2021_Result_2612807020811944606" target="Gene_MMPEG10">
  <data key="d8">MENTIONS</data>
  <data key="d9">Addition of the Peg10UTRs enables functional intercellular transfer of an mRNA via VLPs and that these VLPs require a fusogenic protein for cell entry.</data>
</edge>
<edge source="PDF_22_2021_Result_1284482544037727418" target="Protein_MMPEG10">
  <data key="d8">MENTIONS</data>
  <data key="d9">VLPs produced with rMmPEG10 can mediate the functional transfer of H2B-mCherry.</data>
</edge>
<edge source="PDF_22_2021_Result_4018866932238782064" target="Gene_MMPEG10">
  <data key="d8">MENTIONS</data>
  <data key="d9">Functional transfer of MmSYNA pseudotyped VLPs carrying the native PEG10 transcript into primary mouse cortical neurons led to upregulation of a number of genes involved in neurodevelopment.</data>
</edge>
<edge source="PDF_22_2021_Result_-7744660373325422857" target="Protein_CAS9">
  <data key="d8">MENTIONS</data>
  <data key="d9">SEND was able to functionally transfer SpCas9, leading to ~60% indels in recipient cells.</data>
</edge>
<edge source="PDF_22_2021_Conclusion_-3093210777716935094" target="Protein_MMPEG10">
  <data key="d8">MENTIONS</data>
  <data key="d9">The LTR retrotransposon-derived Gag protein PEG10 can be harnessed to facilitate efficient and specific intercellular delivery of cargo mRNAs in mammalian cells.</data>
</edge>
<edge source="PDF_05_2024" target="PDF_05_2024_Hypothesis_-2296086537642480149">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_05_2024" target="PDF_05_2024_Method_-2522657615328900174">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_05_2024" target="PDF_05_2024_Method_-7317802560765773811">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_05_2024" target="PDF_05_2024_Method_8362744418732544509">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_05_2024" target="PDF_05_2024_Method_1840764957691302589">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_05_2024" target="PDF_05_2024_Result_-8901077775128653536">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_05_2024" target="PDF_05_2024_Result_-3731195017758500881">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_05_2024" target="PDF_05_2024_Result_8824557692865093567">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_05_2024" target="PDF_05_2024_Result_-8333638060710176268">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_05_2024" target="PDF_05_2024_Result_-8427620530971476832">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_05_2024" target="PDF_05_2024_Result_5383194152894092445">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_05_2024" target="PDF_05_2024_Result_-4847983466372511851">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_05_2024" target="PDF_05_2024_Result_-554567313794346505">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_05_2024" target="PDF_05_2024_Conclusion_-2995618956841361330">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_05_2024" target="PDF_05_2024_Conclusion_-5079616839098826086">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_05_2024_Method_-2522657615328900174" target="Gene_METAVIRIDAE">
  <data key="d8">MENTIONS</data>
  <data key="d9">Using a complete human genome assembly and 25 additional vertebrate genomes, we re-analyzed the evolutionary trajectories and functional potential of capsid (CA) genes domesticated from Metaviridae, a lineage of retrovirus-like retrotransposons.</data>
</edge>
<edge source="PDF_05_2024_Method_-7317802560765773811" target="Protein_CA">
  <data key="d8">MENTIONS</data>
  <data key="d9">We built Hidden Markov Models (HMMs) guided by atomic structures and AlphaFold predictions of retroviral and retrotransposon CA domains.</data>
</edge>
<edge source="PDF_05_2024_Result_-8901077775128653536" target="Gene_METAVIRIDAE">
  <data key="d8">MENTIONS</data>
  <data key="d9">We find that at least five independent domestication events occurred from diverse Metaviridae, giving rise to three universally retained single-copy genes evolving under purifying selection and two gene families unique to placental mammals, with multiple members showing evidence of rapid evolution.</data>
</edge>
<edge source="PDF_05_2024_Result_-3731195017758500881" target="Gene_PNMA">
  <data key="d8">MENTIONS</data>
  <data key="d9">Our analyses also reveal that most members of the PNMA family in mammalian genomes encode a conserved putative amino-terminal RNA-binding domain (RBD) both adjoining and independent from domesticated CA domains.</data>
</edge>
<edge source="PDF_05_2024_Result_-3731195017758500881" target="Protein_CA">
  <data key="d8">MENTIONS</data>
  <data key="d9">Our analyses also reveal that most members of the PNMA family in mammalian genomes encode a conserved putative amino-terminal RNA-binding domain (RBD) both adjoining and independent from domesticated CA domains.</data>
</edge>
<edge source="PDF_05_2024_Result_8824557692865093567" target="Gene_METAVIRIDAE">
  <data key="d8">MENTIONS</data>
  <data key="d9">We show that this putative RBD is also present in several extant Metaviridae, revealing a novel protein domain configuration in retrotransposons.</data>
</edge>
<edge source="PDF_05_2024_Result_-8333638060710176268" target="Protein_CA">
  <data key="d8">MENTIONS</data>
  <data key="d9">Our survey found 24 of the 85 previously identified metaviral-derived CA genes.</data>
</edge>
<edge source="PDF_05_2024_Conclusion_-2995618956841361330" target="Gene_METAVIRIDAE">
  <data key="d8">MENTIONS</data>
  <data key="d9">Collectively, our study reveals the divergent outcomes of multiple domestication events from diverse Metaviridae in the common ancestor of placental mammals.</data>
</edge>
<edge source="PDF_05_2024_Conclusion_-5079616839098826086" target="Gene_METAVIRIDAE">
  <data key="d8">MENTIONS</data>
  <data key="d9">Our study reveals that recurrent domestication of the gag domain from structurally diverse Metaviridae gave rise to genes with distinct evolutionary trajectories and structural features in placental mammals.</data>
</edge>
<edge source="PDF_54_2017" target="PDF_54_2017_Method_-8356199968091872640">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_54_2017" target="PDF_54_2017_Method_4772072621524684472">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_54_2017" target="PDF_54_2017_Result_-779300938965813719">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_54_2017" target="PDF_54_2017_Result_7792002420144685221">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_54_2017" target="PDF_54_2017_Result_6754054441199103548">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_54_2017" target="PDF_54_2017_Result_-3164133737264590558">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_54_2017" target="PDF_54_2017_Result_6818367579615438878">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_54_2017" target="PDF_54_2017_Result_-4974036200211890152">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_54_2017_Result_7792002420144685221" target="Protein_V/A-ATPASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">algorithm was able to discern three different conformational states for the enzyme, again from random initializations</data>
</edge>
<edge source="PDF_54_2017_Result_6818367579615438878" target="Protein_80S RIBOSOME">
  <data key="d8">MENTIONS</data>
  <data key="d9">application of the branch and bound method allowed high-resolution refinement of the 80S ribosome to 3.2 Å resolution, equivalent to the published resolution29, in 2.2 hours</data>
</edge>
<edge source="PDF_54_2017_Result_-4974036200211890152" target="Protein_20S PROTEASOME">
  <data key="d8">MENTIONS</data>
  <data key="d9">the 20S proteasome structure was refined to 2.8 Å with D7 symmetry enforced, matching the published sub-3 Å resolution from the dataset 28 (Figure 4B) but in only 70 minutes</data>
</edge>
<edge source="PDF_15_2018" target="PDF_15_2018_Hypothesis_5708965719031571952">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_15_2018" target="PDF_15_2018_Method_-1051758273803831627">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_15_2018" target="PDF_15_2018_Method_8549025233701299368">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_15_2018" target="PDF_15_2018_Method_7827999128385876098">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_15_2018" target="PDF_15_2018_Result_7162504357443096750">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_15_2018" target="PDF_15_2018_Result_-7119612070048112175">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_15_2018" target="PDF_15_2018_Result_-4495429513995912526">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_15_2018" target="PDF_15_2018_Result_5519043289604290788">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_15_2018" target="PDF_15_2018_Result_7208538871817750868">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_15_2018" target="PDF_15_2018_Result_8650488130552305924">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_15_2018" target="PDF_15_2018_Conclusion_7771580740347926323">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_15_2018" target="PDF_15_2018_Conclusion_3265488575977149899">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_15_2018_Hypothesis_5708965719031571952" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">DAZL regulates germ cell survival through a network of polyA-proximal mRNA interactions.</data>
</edge>
<edge source="PDF_15_2018_Hypothesis_5708965719031571952" target="Gene_MRNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">DAZL regulates germ cell survival through a network of polyA-proximal mRNA interactions.</data>
</edge>
<edge source="PDF_15_2018_Method_-1051758273803831627" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">High-throughput sequencing after in vivo cross-linking and immunoprecipitation (HITS-CLIP) libraries were generated from DAZL-RNA complexes purified from UV cross-linked adult mouse testes and sequenced using the Illumina platform.</data>
</edge>
<edge source="PDF_15_2018_Method_-1051758273803831627" target="Gene_RNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">High-throughput sequencing after in vivo cross-linking and immunoprecipitation (HITS-CLIP) libraries were generated from DAZL-RNA complexes purified from UV cross-linked adult mouse testes and sequenced using the Illumina platform.</data>
</edge>
<edge source="PDF_15_2018_Method_8549025233701299368" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">Fluorescence-activated cell sorting (FACS) was used to isolate germ cells from Dazl KO testes and WT controls.</data>
</edge>
<edge source="PDF_15_2018_Method_7827999128385876098" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">RNA-sequencing (RNA-seq) was used to identify mRNAs that are sensitive to DAZL deletion.</data>
</edge>
<edge source="PDF_15_2018_Method_7827999128385876098" target="Gene_MRNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">RNA-sequencing (RNA-seq) was used to identify mRNAs that are sensitive to DAZL deletion.</data>
</edge>
<edge source="PDF_15_2018_Result_7162504357443096750" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">DAZL directly and reproducibly binds distinct sites in &gt;3,900 transcripts in adult testis.</data>
</edge>
<edge source="PDF_15_2018_Result_-7119612070048112175" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">DAZL predominantly binds GUU-rich sequences in vivo.</data>
</edge>
<edge source="PDF_15_2018_Result_-4495429513995912526" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">DAZL preferentially binds GUU sites in close proximity to polyA sequences.</data>
</edge>
<edge source="PDF_15_2018_Result_5519043289604290788" target="Gene_RNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">1,462 transcripts had reduced RNA levels and 1,584 increased in Dazl KO cells</data>
</edge>
<edge source="PDF_15_2018_Result_5519043289604290788" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">1,462 transcripts had reduced RNA levels and 1,584 increased in Dazl KO cells</data>
</edge>
<edge source="PDF_15_2018_Result_7208538871817750868" target="Gene_DDX4">
  <data key="d8">MENTIONS</data>
  <data key="d9">DDX4 and SYCP3 were among the genes with reduced RNA in Dazl KO cells.</data>
</edge>
<edge source="PDF_15_2018_Result_7208538871817750868" target="Gene_SYCP3">
  <data key="d8">MENTIONS</data>
  <data key="d9">DDX4 and SYCP3 were among the genes with reduced RNA in Dazl KO cells.</data>
</edge>
<edge source="PDF_15_2018_Result_7208538871817750868" target="Gene_RNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">DDX4 and SYCP3 were among the genes with reduced RNA in Dazl KO cells.</data>
</edge>
<edge source="PDF_15_2018_Result_7208538871817750868" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">DDX4 and SYCP3 were among the genes with reduced RNA in Dazl KO cells.</data>
</edge>
<edge source="PDF_15_2018_Result_8650488130552305924" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">84% of P6 DAZL BR3 sites (5,400/6,465) mapped to 3' UTRs of 2,290 genes, indicating that DAZL also directly binds to a vast network of RNAs in spermatogonia via 3' UTR interactions.</data>
</edge>
<edge source="PDF_15_2018_Result_8650488130552305924" target="Gene_RNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">84% of P6 DAZL BR3 sites (5,400/6,465) mapped to 3' UTRs of 2,290 genes, indicating that DAZL also directly binds to a vast network of RNAs in spermatogonia via 3' UTR interactions.</data>
</edge>
<edge source="PDF_15_2018_Conclusion_7771580740347926323" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">DAZL functions as a master regulator of a post-transcriptional mRNA program essential for germ cell survival.</data>
</edge>
<edge source="PDF_15_2018_Conclusion_7771580740347926323" target="Gene_MRNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">DAZL functions as a master regulator of a post-transcriptional mRNA program essential for germ cell survival.</data>
</edge>
<edge source="PDF_15_2018_Conclusion_3265488575977149899" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">Dazl primarily functions as a positive post-transcriptional regulator of gene expression through polyA-proximal interactions.</data>
</edge>
<edge source="PDF_23_2024" target="PDF_23_2024_Hypothesis_-3343978425397978656">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_23_2024" target="PDF_23_2024_Method_5399875870720793919">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_23_2024" target="PDF_23_2024_Method_-2118685823376526039">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_23_2024" target="PDF_23_2024_Method_-962667875878043483">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_23_2024" target="PDF_23_2024_Method_-6844345173495192814">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_23_2024" target="PDF_23_2024_Method_1387627994788856560">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_23_2024" target="PDF_23_2024_Method_-963939611664386156">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_23_2024" target="PDF_23_2024_Method_-8358282031659288739">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_23_2024" target="PDF_23_2024_Result_-7950454151905880499">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_23_2024" target="PDF_23_2024_Result_-1426847475356443601">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_23_2024" target="PDF_23_2024_Result_-6231444686870539759">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_23_2024" target="PDF_23_2024_Result_8331014064670918802">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_23_2024" target="PDF_23_2024_Result_-963939611664386156">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_23_2024" target="PDF_23_2024_Result_-8358282031659288739">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_23_2024" target="PDF_23_2024_Conclusion_4394189087389820540">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_23_2024" target="PDF_23_2024_Conclusion_8378018910778163774">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_23_2024_Hypothesis_-3343978425397978656" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Aberrant PNMA2 capsids released outside the central nervous system (CNS) may cause autoantibody generation.</data>
</edge>
<edge source="PDF_23_2024_Method_5399875870720793919" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Mice injected with recombinant PNMA2 capsids.</data>
</edge>
<edge source="PDF_23_2024_Method_-2118685823376526039" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Cryoelectron microscopy (cryo-EM)-derived atomic resolution structures of PNMA2 capsids.</data>
</edge>
<edge source="PDF_23_2024_Method_-962667875878043483" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Designed PNMA2 mutants that are unable to form capsids.</data>
</edge>
<edge source="PDF_23_2024_Method_1387627994788856560" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">PNMA2 autoantibodies from injected mice and CSF from patients with anti-Ma2 paraneoplastic disease.</data>
</edge>
<edge source="PDF_23_2024_Method_-963939611664386156" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">PNMA2 capsids are also capable of inducing maturation of dendritic cells in vitro.</data>
</edge>
<edge source="PDF_23_2024_Method_-8358282031659288739" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Mice injected with PNMA2 capsids develop significant deficits in fear learning and memory.</data>
</edge>
<edge source="PDF_23_2024_Result_-7950454151905880499" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">PNMA2 protein self-assembles into virus-like capsids that are released from cells as non-enveloped capsids.</data>
</edge>
<edge source="PDF_23_2024_Result_-1426847475356443601" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Mice injected with PNMA2 capsids produce strong autoantibody generation, even without adjuvant.</data>
</edge>
<edge source="PDF_23_2024_Result_8331014064670918802" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">PNMA2 autoantibodies from injected mice and CSF from patients with anti-Ma2 paraneoplastic disease preferentially bind to exterior surface spike epitopes of PNMA2 capsids.</data>
</edge>
<edge source="PDF_23_2024_Result_-963939611664386156" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">PNMA2 capsids are also capable of inducing maturation of dendritic cells in vitro.</data>
</edge>
<edge source="PDF_23_2024_Result_-8358282031659288739" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Mice injected with PNMA2 capsids develop significant deficits in fear learning and memory.</data>
</edge>
<edge source="PDF_23_2024_Conclusion_4394189087389820540" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">PNMA2 is a Gag-like protein that forms endogenous virus-like capsids that are released without a membrane. These capsids can trigger a robust immune response when ectopically expressed outside the CNS, which results in neurological deficits.</data>
</edge>
<edge source="PDF_23_2024_Conclusion_8378018910778163774" target="Protein_PNMA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">The virus-like properties of PNMA2 protein may underlie some of the neurological symptoms associated with anti-Ma2 paraneoplastic disease.</data>
</edge>
<edge source="PDF_19_2024" target="PDF_19_2024_Result_-8817860122597384827">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_19_2024" target="PDF_19_2024_Result_-2645281073394551084">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_19_2024" target="PDF_19_2024_Result_-2074743576456389044">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_19_2024" target="PDF_19_2024_Result_3923832235883396720">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_19_2024" target="PDF_19_2024_Result_7123199059174422318">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_19_2024" target="PDF_19_2024_Result_515765872160966783">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_19_2024" target="PDF_19_2024_Result_-4358298089521080577">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_19_2024" target="PDF_19_2024_Result_-1156351625628116488">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_19_2024" target="PDF_19_2024_Result_1380383517768903962">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_19_2024" target="PDF_19_2024_Result_2989690524569484653">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_19_2024" target="PDF_19_2024_Result_-2658558350534186415">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_19_2024" target="PDF_19_2024_Result_2770669046705338483">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_50_2022" target="PDF_50_2022_Result_9053663309313415397">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_50_2022" target="PDF_50_2022_Result_4143230277611537497">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_50_2022" target="PDF_50_2022_Result_1421392516057929338">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_50_2022" target="PDF_50_2022_Result_-4352656610692023950">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_50_2022" target="PDF_50_2022_Result_3490528895718139935">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_50_2022" target="PDF_50_2022_Method_5663550644994586893">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_50_2022" target="PDF_50_2022_Result_-6540827287157967320">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_50_2022" target="PDF_50_2022_Result_4249280198473464805">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_50_2022" target="PDF_50_2022_Result_-1062616581953575234">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_50_2022_Result_9053663309313415397" target="Protein_ACTIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">Mammalian oocyte nuclei contain prominent F-actin structures.</data>
</edge>
<edge source="PDF_50_2022_Result_4143230277611537497" target="Protein_ACTIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">Disruption of the oocyte cytoplasmic actin network by Cytochalasin D treatment triggered excessive nuclear F-actin assembly.</data>
</edge>
<edge source="PDF_50_2022_Result_4143230277611537497" target="Compound_CYTOCHALASIN D">
  <data key="d8">MENTIONS</data>
  <data key="d9">Disruption of the oocyte cytoplasmic actin network by Cytochalasin D treatment triggered excessive nuclear F-actin assembly.</data>
</edge>
<edge source="PDF_50_2022_Result_1421392516057929338" target="Protein_ACTIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">High monomeric G-actin concentration is sufficient to induce F-actin polymerisation in oocytes.</data>
</edge>
<edge source="PDF_50_2022_Result_-4352656610692023950" target="Protein_ACTIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">Maintenance of oocyte cytoplasmic F-actin network organisation requires nuclear import activity</data>
</edge>
<edge source="PDF_50_2022_Result_3490528895718139935" target="Protein_ACTIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">Stable nuclear actin filaments restrict chromatin mobility in oocytes</data>
</edge>
<edge source="PDF_50_2022_Result_-6540827287157967320" target="Protein_ACTIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">the amount and complexity of nuclear actin filaments declines significantly with increasing reproductive age in females.</data>
</edge>
<edge source="PDF_50_2022_Result_4249280198473464805" target="Compound_LATRUNCULIN B">
  <data key="d8">MENTIONS</data>
  <data key="d9">nuclei in Latrunculin B-treated oocytes were not more likely to contain actin filaments</data>
</edge>
<edge source="PDF_50_2022_Result_4249280198473464805" target="Protein_ACTIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">nuclei in Latrunculin B-treated oocytes were not more likely to contain actin filaments</data>
</edge>
<edge source="PDF_50_2022_Result_-1062616581953575234" target="Protein_ACTIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">blocking nuclear import in oocytes not previously treated with cytoskeletal drugs significantly increases cytoplasmic actin network density</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Hypothesis_-7297399529364949691">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Method_7859755160455384525">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Method_-2425396665645958323">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Method_965287074836881133">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Method_6985826768511820878">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Method_4229599673691626499">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Method_-6275390675118843695">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Result_8446244206931902213">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Result_9141560154520856217">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Result_5511359331068376327">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Result_-7167181583136772137">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Result_-5570488036322490938">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Result_-2132393861908106677">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Result_1289278742648875670">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Result_-6502481849591628661">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Result_-3776375590943808273">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Result_-2000097215023003340">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Result_8091112206004911021">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Result_1822898770823356325">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Result_6872771938282106607">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Result_154397273689384569">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Result_8406670794663616537">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Result_2861793387886563837">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Result_-5200047256938123750">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Result_-4725397333331610063">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Result_-9070251541271095943">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Conclusion_8047974710545712584">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Conclusion_-9154970192273007236">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Conclusion_-8764603628917911994">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023" target="PDF_55_2023_Conclusion_-5740230014961952256">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_55_2023_Method_-2425396665645958323" target="Protein_ZIP1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We used Zip1-GFP as a readout for meiotic entry because it is expressed, and localized to the nucleus, specifically during meiotic prophase I.</data>
</edge>
<edge source="PDF_55_2023_Method_965287074836881133" target="Gene_IME1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We conducted an electrophoretic mobility shift assay (EMSA) using in vitro transcribed IMEI mRNA and recombinant Riel purified from Escherichia coli</data>
</edge>
<edge source="PDF_55_2023_Method_965287074836881133" target="Protein_RIE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We conducted an electrophoretic mobility shift assay (EMSA) using in vitro transcribed IMEI mRNA and recombinant Riel purified from Escherichia coli</data>
</edge>
<edge source="PDF_55_2023_Method_6985826768511820878" target="Protein_RIE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We immunoprecipified (IPed) Riel from cells in the early stages of meiosis (0, 2 h in SPO) and analyzed bound proteins by quantitative mass spectrometry.</data>
</edge>
<edge source="PDF_55_2023_Method_4229599673691626499" target="Protein_RIE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We performed an early meiotic RNA sequencing (RNA-seq) time course in wild type and riel∆.</data>
</edge>
<edge source="PDF_55_2023_Result_8446244206931902213" target="Gene_RIE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Our screen revealed several candidates with meiotic entry phenotypes, the most significant being RIE1, which encodes an RRM-containing protein.</data>
</edge>
<edge source="PDF_55_2023_Result_9141560154520856217" target="Protein_RIE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We demonstrate that Rie1 binds RNA, is associated with the translational machinery, and acts posttranscriptionally to enhance protein levels of the master transcription factor Ime1 in sporulation conditions.</data>
</edge>
<edge source="PDF_55_2023_Result_9141560154520856217" target="Protein_IME1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We demonstrate that Rie1 binds RNA, is associated with the translational machinery, and acts posttranscriptionally to enhance protein levels of the master transcription factor Ime1 in sporulation conditions.</data>
</edge>
<edge source="PDF_55_2023_Result_5511359331068376327" target="Protein_RIE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We also identified a physical binding partner of Rie1, Sgn1, which is another RRM-containing protein that plays a role in timely Ime1 expression.</data>
</edge>
<edge source="PDF_55_2023_Result_5511359331068376327" target="Protein_SGN1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We also identified a physical binding partner of Rie1, Sgn1, which is another RRM-containing protein that plays a role in timely Ime1 expression.</data>
</edge>
<edge source="PDF_55_2023_Result_5511359331068376327" target="Protein_IME1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We also identified a physical binding partner of Rie1, Sgn1, which is another RRM-containing protein that plays a role in timely Ime1 expression.</data>
</edge>
<edge source="PDF_55_2023_Result_-5570488036322490938" target="Protein_RIE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">The most severe entry mutant we observed was riel∆, which showed ~15% of cells entering meiotic prophase at 6 h</data>
</edge>
<edge source="PDF_55_2023_Result_-2132393861908106677" target="Gene_RIEI">
  <data key="d8">MENTIONS</data>
  <data key="d9">RIEI (also called WHI8) encodes a protein harboring three predicted RRMs and three intrinsically disordered regions.</data>
</edge>
<edge source="PDF_55_2023_Result_1289278742648875670" target="Protein_RIE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We confirmed that Riel binds RNA and that point mutation of RNP motifs within RRM2 and RRM3 affected RNA binding capacity</data>
</edge>
<edge source="PDF_55_2023_Result_-6502481849591628661" target="Protein_IME1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We found that Imel, Ime2, and Ime4 protein levels were all decreased in riel∆.</data>
</edge>
<edge source="PDF_55_2023_Result_-6502481849591628661" target="Protein_IME2">
  <data key="d8">MENTIONS</data>
  <data key="d9">We found that Imel, Ime2, and Ime4 protein levels were all decreased in riel∆.</data>
</edge>
<edge source="PDF_55_2023_Result_-6502481849591628661" target="Protein_IME4">
  <data key="d8">MENTIONS</data>
  <data key="d9">We found that Imel, Ime2, and Ime4 protein levels were all decreased in riel∆.</data>
</edge>
<edge source="PDF_55_2023_Result_-6502481849591628661" target="Protein_RIE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We found that Imel, Ime2, and Ime4 protein levels were all decreased in riel∆.</data>
</edge>
<edge source="PDF_55_2023_Result_-3776375590943808273" target="Protein_RIE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We found that Riel binds IMEI mRNA compared with a control protein, bovine serum albumin (BSA), which does not bind.</data>
</edge>
<edge source="PDF_55_2023_Result_-3776375590943808273" target="Gene_IME1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We found that Riel binds IMEI mRNA compared with a control protein, bovine serum albumin (BSA), which does not bind.</data>
</edge>
<edge source="PDF_55_2023_Result_-2000097215023003340" target="Gene_CLN3">
  <data key="d8">MENTIONS</data>
  <data key="d9">We found that the riel cln3∆ double mutant did not rescue the riel∆ meiotic entry defect</data>
</edge>
<edge source="PDF_55_2023_Result_-2000097215023003340" target="Protein_RIE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We found that the riel cln3∆ double mutant did not rescue the riel∆ meiotic entry defect</data>
</edge>
<edge source="PDF_55_2023_Result_8091112206004911021" target="Protein_RIE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We observed a pronounced buildup of 80S monosome peaks in riel∆ compared to wild type cells throughout meiosis</data>
</edge>
<edge source="PDF_55_2023_Result_1822898770823356325" target="Protein_RIE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We observed increased abundance of Riel in actively translating fractions (i.e., ribosomes and polysomes) in the crosslinked samples throughout pre-meiotic S-phase.</data>
</edge>
<edge source="PDF_55_2023_Result_6872771938282106607" target="Protein_RIE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We found that presence or absence of Riel did not affect poly(A) tail length of IMEI</data>
</edge>
<edge source="PDF_55_2023_Result_6872771938282106607" target="Gene_IME1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We found that presence or absence of Riel did not affect poly(A) tail length of IMEI</data>
</edge>
<edge source="PDF_55_2023_Result_154397273689384569" target="Protein_SGN1">
  <data key="d8">MENTIONS</data>
  <data key="d9">The most highly enriched protein was another RNA-binding protein Sgnl which harbors significant similarity to the translation initiation factor eIF4B</data>
</edge>
<edge source="PDF_55_2023_Result_8406670794663616537" target="Protein_RIE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We validated the interaction between Riel and Sgn1 by reciprocal co-IP in which FLAG-tagged Sgnl was pulled down and co-purified V5-tagged Riel abundance was measured by immunoblot</data>
</edge>
<edge source="PDF_55_2023_Result_8406670794663616537" target="Protein_SGN1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We validated the interaction between Riel and Sgn1 by reciprocal co-IP in which FLAG-tagged Sgnl was pulled down and co-purified V5-tagged Riel abundance was measured by immunoblot</data>
</edge>
<edge source="PDF_55_2023_Result_2861793387886563837" target="Protein_IME1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We found that both riel∆ and sgnl∆ exhibited decreased Imel protein levels without corresponding downregulation of IMEI mRNA levels</data>
</edge>
<edge source="PDF_55_2023_Result_2861793387886563837" target="Protein_RIE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We found that both riel∆ and sgnl∆ exhibited decreased Imel protein levels without corresponding downregulation of IMEI mRNA levels</data>
</edge>
<edge source="PDF_55_2023_Result_2861793387886563837" target="Protein_SGN1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We found that both riel∆ and sgnl∆ exhibited decreased Imel protein levels without corresponding downregulation of IMEI mRNA levels</data>
</edge>
<edge source="PDF_55_2023_Result_2861793387886563837" target="Gene_IME1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We found that both riel∆ and sgnl∆ exhibited decreased Imel protein levels without corresponding downregulation of IMEI mRNA levels</data>
</edge>
<edge source="PDF_55_2023_Result_-5200047256938123750" target="Protein_SGN1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We found that Sgnl binds IME1 mRNA compared with the BSA control</data>
</edge>
<edge source="PDF_55_2023_Result_-5200047256938123750" target="Gene_IME1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We found that Sgnl binds IME1 mRNA compared with the BSA control</data>
</edge>
<edge source="PDF_55_2023_Result_-4725397333331610063" target="Protein_RIE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">In support of our model, we found that riel predicted interface mutations partially disrupted the physical interaction between Riel and Sgnl.</data>
</edge>
<edge source="PDF_55_2023_Result_-4725397333331610063" target="Protein_SGN1">
  <data key="d8">MENTIONS</data>
  <data key="d9">In support of our model, we found that riel predicted interface mutations partially disrupted the physical interaction between Riel and Sgnl.</data>
</edge>
<edge source="PDF_55_2023_Result_-9070251541271095943" target="Protein_IME1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We found that riel D429A-S433A-S435A mutants exhibited defective Imel accumulation and delayed appearance of bi- and tetranucleate cells compared with wild type</data>
</edge>
<edge source="PDF_55_2023_Result_-9070251541271095943" target="Protein_RIE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We found that riel D429A-S433A-S435A mutants exhibited defective Imel accumulation and delayed appearance of bi- and tetranucleate cells compared with wild type</data>
</edge>
<edge source="PDF_55_2023_Conclusion_8047974710545712584" target="Protein_RIE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We propose a model explaining how constitutively expressed RNA-binding proteins, such as Rie1 and Sgn1, can act in cell fate decisions both as switch-like enforcers and as repressors of spurious cell fate activation.</data>
</edge>
<edge source="PDF_55_2023_Conclusion_8047974710545712584" target="Protein_SGN1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We propose a model explaining how constitutively expressed RNA-binding proteins, such as Rie1 and Sgn1, can act in cell fate decisions both as switch-like enforcers and as repressors of spurious cell fate activation.</data>
</edge>
<edge source="PDF_55_2023_Conclusion_-9154970192273007236" target="Protein_RIE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Our results support a model in which Riel and Sgnl act directly to promote meiotic entry as switch-like enforcers while also playing an indirect role to repress spurious meiotic entry.</data>
</edge>
<edge source="PDF_55_2023_Conclusion_-9154970192273007236" target="Protein_SGN1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Our results support a model in which Riel and Sgnl act directly to promote meiotic entry as switch-like enforcers while also playing an indirect role to repress spurious meiotic entry.</data>
</edge>
<edge source="PDF_55_2023_Conclusion_-8764603628917911994" target="Protein_RIE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Our results support the idea that after promeiotic signaling cues, Riel and Sgn1 posttranscriptionally enhance Imel accumulation, thus contributing to timely meiotic entry.</data>
</edge>
<edge source="PDF_55_2023_Conclusion_-8764603628917911994" target="Protein_SGN1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Our results support the idea that after promeiotic signaling cues, Riel and Sgn1 posttranscriptionally enhance Imel accumulation, thus contributing to timely meiotic entry.</data>
</edge>
<edge source="PDF_55_2023_Conclusion_-8764603628917911994" target="Protein_IME1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Our results support the idea that after promeiotic signaling cues, Riel and Sgn1 posttranscriptionally enhance Imel accumulation, thus contributing to timely meiotic entry.</data>
</edge>
<edge source="PDF_55_2023_Conclusion_-5740230014961952256" target="Protein_RIE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Taken together, our results support a model in which Riel and Sgnl form a complex that acts to enforce the meiotic cell fate decision.</data>
</edge>
<edge source="PDF_55_2023_Conclusion_-5740230014961952256" target="Protein_SGN1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Taken together, our results support a model in which Riel and Sgnl form a complex that acts to enforce the meiotic cell fate decision.</data>
</edge>
<edge source="PDF_02_2017" target="PDF_02_2017_Result_-3107892441378934828">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_02_2017" target="PDF_02_2017_Result_-941646995600860486">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_02_2017" target="PDF_02_2017_Result_-6604700396540919516">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_02_2017" target="PDF_02_2017_Result_-2908174313700732147">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_02_2017" target="PDF_02_2017_Result_-3802694399909305599">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_02_2017" target="PDF_02_2017_Result_-6156591111013576281">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_02_2017" target="PDF_02_2017_Result_9190923915707991205">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_02_2017" target="PDF_02_2017_Result_-3099137440932832607">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_02_2017" target="PDF_02_2017_Result_-3105073551788762154">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_02_2017" target="PDF_02_2017_Result_-2370930132198879483">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_02_2017" target="PDF_02_2017_Result_2425718710238733499">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_02_2017" target="PDF_02_2017_Result_-2598866984362038171">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_02_2017" target="PDF_02_2017_Result_-2859377263582660909">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_02_2017" target="PDF_02_2017_Hypothesis_1810271745774392349">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_02_2017_Result_-3107892441378934828" target="Protein_RAG1">
  <data key="d8">MENTIONS</data>
  <data key="d9">the catalytic core of RAG1, the protein that is responsible for cleavage activity, is a domesticated transposase derived from an ancient lineage of DNA transposons dubbed Transib.</data>
</edge>
<edge source="PDF_02_2017_Result_-3107892441378934828" target="Gene_TRANSIB">
  <data key="d8">MENTIONS</data>
  <data key="d9">the catalytic core of RAG1, the protein that is responsible for cleavage activity, is a domesticated transposase derived from an ancient lineage of DNA transposons dubbed Transib.</data>
</edge>
<edge source="PDF_02_2017_Result_-941646995600860486" target="Protein_RAG2">
  <data key="d8">MENTIONS</data>
  <data key="d9">RAG2 also was shown to have TE origins and several lines of evidence suggested that both RAG1 and RAG2 were domesticated from the same ancestral Transib element</data>
</edge>
<edge source="PDF_02_2017_Result_-941646995600860486" target="Protein_RAG1">
  <data key="d8">MENTIONS</data>
  <data key="d9">RAG2 also was shown to have TE origins and several lines of evidence suggested that both RAG1 and RAG2 were domesticated from the same ancestral Transib element</data>
</edge>
<edge source="PDF_02_2017_Result_-941646995600860486" target="Gene_TRANSIB">
  <data key="d8">MENTIONS</data>
  <data key="d9">RAG2 also was shown to have TE origins and several lines of evidence suggested that both RAG1 and RAG2 were domesticated from the same ancestral Transib element</data>
</edge>
<edge source="PDF_02_2017_Result_-6604700396540919516" target="Protein_CAS1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Cas1, the most prominent Cas protein found in CRISPR-Cas systems, shares sequence similarity to the transposases encoded by a group of TEs called Casposons</data>
</edge>
<edge source="PDF_02_2017_Result_-6604700396540919516" target="Gene_CASPOSONS">
  <data key="d8">MENTIONS</data>
  <data key="d9">Cas1, the most prominent Cas protein found in CRISPR-Cas systems, shares sequence similarity to the transposases encoded by a group of TEs called Casposons</data>
</edge>
<edge source="PDF_02_2017_Result_-2908174313700732147" target="Protein_CAS9">
  <data key="d8">MENTIONS</data>
  <data key="d9">Cas9-like proteins, which act as effectors in most class 2 systems, show sequence similarity to proteins called TnpB, which are poorly characterized but are commonly found in both autonomous and non-autonomous TEs</data>
</edge>
<edge source="PDF_02_2017_Result_-2908174313700732147" target="Protein_TNPB">
  <data key="d8">MENTIONS</data>
  <data key="d9">Cas9-like proteins, which act as effectors in most class 2 systems, show sequence similarity to proteins called TnpB, which are poorly characterized but are commonly found in both autonomous and non-autonomous TEs</data>
</edge>
<edge source="PDF_02_2017_Result_-3802694399909305599" target="Protein_ENV">
  <data key="d8">MENTIONS</data>
  <data key="d9">Several proteins derived from the Envelope (Env) gene of endogenous retroviruses are known to aid in the protection of the host cell by restricting infection of related retroviruses</data>
</edge>
<edge source="PDF_02_2017_Result_-6156591111013576281" target="Gene_FVL">
  <data key="d8">MENTIONS</data>
  <data key="d9">the Gag proteins encoded by endogenous retroviruses can also be coopted for restricting retroviral infection. A classic example is the mouse Fvl gene which is derived from the Gag gene of a member of the endogenous retrovirus family ERV-L</data>
</edge>
<edge source="PDF_02_2017_Result_-6156591111013576281" target="Protein_GAG">
  <data key="d8">MENTIONS</data>
  <data key="d9">the Gag proteins encoded by endogenous retroviruses can also be coopted for restricting retroviral infection. A classic example is the mouse Fvl gene which is derived from the Gag gene of a member of the endogenous retrovirus family ERV-L</data>
</edge>
<edge source="PDF_02_2017_Result_-6156591111013576281" target="Gene_ERV-L">
  <data key="d8">MENTIONS</data>
  <data key="d9">the Gag proteins encoded by endogenous retroviruses can also be coopted for restricting retroviral infection. A classic example is the mouse Fvl gene which is derived from the Gag gene of a member of the endogenous retrovirus family ERV-L</data>
</edge>
<edge source="PDF_02_2017_Result_9190923915707991205" target="Protein_ABP1">
  <data key="d8">MENTIONS</data>
  <data key="d9">three transposase-derived proteins (Abp1, Cbh1 and Cbh2) originated from pogo transposons have taken on partially overlapping function in controlling unrelated retrotransposons called Tf2 elements. These domesticated proteins have been reported to transcriptionally silence Tf2 retrotransposons by tethering histone deacetylases to the long terminal repeats of these elements, which also prevents the chromosomal integration of Tf2 elements via homologous recombination</data>
</edge>
<edge source="PDF_02_2017_Result_9190923915707991205" target="Protein_CBH1">
  <data key="d8">MENTIONS</data>
  <data key="d9">three transposase-derived proteins (Abp1, Cbh1 and Cbh2) originated from pogo transposons have taken on partially overlapping function in controlling unrelated retrotransposons called Tf2 elements. These domesticated proteins have been reported to transcriptionally silence Tf2 retrotransposons by tethering histone deacetylases to the long terminal repeats of these elements, which also prevents the chromosomal integration of Tf2 elements via homologous recombination</data>
</edge>
<edge source="PDF_02_2017_Result_9190923915707991205" target="Protein_CBH2">
  <data key="d8">MENTIONS</data>
  <data key="d9">three transposase-derived proteins (Abp1, Cbh1 and Cbh2) originated from pogo transposons have taken on partially overlapping function in controlling unrelated retrotransposons called Tf2 elements. These domesticated proteins have been reported to transcriptionally silence Tf2 retrotransposons by tethering histone deacetylases to the long terminal repeats of these elements, which also prevents the chromosomal integration of Tf2 elements via homologous recombination</data>
</edge>
<edge source="PDF_02_2017_Result_9190923915707991205" target="Gene_TY3/GYPSY">
  <data key="d8">MENTIONS</data>
  <data key="d9">three transposase-derived proteins (Abp1, Cbh1 and Cbh2) originated from pogo transposons have taken on partially overlapping function in controlling unrelated retrotransposons called Tf2 elements. These domesticated proteins have been reported to transcriptionally silence Tf2 retrotransposons by tethering histone deacetylases to the long terminal repeats of these elements, which also prevents the chromosomal integration of Tf2 elements via homologous recombination</data>
</edge>
<edge source="PDF_02_2017_Result_-3099137440932832607" target="Gene_MAIL1">
  <data key="d8">MENTIONS</data>
  <data key="d9">In Arabidopsis, two genes MAIL1 and MAIN encode related proteins that appear to be evolutionarily derived from a subset of Ty3/gypsy retrotransposons found in angiosperms. Genetic loss of these genes resulted in impaired condensation of pericentromeric heterochromatin and upregulation of TE transcription suggesting their protein products are acting as transcriptional repressors</data>
</edge>
<edge source="PDF_02_2017_Result_-3099137440932832607" target="Gene_MAIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">In Arabidopsis, two genes MAIL1 and MAIN encode related proteins that appear to be evolutionarily derived from a subset of Ty3/gypsy retrotransposons found in angiosperms. Genetic loss of these genes resulted in impaired condensation of pericentromeric heterochromatin and upregulation of TE transcription suggesting their protein products are acting as transcriptional repressors</data>
</edge>
<edge source="PDF_02_2017_Result_-3099137440932832607" target="Gene_TY3/GYPSY">
  <data key="d8">MENTIONS</data>
  <data key="d9">In Arabidopsis, two genes MAIL1 and MAIN encode related proteins that appear to be evolutionarily derived from a subset of Ty3/gypsy retrotransposons found in angiosperms. Genetic loss of these genes resulted in impaired condensation of pericentromeric heterochromatin and upregulation of TE transcription suggesting their protein products are acting as transcriptional repressors</data>
</edge>
<edge source="PDF_02_2017_Result_-3105073551788762154" target="Protein_ALP1">
  <data key="d8">MENTIONS</data>
  <data key="d9">ALP1 is another domesticated TE protein identified in Arabidopsis that is involved in yet another epigenetic silencing pathway. ALP1 directly derives from a PIF-like transposase and antagonizes silencing through a direct interaction with the Polycomb Repressor Complex 2 (PRC2), which is known to contribute to TE silencing in Arabidopsis</data>
</edge>
<edge source="PDF_02_2017_Result_-3105073551788762154" target="Gene_PIF">
  <data key="d8">MENTIONS</data>
  <data key="d9">ALP1 is another domesticated TE protein identified in Arabidopsis that is involved in yet another epigenetic silencing pathway. ALP1 directly derives from a PIF-like transposase and antagonizes silencing through a direct interaction with the Polycomb Repressor Complex 2 (PRC2), which is known to contribute to TE silencing in Arabidopsis</data>
</edge>
<edge source="PDF_02_2017_Result_-3105073551788762154" target="Protein_PRC2">
  <data key="d8">MENTIONS</data>
  <data key="d9">ALP1 is another domesticated TE protein identified in Arabidopsis that is involved in yet another epigenetic silencing pathway. ALP1 directly derives from a PIF-like transposase and antagonizes silencing through a direct interaction with the Polycomb Repressor Complex 2 (PRC2), which is known to contribute to TE silencing in Arabidopsis</data>
</edge>
<edge source="PDF_02_2017_Result_-2370930132198879483" target="Protein_L1TD1">
  <data key="d8">MENTIONS</data>
  <data key="d9">LINE-1 type Transposase Domain-containing 1 (L1TD1) was coopted in the ancestor of placental mammals from the ORF1 coding region of long interspersed nuclear elements LINE-1 (or L1s), one of the most abundant and persistent TE families in mammalian genomes</data>
</edge>
<edge source="PDF_02_2017_Result_-2370930132198879483" target="Gene_LINE-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">LINE-1 type Transposase Domain-containing 1 (L1TD1) was coopted in the ancestor of placental mammals from the ORF1 coding region of long interspersed nuclear elements LINE-1 (or L1s), one of the most abundant and persistent TE families in mammalian genomes</data>
</edge>
<edge source="PDF_02_2017_Result_2425718710238733499" target="Protein_PIGGYMAC">
  <data key="d8">MENTIONS</data>
  <data key="d9">Paramecium uses PiggyMac (Pgm), a domesticated transposase, while in Tetrahymena at least four other transposase-derived proteins (TPB2, TPB1, TBP6, and Lia5) are required for IES removal</data>
</edge>
<edge source="PDF_02_2017_Result_2425718710238733499" target="Protein_TPB2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Paramecium uses PiggyMac (Pgm), a domesticated transposase, while in Tetrahymena at least four other transposase-derived proteins (TPB2, TPB1, TBP6, and Lia5) are required for IES removal</data>
</edge>
<edge source="PDF_02_2017_Result_2425718710238733499" target="Protein_TPB1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Paramecium uses PiggyMac (Pgm), a domesticated transposase, while in Tetrahymena at least four other transposase-derived proteins (TPB2, TPB1, TBP6, and Lia5) are required for IES removal</data>
</edge>
<edge source="PDF_02_2017_Result_2425718710238733499" target="Protein_TBP6">
  <data key="d8">MENTIONS</data>
  <data key="d9">Paramecium uses PiggyMac (Pgm), a domesticated transposase, while in Tetrahymena at least four other transposase-derived proteins (TPB2, TPB1, TBP6, and Lia5) are required for IES removal</data>
</edge>
<edge source="PDF_02_2017_Result_2425718710238733499" target="Protein_LIA5">
  <data key="d8">MENTIONS</data>
  <data key="d9">Paramecium uses PiggyMac (Pgm), a domesticated transposase, while in Tetrahymena at least four other transposase-derived proteins (TPB2, TPB1, TBP6, and Lia5) are required for IES removal</data>
</edge>
<edge source="PDF_02_2017_Result_-2598866984362038171" target="Protein_PRP8">
  <data key="d8">MENTIONS</data>
  <data key="d9">the prp8 protein, which is an integral component of the spliceosomal complex, displays significant sequence similarity with reverse transcriptases and as such has been proposed to derive from an anciently domesticated retroelement</data>
</edge>
<edge source="PDF_02_2017_Result_-2859377263582660909" target="Protein_SYNCYTINS">
  <data key="d8">MENTIONS</data>
  <data key="d9">Syncytins are proteins derived from the Env gene of retroviruses that have been coopted at least nine times during mammal evolution and are thought to play a role in placentation</data>
</edge>
<edge source="PDF_02_2017_Result_-2859377263582660909" target="Protein_ENV">
  <data key="d8">MENTIONS</data>
  <data key="d9">Syncytins are proteins derived from the Env gene of retroviruses that have been coopted at least nine times during mammal evolution and are thought to play a role in placentation</data>
</edge>
<edge source="PDF_02_2017_Hypothesis_1810271745774392349" target="Gene_TES">
  <data key="d8">MENTIONS</data>
  <data key="d9">Expanding upon this idea, we propose a model in which the dimorphic nuclei system of ciliates fosters the evolution of TEs that are specifically expressed during the transition from MIC to MAC as to be excised during that transition, which would minimize their deleterious impact and lead to their eventual domestication</data>
</edge>
<edge source="PDF_08_2021" target="PDF_08_2021_Result_7408030357536987208">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_08_2021" target="PDF_08_2021_Result_-1323406727949833849">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_08_2021" target="PDF_08_2021_Result_-5141428779280669527">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_08_2021" target="PDF_08_2021_Result_5145968416737818844">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_08_2021" target="PDF_08_2021_Result_-348523210398706426">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_08_2021" target="PDF_08_2021_Result_-6934201791794996677">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_08_2021" target="PDF_08_2021_Result_334940822866829859">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_08_2021" target="PDF_08_2021_Result_-3234471239190793867">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_08_2021" target="PDF_08_2021_Result_553740297183743922">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_08_2021" target="PDF_08_2021_Result_-2094195057826103054">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_08_2021" target="PDF_08_2021_Result_-1231270748536062013">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_08_2021" target="PDF_08_2021_Result_-5487901093502027533">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_08_2021" target="PDF_08_2021_Result_483480449044224527">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_08_2021" target="PDF_08_2021_Result_-1196288416550912698">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_08_2021" target="PDF_08_2021_Result_-8515337521379246039">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_08_2021_Result_7408030357536987208" target="Protein_ANNA-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">ANNA-1 or "anti-Hu" has been described with various paraneoplastic manifestations including sensory neuronopathy, gastroparesis, and limbic encephalitis.</data>
</edge>
<edge source="PDF_08_2021_Result_-1323406727949833849" target="Protein_PCA-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">The most common clinical syndrome associated with PCA-1 IgG is paraneoplastic cerebellar degeneration (PCD).</data>
</edge>
<edge source="PDF_08_2021_Result_-5141428779280669527" target="Protein_CRMP5">
  <data key="d8">MENTIONS</data>
  <data key="d9">CRMP5 IgG has been described in association with paraneoplastic peripheral neuropathy, cranial neuropathy, gastroparesis, encephalitis, cerebellar ataxia, myelopathy, and chorea.</data>
</edge>
<edge source="PDF_08_2021_Result_5145968416737818844" target="Protein_MA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Paraneoplastic limbic and/or diencephalic encephalitis is the typical clinical phenotype associated with Ma2 IgG.</data>
</edge>
<edge source="PDF_08_2021_Result_-348523210398706426" target="Protein_AMPHIPHYSIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">Amphiphysin IgG was initially described in women with paraneoplastic stiff person syndrome and breast cancer.</data>
</edge>
<edge source="PDF_08_2021_Result_-6934201791794996677" target="Gene_SOX1">
  <data key="d8">MENTIONS</data>
  <data key="d9">SOX1 antibodies have been described in association with PNS and small-cell cancer, especially Lambert-Eaton myasthenic syndrome (LEMS).</data>
</edge>
<edge source="PDF_08_2021_Result_334940822866829859" target="Protein_KLHL11">
  <data key="d8">MENTIONS</data>
  <data key="d9">KLHL11 is a novel onconeural antibody associated with rhombencephalitis phenotype (brainstem and/or cerebellar involvement) and a few cases of limbic encephalitis with or without rhombencephalitis.</data>
</edge>
<edge source="PDF_08_2021_Result_-2094195057826103054" target="Protein_GABA-B-R">
  <data key="d8">MENTIONS</data>
  <data key="d9">GABA-B-R encephalitis commonly presents with refractory non-convulsive status epilepticus and/or limbic encephalitis.</data>
</edge>
<edge source="PDF_08_2021_Result_-1231270748536062013" target="Protein_MGLUR5">
  <data key="d8">MENTIONS</data>
  <data key="d9">mGlur5 autoantibodies have been described in association with Ophelia syndrome which presents with encephalopathy, mood disturbances, and seizures.</data>
</edge>
<edge source="PDF_08_2021_Result_-5487901093502027533" target="Protein_AMPA-R">
  <data key="d8">MENTIONS</data>
  <data key="d9">Limbic encephalitis is a common neurological presentation for AMPA-R IgG-seropositive cases, though phenotypic variability ranges from minimal symptoms to fulminant panencephalitis.</data>
</edge>
<edge source="PDF_08_2021_Result_483480449044224527" target="Protein_NMDA-R">
  <data key="d8">MENTIONS</data>
  <data key="d9">NMDA-R encephalitis can be associated with a neoplasm in 20-40% of cases.</data>
</edge>
<edge source="PDF_08_2021_Result_-1196288416550912698" target="Protein_CASPR2">
  <data key="d8">MENTIONS</data>
  <data key="d9">CASPR2-IgG is associated with thymomas in about 20% of cases, though other tumors have been reported rarely (melanomas).</data>
</edge>
<edge source="PDF_08_2021_Result_-8515337521379246039" target="Protein_LGI1">
  <data key="d8">MENTIONS</data>
  <data key="d9">LGI1-IgG is associated with thymoma in about 5-15% of cases; rare cases of squamous cell lung cancer have also been reported.</data>
</edge>
<edge source="PDF_20_2018" target="PDF_20_2018_Hypothesis_2440098807983713505">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_20_2018" target="PDF_20_2018_Method_-1955903706452186889">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_20_2018" target="PDF_20_2018_Method_2040376082369245937">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_20_2018" target="PDF_20_2018_Method_-3474688735602539031">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_20_2018" target="PDF_20_2018_Result_659502853426524656">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_20_2018" target="PDF_20_2018_Result_7699402121336811946">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_20_2018" target="PDF_20_2018_Result_8082139644017431996">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_20_2018" target="PDF_20_2018_Result_3032866769162580276">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_20_2018" target="PDF_20_2018_Conclusion_-6414324108582099157">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_20_2018" target="PDF_20_2018_Result_-1807613030103283507">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_20_2018" target="PDF_20_2018_Result_4630280045512000566">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_20_2018_Hypothesis_2440098807983713505" target="Protein_DARC1">
  <data key="d8">MENTIONS</data>
  <data key="d9">dArc1 influences synaptic plasticity by utilizing a retroviral-like mechanism for transport between synaptic partners in Drosophila.</data>
</edge>
<edge source="PDF_20_2018_Method_-1955903706452186889" target="Gene_DARC1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Downregulated darc1 exclusively in motorneurons, using the Gal4 driver C380-Gal4 to express UAS-dArc1-RNAi and examined the pre-and postsynaptic levels of dArc1 mRNA via FISH.</data>
</edge>
<edge source="PDF_20_2018_Method_-1955903706452186889" target="Protein_DARC1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Downregulated darc1 exclusively in motorneurons, using the Gal4 driver C380-Gal4 to express UAS-dArc1-RNAi and examined the pre-and postsynaptic levels of dArc1 mRNA via FISH.</data>
</edge>
<edge source="PDF_20_2018_Method_2040376082369245937" target="Gene_DARC1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Expressed Rab11 dominant-negative (Rab11-DN) specifically in neurons and examined the levels of darc1 RNA or protein in the postsynaptic region.</data>
</edge>
<edge source="PDF_20_2018_Method_2040376082369245937" target="Protein_DARC1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Expressed Rab11 dominant-negative (Rab11-DN) specifically in neurons and examined the levels of darc1 RNA or protein in the postsynaptic region.</data>
</edge>
<edge source="PDF_20_2018_Method_2040376082369245937" target="Protein_RAB11">
  <data key="d8">MENTIONS</data>
  <data key="d9">Expressed Rab11 dominant-negative (Rab11-DN) specifically in neurons and examined the levels of darc1 RNA or protein in the postsynaptic region.</data>
</edge>
<edge source="PDF_20_2018_Method_-3474688735602539031" target="Protein_DARC1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Expressed a dArc1 transgene in neurons, in a darc1E8/darc1esm113 mutant background.</data>
</edge>
<edge source="PDF_20_2018_Method_-3474688735602539031" target="Gene_DARC1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Expressed a dArc1 transgene in neurons, in a darc1E8/darc1esm113 mutant background.</data>
</edge>
<edge source="PDF_20_2018_Result_659502853426524656" target="Protein_DARC1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Expressing dArc1-RNAi in motorneurons resulted in a significant decrease in darc 1 FISH signal, not only at presynaptic boutons, but also at the muscle postsynaptic region.</data>
</edge>
<edge source="PDF_20_2018_Result_659502853426524656" target="Gene_DARC1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Expressing dArc1-RNAi in motorneurons resulted in a significant decrease in darc 1 FISH signal, not only at presynaptic boutons, but also at the muscle postsynaptic region.</data>
</edge>
<edge source="PDF_20_2018_Result_7699402121336811946" target="Protein_DARC1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Expressing dArc1-RNAi in motorneurons resulted in a significant decrease in dArc1 protein immunoreactive signal, both in pre- and postsynaptic compartments.</data>
</edge>
<edge source="PDF_20_2018_Result_8082139644017431996" target="Gene_DARC1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Expressing Rab11 dominant-negative (Rab11-DN) specifically in neurons induced a change in the levels of darc1 RNA and protein in the postsynaptic region, resulting in a significant reduction.</data>
</edge>
<edge source="PDF_20_2018_Result_8082139644017431996" target="Protein_DARC1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Expressing Rab11 dominant-negative (Rab11-DN) specifically in neurons induced a change in the levels of darc1 RNA and protein in the postsynaptic region, resulting in a significant reduction.</data>
</edge>
<edge source="PDF_20_2018_Result_8082139644017431996" target="Protein_RAB11">
  <data key="d8">MENTIONS</data>
  <data key="d9">Expressing Rab11 dominant-negative (Rab11-DN) specifically in neurons induced a change in the levels of darc1 RNA and protein in the postsynaptic region, resulting in a significant reduction.</data>
</edge>
<edge source="PDF_20_2018_Result_3032866769162580276" target="Protein_DARC1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Expressing a dArc1 transgene lacking the 3' UTR resulted in accumulation of the dArc1 signal in presynaptic terminals, but virtually no signal was observed at the postsynaptic region</data>
</edge>
<edge source="PDF_20_2018_Conclusion_-6414324108582099157" target="Gene_DARC1">
  <data key="d8">MENTIONS</data>
  <data key="d9">darc1 mRNA can be transferred from neurons to postsynaptic muscles in a manner dependent on its 3' UTR.</data>
</edge>
<edge source="PDF_20_2018_Result_-1807613030103283507" target="Gene_COPIA">
  <data key="d8">MENTIONS</data>
  <data key="d9">copia mRNA, a common Drosophila retrotransposon, was highly enriched in S2 EVs</data>
</edge>
<edge source="PDF_20_2018_Result_4630280045512000566" target="Protein_COPIA">
  <data key="d8">MENTIONS</data>
  <data key="d9">the short Copia protein isoform was enriched in EVs</data>
</edge>
<edge source="PDF_12_2018" target="PDF_12_2018_Result_8231132027423017619">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_12_2018" target="PDF_12_2018_Result_5148420689062950713">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_12_2018" target="PDF_12_2018_Result_6134140273532031699">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_12_2018" target="PDF_12_2018_Result_-5523895506454444793">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_12_2018" target="PDF_12_2018_Method_-3760152990683898893">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_12_2018" target="PDF_12_2018_Result_5822347928890405041">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_12_2018" target="PDF_12_2018_Result_7747048996402230001">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_12_2018" target="PDF_12_2018_Result_9197870052569855966">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_12_2018" target="PDF_12_2018_Conclusion_6393039800423848470">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_12_2018" target="PDF_12_2018_Result_-2607874180611961521">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_12_2018" target="PDF_12_2018_Result_-4281626095195189638">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_12_2018" target="PDF_12_2018_Result_1420959278330774340">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_12_2018" target="PDF_12_2018_Result_-858661789731053937">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_12_2018" target="PDF_12_2018_Result_-9139940819274568393">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_12_2018" target="PDF_12_2018_Result_4111218568798351145">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_12_2018" target="PDF_12_2018_Result_-7452455469803940683">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_12_2018" target="PDF_12_2018_Result_3918238744266758020">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_12_2018" target="PDF_12_2018_Result_-8986841771365759825">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_12_2018" target="PDF_12_2018_Result_5956478383114071180">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_12_2018" target="PDF_12_2018_Result_2020864101128395712">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_12_2018_Result_-2607874180611961521" target="Gene_RBM24">
  <data key="d8">MENTIONS</data>
  <data key="d9">IHC results showed that RBM24 was expressed only at the primordial and primary stages.</data>
</edge>
<edge source="PDF_12_2018_Result_-4281626095195189638" target="Gene_GPD1">
  <data key="d8">MENTIONS</data>
  <data key="d9">GPD1 was primarily expressed at the sec-ondary and antral stages.</data>
</edge>
<edge source="PDF_12_2018_Result_1420959278330774340" target="Gene_NTF4">
  <data key="d8">MENTIONS</data>
  <data key="d9">NTF4 and LCP2 were specifically ex-pressed at antral stage</data>
</edge>
<edge source="PDF_12_2018_Result_1420959278330774340" target="Gene_LCP2">
  <data key="d8">MENTIONS</data>
  <data key="d9">NTF4 and LCP2 were specifically ex-pressed at antral stage</data>
</edge>
<edge source="PDF_12_2018_Result_-858661789731053937" target="Gene_ZP2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Notably, the expression levels of ZP2, ZP3, and ZP4 re-mained stable across all stages</data>
</edge>
<edge source="PDF_12_2018_Result_-858661789731053937" target="Gene_ZP3">
  <data key="d8">MENTIONS</data>
  <data key="d9">Notably, the expression levels of ZP2, ZP3, and ZP4 re-mained stable across all stages</data>
</edge>
<edge source="PDF_12_2018_Result_-858661789731053937" target="Gene_ZP4">
  <data key="d8">MENTIONS</data>
  <data key="d9">Notably, the expression levels of ZP2, ZP3, and ZP4 re-mained stable across all stages</data>
</edge>
<edge source="PDF_12_2018_Result_-9139940819274568393" target="Gene_NANOG">
  <data key="d8">MENTIONS</data>
  <data key="d9">In contrast to the high expression levels of NANOG and POU5F1 in primordial germ cells (PGCs), the pluripo-tency markers NANOG and POU5F1 were under-expressed in most stages in oocytes</data>
</edge>
<edge source="PDF_12_2018_Result_-9139940819274568393" target="Gene_POU5F1">
  <data key="d8">MENTIONS</data>
  <data key="d9">In contrast to the high expression levels of NANOG and POU5F1 in primordial germ cells (PGCs), the pluripo-tency markers NANOG and POU5F1 were under-expressed in most stages in oocytes</data>
</edge>
<edge source="PDF_12_2018_Result_-7452455469803940683" target="Gene_DNMT1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Relatively high expression levels of DNMT1, DNMT3A, and DNMT3B in the oocytes of all stages with mounting abundance, indicating that the degree of DNA methylation is continually increasing with oocyte maturation</data>
</edge>
<edge source="PDF_12_2018_Result_-7452455469803940683" target="Gene_DNMT3A">
  <data key="d8">MENTIONS</data>
  <data key="d9">Relatively high expression levels of DNMT1, DNMT3A, and DNMT3B in the oocytes of all stages with mounting abundance, indicating that the degree of DNA methylation is continually increasing with oocyte maturation</data>
</edge>
<edge source="PDF_12_2018_Result_-7452455469803940683" target="Gene_DNMT3B">
  <data key="d8">MENTIONS</data>
  <data key="d9">Relatively high expression levels of DNMT1, DNMT3A, and DNMT3B in the oocytes of all stages with mounting abundance, indicating that the degree of DNA methylation is continually increasing with oocyte maturation</data>
</edge>
<edge source="PDF_12_2018_Result_3918238744266758020" target="Gene_CDCA3">
  <data key="d8">MENTIONS</data>
  <data key="d9">Consistent with the results of RNA-seq, the IHC results showed a similar expression pattern of CDCA3, BNIPL, and TST on the ovarian tissues obtained from the RNA-seq sample set</data>
</edge>
<edge source="PDF_12_2018_Result_3918238744266758020" target="Gene_BNIPL">
  <data key="d8">MENTIONS</data>
  <data key="d9">Consistent with the results of RNA-seq, the IHC results showed a similar expression pattern of CDCA3, BNIPL, and TST on the ovarian tissues obtained from the RNA-seq sample set</data>
</edge>
<edge source="PDF_12_2018_Result_3918238744266758020" target="Gene_TST">
  <data key="d8">MENTIONS</data>
  <data key="d9">Consistent with the results of RNA-seq, the IHC results showed a similar expression pattern of CDCA3, BNIPL, and TST on the ovarian tissues obtained from the RNA-seq sample set</data>
</edge>
<edge source="PDF_12_2018_Result_-8986841771365759825" target="Gene_CYP11A1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Several genes that encode steroidogenic enzymes, including CYP11A1, CYP19A1, HSD17B1, and HSD3B2, were upregu-lated in the antral follicles, with a peak expression level in the pre-ovulatory follicles</data>
</edge>
<edge source="PDF_12_2018_Result_-8986841771365759825" target="Gene_CYP19A1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Several genes that encode steroidogenic enzymes, including CYP11A1, CYP19A1, HSD17B1, and HSD3B2, were upregu-lated in the antral follicles, with a peak expression level in the pre-ovulatory follicles</data>
</edge>
<edge source="PDF_12_2018_Result_-8986841771365759825" target="Gene_HSD17B1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Several genes that encode steroidogenic enzymes, including CYP11A1, CYP19A1, HSD17B1, and HSD3B2, were upregu-lated in the antral follicles, with a peak expression level in the pre-ovulatory follicles</data>
</edge>
<edge source="PDF_12_2018_Result_-8986841771365759825" target="Gene_HSD3B2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Several genes that encode steroidogenic enzymes, including CYP11A1, CYP19A1, HSD17B1, and HSD3B2, were upregu-lated in the antral follicles, with a peak expression level in the pre-ovulatory follicles</data>
</edge>
<edge source="PDF_12_2018_Result_5956478383114071180" target="Gene_NR5A1">
  <data key="d8">MENTIONS</data>
  <data key="d9">NR5A1, a key regulator of the steroidogenic enzyme-encoding genes that has been previously described in sheep GCs exhibited an upregulation with the progression of follicular growth</data>
</edge>
<edge source="PDF_12_2018_Result_2020864101128395712" target="Gene_AR">
  <data key="d8">MENTIONS</data>
  <data key="d9">AR, ESR (ESR1 and ESR2), and PGR, encoding for androgen, estrogen, and progesterone hormone receptors, respectively, were expressed in GCs from primary follicles, with the highest expression level in antral follicles.</data>
</edge>
<edge source="PDF_12_2018_Result_2020864101128395712" target="Gene_ESR1">
  <data key="d8">MENTIONS</data>
  <data key="d9">AR, ESR (ESR1 and ESR2), and PGR, encoding for androgen, estrogen, and progesterone hormone receptors, respectively, were expressed in GCs from primary follicles, with the highest expression level in antral follicles.</data>
</edge>
<edge source="PDF_12_2018_Result_2020864101128395712" target="Gene_ESR2">
  <data key="d8">MENTIONS</data>
  <data key="d9">AR, ESR (ESR1 and ESR2), and PGR, encoding for androgen, estrogen, and progesterone hormone receptors, respectively, were expressed in GCs from primary follicles, with the highest expression level in antral follicles.</data>
</edge>
<edge source="PDF_12_2018_Result_2020864101128395712" target="Gene_PGR">
  <data key="d8">MENTIONS</data>
  <data key="d9">AR, ESR (ESR1 and ESR2), and PGR, encoding for androgen, estrogen, and progesterone hormone receptors, respectively, were expressed in GCs from primary follicles, with the highest expression level in antral follicles.</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Result_7660639465545493236">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Result_-6227014357902030541">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Result_2989983545862870772">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Result_8264196092172785362">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Result_7389490728307779516">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Result_5283225216925315128">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Result_420236917476400032">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Result_7996577112299451193">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Result_-2332817142182407515">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Result_-4668032360149998449">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Result_2987051478517357551">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Result_-6065915869636728351">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Result_2142565753247946721">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Result_-8161811732862639655">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Result_2613013752129771342">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Result_3525795321615417002">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Result_406078476358270010">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Result_-1602343731690292095">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Conclusion_-7817475420056821586">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Conclusion_-5114861423823520268">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Method_-1154998830364791936">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Method_-6635551054193205326">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_10_2013" target="PDF_10_2013_Method_2873418557632259137">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Result_-1406664229123110075">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Result_2449857216096601196">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Result_-4530820129589716056">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Result_6733583506875309280">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Result_-8602808043301586197">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Result_2301375868642044250">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Result_-3381954708418817692">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Method_-8976447147640461678">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Result_2880652585661967698">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Result_2438720786959728430">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Result_3841224437418375056">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Result_5898260031081342840">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Result_-8239913640821835535">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Result_-844600880480320235">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Result_4214243624179199811">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Result_853693060358169077">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Method_-3512103989150941167">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Method_1800362366101282462">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Method_-912887596059014410">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Method_1946689005624197172">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Result_-4906500001861674686">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Result_3635515074531159089">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Method_-8577085393107265036">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_27_2021" target="PDF_27_2021_Method_7274297947901528281">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_09_2017" target="PDF_09_2017_Hypothesis_-823536038409716850">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_09_2017" target="PDF_09_2017_Method_-5916248252771113392">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_09_2017" target="PDF_09_2017_Result_2918064835761663307">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_09_2017" target="PDF_09_2017_Result_-6899339675324614913">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_09_2017" target="PDF_09_2017_Result_-4894716366255718112">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_09_2017" target="PDF_09_2017_Result_-4284888244655995464">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_09_2017" target="PDF_09_2017_Conclusion_-6511780672371724639">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_09_2017" target="PDF_09_2017_Result_-6261464948747278153">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_09_2017" target="PDF_09_2017_Result_5312661458836239154">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_09_2017" target="PDF_09_2017_Result_-4283512138045495103">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_09_2017" target="PDF_09_2017_Result_-3556133635542159306">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_09_2017" target="PDF_09_2017_Result_7013219452746291712">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_09_2017" target="PDF_09_2017_Result_4678989147869615074">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_09_2017" target="PDF_09_2017_Result_7887175685820429368">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_09_2017" target="PDF_09_2017_Result_-3423247757071777685">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_09_2017" target="PDF_09_2017_Conclusion_2714058693539317562">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_09_2017_Hypothesis_-823536038409716850" target="Protein_PNMA5">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 might play important roles in meiosis.</data>
</edge>
<edge source="PDF_09_2017_Hypothesis_-823536038409716850" target="Process_MEIOSIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 might play important roles in meiosis.</data>
</edge>
<edge source="PDF_09_2017_Method_-5916248252771113392" target="Protein_PNMA5">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 was knocked down in in-vitro maturated (IVM) mouse oocytes by specific siRNA.</data>
</edge>
<edge source="PDF_09_2017_Result_2918064835761663307" target="Protein_PNMA5">
  <data key="d8">MENTIONS</data>
  <data key="d9">Loss of Pnma5 significantly delayed the progression of meiosis I and increased chromosome segregation errors during anaphase I.</data>
</edge>
<edge source="PDF_09_2017_Result_2918064835761663307" target="Process_MEIOSIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">Loss of Pnma5 significantly delayed the progression of meiosis I and increased chromosome segregation errors during anaphase I.</data>
</edge>
<edge source="PDF_09_2017_Result_-6899339675324614913" target="Protein_PNMA5">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 knockdown caused significantly lower fertilization in in-vitro fertilization (IVF).</data>
</edge>
<edge source="PDF_09_2017_Result_-4894716366255718112" target="Protein_PNMA5">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 knockdown was found to significantly decrease the stability of spindle microtubules and altered F-actin organization within actin cap regions, cause significantly abnormal mitochondria aggregation and lower ATP concentration.</data>
</edge>
<edge source="PDF_09_2017_Result_-4284888244655995464" target="Protein_PNMA5">
  <data key="d8">MENTIONS</data>
  <data key="d9">Phosphorylation at Thr533 re-located Pnma5 strongly to spindles &amp; cortex and was required for the phosphorylation of Akt and Gsk3ẞ, while Src and Erk1/2 phosphorylation was required for the phosphorylation of Pnma5, indicating that phosphorylated Pnma5 is the active form and subsequently activates Akt and Gsk3ẞ.</data>
</edge>
<edge source="PDF_09_2017_Result_-4284888244655995464" target="Protein_AKT1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Phosphorylation at Thr533 re-located Pnma5 strongly to spindles &amp; cortex and was required for the phosphorylation of Akt and Gsk3ẞ, while Src and Erk1/2 phosphorylation was required for the phosphorylation of Pnma5, indicating that phosphorylated Pnma5 is the active form and subsequently activates Akt and Gsk3ẞ.</data>
</edge>
<edge source="PDF_09_2017_Result_-4284888244655995464" target="Protein_GSK3B">
  <data key="d8">MENTIONS</data>
  <data key="d9">Phosphorylation at Thr533 re-located Pnma5 strongly to spindles &amp; cortex and was required for the phosphorylation of Akt and Gsk3ẞ, while Src and Erk1/2 phosphorylation was required for the phosphorylation of Pnma5, indicating that phosphorylated Pnma5 is the active form and subsequently activates Akt and Gsk3ẞ.</data>
</edge>
<edge source="PDF_09_2017_Result_-4284888244655995464" target="Gene_SRC">
  <data key="d8">MENTIONS</data>
  <data key="d9">Phosphorylation at Thr533 re-located Pnma5 strongly to spindles &amp; cortex and was required for the phosphorylation of Akt and Gsk3ẞ, while Src and Erk1/2 phosphorylation was required for the phosphorylation of Pnma5, indicating that phosphorylated Pnma5 is the active form and subsequently activates Akt and Gsk3ẞ.</data>
</edge>
<edge source="PDF_09_2017_Result_-4284888244655995464" target="Protein_ERK1/2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Phosphorylation at Thr533 re-located Pnma5 strongly to spindles &amp; cortex and was required for the phosphorylation of Akt and Gsk3ẞ, while Src and Erk1/2 phosphorylation was required for the phosphorylation of Pnma5, indicating that phosphorylated Pnma5 is the active form and subsequently activates Akt and Gsk3ẞ.</data>
</edge>
<edge source="PDF_09_2017_Conclusion_-6511780672371724639" target="Protein_PNMA5">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 is important for meiosis and is the pivot of Src→Erk1/2→Pnma5→Akt→Gsk3ẞ pathway.</data>
</edge>
<edge source="PDF_09_2017_Conclusion_-6511780672371724639" target="Process_MEIOSIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 is important for meiosis and is the pivot of Src→Erk1/2→Pnma5→Akt→Gsk3ẞ pathway.</data>
</edge>
<edge source="PDF_09_2017_Conclusion_-6511780672371724639" target="Gene_SRC">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 is important for meiosis and is the pivot of Src→Erk1/2→Pnma5→Akt→Gsk3ẞ pathway.</data>
</edge>
<edge source="PDF_09_2017_Conclusion_-6511780672371724639" target="Protein_ERK1/2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 is important for meiosis and is the pivot of Src→Erk1/2→Pnma5→Akt→Gsk3ẞ pathway.</data>
</edge>
<edge source="PDF_09_2017_Conclusion_-6511780672371724639" target="Protein_AKT1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 is important for meiosis and is the pivot of Src→Erk1/2→Pnma5→Akt→Gsk3ẞ pathway.</data>
</edge>
<edge source="PDF_09_2017_Conclusion_-6511780672371724639" target="Protein_GSK3B">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 is important for meiosis and is the pivot of Src→Erk1/2→Pnma5→Akt→Gsk3ẞ pathway.</data>
</edge>
<edge source="PDF_09_2017_Result_-6261464948747278153" target="Protein_PNMA5">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 is much more prominent in oocytes than in GCs and is the most abundant among PNMAs in oocytes, suggesting that compared with the others, Pnma5 is the selected Pnma family member particularly important in oocytes.</data>
</edge>
<edge source="PDF_09_2017_Result_5312661458836239154" target="Protein_PNMA5">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 knockdown was found to cause significant meiotic defects, which was manifested mainly through delayed meiotic resumption, disturbed meiosis I, abnormal anaphase I with lagging chromosomes.</data>
</edge>
<edge source="PDF_09_2017_Result_5312661458836239154" target="Process_MEIOSIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 knockdown was found to cause significant meiotic defects, which was manifested mainly through delayed meiotic resumption, disturbed meiosis I, abnormal anaphase I with lagging chromosomes.</data>
</edge>
<edge source="PDF_09_2017_Result_-4283512138045495103" target="Protein_PNMA5">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 knockdown also significantly decreased the level of acetylated tubulin, a major form of stable microtubules within spindles, which were also closely related to the meiotic defects.</data>
</edge>
<edge source="PDF_09_2017_Result_-3556133635542159306" target="Protein_PNMA5">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 knockdown significantly affected the translocation of MI spindles and the organization of F-actin at actin cap region.</data>
</edge>
<edge source="PDF_09_2017_Result_7013219452746291712" target="Protein_PNMA5">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 knockdown dramatically increased abnormal MII oocytes with less congressed chromosomes.</data>
</edge>
<edge source="PDF_09_2017_Result_4678989147869615074" target="Protein_PNMA5">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 knockdown also dramatically disrupted mitochondrial distribution and significantly decreased ATP levels in maturated MII oocytes.</data>
</edge>
<edge source="PDF_09_2017_Result_7887175685820429368" target="Protein_PNMA5">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 phosphorylation is controlled by upstream phosphorylation of Src→Erk1/2, since it's well-known that Src Erk1/2 is activatied by phosphorylation, so probably the phosphorylated Pnma5 is the active form of total Pnma5.</data>
</edge>
<edge source="PDF_09_2017_Result_7887175685820429368" target="Gene_SRC">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 phosphorylation is controlled by upstream phosphorylation of Src→Erk1/2, since it's well-known that Src Erk1/2 is activatied by phosphorylation, so probably the phosphorylated Pnma5 is the active form of total Pnma5.</data>
</edge>
<edge source="PDF_09_2017_Result_7887175685820429368" target="Protein_ERK1/2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 phosphorylation is controlled by upstream phosphorylation of Src→Erk1/2, since it's well-known that Src Erk1/2 is activatied by phosphorylation, so probably the phosphorylated Pnma5 is the active form of total Pnma5.</data>
</edge>
<edge source="PDF_09_2017_Result_-3423247757071777685" target="Protein_PNMA5">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 could phosphorylate downstream Akt→Gsk3ẞ.</data>
</edge>
<edge source="PDF_09_2017_Result_-3423247757071777685" target="Protein_AKT1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 could phosphorylate downstream Akt→Gsk3ẞ.</data>
</edge>
<edge source="PDF_09_2017_Result_-3423247757071777685" target="Protein_GSK3B">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma5 could phosphorylate downstream Akt→Gsk3ẞ.</data>
</edge>
<edge source="PDF_09_2017_Conclusion_2714058693539317562" target="Protein_PNMA5">
  <data key="d8">MENTIONS</data>
  <data key="d9">The signal pathway for Pnma5 appears to be Src Erk1/2→Pnma5→Akt→Gsk3ẞ, where Pnma5 is at a pivotal position.</data>
</edge>
<edge source="PDF_09_2017_Conclusion_2714058693539317562" target="Gene_SRC">
  <data key="d8">MENTIONS</data>
  <data key="d9">The signal pathway for Pnma5 appears to be Src Erk1/2→Pnma5→Akt→Gsk3ẞ, where Pnma5 is at a pivotal position.</data>
</edge>
<edge source="PDF_09_2017_Conclusion_2714058693539317562" target="Protein_ERK1/2">
  <data key="d8">MENTIONS</data>
  <data key="d9">The signal pathway for Pnma5 appears to be Src Erk1/2→Pnma5→Akt→Gsk3ẞ, where Pnma5 is at a pivotal position.</data>
</edge>
<edge source="PDF_09_2017_Conclusion_2714058693539317562" target="Protein_AKT1">
  <data key="d8">MENTIONS</data>
  <data key="d9">The signal pathway for Pnma5 appears to be Src Erk1/2→Pnma5→Akt→Gsk3ẞ, where Pnma5 is at a pivotal position.</data>
</edge>
<edge source="PDF_09_2017_Conclusion_2714058693539317562" target="Protein_GSK3B">
  <data key="d8">MENTIONS</data>
  <data key="d9">The signal pathway for Pnma5 appears to be Src Erk1/2→Pnma5→Akt→Gsk3ẞ, where Pnma5 is at a pivotal position.</data>
</edge>
<edge source="PDF_41_2007" target="PDF_41_2007_Hypothesis_1845554087649987154">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_41_2007" target="PDF_41_2007_Method_4932639676826302701">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_41_2007" target="PDF_41_2007_Method_1326454549095164944">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_41_2007" target="PDF_41_2007_Method_-6634265973247530439">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_41_2007" target="PDF_41_2007_Method_4907608771826218470">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_41_2007" target="PDF_41_2007_Method_9218436023312221288">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_41_2007" target="PDF_41_2007_Method_-8368613888239113054">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_41_2007" target="PDF_41_2007_Result_-4440267453667459716">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_41_2007" target="PDF_41_2007_Result_875328654420229611">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_41_2007" target="PDF_41_2007_Result_5235726866360229377">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_41_2007" target="PDF_41_2007_Result_4840550149737968855">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_41_2007" target="PDF_41_2007_Result_7968539060733958719">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_41_2007" target="PDF_41_2007_Result_3554482876249373722">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_41_2007" target="PDF_41_2007_Result_-3382147042930824034">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_41_2007" target="PDF_41_2007_Result_5909327930269608857">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_41_2007" target="PDF_41_2007_Result_-7980773298399431532">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_41_2007" target="PDF_41_2007_Conclusion_-6269182097353802293">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_41_2007_Hypothesis_1845554087649987154" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">apoptotic stimuli can facilitate the proapoptotic function of Bax in mitochondria through stabilization of MOAP-1</data>
</edge>
<edge source="PDF_41_2007_Hypothesis_1845554087649987154" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">apoptotic stimuli can facilitate the proapoptotic function of Bax in mitochondria through stabilization of MOAP-1</data>
</edge>
<edge source="PDF_41_2007_Method_1326454549095164944" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1 mRNA levels by real-time PCR</data>
</edge>
<edge source="PDF_41_2007_Method_-6634265973247530439" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">cells were transiently transfected with a HA-tagged MOAP-1-expressing plasmid</data>
</edge>
<edge source="PDF_41_2007_Result_-4440267453667459716" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1 protein levels were first found to be rapidly up-regulated in HCT116, H1299, SY5Y, and HeLa cells upon tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) treatment</data>
</edge>
<edge source="PDF_41_2007_Result_-4440267453667459716" target="Protein_TRAIL">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1 protein levels were first found to be rapidly up-regulated in HCT116, H1299, SY5Y, and HeLa cells upon tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) treatment</data>
</edge>
<edge source="PDF_41_2007_Result_875328654420229611" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">the induction of MOAP-1 by TRAIL displayed a fast kinetics similar to Bax activation in the HCT116, H1299 and HeLa cells</data>
</edge>
<edge source="PDF_41_2007_Result_875328654420229611" target="Protein_TRAIL">
  <data key="d8">MENTIONS</data>
  <data key="d9">the induction of MOAP-1 by TRAIL displayed a fast kinetics similar to Bax activation in the HCT116, H1299 and HeLa cells</data>
</edge>
<edge source="PDF_41_2007_Result_875328654420229611" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">the induction of MOAP-1 by TRAIL displayed a fast kinetics similar to Bax activation in the HCT116, H1299 and HeLa cells</data>
</edge>
<edge source="PDF_41_2007_Result_5235726866360229377" target="Protein_TRAIL">
  <data key="d8">MENTIONS</data>
  <data key="d9">TRAIL failed to induce Bax activation and apoptosis in SY5Y cells, it was effective in triggering up-regulation of MOAP-1 protein in these cells</data>
</edge>
<edge source="PDF_41_2007_Result_5235726866360229377" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">TRAIL failed to induce Bax activation and apoptosis in SY5Y cells, it was effective in triggering up-regulation of MOAP-1 protein in these cells</data>
</edge>
<edge source="PDF_41_2007_Result_5235726866360229377" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">TRAIL failed to induce Bax activation and apoptosis in SY5Y cells, it was effective in triggering up-regulation of MOAP-1 protein in these cells</data>
</edge>
<edge source="PDF_41_2007_Result_5235726866360229377" target="Process_APOPTOSIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">TRAIL failed to induce Bax activation and apoptosis in SY5Y cells, it was effective in triggering up-regulation of MOAP-1 protein in these cells</data>
</edge>
<edge source="PDF_41_2007_Result_4840550149737968855" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">all apoptotic stimuli tested were able to rapidly enhance MOAP-1 levels in mammalian cell lines, including SY5Y, HCT116, HepG2, 293T, H1299, and HeLa cells</data>
</edge>
<edge source="PDF_41_2007_Result_7968539060733958719" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">The broad spectrum caspase inhibitor z-VAD failed to inhibit MOAP-1 up-regulation by ETOP and TRAIL, whereas it effectively blocked DNA fragmentation</data>
</edge>
<edge source="PDF_41_2007_Result_7968539060733958719" target="Compound_ETOP">
  <data key="d8">MENTIONS</data>
  <data key="d9">The broad spectrum caspase inhibitor z-VAD failed to inhibit MOAP-1 up-regulation by ETOP and TRAIL, whereas it effectively blocked DNA fragmentation</data>
</edge>
<edge source="PDF_41_2007_Result_7968539060733958719" target="Protein_TRAIL">
  <data key="d8">MENTIONS</data>
  <data key="d9">The broad spectrum caspase inhibitor z-VAD failed to inhibit MOAP-1 up-regulation by ETOP and TRAIL, whereas it effectively blocked DNA fragmentation</data>
</edge>
<edge source="PDF_41_2007_Result_3554482876249373722" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Similar to the endogenous MOAP-1 protein, the levels of HA-tagged MOAP-1 protein were rapidly increased by treatment with TRAIL or ETOP</data>
</edge>
<edge source="PDF_41_2007_Result_3554482876249373722" target="Protein_TRAIL">
  <data key="d8">MENTIONS</data>
  <data key="d9">Similar to the endogenous MOAP-1 protein, the levels of HA-tagged MOAP-1 protein were rapidly increased by treatment with TRAIL or ETOP</data>
</edge>
<edge source="PDF_41_2007_Result_3554482876249373722" target="Compound_ETOP">
  <data key="d8">MENTIONS</data>
  <data key="d9">Similar to the endogenous MOAP-1 protein, the levels of HA-tagged MOAP-1 protein were rapidly increased by treatment with TRAIL or ETOP</data>
</edge>
<edge source="PDF_41_2007_Result_-3382147042930824034" target="Protein_TRAIL">
  <data key="d8">MENTIONS</data>
  <data key="d9">TRAIL or ETOP treatment led to a pronounced extension of MOAP-1 half-life compared with the untreated control</data>
</edge>
<edge source="PDF_41_2007_Result_-3382147042930824034" target="Compound_ETOP">
  <data key="d8">MENTIONS</data>
  <data key="d9">TRAIL or ETOP treatment led to a pronounced extension of MOAP-1 half-life compared with the untreated control</data>
</edge>
<edge source="PDF_41_2007_Result_-3382147042930824034" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">TRAIL or ETOP treatment led to a pronounced extension of MOAP-1 half-life compared with the untreated control</data>
</edge>
<edge source="PDF_41_2007_Result_5909327930269608857" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">only the proteasome inhibitors (i.e., MG132, LLnL, epoxomycin and lactacystin) were found to dramatically elevate endogenous MOAP-1 protein levels through extension of its half-life</data>
</edge>
<edge source="PDF_41_2007_Result_-7980773298399431532" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1 knockdown by RNAi has been shown to attenuate recombinant Bax- and tBid- mediated Cyto c release</data>
</edge>
<edge source="PDF_41_2007_Result_-7980773298399431532" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">MOAP-1 knockdown by RNAi has been shown to attenuate recombinant Bax- and tBid- mediated Cyto c release</data>
</edge>
<edge source="PDF_41_2007_Conclusion_-6269182097353802293" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">We propose that apoptotic stimuli can facilitate the proapoptotic function of Bax in mitochondria through stabilization of MOAP-1.</data>
</edge>
<edge source="PDF_41_2007_Conclusion_-6269182097353802293" target="Protein_MOAP-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">We propose that apoptotic stimuli can facilitate the proapoptotic function of Bax in mitochondria through stabilization of MOAP-1.</data>
</edge>
<edge source="PDF_17_2020" target="PDF_17_2020_Result_-980599211666020308">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_17_2020" target="PDF_17_2020_Result_-6168667314122613882">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_17_2020" target="PDF_17_2020_Result_-7733120735039512864">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_17_2020" target="PDF_17_2020_Result_4232220067037490103">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_17_2020" target="PDF_17_2020_Conclusion_7910753888088406109">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_17_2020" target="PDF_17_2020_Result_-8982414712985685890">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_17_2020" target="PDF_17_2020_Result_4657786812539322725">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_17_2020" target="PDF_17_2020_Result_-8139204930781012277">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_17_2020" target="PDF_17_2020_Result_-4104397398872225064">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_17_2020" target="PDF_17_2020_Result_-3525531358675821859">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_17_2020" target="PDF_17_2020_Result_-7563912959373531681">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_17_2020" target="PDF_17_2020_Result_8103721274521775049">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_17_2020" target="PDF_17_2020_Result_-3316046931134377020">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_17_2020" target="PDF_17_2020_Result_-6722892752945433645">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_17_2020" target="PDF_17_2020_Result_2889273631862273294">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_17_2020" target="PDF_17_2020_Result_-4520606036701953389">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_17_2020" target="PDF_17_2020_Conclusion_9156115554715097118">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_17_2020" target="PDF_17_2020_Result_5606996305972567241">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_17_2020_Result_-980599211666020308" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">DAZL depletion causes a block in maturation and widespread disruption in the pattern of ribosome loading on maternal transcripts.</data>
</edge>
<edge source="PDF_17_2020_Result_-6168667314122613882" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">DAZL depletion also causes translational activation of a distinct subset of mRNAs both in quiescent and maturing oocytes.</data>
</edge>
<edge source="PDF_17_2020_Result_-6168667314122613882" target="Gene_MRNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">DAZL depletion also causes translational activation of a distinct subset of mRNAs both in quiescent and maturing oocytes.</data>
</edge>
<edge source="PDF_17_2020_Result_-7733120735039512864" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">DAZL binds to mRNAs whose translation is both repressed and activated during maturation.</data>
</edge>
<edge source="PDF_17_2020_Result_-7733120735039512864" target="Gene_MRNAS">
  <data key="d8">MENTIONS</data>
  <data key="d9">DAZL binds to mRNAs whose translation is both repressed and activated during maturation.</data>
</edge>
<edge source="PDF_17_2020_Result_4232220067037490103" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">Injection of recombinant DAZL protein in DAZL-depleted oocytes rescues the translation and maturation to MII.</data>
</edge>
<edge source="PDF_17_2020_Conclusion_7910753888088406109" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">DAZL regulates translation of maternal mRNAs, functioning both as the translational repressor and activator during oocyte maturation.</data>
</edge>
<edge source="PDF_17_2020_Conclusion_7910753888088406109" target="Gene_MRNAS">
  <data key="d8">MENTIONS</data>
  <data key="d9">DAZL regulates translation of maternal mRNAs, functioning both as the translational repressor and activator during oocyte maturation.</data>
</edge>
<edge source="PDF_17_2020_Result_-8982414712985685890" target="Gene_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">Blockage of Dazl mRNA translation by this specific MO markedly reduces the endogenous DAZL protein expression compared to a CON-MO.</data>
</edge>
<edge source="PDF_17_2020_Result_-8982414712985685890" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">Blockage of Dazl mRNA translation by this specific MO markedly reduces the endogenous DAZL protein expression compared to a CON-MO.</data>
</edge>
<edge source="PDF_17_2020_Result_4657786812539322725" target="Gene_TEX19">
  <data key="d8">MENTIONS</data>
  <data key="d9">mRNA loading onto ribosomes of Tex19.1 is significantly decreased after injection of DAZL-MO at the MI stage.</data>
</edge>
<edge source="PDF_17_2020_Result_4657786812539322725" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">mRNA loading onto ribosomes of Tex19.1 is significantly decreased after injection of DAZL-MO at the MI stage.</data>
</edge>
<edge source="PDF_17_2020_Result_-8139204930781012277" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">Knockdown of DAZL had no effect on ribosome loading onto the non-target CcnB1.</data>
</edge>
<edge source="PDF_17_2020_Result_-8139204930781012277" target="Gene_CCNB1">
  <data key="d8">MENTIONS</data>
  <data key="d9">Knockdown of DAZL had no effect on ribosome loading onto the non-target CcnB1.</data>
</edge>
<edge source="PDF_17_2020_Result_-4104397398872225064" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">DAZL depletion disrupts oocyte maturation to MII.</data>
</edge>
<edge source="PDF_17_2020_Result_-3525531358675821859" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">DAZL depletion causes increases and decreases in translational efficiency of a wide range of transcripts expressed in the oocyte.</data>
</edge>
<edge source="PDF_17_2020_Result_-7563912959373531681" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">Ribosome loading onto a group of transcripts decreases after DAZL depletion.</data>
</edge>
<edge source="PDF_17_2020_Result_8103721274521775049" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">A group of transcripts whose translation increases after DAZL removal was identified.</data>
</edge>
<edge source="PDF_17_2020_Result_-3316046931134377020" target="Gene_TEX19">
  <data key="d8">MENTIONS</data>
  <data key="d9">RiboTag IP/RNA-Seq shows an increase in ribosome loading for transcripts Tex19.1 and Txnip during maturation in CON-MO injected oocytes, whereas the recruitment is blunted after DAZL KD in MI stage.</data>
</edge>
<edge source="PDF_17_2020_Result_-3316046931134377020" target="Gene_TXNIP">
  <data key="d8">MENTIONS</data>
  <data key="d9">RiboTag IP/RNA-Seq shows an increase in ribosome loading for transcripts Tex19.1 and Txnip during maturation in CON-MO injected oocytes, whereas the recruitment is blunted after DAZL KD in MI stage.</data>
</edge>
<edge source="PDF_17_2020_Result_-3316046931134377020" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">RiboTag IP/RNA-Seq shows an increase in ribosome loading for transcripts Tex19.1 and Txnip during maturation in CON-MO injected oocytes, whereas the recruitment is blunted after DAZL KD in MI stage.</data>
</edge>
<edge source="PDF_17_2020_Result_-6722892752945433645" target="Gene_AKAP10">
  <data key="d8">MENTIONS</data>
  <data key="d9">Ribosome loading onto Akap10 and Nsf mRNAs is increased after DAZL depletion.</data>
</edge>
<edge source="PDF_17_2020_Result_-6722892752945433645" target="Gene_NSF">
  <data key="d8">MENTIONS</data>
  <data key="d9">Ribosome loading onto Akap10 and Nsf mRNAs is increased after DAZL depletion.</data>
</edge>
<edge source="PDF_17_2020_Result_-6722892752945433645" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">Ribosome loading onto Akap10 and Nsf mRNAs is increased after DAZL depletion.</data>
</edge>
<edge source="PDF_17_2020_Result_2889273631862273294" target="Gene_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">RiboTag IP/qPCR shows a decrease in translation for Dazl, Tex19.1, Txnip, Rad51C, Btg4, Erol, Oosp1, Obox5, Ireb2, and Tcll after DAZL removal.</data>
</edge>
<edge source="PDF_17_2020_Result_2889273631862273294" target="Gene_TEX19">
  <data key="d8">MENTIONS</data>
  <data key="d9">RiboTag IP/qPCR shows a decrease in translation for Dazl, Tex19.1, Txnip, Rad51C, Btg4, Erol, Oosp1, Obox5, Ireb2, and Tcll after DAZL removal.</data>
</edge>
<edge source="PDF_17_2020_Result_2889273631862273294" target="Gene_TXNIP">
  <data key="d8">MENTIONS</data>
  <data key="d9">RiboTag IP/qPCR shows a decrease in translation for Dazl, Tex19.1, Txnip, Rad51C, Btg4, Erol, Oosp1, Obox5, Ireb2, and Tcll after DAZL removal.</data>
</edge>
<edge source="PDF_17_2020_Result_2889273631862273294" target="Gene_RAD51C">
  <data key="d8">MENTIONS</data>
  <data key="d9">RiboTag IP/qPCR shows a decrease in translation for Dazl, Tex19.1, Txnip, Rad51C, Btg4, Erol, Oosp1, Obox5, Ireb2, and Tcll after DAZL removal.</data>
</edge>
<edge source="PDF_17_2020_Result_2889273631862273294" target="Gene_BTG4">
  <data key="d8">MENTIONS</data>
  <data key="d9">RiboTag IP/qPCR shows a decrease in translation for Dazl, Tex19.1, Txnip, Rad51C, Btg4, Erol, Oosp1, Obox5, Ireb2, and Tcll after DAZL removal.</data>
</edge>
<edge source="PDF_17_2020_Result_2889273631862273294" target="Gene_EROL">
  <data key="d8">MENTIONS</data>
  <data key="d9">RiboTag IP/qPCR shows a decrease in translation for Dazl, Tex19.1, Txnip, Rad51C, Btg4, Erol, Oosp1, Obox5, Ireb2, and Tcll after DAZL removal.</data>
</edge>
<edge source="PDF_17_2020_Result_2889273631862273294" target="Gene_OOSP1">
  <data key="d8">MENTIONS</data>
  <data key="d9">RiboTag IP/qPCR shows a decrease in translation for Dazl, Tex19.1, Txnip, Rad51C, Btg4, Erol, Oosp1, Obox5, Ireb2, and Tcll after DAZL removal.</data>
</edge>
<edge source="PDF_17_2020_Result_2889273631862273294" target="Gene_OBOX5">
  <data key="d8">MENTIONS</data>
  <data key="d9">RiboTag IP/qPCR shows a decrease in translation for Dazl, Tex19.1, Txnip, Rad51C, Btg4, Erol, Oosp1, Obox5, Ireb2, and Tcll after DAZL removal.</data>
</edge>
<edge source="PDF_17_2020_Result_2889273631862273294" target="Gene_IREB2">
  <data key="d8">MENTIONS</data>
  <data key="d9">RiboTag IP/qPCR shows a decrease in translation for Dazl, Tex19.1, Txnip, Rad51C, Btg4, Erol, Oosp1, Obox5, Ireb2, and Tcll after DAZL removal.</data>
</edge>
<edge source="PDF_17_2020_Result_2889273631862273294" target="Gene_TCLL">
  <data key="d8">MENTIONS</data>
  <data key="d9">RiboTag IP/qPCR shows a decrease in translation for Dazl, Tex19.1, Txnip, Rad51C, Btg4, Erol, Oosp1, Obox5, Ireb2, and Tcll after DAZL removal.</data>
</edge>
<edge source="PDF_17_2020_Result_2889273631862273294" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">RiboTag IP/qPCR shows a decrease in translation for Dazl, Tex19.1, Txnip, Rad51C, Btg4, Erol, Oosp1, Obox5, Ireb2, and Tcll after DAZL removal.</data>
</edge>
<edge source="PDF_17_2020_Result_-4520606036701953389" target="Gene_AKAP10">
  <data key="d8">MENTIONS</data>
  <data key="d9">Translation of transcripts coding for Akap10, Cenpe, Nsf, Ywhaz, Nin, and YTHDF3 is upregulated after DAZL removal.</data>
</edge>
<edge source="PDF_17_2020_Result_-4520606036701953389" target="Gene_CENPE">
  <data key="d8">MENTIONS</data>
  <data key="d9">Translation of transcripts coding for Akap10, Cenpe, Nsf, Ywhaz, Nin, and YTHDF3 is upregulated after DAZL removal.</data>
</edge>
<edge source="PDF_17_2020_Result_-4520606036701953389" target="Gene_NSF">
  <data key="d8">MENTIONS</data>
  <data key="d9">Translation of transcripts coding for Akap10, Cenpe, Nsf, Ywhaz, Nin, and YTHDF3 is upregulated after DAZL removal.</data>
</edge>
<edge source="PDF_17_2020_Result_-4520606036701953389" target="Gene_YWHAZ">
  <data key="d8">MENTIONS</data>
  <data key="d9">Translation of transcripts coding for Akap10, Cenpe, Nsf, Ywhaz, Nin, and YTHDF3 is upregulated after DAZL removal.</data>
</edge>
<edge source="PDF_17_2020_Result_-4520606036701953389" target="Gene_NIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">Translation of transcripts coding for Akap10, Cenpe, Nsf, Ywhaz, Nin, and YTHDF3 is upregulated after DAZL removal.</data>
</edge>
<edge source="PDF_17_2020_Result_-4520606036701953389" target="Gene_YTHDF3">
  <data key="d8">MENTIONS</data>
  <data key="d9">Translation of transcripts coding for Akap10, Cenpe, Nsf, Ywhaz, Nin, and YTHDF3 is upregulated after DAZL removal.</data>
</edge>
<edge source="PDF_17_2020_Result_-4520606036701953389" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">Translation of transcripts coding for Akap10, Cenpe, Nsf, Ywhaz, Nin, and YTHDF3 is upregulated after DAZL removal.</data>
</edge>
<edge source="PDF_17_2020_Conclusion_9156115554715097118" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">DAZL may play a dual function (both translational activator and repressor) during oocyte maturation.</data>
</edge>
<edge source="PDF_17_2020_Result_5606996305972567241" target="Protein_DAZL">
  <data key="d8">MENTIONS</data>
  <data key="d9">DAZL binding to maternal mRNA leads to an increase and decrease in translation.</data>
</edge>
<edge source="PDF_17_2020_Result_5606996305972567241" target="Gene_MRNA">
  <data key="d8">MENTIONS</data>
  <data key="d9">DAZL binding to maternal mRNA leads to an increase and decrease in translation.</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_-2585656780267943343">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Method_-1631782468720367454">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_-2325768832848065975">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_233866424154959566">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_240066150997085673">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_-5201337009747604388">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_6834090465481552738">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_1698627113773803473">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_5125497776235445436">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_-6827799273926872532">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_4797238506809767795">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_-3520867239035683269">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_-5731736455124499248">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_-6837675869442569123">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_-2168887568482952382">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_418644541576375920">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_7147866663107401983">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_1132378231311873623">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_-4558964390352668683">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_4538883070159406809">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_7098111269807349278">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_-7548059631000195813">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_8218078299226839869">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_-603430371271684152">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_-3106995970904756223">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_-8265794064548944133">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_-2116837359288474551">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_2575703314355210802">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_-2361164632489912218">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_-6354715977465030224">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_-8766377227572290641">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_-738583257906051561">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_4332550590543243693">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_-967102195879578252">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_-478275195892596815">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_7278440245603404407">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_1100926031557611908">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_6419039013111316253">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_739995519673443118">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_8015836603834141161">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018" target="PDF_13_2018_Result_3390424010982936346">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_13_2018_Result_-2585656780267943343" target="Gene_HMGA1">
  <data key="d8">MENTIONS</data>
  <data key="d9">scRNA-seq analysis identified stage-specific marker genes of human germ cells, such as HMGA1, PIWIL4, TEX29, SCML1, and CCDC112.</data>
</edge>
<edge source="PDF_13_2018_Result_-2585656780267943343" target="Gene_PIWIL4">
  <data key="d8">MENTIONS</data>
  <data key="d9">scRNA-seq analysis identified stage-specific marker genes of human germ cells, such as HMGA1, PIWIL4, TEX29, SCML1, and CCDC112.</data>
</edge>
<edge source="PDF_13_2018_Result_-2585656780267943343" target="Gene_TEX29">
  <data key="d8">MENTIONS</data>
  <data key="d9">scRNA-seq analysis identified stage-specific marker genes of human germ cells, such as HMGA1, PIWIL4, TEX29, SCML1, and CCDC112.</data>
</edge>
<edge source="PDF_13_2018_Result_-2585656780267943343" target="Gene_SCML1">
  <data key="d8">MENTIONS</data>
  <data key="d9">scRNA-seq analysis identified stage-specific marker genes of human germ cells, such as HMGA1, PIWIL4, TEX29, SCML1, and CCDC112.</data>
</edge>
<edge source="PDF_13_2018_Result_-2585656780267943343" target="Gene_CCDC112">
  <data key="d8">MENTIONS</data>
  <data key="d9">scRNA-seq analysis identified stage-specific marker genes of human germ cells, such as HMGA1, PIWIL4, TEX29, SCML1, and CCDC112.</data>
</edge>
<edge source="PDF_13_2018_Result_-2325768832848065975" target="Gene_GFRA1">
  <data key="d8">MENTIONS</data>
  <data key="d9">GFRA1, UTF1, KIT, MKI67, and STRA8 were specifically expressed in clusters 1, 2, and 3, respectively.</data>
</edge>
<edge source="PDF_13_2018_Result_-2325768832848065975" target="Gene_UTF1">
  <data key="d8">MENTIONS</data>
  <data key="d9">GFRA1, UTF1, KIT, MKI67, and STRA8 were specifically expressed in clusters 1, 2, and 3, respectively.</data>
</edge>
<edge source="PDF_13_2018_Result_-2325768832848065975" target="Gene_KIT">
  <data key="d8">MENTIONS</data>
  <data key="d9">GFRA1, UTF1, KIT, MKI67, and STRA8 were specifically expressed in clusters 1, 2, and 3, respectively.</data>
</edge>
<edge source="PDF_13_2018_Result_-2325768832848065975" target="Gene_MKI67">
  <data key="d8">MENTIONS</data>
  <data key="d9">GFRA1, UTF1, KIT, MKI67, and STRA8 were specifically expressed in clusters 1, 2, and 3, respectively.</data>
</edge>
<edge source="PDF_13_2018_Result_-2325768832848065975" target="Gene_STRA8">
  <data key="d8">MENTIONS</data>
  <data key="d9">GFRA1, UTF1, KIT, MKI67, and STRA8 were specifically expressed in clusters 1, 2, and 3, respectively.</data>
</edge>
<edge source="PDF_13_2018_Result_233866424154959566" target="Gene_SPO11">
  <data key="d8">MENTIONS</data>
  <data key="d9">SPO11 and SYCP1, markers of meiotic-specific double-strand breaks and synapsis, respectively, were expressed in clusters 4-7.</data>
</edge>
<edge source="PDF_13_2018_Result_233866424154959566" target="Gene_SYCP1">
  <data key="d8">MENTIONS</data>
  <data key="d9">SPO11 and SYCP1, markers of meiotic-specific double-strand breaks and synapsis, respectively, were expressed in clusters 4-7.</data>
</edge>
<edge source="PDF_13_2018_Result_240066150997085673" target="Gene_TEX19">
  <data key="d8">MENTIONS</data>
  <data key="d9">TEX19, a regulator of SPO11-dependent meiotic recombination in leptotene, was mainly expressed in clusters 3-6.</data>
</edge>
<edge source="PDF_13_2018_Result_240066150997085673" target="Gene_SPO11">
  <data key="d8">MENTIONS</data>
  <data key="d9">TEX19, a regulator of SPO11-dependent meiotic recombination in leptotene, was mainly expressed in clusters 3-6.</data>
</edge>
<edge source="PDF_13_2018_Result_-5201337009747604388" target="Gene_OVOL1">
  <data key="d8">MENTIONS</data>
  <data key="d9">OVOL1 and OVOL2, which are localized in the XY body of and human spermatocytes at the pachytene and diplotene stages, were exclusively highly expressed in clusters 8 and 9.</data>
</edge>
<edge source="PDF_13_2018_Result_-5201337009747604388" target="Gene_OVOL2">
  <data key="d8">MENTIONS</data>
  <data key="d9">OVOL1 and OVOL2, which are localized in the XY body of and human spermatocytes at the pachytene and diplotene stages, were exclusively highly expressed in clusters 8 and 9.</data>
</edge>
<edge source="PDF_13_2018_Result_6834090465481552738" target="Gene_NME8">
  <data key="d8">MENTIONS</data>
  <data key="d9">NME8, which is expressed from pachytene spermatocytes to the early stage of spermatids, was expressed from cluster 8 to cluster 11.</data>
</edge>
<edge source="PDF_13_2018_Result_1698627113773803473" target="Gene_TXNDC2">
  <data key="d8">MENTIONS</data>
  <data key="d9">TXNDC2, the marker gene of round spermatids and elongated spermatids, was highly expressed in clusters 11 and 12</data>
</edge>
<edge source="PDF_13_2018_Result_5125497776235445436" target="Gene_TNP1">
  <data key="d8">MENTIONS</data>
  <data key="d9">TNP1 and PRM1, two markers of spermatids or spermatozoa, clusters 11, 12, 13, and 14 were the four stages of spermatids</data>
</edge>
<edge source="PDF_13_2018_Result_5125497776235445436" target="Gene_PRM1">
  <data key="d8">MENTIONS</data>
  <data key="d9">TNP1 and PRM1, two markers of spermatids or spermatozoa, clusters 11, 12, 13, and 14 were the four stages of spermatids</data>
</edge>
<edge source="PDF_13_2018_Result_-6827799273926872532" target="Gene_AMH">
  <data key="d8">MENTIONS</data>
  <data key="d9">AMH and SOX9 specifically expressed by Sertoli cells</data>
</edge>
<edge source="PDF_13_2018_Result_-6827799273926872532" target="Gene_SOX9">
  <data key="d8">MENTIONS</data>
  <data key="d9">AMH and SOX9 specifically expressed by Sertoli cells</data>
</edge>
<edge source="PDF_13_2018_Result_4797238506809767795" target="Gene_MYH11">
  <data key="d8">MENTIONS</data>
  <data key="d9">MYH11 and DLK1 were particularly expressed in peritubular myoid cells (PMCs) and Leydig cells</data>
</edge>
<edge source="PDF_13_2018_Result_4797238506809767795" target="Gene_DLK1">
  <data key="d8">MENTIONS</data>
  <data key="d9">MYH11 and DLK1 were particularly expressed in peritubular myoid cells (PMCs) and Leydig cells</data>
</edge>
<edge source="PDF_13_2018_Result_-3520867239035683269" target="Gene_CD68">
  <data key="d8">MENTIONS</data>
  <data key="d9">CD68 and CD163 exclusively expressed by testicular macrophages (tMφ)</data>
</edge>
<edge source="PDF_13_2018_Result_-3520867239035683269" target="Gene_CD163">
  <data key="d8">MENTIONS</data>
  <data key="d9">CD68 and CD163 exclusively expressed by testicular macrophages (tMφ)</data>
</edge>
<edge source="PDF_13_2018_Result_-5731736455124499248" target="Gene_HMGA1">
  <data key="d8">MENTIONS</data>
  <data key="d9">HMGA1 was actively transcribed in the spermatogonia located near the basal layer of seminiferous epithelium</data>
</edge>
<edge source="PDF_13_2018_Result_-6837675869442569123" target="Gene_SCML1">
  <data key="d8">MENTIONS</data>
  <data key="d9">SCML1 exhibited similar expression pattern to that of DMC1 in spermatocytes</data>
</edge>
<edge source="PDF_13_2018_Result_-6837675869442569123" target="Gene_DMC1">
  <data key="d8">MENTIONS</data>
  <data key="d9">SCML1 exhibited similar expression pattern to that of DMC1 in spermatocytes</data>
</edge>
<edge source="PDF_13_2018_Result_-2168887568482952382" target="Gene_CCDC112">
  <data key="d8">MENTIONS</data>
  <data key="d9">CCDC112 was highly expressed in both pachytene and diplotene spermatocytes</data>
</edge>
<edge source="PDF_13_2018_Result_418644541576375920" target="Gene_TEX29">
  <data key="d8">MENTIONS</data>
  <data key="d9">intense signal of the TEX29 transcript was observed in the early stage of spermatids</data>
</edge>
<edge source="PDF_13_2018_Result_7147866663107401983" target="Gene_GFRA1">
  <data key="d8">MENTIONS</data>
  <data key="d9">GFRA1 and RET were highly enriched in cluster 1</data>
</edge>
<edge source="PDF_13_2018_Result_7147866663107401983" target="Gene_RET">
  <data key="d8">MENTIONS</data>
  <data key="d9">GFRA1 and RET were highly enriched in cluster 1</data>
</edge>
<edge source="PDF_13_2018_Result_1132378231311873623" target="Gene_NANOS2">
  <data key="d8">MENTIONS</data>
  <data key="d9">NANOS2, ZBTB16, SALL4, POU3F1, UTF1, and NANOS3 were all highly expressed in cluster 1</data>
</edge>
<edge source="PDF_13_2018_Result_1132378231311873623" target="Gene_ZBTB16">
  <data key="d8">MENTIONS</data>
  <data key="d9">NANOS2, ZBTB16, SALL4, POU3F1, UTF1, and NANOS3 were all highly expressed in cluster 1</data>
</edge>
<edge source="PDF_13_2018_Result_1132378231311873623" target="Gene_SALL4">
  <data key="d8">MENTIONS</data>
  <data key="d9">NANOS2, ZBTB16, SALL4, POU3F1, UTF1, and NANOS3 were all highly expressed in cluster 1</data>
</edge>
<edge source="PDF_13_2018_Result_1132378231311873623" target="Gene_POU3F1">
  <data key="d8">MENTIONS</data>
  <data key="d9">NANOS2, ZBTB16, SALL4, POU3F1, UTF1, and NANOS3 were all highly expressed in cluster 1</data>
</edge>
<edge source="PDF_13_2018_Result_1132378231311873623" target="Gene_UTF1">
  <data key="d8">MENTIONS</data>
  <data key="d9">NANOS2, ZBTB16, SALL4, POU3F1, UTF1, and NANOS3 were all highly expressed in cluster 1</data>
</edge>
<edge source="PDF_13_2018_Result_1132378231311873623" target="Gene_NANOS3">
  <data key="d8">MENTIONS</data>
  <data key="d9">NANOS2, ZBTB16, SALL4, POU3F1, UTF1, and NANOS3 were all highly expressed in cluster 1</data>
</edge>
<edge source="PDF_13_2018_Result_-4558964390352668683" target="Gene_FGFR3">
  <data key="d8">MENTIONS</data>
  <data key="d9">FGFR3 and BMPR1B were predominantly co-expressed in cluster 1</data>
</edge>
<edge source="PDF_13_2018_Result_-4558964390352668683" target="Gene_BMPR1B">
  <data key="d8">MENTIONS</data>
  <data key="d9">FGFR3 and BMPR1B were predominantly co-expressed in cluster 1</data>
</edge>
<edge source="PDF_13_2018_Result_4538883070159406809" target="Gene_KIT">
  <data key="d8">MENTIONS</data>
  <data key="d9">KIT had a relatively intense expression in cluster 2</data>
</edge>
<edge source="PDF_13_2018_Result_7098111269807349278" target="Gene_MKI67">
  <data key="d8">MENTIONS</data>
  <data key="d9">MKI67 exhibited an expression pattern similar to that of KIT</data>
</edge>
<edge source="PDF_13_2018_Result_7098111269807349278" target="Gene_KIT">
  <data key="d8">MENTIONS</data>
  <data key="d9">MKI67 exhibited an expression pattern similar to that of KIT</data>
</edge>
<edge source="PDF_13_2018_Result_-7548059631000195813" target="Gene_STRA8">
  <data key="d8">MENTIONS</data>
  <data key="d9">The expression of STRA8 initiated at cluster 2 and culminated in cluster 3.</data>
</edge>
<edge source="PDF_13_2018_Result_8218078299226839869" target="Gene_DMRT1">
  <data key="d8">MENTIONS</data>
  <data key="d9">DMRT1 was highly expressed in GFRA1highUTF1low cells but downregulated in GFRA1lowUTF1high cells</data>
</edge>
<edge source="PDF_13_2018_Result_8218078299226839869" target="Gene_GFRA1">
  <data key="d8">MENTIONS</data>
  <data key="d9">DMRT1 was highly expressed in GFRA1highUTF1low cells but downregulated in GFRA1lowUTF1high cells</data>
</edge>
<edge source="PDF_13_2018_Result_8218078299226839869" target="Gene_UTF1">
  <data key="d8">MENTIONS</data>
  <data key="d9">DMRT1 was highly expressed in GFRA1highUTF1low cells but downregulated in GFRA1lowUTF1high cells</data>
</edge>
<edge source="PDF_13_2018_Result_-603430371271684152" target="Gene_PIWIL4">
  <data key="d8">MENTIONS</data>
  <data key="d9">PIWIL4 was highly expressed in a proportion of FGFR3high SSCs</data>
</edge>
<edge source="PDF_13_2018_Result_-603430371271684152" target="Gene_FGFR3">
  <data key="d8">MENTIONS</data>
  <data key="d9">PIWIL4 was highly expressed in a proportion of FGFR3high SSCs</data>
</edge>
<edge source="PDF_13_2018_Result_-3106995970904756223" target="Gene_ALDH1A1">
  <data key="d8">MENTIONS</data>
  <data key="d9">ALDH1A1 highly expressed by Sertoli cells</data>
</edge>
<edge source="PDF_13_2018_Result_-8265794064548944133" target="Gene_ALDH1A1">
  <data key="d8">MENTIONS</data>
  <data key="d9">MIX exhibited upregulated expression of ALDH1A1 and CYP26B1</data>
</edge>
<edge source="PDF_13_2018_Result_-8265794064548944133" target="Gene_CYP26B1">
  <data key="d8">MENTIONS</data>
  <data key="d9">MIX exhibited upregulated expression of ALDH1A1 and CYP26B1</data>
</edge>
<edge source="PDF_13_2018_Result_-2116837359288474551" target="Gene_ALDH1A2">
  <data key="d8">MENTIONS</data>
  <data key="d9">ALDH1A2 was highly expressed at the pachytene, diplotene, and SPC7 stages, and ALDH1A3 was highly expressed in pachytene spermatocytes</data>
</edge>
<edge source="PDF_13_2018_Result_-2116837359288474551" target="Gene_ALDH1A3">
  <data key="d8">MENTIONS</data>
  <data key="d9">ALDH1A2 was highly expressed at the pachytene, diplotene, and SPC7 stages, and ALDH1A3 was highly expressed in pachytene spermatocytes</data>
</edge>
<edge source="PDF_13_2018_Result_2575703314355210802" target="Gene_DMRT1">
  <data key="d8">MENTIONS</data>
  <data key="d9">DMRT1 and SOHLH1 were highly expressed in SSCs and differentiating spermatogonia</data>
</edge>
<edge source="PDF_13_2018_Result_2575703314355210802" target="Gene_SOHLH1">
  <data key="d8">MENTIONS</data>
  <data key="d9">DMRT1 and SOHLH1 were highly expressed in SSCs and differentiating spermatogonia</data>
</edge>
<edge source="PDF_13_2018_Result_-2361164632489912218" target="Gene_FGFR1">
  <data key="d8">MENTIONS</data>
  <data key="d9">FGFR1 and FGFR2, FGFR3, KRAS, MAP2K2, ΜΑPK1, and MAPK3 were highly expressed in SSCs.</data>
</edge>
<edge source="PDF_13_2018_Result_-2361164632489912218" target="Gene_FGFR2">
  <data key="d8">MENTIONS</data>
  <data key="d9">FGFR1 and FGFR2, FGFR3, KRAS, MAP2K2, ΜΑPK1, and MAPK3 were highly expressed in SSCs.</data>
</edge>
<edge source="PDF_13_2018_Result_-2361164632489912218" target="Gene_FGFR3">
  <data key="d8">MENTIONS</data>
  <data key="d9">FGFR1 and FGFR2, FGFR3, KRAS, MAP2K2, ΜΑPK1, and MAPK3 were highly expressed in SSCs.</data>
</edge>
<edge source="PDF_13_2018_Result_-2361164632489912218" target="Gene_KRAS">
  <data key="d8">MENTIONS</data>
  <data key="d9">FGFR1 and FGFR2, FGFR3, KRAS, MAP2K2, ΜΑPK1, and MAPK3 were highly expressed in SSCs.</data>
</edge>
<edge source="PDF_13_2018_Result_-2361164632489912218" target="Gene_MAP2K2">
  <data key="d8">MENTIONS</data>
  <data key="d9">FGFR1 and FGFR2, FGFR3, KRAS, MAP2K2, ΜΑPK1, and MAPK3 were highly expressed in SSCs.</data>
</edge>
<edge source="PDF_13_2018_Result_-2361164632489912218" target="Gene_ΜΑPK1">
  <data key="d8">MENTIONS</data>
  <data key="d9">FGFR1 and FGFR2, FGFR3, KRAS, MAP2K2, ΜΑPK1, and MAPK3 were highly expressed in SSCs.</data>
</edge>
<edge source="PDF_13_2018_Result_-2361164632489912218" target="Gene_MAPK3">
  <data key="d8">MENTIONS</data>
  <data key="d9">FGFR1 and FGFR2, FGFR3, KRAS, MAP2K2, ΜΑPK1, and MAPK3 were highly expressed in SSCs.</data>
</edge>
<edge source="PDF_13_2018_Result_-6354715977465030224" target="Gene_FGF1">
  <data key="d8">MENTIONS</data>
  <data key="d9">FGF1 was specifically expressed in Sertoli cells, whereas FGF2 and FGF9 were expressed in SSCs and other-stage germ cells</data>
</edge>
<edge source="PDF_13_2018_Result_-6354715977465030224" target="Gene_FGF2">
  <data key="d8">MENTIONS</data>
  <data key="d9">FGF1 was specifically expressed in Sertoli cells, whereas FGF2 and FGF9 were expressed in SSCs and other-stage germ cells</data>
</edge>
<edge source="PDF_13_2018_Result_-6354715977465030224" target="Gene_FGF9">
  <data key="d8">MENTIONS</data>
  <data key="d9">FGF1 was specifically expressed in Sertoli cells, whereas FGF2 and FGF9 were expressed in SSCs and other-stage germ cells</data>
</edge>
<edge source="PDF_13_2018_Result_-8766377227572290641" target="Gene_BMPR1B">
  <data key="d8">MENTIONS</data>
  <data key="d9">BMPR1B was exclusively enriched in SSCs</data>
</edge>
<edge source="PDF_13_2018_Result_-738583257906051561" target="Gene_BMP7">
  <data key="d8">MENTIONS</data>
  <data key="d9">BMP7, BMPR2, SMAD1, SMAD5, SMAD9, ID1, ID2, and ID4 were all clearly expressed in SSCs</data>
</edge>
<edge source="PDF_13_2018_Result_-738583257906051561" target="Gene_BMPR2">
  <data key="d8">MENTIONS</data>
  <data key="d9">BMP7, BMPR2, SMAD1, SMAD5, SMAD9, ID1, ID2, and ID4 were all clearly expressed in SSCs</data>
</edge>
<edge source="PDF_13_2018_Result_-738583257906051561" target="Gene_SMAD1">
  <data key="d8">MENTIONS</data>
  <data key="d9">BMP7, BMPR2, SMAD1, SMAD5, SMAD9, ID1, ID2, and ID4 were all clearly expressed in SSCs</data>
</edge>
<edge source="PDF_13_2018_Result_-738583257906051561" target="Gene_SMAD5">
  <data key="d8">MENTIONS</data>
  <data key="d9">BMP7, BMPR2, SMAD1, SMAD5, SMAD9, ID1, ID2, and ID4 were all clearly expressed in SSCs</data>
</edge>
<edge source="PDF_13_2018_Result_-738583257906051561" target="Gene_SMAD9">
  <data key="d8">MENTIONS</data>
  <data key="d9">BMP7, BMPR2, SMAD1, SMAD5, SMAD9, ID1, ID2, and ID4 were all clearly expressed in SSCs</data>
</edge>
<edge source="PDF_13_2018_Result_-738583257906051561" target="Gene_ID1">
  <data key="d8">MENTIONS</data>
  <data key="d9">BMP7, BMPR2, SMAD1, SMAD5, SMAD9, ID1, ID2, and ID4 were all clearly expressed in SSCs</data>
</edge>
<edge source="PDF_13_2018_Result_-738583257906051561" target="Gene_ID2">
  <data key="d8">MENTIONS</data>
  <data key="d9">BMP7, BMPR2, SMAD1, SMAD5, SMAD9, ID1, ID2, and ID4 were all clearly expressed in SSCs</data>
</edge>
<edge source="PDF_13_2018_Result_-738583257906051561" target="Gene_ID4">
  <data key="d8">MENTIONS</data>
  <data key="d9">BMP7, BMPR2, SMAD1, SMAD5, SMAD9, ID1, ID2, and ID4 were all clearly expressed in SSCs</data>
</edge>
<edge source="PDF_13_2018_Result_4332550590543243693" target="Gene_BMPR1B">
  <data key="d8">MENTIONS</data>
  <data key="d9">large fraction of BMPR1B+ SSCs were also positive for phosphorylated SMAD1/5/9 (P-SMAD1/5/9), ID1, and ID4</data>
</edge>
<edge source="PDF_13_2018_Result_4332550590543243693" target="Gene_SMAD1">
  <data key="d8">MENTIONS</data>
  <data key="d9">large fraction of BMPR1B+ SSCs were also positive for phosphorylated SMAD1/5/9 (P-SMAD1/5/9), ID1, and ID4</data>
</edge>
<edge source="PDF_13_2018_Result_4332550590543243693" target="Gene_SMAD5">
  <data key="d8">MENTIONS</data>
  <data key="d9">large fraction of BMPR1B+ SSCs were also positive for phosphorylated SMAD1/5/9 (P-SMAD1/5/9), ID1, and ID4</data>
</edge>
<edge source="PDF_13_2018_Result_4332550590543243693" target="Gene_SMAD9">
  <data key="d8">MENTIONS</data>
  <data key="d9">large fraction of BMPR1B+ SSCs were also positive for phosphorylated SMAD1/5/9 (P-SMAD1/5/9), ID1, and ID4</data>
</edge>
<edge source="PDF_13_2018_Result_4332550590543243693" target="Gene_ID1">
  <data key="d8">MENTIONS</data>
  <data key="d9">large fraction of BMPR1B+ SSCs were also positive for phosphorylated SMAD1/5/9 (P-SMAD1/5/9), ID1, and ID4</data>
</edge>
<edge source="PDF_13_2018_Result_4332550590543243693" target="Gene_ID4">
  <data key="d8">MENTIONS</data>
  <data key="d9">large fraction of BMPR1B+ SSCs were also positive for phosphorylated SMAD1/5/9 (P-SMAD1/5/9), ID1, and ID4</data>
</edge>
<edge source="PDF_13_2018_Result_-967102195879578252" target="Gene_SPO11">
  <data key="d8">MENTIONS</data>
  <data key="d9">SPO11, DMC1, and RAD51AP2, were especially expressed in spermatocytes in the leptotene and zygotene stages</data>
</edge>
<edge source="PDF_13_2018_Result_-967102195879578252" target="Gene_DMC1">
  <data key="d8">MENTIONS</data>
  <data key="d9">SPO11, DMC1, and RAD51AP2, were especially expressed in spermatocytes in the leptotene and zygotene stages</data>
</edge>
<edge source="PDF_13_2018_Result_-967102195879578252" target="Gene_RAD51AP2">
  <data key="d8">MENTIONS</data>
  <data key="d9">SPO11, DMC1, and RAD51AP2, were especially expressed in spermatocytes in the leptotene and zygotene stages</data>
</edge>
<edge source="PDF_13_2018_Result_-478275195892596815" target="Gene_SYCP3">
  <data key="d8">MENTIONS</data>
  <data key="d9">SC components, such as SYCP3, SYCP1, SYCP2, SYCE1, and TEX12 were also upregulated from the leptotene to the zygotene stage</data>
</edge>
<edge source="PDF_13_2018_Result_-478275195892596815" target="Gene_SYCP1">
  <data key="d8">MENTIONS</data>
  <data key="d9">SC components, such as SYCP3, SYCP1, SYCP2, SYCE1, and TEX12 were also upregulated from the leptotene to the zygotene stage</data>
</edge>
<edge source="PDF_13_2018_Result_-478275195892596815" target="Gene_SYCP2">
  <data key="d8">MENTIONS</data>
  <data key="d9">SC components, such as SYCP3, SYCP1, SYCP2, SYCE1, and TEX12 were also upregulated from the leptotene to the zygotene stage</data>
</edge>
<edge source="PDF_13_2018_Result_-478275195892596815" target="Gene_SYCE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">SC components, such as SYCP3, SYCP1, SYCP2, SYCE1, and TEX12 were also upregulated from the leptotene to the zygotene stage</data>
</edge>
<edge source="PDF_13_2018_Result_-478275195892596815" target="Gene_TEX12">
  <data key="d8">MENTIONS</data>
  <data key="d9">SC components, such as SYCP3, SYCP1, SYCP2, SYCE1, and TEX12 were also upregulated from the leptotene to the zygotene stage</data>
</edge>
<edge source="PDF_13_2018_Result_7278440245603404407" target="Gene_OVOL1">
  <data key="d8">MENTIONS</data>
  <data key="d9">OVOL1 and OVOL2 were found to be highly expressed from the pachytene to the diplotene stage</data>
</edge>
<edge source="PDF_13_2018_Result_7278440245603404407" target="Gene_OVOL2">
  <data key="d8">MENTIONS</data>
  <data key="d9">OVOL1 and OVOL2 were found to be highly expressed from the pachytene to the diplotene stage</data>
</edge>
<edge source="PDF_13_2018_Result_1100926031557611908" target="Gene_CCNA1">
  <data key="d8">MENTIONS</data>
  <data key="d9">both CCNA1 and CCNA2 were highly enriched from pachytene to SPC7</data>
</edge>
<edge source="PDF_13_2018_Result_1100926031557611908" target="Gene_CCNA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">both CCNA1 and CCNA2 were highly enriched from pachytene to SPC7</data>
</edge>
<edge source="PDF_13_2018_Result_6419039013111316253" target="Gene_CCNA1">
  <data key="d8">MENTIONS</data>
  <data key="d9">SPC7, which consisted of diakinesis, metaphase, anaphase, telophase, and secondary spermatocytes, exhibited upregulation of CCNA1, CCNA2, TJP3, SLC26A3, and SIRPG</data>
</edge>
<edge source="PDF_13_2018_Result_6419039013111316253" target="Gene_CCNA2">
  <data key="d8">MENTIONS</data>
  <data key="d9">SPC7, which consisted of diakinesis, metaphase, anaphase, telophase, and secondary spermatocytes, exhibited upregulation of CCNA1, CCNA2, TJP3, SLC26A3, and SIRPG</data>
</edge>
<edge source="PDF_13_2018_Result_6419039013111316253" target="Gene_TJP3">
  <data key="d8">MENTIONS</data>
  <data key="d9">SPC7, which consisted of diakinesis, metaphase, anaphase, telophase, and secondary spermatocytes, exhibited upregulation of CCNA1, CCNA2, TJP3, SLC26A3, and SIRPG</data>
</edge>
<edge source="PDF_13_2018_Result_6419039013111316253" target="Gene_SLC26A3">
  <data key="d8">MENTIONS</data>
  <data key="d9">SPC7, which consisted of diakinesis, metaphase, anaphase, telophase, and secondary spermatocytes, exhibited upregulation of CCNA1, CCNA2, TJP3, SLC26A3, and SIRPG</data>
</edge>
<edge source="PDF_13_2018_Result_6419039013111316253" target="Gene_SIRPG">
  <data key="d8">MENTIONS</data>
  <data key="d9">SPC7, which consisted of diakinesis, metaphase, anaphase, telophase, and secondary spermatocytes, exhibited upregulation of CCNA1, CCNA2, TJP3, SLC26A3, and SIRPG</data>
</edge>
<edge source="PDF_13_2018_Result_739995519673443118" target="Gene_ACR">
  <data key="d8">MENTIONS</data>
  <data key="d9">ACR was highly expressed in the stages from pachytene to S4</data>
</edge>
<edge source="PDF_13_2018_Result_8015836603834141161" target="Gene_DMC1">
  <data key="d8">MENTIONS</data>
  <data key="d9">DMC1 protein was highly expressed in the stages from leptotene to zygotene and retained in pachytene spermatocytes</data>
</edge>
<edge source="PDF_13_2018_Result_3390424010982936346" target="Gene_SYCP2">
  <data key="d8">MENTIONS</data>
  <data key="d9">SYCP2, SYCP3, and SYCE1 were also upregulated from the leptotene to the pachytene stage. Especially, SYCP3 protein was expressed from the leptotene to the pachytene stage</data>
</edge>
<edge source="PDF_13_2018_Result_3390424010982936346" target="Gene_SYCP3">
  <data key="d8">MENTIONS</data>
  <data key="d9">SYCP2, SYCP3, and SYCE1 were also upregulated from the leptotene to the pachytene stage. Especially, SYCP3 protein was expressed from the leptotene to the pachytene stage</data>
</edge>
<edge source="PDF_13_2018_Result_3390424010982936346" target="Gene_SYCE1">
  <data key="d8">MENTIONS</data>
  <data key="d9">SYCP2, SYCP3, and SYCE1 were also upregulated from the leptotene to the pachytene stage. Especially, SYCP3 protein was expressed from the leptotene to the pachytene stage</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Hypothesis_-2505351006953661186">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Method_-3810266808512889234">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Method_7622518009099704019">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Method_3582097726647072040">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Method_1675248724131067389">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_4261585918296958017">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_8444100787297833661">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-1940611298464184448">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-654978772005704754">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-2113211573748693212">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-509827256225457201">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_4586619883533712137">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-5445114003000852953">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-5249027082067024832">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-5368129289754909413">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-2832035924117954040">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-8976027927423428532">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-8889034665994520849">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_5071185389621275607">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-5877346504939176835">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-4221729511752295252">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_2977106505218234330">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_2428702352743802929">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-5380714902332756007">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_4039113898606538160">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_9153768662042259724">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-592902069678588903">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-710225815859847602">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-73008443620360455">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_646666475697248923">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-6615300606113970582">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-8638093714097755657">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-3755063657638932584">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-7552275888856269627">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-4201111930626082783">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_2729564798083139075">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-3349541591639341791">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_4001098613197549686">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_6142937756838132795">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-8007171609199782149">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-8639879267144360643">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_8465833011909455292">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-6867944860966669618">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_1446722532634649339">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-4997994686314589138">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_4786714691298363183">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-7248453938590399397">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_-242860860274716819">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_5865510701742958866">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Result_2926063715828468877">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021" target="PDF_29_2021_Conclusion_-6275312812223095918">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_29_2021_Result_8444100787297833661" target="Compound_URATE">
  <data key="d8">MENTIONS</data>
  <data key="d9">discovery of 51 causal relationships, including previously known agonistic effects of urate on gout and cystatin C on stroke</data>
</edge>
<edge source="PDF_29_2021_Result_8444100787297833661" target="Disease_GOUT">
  <data key="d8">MENTIONS</data>
  <data key="d9">discovery of 51 causal relationships, including previously known agonistic effects of urate on gout and cystatin C on stroke</data>
</edge>
<edge source="PDF_29_2021_Result_8444100787297833661" target="Protein_CYSTATIN C">
  <data key="d8">MENTIONS</data>
  <data key="d9">discovery of 51 causal relationships, including previously known agonistic effects of urate on gout and cystatin C on stroke</data>
</edge>
<edge source="PDF_29_2021_Result_8444100787297833661" target="Disease_STROKE">
  <data key="d8">MENTIONS</data>
  <data key="d9">discovery of 51 causal relationships, including previously known agonistic effects of urate on gout and cystatin C on stroke</data>
</edge>
<edge source="PDF_29_2021_Result_-1940611298464184448" target="Disease_KIDNEY DISEASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">development of polygenic risk scores for each biomarker and built "multi-PRS" models for diseases using 35 PRSs simultaneously, which improved chronic kidney disease, type 2 diabetes, gout, and alcoholic cirrhosis genetic risk stratification in an independent dataset (FinnGen; n=135,500) relative to single-disease PRSs</data>
</edge>
<edge source="PDF_29_2021_Result_-1940611298464184448" target="Disease_TYPE 2 DIABETES">
  <data key="d8">MENTIONS</data>
  <data key="d9">development of polygenic risk scores for each biomarker and built "multi-PRS" models for diseases using 35 PRSs simultaneously, which improved chronic kidney disease, type 2 diabetes, gout, and alcoholic cirrhosis genetic risk stratification in an independent dataset (FinnGen; n=135,500) relative to single-disease PRSs</data>
</edge>
<edge source="PDF_29_2021_Result_-1940611298464184448" target="Disease_GOUT">
  <data key="d8">MENTIONS</data>
  <data key="d9">development of polygenic risk scores for each biomarker and built "multi-PRS" models for diseases using 35 PRSs simultaneously, which improved chronic kidney disease, type 2 diabetes, gout, and alcoholic cirrhosis genetic risk stratification in an independent dataset (FinnGen; n=135,500) relative to single-disease PRSs</data>
</edge>
<edge source="PDF_29_2021_Result_-1940611298464184448" target="Disease_ALCOHOLIC CIRRHOSIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">development of polygenic risk scores for each biomarker and built "multi-PRS" models for diseases using 35 PRSs simultaneously, which improved chronic kidney disease, type 2 diabetes, gout, and alcoholic cirrhosis genetic risk stratification in an independent dataset (FinnGen; n=135,500) relative to single-disease PRSs</data>
</edge>
<edge source="PDF_29_2021_Result_-654978772005704754" target="Gene_PDE3B">
  <data key="d8">MENTIONS</data>
  <data key="d9">identified a stop-gain variant in PDE3B with documented protection against high cholesterol and a range of effects on increasing HDL cholesterol and Apolipoprotein A (0.40, 0.27 sd) and decreasing triglycerides and Apolipoprotein B (0.43, 0.27 sd)</data>
</edge>
<edge source="PDF_29_2021_Result_-654978772005704754" target="Compound_HDL CHOLESTEROL">
  <data key="d8">MENTIONS</data>
  <data key="d9">identified a stop-gain variant in PDE3B with documented protection against high cholesterol and a range of effects on increasing HDL cholesterol and Apolipoprotein A (0.40, 0.27 sd) and decreasing triglycerides and Apolipoprotein B (0.43, 0.27 sd)</data>
</edge>
<edge source="PDF_29_2021_Result_-654978772005704754" target="Protein_APOLIPOPROTEIN A">
  <data key="d8">MENTIONS</data>
  <data key="d9">identified a stop-gain variant in PDE3B with documented protection against high cholesterol and a range of effects on increasing HDL cholesterol and Apolipoprotein A (0.40, 0.27 sd) and decreasing triglycerides and Apolipoprotein B (0.43, 0.27 sd)</data>
</edge>
<edge source="PDF_29_2021_Result_-654978772005704754" target="Compound_TRIGLYCERIDE">
  <data key="d8">MENTIONS</data>
  <data key="d9">identified a stop-gain variant in PDE3B with documented protection against high cholesterol and a range of effects on increasing HDL cholesterol and Apolipoprotein A (0.40, 0.27 sd) and decreasing triglycerides and Apolipoprotein B (0.43, 0.27 sd)</data>
</edge>
<edge source="PDF_29_2021_Result_-654978772005704754" target="Protein_APOLIPOPROTEIN B">
  <data key="d8">MENTIONS</data>
  <data key="d9">identified a stop-gain variant in PDE3B with documented protection against high cholesterol and a range of effects on increasing HDL cholesterol and Apolipoprotein A (0.40, 0.27 sd) and decreasing triglycerides and Apolipoprotein B (0.43, 0.27 sd)</data>
</edge>
<edge source="PDF_29_2021_Result_-654978772005704754" target="Compound_CHOLESTEROL">
  <data key="d8">MENTIONS</data>
  <data key="d9">identified a stop-gain variant in PDE3B with documented protection against high cholesterol and a range of effects on increasing HDL cholesterol and Apolipoprotein A (0.40, 0.27 sd) and decreasing triglycerides and Apolipoprotein B (0.43, 0.27 sd)</data>
</edge>
<edge source="PDF_29_2021_Result_-2113211573748693212" target="Gene_ANGPTL8">
  <data key="d8">MENTIONS</data>
  <data key="d9">a stop gain variant in ANGPTL8, where we replicated a previously-reported effect on HDL cholesterol (0.06 sd in our dataset) and discovered a triglyceride-lowering effect (0.06 sd)</data>
</edge>
<edge source="PDF_29_2021_Result_-2113211573748693212" target="Compound_HDL CHOLESTEROL">
  <data key="d8">MENTIONS</data>
  <data key="d9">a stop gain variant in ANGPTL8, where we replicated a previously-reported effect on HDL cholesterol (0.06 sd in our dataset) and discovered a triglyceride-lowering effect (0.06 sd)</data>
</edge>
<edge source="PDF_29_2021_Result_-2113211573748693212" target="Compound_TRIGLYCERIDE">
  <data key="d8">MENTIONS</data>
  <data key="d9">a stop gain variant in ANGPTL8, where we replicated a previously-reported effect on HDL cholesterol (0.06 sd in our dataset) and discovered a triglyceride-lowering effect (0.06 sd)</data>
</edge>
<edge source="PDF_29_2021_Result_-509827256225457201" target="Gene_LIPOPROTEIN A">
  <data key="d8">MENTIONS</data>
  <data key="d9">two PTVs in LPA with lowering effects on Lipoprotein A levels (0.37, 0.42 sd), of which one is known to be associated with decreased risk of coronary artery disease (p = 3 × 10-11; OR = 0.89 [95% CI 0.86, 0.92])</data>
</edge>
<edge source="PDF_29_2021_Result_-509827256225457201" target="Protein_LIPOPROTEIN A">
  <data key="d8">MENTIONS</data>
  <data key="d9">two PTVs in LPA with lowering effects on Lipoprotein A levels (0.37, 0.42 sd), of which one is known to be associated with decreased risk of coronary artery disease (p = 3 × 10-11; OR = 0.89 [95% CI 0.86, 0.92])</data>
</edge>
<edge source="PDF_29_2021_Result_-509827256225457201" target="Disease_CORONARY ARTERY DISEASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">two PTVs in LPA with lowering effects on Lipoprotein A levels (0.37, 0.42 sd), of which one is known to be associated with decreased risk of coronary artery disease (p = 3 × 10-11; OR = 0.89 [95% CI 0.86, 0.92])</data>
</edge>
<edge source="PDF_29_2021_Result_4586619883533712137" target="Gene_ACACB">
  <data key="d8">MENTIONS</data>
  <data key="d9">a 0.2% MAF missense allele in ACACB associated with LDL, triglyceride, ApoB, and alkaline phosphatase</data>
</edge>
<edge source="PDF_29_2021_Result_4586619883533712137" target="Compound_LDL">
  <data key="d8">MENTIONS</data>
  <data key="d9">a 0.2% MAF missense allele in ACACB associated with LDL, triglyceride, ApoB, and alkaline phosphatase</data>
</edge>
<edge source="PDF_29_2021_Result_4586619883533712137" target="Compound_TRIGLYCERIDE">
  <data key="d8">MENTIONS</data>
  <data key="d9">a 0.2% MAF missense allele in ACACB associated with LDL, triglyceride, ApoB, and alkaline phosphatase</data>
</edge>
<edge source="PDF_29_2021_Result_4586619883533712137" target="Protein_APOLIPOPROTEIN B">
  <data key="d8">MENTIONS</data>
  <data key="d9">a 0.2% MAF missense allele in ACACB associated with LDL, triglyceride, ApoB, and alkaline phosphatase</data>
</edge>
<edge source="PDF_29_2021_Result_4586619883533712137" target="Protein_ALKALINE PHOSPHATASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">a 0.2% MAF missense allele in ACACB associated with LDL, triglyceride, ApoB, and alkaline phosphatase</data>
</edge>
<edge source="PDF_29_2021_Result_-5445114003000852953" target="Gene_PLA2G12A">
  <data key="d8">MENTIONS</data>
  <data key="d9">two independent missense alleles in PLA2G12A with increasing effects on triglycerides, sex-hormone binding globulin (SHBG), and testosterone, and lowering effects on HDL cholesterol, ApoA, and HbA1c levels</data>
</edge>
<edge source="PDF_29_2021_Result_-5445114003000852953" target="Compound_TRIGLYCERIDE">
  <data key="d8">MENTIONS</data>
  <data key="d9">two independent missense alleles in PLA2G12A with increasing effects on triglycerides, sex-hormone binding globulin (SHBG), and testosterone, and lowering effects on HDL cholesterol, ApoA, and HbA1c levels</data>
</edge>
<edge source="PDF_29_2021_Result_-5445114003000852953" target="Protein_SEX HORMONE BINDING GLOBULIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">two independent missense alleles in PLA2G12A with increasing effects on triglycerides, sex-hormone binding globulin (SHBG), and testosterone, and lowering effects on HDL cholesterol, ApoA, and HbA1c levels</data>
</edge>
<edge source="PDF_29_2021_Result_-5445114003000852953" target="Compound_TESTOSTERONE">
  <data key="d8">MENTIONS</data>
  <data key="d9">two independent missense alleles in PLA2G12A with increasing effects on triglycerides, sex-hormone binding globulin (SHBG), and testosterone, and lowering effects on HDL cholesterol, ApoA, and HbA1c levels</data>
</edge>
<edge source="PDF_29_2021_Result_-5445114003000852953" target="Compound_HDL CHOLESTEROL">
  <data key="d8">MENTIONS</data>
  <data key="d9">two independent missense alleles in PLA2G12A with increasing effects on triglycerides, sex-hormone binding globulin (SHBG), and testosterone, and lowering effects on HDL cholesterol, ApoA, and HbA1c levels</data>
</edge>
<edge source="PDF_29_2021_Result_-5445114003000852953" target="Protein_APOLIPOPROTEIN A">
  <data key="d8">MENTIONS</data>
  <data key="d9">two independent missense alleles in PLA2G12A with increasing effects on triglycerides, sex-hormone binding globulin (SHBG), and testosterone, and lowering effects on HDL cholesterol, ApoA, and HbA1c levels</data>
</edge>
<edge source="PDF_29_2021_Result_-5445114003000852953" target="Protein_HBA1C">
  <data key="d8">MENTIONS</data>
  <data key="d9">two independent missense alleles in PLA2G12A with increasing effects on triglycerides, sex-hormone binding globulin (SHBG), and testosterone, and lowering effects on HDL cholesterol, ApoA, and HbA1c levels</data>
</edge>
<edge source="PDF_29_2021_Result_-5249027082067024832" target="Gene_CPTIA">
  <data key="d8">MENTIONS</data>
  <data key="d9">a splice region variant in CPTIA, with lowering effects on triglycerides</data>
</edge>
<edge source="PDF_29_2021_Result_-5249027082067024832" target="Compound_TRIGLYCERIDE">
  <data key="d8">MENTIONS</data>
  <data key="d9">a splice region variant in CPTIA, with lowering effects on triglycerides</data>
</edge>
<edge source="PDF_29_2021_Result_-5368129289754909413" target="Gene_PCSK6">
  <data key="d8">MENTIONS</data>
  <data key="d9">a missense variant in PCSK6 with ApoB- and LDL-lowering effects</data>
</edge>
<edge source="PDF_29_2021_Result_-5368129289754909413" target="Protein_APOLIPOPROTEIN B">
  <data key="d8">MENTIONS</data>
  <data key="d9">a missense variant in PCSK6 with ApoB- and LDL-lowering effects</data>
</edge>
<edge source="PDF_29_2021_Result_-5368129289754909413" target="Compound_LDL">
  <data key="d8">MENTIONS</data>
  <data key="d9">a missense variant in PCSK6 with ApoB- and LDL-lowering effects</data>
</edge>
<edge source="PDF_29_2021_Result_-2832035924117954040" target="Gene_ASPARTATE AMINOTRANSFERASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">a 0.05% MAF inframe deletion in GOT1 with a lowering effect on aspartate aminotransferase (2.6 sd)</data>
</edge>
<edge source="PDF_29_2021_Result_-2832035924117954040" target="Protein_ASPARTATE AMINOTRANSFERASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">a 0.05% MAF inframe deletion in GOT1 with a lowering effect on aspartate aminotransferase (2.6 sd)</data>
</edge>
<edge source="PDF_29_2021_Result_-8976027927423428532" target="Gene_SLC30A10">
  <data key="d8">MENTIONS</data>
  <data key="d9">a 0.1% MAF missense allele in SLC30A10 with increasing effects on alanine and aspartate aminotransferases</data>
</edge>
<edge source="PDF_29_2021_Result_-8976027927423428532" target="Protein_ALANINE AMINOTRANSFERASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">a 0.1% MAF missense allele in SLC30A10 with increasing effects on alanine and aspartate aminotransferases</data>
</edge>
<edge source="PDF_29_2021_Result_-8976027927423428532" target="Protein_ASPARTATE AMINOTRANSFERASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">a 0.1% MAF missense allele in SLC30A10 with increasing effects on alanine and aspartate aminotransferases</data>
</edge>
<edge source="PDF_29_2021_Result_-8889034665994520849" target="Gene_ALANINE AMINOTRANSFERASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">four missense alleles in GPT with alanine aminotransferase lowering effects</data>
</edge>
<edge source="PDF_29_2021_Result_-8889034665994520849" target="Protein_ALANINE AMINOTRANSFERASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">four missense alleles in GPT with alanine aminotransferase lowering effects</data>
</edge>
<edge source="PDF_29_2021_Result_5071185389621275607" target="Gene_ABCB4">
  <data key="d8">MENTIONS</data>
  <data key="d9">a missense variant in ABCB4 with increasing effect on alanine aminotransferase and increased risk of gallstones in UK Biobank (p = 1.2 × 10−8, OR = 1.38 [95% CI: 1.23, 1.38])</data>
</edge>
<edge source="PDF_29_2021_Result_5071185389621275607" target="Protein_ALANINE AMINOTRANSFERASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">a missense variant in ABCB4 with increasing effect on alanine aminotransferase and increased risk of gallstones in UK Biobank (p = 1.2 × 10−8, OR = 1.38 [95% CI: 1.23, 1.38])</data>
</edge>
<edge source="PDF_29_2021_Result_5071185389621275607" target="Disease_GALLSTONES">
  <data key="d8">MENTIONS</data>
  <data key="d9">a missense variant in ABCB4 with increasing effect on alanine aminotransferase and increased risk of gallstones in UK Biobank (p = 1.2 × 10−8, OR = 1.38 [95% CI: 1.23, 1.38])</data>
</edge>
<edge source="PDF_29_2021_Result_-5877346504939176835" target="Gene_SERPINA1">
  <data key="d8">MENTIONS</data>
  <data key="d9">an allelic series of 3 missense variants in SERPINA1 with pleiotropic increasing effects on albumin, aspartate aminotransferase, direct bilirubin, and gamma glutamyltransferase, and lowering effects on AST to ALT ratio, with one of these missense alleles associated with increased risk of gallstones (p = 8.1 × 10–17, OR = 1.36 [95% CI:
1.27, 1.47]) and cholecystitis (p = 1.6 × 10~8, OR = 1.26 [95% CI: 1.16, 1.37]) in UK
Biobank</data>
</edge>
<edge source="PDF_29_2021_Result_-5877346504939176835" target="Protein_ALBUMIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">an allelic series of 3 missense variants in SERPINA1 with pleiotropic increasing effects on albumin, aspartate aminotransferase, direct bilirubin, and gamma glutamyltransferase, and lowering effects on AST to ALT ratio, with one of these missense alleles associated with increased risk of gallstones (p = 8.1 × 10–17, OR = 1.36 [95% CI:
1.27, 1.47]) and cholecystitis (p = 1.6 × 10~8, OR = 1.26 [95% CI: 1.16, 1.37]) in UK
Biobank</data>
</edge>
<edge source="PDF_29_2021_Result_-5877346504939176835" target="Protein_ASPARTATE AMINOTRANSFERASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">an allelic series of 3 missense variants in SERPINA1 with pleiotropic increasing effects on albumin, aspartate aminotransferase, direct bilirubin, and gamma glutamyltransferase, and lowering effects on AST to ALT ratio, with one of these missense alleles associated with increased risk of gallstones (p = 8.1 × 10–17, OR = 1.36 [95% CI:
1.27, 1.47]) and cholecystitis (p = 1.6 × 10~8, OR = 1.26 [95% CI: 1.16, 1.37]) in UK
Biobank</data>
</edge>
<edge source="PDF_29_2021_Result_-5877346504939176835" target="Compound_DIRECT BILIRUBIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">an allelic series of 3 missense variants in SERPINA1 with pleiotropic increasing effects on albumin, aspartate aminotransferase, direct bilirubin, and gamma glutamyltransferase, and lowering effects on AST to ALT ratio, with one of these missense alleles associated with increased risk of gallstones (p = 8.1 × 10–17, OR = 1.36 [95% CI:
1.27, 1.47]) and cholecystitis (p = 1.6 × 10~8, OR = 1.26 [95% CI: 1.16, 1.37]) in UK
Biobank</data>
</edge>
<edge source="PDF_29_2021_Result_-5877346504939176835" target="Protein_GAMMA GLUTAMYLTRANSFERASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">an allelic series of 3 missense variants in SERPINA1 with pleiotropic increasing effects on albumin, aspartate aminotransferase, direct bilirubin, and gamma glutamyltransferase, and lowering effects on AST to ALT ratio, with one of these missense alleles associated with increased risk of gallstones (p = 8.1 × 10–17, OR = 1.36 [95% CI:
1.27, 1.47]) and cholecystitis (p = 1.6 × 10~8, OR = 1.26 [95% CI: 1.16, 1.37]) in UK
Biobank</data>
</edge>
<edge source="PDF_29_2021_Result_-5877346504939176835" target="Disease_GALLSTONES">
  <data key="d8">MENTIONS</data>
  <data key="d9">an allelic series of 3 missense variants in SERPINA1 with pleiotropic increasing effects on albumin, aspartate aminotransferase, direct bilirubin, and gamma glutamyltransferase, and lowering effects on AST to ALT ratio, with one of these missense alleles associated with increased risk of gallstones (p = 8.1 × 10–17, OR = 1.36 [95% CI:
1.27, 1.47]) and cholecystitis (p = 1.6 × 10~8, OR = 1.26 [95% CI: 1.16, 1.37]) in UK
Biobank</data>
</edge>
<edge source="PDF_29_2021_Result_-5877346504939176835" target="Disease_CHOLECYSTITIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">an allelic series of 3 missense variants in SERPINA1 with pleiotropic increasing effects on albumin, aspartate aminotransferase, direct bilirubin, and gamma glutamyltransferase, and lowering effects on AST to ALT ratio, with one of these missense alleles associated with increased risk of gallstones (p = 8.1 × 10–17, OR = 1.36 [95% CI:
1.27, 1.47]) and cholecystitis (p = 1.6 × 10~8, OR = 1.26 [95% CI: 1.16, 1.37]) in UK
Biobank</data>
</edge>
<edge source="PDF_29_2021_Result_-4221729511752295252" target="Gene_DGKD">
  <data key="d8">MENTIONS</data>
  <data key="d9">two missense alleles in DGKD, with raising and lowering effects, respectively, on direct and total bilirubin</data>
</edge>
<edge source="PDF_29_2021_Result_-4221729511752295252" target="Compound_DIRECT BILIRUBIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">two missense alleles in DGKD, with raising and lowering effects, respectively, on direct and total bilirubin</data>
</edge>
<edge source="PDF_29_2021_Result_-4221729511752295252" target="Compound_TOTAL BILIRUBIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">two missense alleles in DGKD, with raising and lowering effects, respectively, on direct and total bilirubin</data>
</edge>
<edge source="PDF_29_2021_Result_2977106505218234330" target="Gene_COL4A4">
  <data key="d8">MENTIONS</data>
  <data key="d9">a PTV in COL4A4 associated with an increasing effect on microalbumin in urine (0.77 sd) and an increased risk of kidney disease (p = 6.7 × 10-13, OR = 6.9 [95% CI: 4.06, 11.6]) in UK Biobank</data>
</edge>
<edge source="PDF_29_2021_Result_2977106505218234330" target="Protein_MICROALBUMIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">a PTV in COL4A4 associated with an increasing effect on microalbumin in urine (0.77 sd) and an increased risk of kidney disease (p = 6.7 × 10-13, OR = 6.9 [95% CI: 4.06, 11.6]) in UK Biobank</data>
</edge>
<edge source="PDF_29_2021_Result_2977106505218234330" target="Disease_KIDNEY DISEASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">a PTV in COL4A4 associated with an increasing effect on microalbumin in urine (0.77 sd) and an increased risk of kidney disease (p = 6.7 × 10-13, OR = 6.9 [95% CI: 4.06, 11.6]) in UK Biobank</data>
</edge>
<edge source="PDF_29_2021_Result_2428702352743802929" target="Gene_SLC22A2">
  <data key="d8">MENTIONS</data>
  <data key="d9">a frame-shift variant in SLC22A2 with strong lowering effects on eGFR (0.52 sd) and increasing effect on creatinine (0.52 sd)</data>
</edge>
<edge source="PDF_29_2021_Result_2428702352743802929" target="Protein_EGFR">
  <data key="d8">MENTIONS</data>
  <data key="d9">a frame-shift variant in SLC22A2 with strong lowering effects on eGFR (0.52 sd) and increasing effect on creatinine (0.52 sd)</data>
</edge>
<edge source="PDF_29_2021_Result_2428702352743802929" target="Compound_CREATININE">
  <data key="d8">MENTIONS</data>
  <data key="d9">a frame-shift variant in SLC22A2 with strong lowering effects on eGFR (0.52 sd) and increasing effect on creatinine (0.52 sd)</data>
</edge>
<edge source="PDF_29_2021_Result_-5380714902332756007" target="Gene_SLC22A11">
  <data key="d8">MENTIONS</data>
  <data key="d9">a stop-gain variant in SLC22A11 with raising effects on urate (0.14 sd)</data>
</edge>
<edge source="PDF_29_2021_Result_-5380714902332756007" target="Compound_URATE">
  <data key="d8">MENTIONS</data>
  <data key="d9">a stop-gain variant in SLC22A11 with raising effects on urate (0.14 sd)</data>
</edge>
<edge source="PDF_29_2021_Result_4039113898606538160" target="Gene_SLC34A3">
  <data key="d8">MENTIONS</data>
  <data key="d9">a 0.1% rare missense allele in SLC34A3 with strong eGFR and phosphate lowering and serum creatinine, Cystatin C, and urea raising effects</data>
</edge>
<edge source="PDF_29_2021_Result_4039113898606538160" target="Protein_EGFR">
  <data key="d8">MENTIONS</data>
  <data key="d9">a 0.1% rare missense allele in SLC34A3 with strong eGFR and phosphate lowering and serum creatinine, Cystatin C, and urea raising effects</data>
</edge>
<edge source="PDF_29_2021_Result_4039113898606538160" target="Compound_PHOSPHATE">
  <data key="d8">MENTIONS</data>
  <data key="d9">a 0.1% rare missense allele in SLC34A3 with strong eGFR and phosphate lowering and serum creatinine, Cystatin C, and urea raising effects</data>
</edge>
<edge source="PDF_29_2021_Result_4039113898606538160" target="Compound_CREATININE">
  <data key="d8">MENTIONS</data>
  <data key="d9">a 0.1% rare missense allele in SLC34A3 with strong eGFR and phosphate lowering and serum creatinine, Cystatin C, and urea raising effects</data>
</edge>
<edge source="PDF_29_2021_Result_4039113898606538160" target="Protein_CYSTATIN C">
  <data key="d8">MENTIONS</data>
  <data key="d9">a 0.1% rare missense allele in SLC34A3 with strong eGFR and phosphate lowering and serum creatinine, Cystatin C, and urea raising effects</data>
</edge>
<edge source="PDF_29_2021_Result_4039113898606538160" target="Compound_UREA">
  <data key="d8">MENTIONS</data>
  <data key="d9">a 0.1% rare missense allele in SLC34A3 with strong eGFR and phosphate lowering and serum creatinine, Cystatin C, and urea raising effects</data>
</edge>
<edge source="PDF_29_2021_Result_9153768662042259724" target="Gene_SLC6A19">
  <data key="d8">MENTIONS</data>
  <data key="d9">missense alleles in SLC6A19, LRP2, ALDOB, and SLC7A9, and two missense variants in
SLC25A45, all associated with creatinine lowering and eGFR raising</data>
</edge>
<edge source="PDF_29_2021_Result_9153768662042259724" target="Gene_LRP2">
  <data key="d8">MENTIONS</data>
  <data key="d9">missense alleles in SLC6A19, LRP2, ALDOB, and SLC7A9, and two missense variants in
SLC25A45, all associated with creatinine lowering and eGFR raising</data>
</edge>
<edge source="PDF_29_2021_Result_9153768662042259724" target="Gene_ALDOB">
  <data key="d8">MENTIONS</data>
  <data key="d9">missense alleles in SLC6A19, LRP2, ALDOB, and SLC7A9, and two missense variants in
SLC25A45, all associated with creatinine lowering and eGFR raising</data>
</edge>
<edge source="PDF_29_2021_Result_9153768662042259724" target="Gene_SLC7A9">
  <data key="d8">MENTIONS</data>
  <data key="d9">missense alleles in SLC6A19, LRP2, ALDOB, and SLC7A9, and two missense variants in
SLC25A45, all associated with creatinine lowering and eGFR raising</data>
</edge>
<edge source="PDF_29_2021_Result_9153768662042259724" target="Gene_SLC25A45">
  <data key="d8">MENTIONS</data>
  <data key="d9">missense alleles in SLC6A19, LRP2, ALDOB, and SLC7A9, and two missense variants in
SLC25A45, all associated with creatinine lowering and eGFR raising</data>
</edge>
<edge source="PDF_29_2021_Result_9153768662042259724" target="Compound_CREATININE">
  <data key="d8">MENTIONS</data>
  <data key="d9">missense alleles in SLC6A19, LRP2, ALDOB, and SLC7A9, and two missense variants in
SLC25A45, all associated with creatinine lowering and eGFR raising</data>
</edge>
<edge source="PDF_29_2021_Result_9153768662042259724" target="Protein_EGFR">
  <data key="d8">MENTIONS</data>
  <data key="d9">missense alleles in SLC6A19, LRP2, ALDOB, and SLC7A9, and two missense variants in
SLC25A45, all associated with creatinine lowering and eGFR raising</data>
</edge>
<edge source="PDF_29_2021_Result_-592902069678588903" target="Gene_GPLD1">
  <data key="d8">MENTIONS</data>
  <data key="d9">an allelic series of two frame-shift variants and a missense variant in GPLD1</data>
</edge>
<edge source="PDF_29_2021_Result_-710225815859847602" target="Gene_ALKALINE PHOSPHATASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">an allelic series of missense variants in ALPL</data>
</edge>
<edge source="PDF_29_2021_Result_-73008443620360455" target="Gene_CASR">
  <data key="d8">MENTIONS</data>
  <data key="d9">an allelic series in CASR that is associated with both calcium increasing and lowering effects</data>
</edge>
<edge source="PDF_29_2021_Result_-73008443620360455" target="Compound_CALCIUM">
  <data key="d8">MENTIONS</data>
  <data key="d9">an allelic series in CASR that is associated with both calcium increasing and lowering effects</data>
</edge>
<edge source="PDF_29_2021_Result_646666475697248923" target="Gene_ANKH">
  <data key="d8">MENTIONS</data>
  <data key="d9">a known missense variant association in ANKH(-0.11 and −0.17 sd for glucose and HbA1C,
respectively), which we also replicated the documented protective effects to diabetes (p = 1.2
× 10-8, OR = 0.66 [95% CI: 0.57, 0.76])</data>
</edge>
<edge source="PDF_29_2021_Result_646666475697248923" target="Compound_GLUCOSE">
  <data key="d8">MENTIONS</data>
  <data key="d9">a known missense variant association in ANKH(-0.11 and −0.17 sd for glucose and HbA1C,
respectively), which we also replicated the documented protective effects to diabetes (p = 1.2
× 10-8, OR = 0.66 [95% CI: 0.57, 0.76])</data>
</edge>
<edge source="PDF_29_2021_Result_646666475697248923" target="Protein_HBA1C">
  <data key="d8">MENTIONS</data>
  <data key="d9">a known missense variant association in ANKH(-0.11 and −0.17 sd for glucose and HbA1C,
respectively), which we also replicated the documented protective effects to diabetes (p = 1.2
× 10-8, OR = 0.66 [95% CI: 0.57, 0.76])</data>
</edge>
<edge source="PDF_29_2021_Result_646666475697248923" target="Disease_DIABETES">
  <data key="d8">MENTIONS</data>
  <data key="d9">a known missense variant association in ANKH(-0.11 and −0.17 sd for glucose and HbA1C,
respectively), which we also replicated the documented protective effects to diabetes (p = 1.2
× 10-8, OR = 0.66 [95% CI: 0.57, 0.76])</data>
</edge>
<edge source="PDF_29_2021_Result_-6615300606113970582" target="Gene_RHAG">
  <data key="d8">MENTIONS</data>
  <data key="d9">a splice-donor variant in RHAG that is strongly associated with lower HbA1c (0.80 sd) and allelic series containing 4 missense variants each in G6PC2 and TMC8</data>
</edge>
<edge source="PDF_29_2021_Result_-6615300606113970582" target="Protein_HBA1C">
  <data key="d8">MENTIONS</data>
  <data key="d9">a splice-donor variant in RHAG that is strongly associated with lower HbA1c (0.80 sd) and allelic series containing 4 missense variants each in G6PC2 and TMC8</data>
</edge>
<edge source="PDF_29_2021_Result_-6615300606113970582" target="Gene_G6PC2">
  <data key="d8">MENTIONS</data>
  <data key="d9">a splice-donor variant in RHAG that is strongly associated with lower HbA1c (0.80 sd) and allelic series containing 4 missense variants each in G6PC2 and TMC8</data>
</edge>
<edge source="PDF_29_2021_Result_-6615300606113970582" target="Gene_TMC8">
  <data key="d8">MENTIONS</data>
  <data key="d9">a splice-donor variant in RHAG that is strongly associated with lower HbA1c (0.80 sd) and allelic series containing 4 missense variants each in G6PC2 and TMC8</data>
</edge>
<edge source="PDF_29_2021_Result_-8638093714097755657" target="Gene_ADH1C">
  <data key="d8">MENTIONS</data>
  <data key="d9">a PTV in ADH1C, MSR1, and NUBP2 affecting serum IGF-1 levels, and an allelic series including the
hepatocyte growth factor genes HGFAC, HGF, and HNF4A with effects on SHBG</data>
</edge>
<edge source="PDF_29_2021_Result_-8638093714097755657" target="Gene_MSR1">
  <data key="d8">MENTIONS</data>
  <data key="d9">a PTV in ADH1C, MSR1, and NUBP2 affecting serum IGF-1 levels, and an allelic series including the
hepatocyte growth factor genes HGFAC, HGF, and HNF4A with effects on SHBG</data>
</edge>
<edge source="PDF_29_2021_Result_-8638093714097755657" target="Gene_NUBP2">
  <data key="d8">MENTIONS</data>
  <data key="d9">a PTV in ADH1C, MSR1, and NUBP2 affecting serum IGF-1 levels, and an allelic series including the
hepatocyte growth factor genes HGFAC, HGF, and HNF4A with effects on SHBG</data>
</edge>
<edge source="PDF_29_2021_Result_-8638093714097755657" target="Protein_IGF-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">a PTV in ADH1C, MSR1, and NUBP2 affecting serum IGF-1 levels, and an allelic series including the
hepatocyte growth factor genes HGFAC, HGF, and HNF4A with effects on SHBG</data>
</edge>
<edge source="PDF_29_2021_Result_-8638093714097755657" target="Gene_HEPATOCYTE GROWTH FACTOR ACTIVATOR">
  <data key="d8">MENTIONS</data>
  <data key="d9">a PTV in ADH1C, MSR1, and NUBP2 affecting serum IGF-1 levels, and an allelic series including the
hepatocyte growth factor genes HGFAC, HGF, and HNF4A with effects on SHBG</data>
</edge>
<edge source="PDF_29_2021_Result_-8638093714097755657" target="Gene_HEPATOCYTE GROWTH FACTOR">
  <data key="d8">MENTIONS</data>
  <data key="d9">a PTV in ADH1C, MSR1, and NUBP2 affecting serum IGF-1 levels, and an allelic series including the
hepatocyte growth factor genes HGFAC, HGF, and HNF4A with effects on SHBG</data>
</edge>
<edge source="PDF_29_2021_Result_-8638093714097755657" target="Gene_HNF4A">
  <data key="d8">MENTIONS</data>
  <data key="d9">a PTV in ADH1C, MSR1, and NUBP2 affecting serum IGF-1 levels, and an allelic series including the
hepatocyte growth factor genes HGFAC, HGF, and HNF4A with effects on SHBG</data>
</edge>
<edge source="PDF_29_2021_Result_-8638093714097755657" target="Protein_SEX HORMONE BINDING GLOBULIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">a PTV in ADH1C, MSR1, and NUBP2 affecting serum IGF-1 levels, and an allelic series including the
hepatocyte growth factor genes HGFAC, HGF, and HNF4A with effects on SHBG</data>
</edge>
<edge source="PDF_29_2021_Result_-3755063657638932584" target="Disease_DIABETES">
  <data key="d8">MENTIONS</data>
  <data key="d9">a missense variant with MAF 0.02% was associated with increased risk for diabetic eye disorders (p = 3.1 × 10−8, OR =
9.60 ]95% CI: 4.30, 21.4]) and diabetes (p = 4.7 × 108־, OR = 3.8 [95% CI: 2.34, 6.09])</data>
</edge>
<edge source="PDF_29_2021_Result_-7552275888856269627" target="Disease_CHOLECYSTITIS">
  <data key="d8">MENTIONS</data>
  <data key="d9">a missense variant (MAF 3.1%) was associated with increased risk for cholecystitis (p
= 2.2 × 10-13, OR = 1.27 [95% CI: 1.22, 1.38] in UK Biobank, and also replicated in
FinnGen R2, p = 2.9 × 10-17, OR = 1.46 [95% CI: 1.34, 1.60])</data>
</edge>
<edge source="PDF_29_2021_Result_-4201111930626082783" target="Gene_HNF1B">
  <data key="d8">MENTIONS</data>
  <data key="d9">rare CNVs overlapping HNF1B associated with serum urea, eGFR, creatinine, and cystatin C</data>
</edge>
<edge source="PDF_29_2021_Result_-4201111930626082783" target="Compound_UREA">
  <data key="d8">MENTIONS</data>
  <data key="d9">rare CNVs overlapping HNF1B associated with serum urea, eGFR, creatinine, and cystatin C</data>
</edge>
<edge source="PDF_29_2021_Result_-4201111930626082783" target="Protein_EGFR">
  <data key="d8">MENTIONS</data>
  <data key="d9">rare CNVs overlapping HNF1B associated with serum urea, eGFR, creatinine, and cystatin C</data>
</edge>
<edge source="PDF_29_2021_Result_-4201111930626082783" target="Compound_CREATININE">
  <data key="d8">MENTIONS</data>
  <data key="d9">rare CNVs overlapping HNF1B associated with serum urea, eGFR, creatinine, and cystatin C</data>
</edge>
<edge source="PDF_29_2021_Result_-4201111930626082783" target="Protein_CYSTATIN C">
  <data key="d8">MENTIONS</data>
  <data key="d9">rare CNVs overlapping HNF1B associated with serum urea, eGFR, creatinine, and cystatin C</data>
</edge>
<edge source="PDF_29_2021_Result_2729564798083139075" target="Gene_HNF1B">
  <data key="d8">MENTIONS</data>
  <data key="d9">mutations in HNF1B with maturity onset diabetes of the young (MODY5) and altered
kidney function</data>
</edge>
<edge source="PDF_29_2021_Result_2729564798083139075" target="Disease_MATURITY ONSET DIABETES OF THE YOUNG">
  <data key="d8">MENTIONS</data>
  <data key="d9">mutations in HNF1B with maturity onset diabetes of the young (MODY5) and altered
kidney function</data>
</edge>
<edge source="PDF_29_2021_Result_2729564798083139075" target="Process_KIDNEY FUNCTION">
  <data key="d8">MENTIONS</data>
  <data key="d9">mutations in HNF1B with maturity onset diabetes of the young (MODY5) and altered
kidney function</data>
</edge>
<edge source="PDF_29_2021_Result_-3349541591639341791" target="Gene_HNF1B">
  <data key="d8">MENTIONS</data>
  <data key="d9">rare CNVs overlapping HNF1B were associated with chronic kidney
disease (p = 1 × 10–7; OR = 4.94, SE = 0.30</data>
</edge>
<edge source="PDF_29_2021_Result_-3349541591639341791" target="Disease_KIDNEY DISEASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">rare CNVs overlapping HNF1B were associated with chronic kidney
disease (p = 1 × 10–7; OR = 4.94, SE = 0.30</data>
</edge>
<edge source="PDF_29_2021_Result_4001098613197549686" target="Gene_CYSTATIN C">
  <data key="d8">MENTIONS</data>
  <data key="d9">rare duplication in the CST3 gene associated with increased levels of cystatin C, the protein it encodes, of opposite effect
to a rare PTV at the same locus</data>
</edge>
<edge source="PDF_29_2021_Result_4001098613197549686" target="Protein_CYSTATIN C">
  <data key="d8">MENTIONS</data>
  <data key="d9">rare duplication in the CST3 gene associated with increased levels of cystatin C, the protein it encodes, of opposite effect
to a rare PTV at the same locus</data>
</edge>
<edge source="PDF_29_2021_Result_6142937756838132795" target="Gene_HEPATOCYTE GROWTH FACTOR ACTIVATOR">
  <data key="d8">MENTIONS</data>
  <data key="d9">HGFAC, the gene encoding hepatocyte growth factor activator, variants show significant associations with a number of diverse biomarker traits, including lipids, IGF-1, albumin, and calcium</data>
</edge>
<edge source="PDF_29_2021_Result_6142937756838132795" target="Protein_HEPATOCYTE GROWTH FACTOR ACTIVATOR">
  <data key="d8">MENTIONS</data>
  <data key="d9">HGFAC, the gene encoding hepatocyte growth factor activator, variants show significant associations with a number of diverse biomarker traits, including lipids, IGF-1, albumin, and calcium</data>
</edge>
<edge source="PDF_29_2021_Result_6142937756838132795" target="Compound_LIPIDS">
  <data key="d8">MENTIONS</data>
  <data key="d9">HGFAC, the gene encoding hepatocyte growth factor activator, variants show significant associations with a number of diverse biomarker traits, including lipids, IGF-1, albumin, and calcium</data>
</edge>
<edge source="PDF_29_2021_Result_6142937756838132795" target="Protein_IGF-1">
  <data key="d8">MENTIONS</data>
  <data key="d9">HGFAC, the gene encoding hepatocyte growth factor activator, variants show significant associations with a number of diverse biomarker traits, including lipids, IGF-1, albumin, and calcium</data>
</edge>
<edge source="PDF_29_2021_Result_6142937756838132795" target="Protein_ALBUMIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">HGFAC, the gene encoding hepatocyte growth factor activator, variants show significant associations with a number of diverse biomarker traits, including lipids, IGF-1, albumin, and calcium</data>
</edge>
<edge source="PDF_29_2021_Result_6142937756838132795" target="Compound_CALCIUM">
  <data key="d8">MENTIONS</data>
  <data key="d9">HGFAC, the gene encoding hepatocyte growth factor activator, variants show significant associations with a number of diverse biomarker traits, including lipids, IGF-1, albumin, and calcium</data>
</edge>
<edge source="PDF_29_2021_Result_-8007171609199782149" target="Gene_HEPATOCYTE GROWTH FACTOR">
  <data key="d8">MENTIONS</data>
  <data key="d9">rs114303452 has been previously associated with serum HGF levels47, supporting the role of HGFAC in control of a number of other serum biomarkers through regulation of hepatocyte growth factor</data>
</edge>
<edge source="PDF_29_2021_Result_-8007171609199782149" target="Gene_HEPATOCYTE GROWTH FACTOR ACTIVATOR">
  <data key="d8">MENTIONS</data>
  <data key="d9">rs114303452 has been previously associated with serum HGF levels47, supporting the role of HGFAC in control of a number of other serum biomarkers through regulation of hepatocyte growth factor</data>
</edge>
<edge source="PDF_29_2021_Result_-8007171609199782149" target="Protein_HEPATOCYTE GROWTH FACTOR">
  <data key="d8">MENTIONS</data>
  <data key="d9">rs114303452 has been previously associated with serum HGF levels47, supporting the role of HGFAC in control of a number of other serum biomarkers through regulation of hepatocyte growth factor</data>
</edge>
<edge source="PDF_29_2021_Result_-8639879267144360643" target="Gene_DPEPI">
  <data key="d8">MENTIONS</data>
  <data key="d9">common (MAF = 33%) intronic
variant in DPEPI has protective effects against skin cancers (OR = 0.88 [95% CI: 0.86,
0.90], 0.81 [0.77, 0.84], and 0.89 [0.87, 0.91] for skin cancer, malignant melanoma, and
non-melanoma skin cancer, respectively), with replication in FinnGen R2 (p = 3.1 × 10~5,
OR = 0.81 [95% CI: 0.74, 0.90] for malignant neoplasm of skin)</data>
</edge>
<edge source="PDF_29_2021_Result_-8639879267144360643" target="Disease_SKIN CANCERS">
  <data key="d8">MENTIONS</data>
  <data key="d9">common (MAF = 33%) intronic
variant in DPEPI has protective effects against skin cancers (OR = 0.88 [95% CI: 0.86,
0.90], 0.81 [0.77, 0.84], and 0.89 [0.87, 0.91] for skin cancer, malignant melanoma, and
non-melanoma skin cancer, respectively), with replication in FinnGen R2 (p = 3.1 × 10~5,
OR = 0.81 [95% CI: 0.74, 0.90] for malignant neoplasm of skin)</data>
</edge>
<edge source="PDF_29_2021_Result_-8639879267144360643" target="Disease_MALIGNANT MELANOMA">
  <data key="d8">MENTIONS</data>
  <data key="d9">common (MAF = 33%) intronic
variant in DPEPI has protective effects against skin cancers (OR = 0.88 [95% CI: 0.86,
0.90], 0.81 [0.77, 0.84], and 0.89 [0.87, 0.91] for skin cancer, malignant melanoma, and
non-melanoma skin cancer, respectively), with replication in FinnGen R2 (p = 3.1 × 10~5,
OR = 0.81 [95% CI: 0.74, 0.90] for malignant neoplasm of skin)</data>
</edge>
<edge source="PDF_29_2021_Result_-8639879267144360643" target="Disease_NON-MELANOMA SKIN CANCER">
  <data key="d8">MENTIONS</data>
  <data key="d9">common (MAF = 33%) intronic
variant in DPEPI has protective effects against skin cancers (OR = 0.88 [95% CI: 0.86,
0.90], 0.81 [0.77, 0.84], and 0.89 [0.87, 0.91] for skin cancer, malignant melanoma, and
non-melanoma skin cancer, respectively), with replication in FinnGen R2 (p = 3.1 × 10~5,
OR = 0.81 [95% CI: 0.74, 0.90] for malignant neoplasm of skin)</data>
</edge>
<edge source="PDF_29_2021_Result_8465833011909455292" target="Gene_ABCG2">
  <data key="d8">MENTIONS</data>
  <data key="d9">allelic series of two
intronic variants in ABCG2 identified with increasing and lowering urate level associations
that have risk-increasing (p = 2.8 × 10–67, OR = 1.38 [95% CI: 1.33, 1.44]) and protective
(OR = 0.72 [95% CI: 0.69, 0.74]) associations with gout, respectively</data>
</edge>
<edge source="PDF_29_2021_Result_8465833011909455292" target="Compound_URATE">
  <data key="d8">MENTIONS</data>
  <data key="d9">allelic series of two
intronic variants in ABCG2 identified with increasing and lowering urate level associations
that have risk-increasing (p = 2.8 × 10–67, OR = 1.38 [95% CI: 1.33, 1.44]) and protective
(OR = 0.72 [95% CI: 0.69, 0.74]) associations with gout, respectively</data>
</edge>
<edge source="PDF_29_2021_Result_8465833011909455292" target="Disease_GOUT">
  <data key="d8">MENTIONS</data>
  <data key="d9">allelic series of two
intronic variants in ABCG2 identified with increasing and lowering urate level associations
that have risk-increasing (p = 2.8 × 10–67, OR = 1.38 [95% CI: 1.33, 1.44]) and protective
(OR = 0.72 [95% CI: 0.69, 0.74]) associations with gout, respectively</data>
</edge>
<edge source="PDF_29_2021_Result_-6867944860966669618" target="Protein_SEX HORMONE BINDING GLOBULIN">
  <data key="d8">MENTIONS</data>
  <data key="d9">genetic evidence supporting the protective effect of sex hormone binding globulin on diabetes (0.7 OR/SD) consistent with existing reports</data>
</edge>
<edge source="PDF_29_2021_Result_-6867944860966669618" target="Disease_DIABETES">
  <data key="d8">MENTIONS</data>
  <data key="d9">genetic evidence supporting the protective effect of sex hormone binding globulin on diabetes (0.7 OR/SD) consistent with existing reports</data>
</edge>
<edge source="PDF_29_2021_Result_1446722532634649339" target="Protein_APOLIPOPROTEIN A">
  <data key="d8">MENTIONS</data>
  <data key="d9">ApoA on fasting glucose (0.84 OR/SD, FDR-adjusted p = 0.02)</data>
</edge>
<edge source="PDF_29_2021_Result_1446722532634649339" target="Compound_GLUCOSE">
  <data key="d8">MENTIONS</data>
  <data key="d9">ApoA on fasting glucose (0.84 OR/SD, FDR-adjusted p = 0.02)</data>
</edge>
<edge source="PDF_29_2021_Result_-4997994686314589138" target="Protein_ALANINE AMINOTRANSFERASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">increasing effect of alanine
aminotransferase levels on diabetes (1.53 OR/SD, FDR-adjusted p = 0.0018)</data>
</edge>
<edge source="PDF_29_2021_Result_-4997994686314589138" target="Disease_DIABETES">
  <data key="d8">MENTIONS</data>
  <data key="d9">increasing effect of alanine
aminotransferase levels on diabetes (1.53 OR/SD, FDR-adjusted p = 0.0018)</data>
</edge>
<edge source="PDF_29_2021_Result_4786714691298363183" target="Protein_CYSTATIN C">
  <data key="d8">MENTIONS</data>
  <data key="d9">consistent effect of cystatin C on stroke (1.2 OR/SD, FDR-adjusted p = 8.7×10−4 for any
stroke and 1.21 OR/SD, FDR-adjusted p = 2.8×10−3 for ischemic stroke)</data>
</edge>
<edge source="PDF_29_2021_Result_4786714691298363183" target="Disease_STROKE">
  <data key="d8">MENTIONS</data>
  <data key="d9">consistent effect of cystatin C on stroke (1.2 OR/SD, FDR-adjusted p = 8.7×10−4 for any
stroke and 1.21 OR/SD, FDR-adjusted p = 2.8×10−3 for ischemic stroke)</data>
</edge>
<edge source="PDF_29_2021_Result_-7248453938590399397" target="Compound_HDL CHOLESTEROL">
  <data key="d8">MENTIONS</data>
  <data key="d9">HDL and ApoA were associated with increased risk of age-related macular degeneration</data>
</edge>
<edge source="PDF_29_2021_Result_-7248453938590399397" target="Protein_APOLIPOPROTEIN A">
  <data key="d8">MENTIONS</data>
  <data key="d9">HDL and ApoA were associated with increased risk of age-related macular degeneration</data>
</edge>
<edge source="PDF_29_2021_Result_-7248453938590399397" target="Disease_AGE-RELATED MACULAR DEGENERATION">
  <data key="d8">MENTIONS</data>
  <data key="d9">HDL and ApoA were associated with increased risk of age-related macular degeneration</data>
</edge>
<edge source="PDF_29_2021_Result_-242860860274716819" target="Protein_CYSTATIN C">
  <data key="d8">MENTIONS</data>
  <data key="d9">cystatin C on age-related macular degeneration</data>
</edge>
<edge source="PDF_29_2021_Result_-242860860274716819" target="Disease_AGE-RELATED MACULAR DEGENERATION">
  <data key="d8">MENTIONS</data>
  <data key="d9">cystatin C on age-related macular degeneration</data>
</edge>
<edge source="PDF_29_2021_Result_5865510701742958866" target="Compound_TESTOSTERONE">
  <data key="d8">MENTIONS</data>
  <data key="d9">causal protective effect of testosterone on inflammatory bowel disease (0.70
OR/SD, FDR-adjusted p = 3.86×10−3)</data>
</edge>
<edge source="PDF_29_2021_Result_5865510701742958866" target="Disease_INFLAMMATORY BOWEL DISEASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">causal protective effect of testosterone on inflammatory bowel disease (0.70
OR/SD, FDR-adjusted p = 3.86×10−3)</data>
</edge>
<edge source="PDF_29_2021_Result_2926063715828468877" target="Compound_URATE">
  <data key="d8">MENTIONS</data>
  <data key="d9">protective effect of urate on breast cancer
risk (0.87 OR/SD, FDR-adjusted p = 0.033)</data>
</edge>
<edge source="PDF_29_2021_Result_2926063715828468877" target="Disease_BREAST CANCER">
  <data key="d8">MENTIONS</data>
  <data key="d9">protective effect of urate on breast cancer
risk (0.87 OR/SD, FDR-adjusted p = 0.033)</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Conclusion_-643451381044668031">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Conclusion_145202335114919830">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Conclusion_3575593707632110593">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Conclusion_-532478394493600253">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_2611395328384755538">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-6506083880635425266">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-1338665336501691604">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_5237846299816503068">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_1090941322669377502">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-7097743009099374394">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-4855797592693601594">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_6516712969677708757">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-192296634193942865">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_6316432437868048452">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_1016911348703401768">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_6182808461083643693">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-6260615307188953613">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_2452383165856283543">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_1243368607826909004">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-626512274622576483">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_8204497841698412773">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-5405089879357394740">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_4819660478751447880">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-1765181065565569119">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-4742793393373640942">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-8022210761480170780">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-1707995260394507711">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_8130796514709054219">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-2298838677054812738">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_2768816900533462166">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-218620009308765095">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_6966711558591681604">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_3591124625376200672">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_7195033068660679754">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-3356635196631907474">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_6041168224285911215">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-4752682912734643746">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_3170009576357379118">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-8525835524271274561">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_8326470630231534351">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_6514576396171389801">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_6729994292218247921">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_5231125941815717684">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_484880477693735595">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_5807435356745159919">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_2879939869721617914">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_4181264621298161287">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_187317135494929868">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-5912592020987490968">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_2776163156402196038">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-6615997024763038732">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-7904140944362345877">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-4065146560459111244">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-5484845071041109114">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_7927968620823455195">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_4860711557052946174">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-8019904981425352654">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_435226949226979638">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_4948576322101467019">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-6605973537982548892">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-7273747954525077845">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_8665009682326536185">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_8997888408379898657">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-4249170324546643797">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-4674289829848126397">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_8604739485804645421">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-8149516773716739703">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_6138912185392396335">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-5248946010868100813">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_3842845297345155070">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-2769329775037719334">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_4368022153806193586">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_6394915112418864867">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_7751973788691617524">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_4046510346252145046">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_8943811499915257727">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-7798959133294810114">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_2147677484367228702">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_4689609401511785160">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-2733308991801400711">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-6363912091192157552">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_2291854045400655013">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-349997672573353110">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-4862312033229545929">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-1082889079323691771">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-7934512523283457974">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_5242860508786423365">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-7866323607528034826">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-1410001266504977847">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_782228815989570679">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_1309553967301455561">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_4708305334563415109">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-2180706313580158849">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_5513406597114021216">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-8716936521240148936">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-8770586852948316027">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-1265511982591255889">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-8557359170346303004">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-5471715600935533770">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_1099131292023905312">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_7344316095245262954">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-5437192387775896707">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-6306807145602007753">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_6968961274516821675">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-4443640459229702546">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-7981679838125482304">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-4221535811612929792">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-5407220415233439904">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_5209383823554195311">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_8993459347457690362">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_6375875421462555005">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_9125790733851897827">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_1963783371072672739">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-4389366504757811525">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_2800497317580016243">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_458064007711797466">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_7082090687118344914">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-4867061353284130689">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_5051524760802359573">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-4205445665452748532">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_7101319638586571796">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-1531191695952572802">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-280540192320232240">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_-7590497477455818820">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_1702324324304191159">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_1068733771608301059">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016" target="PDF_03_2016_Result_6166757899220619831">
  <data key="d8">CONTAINS</data>
</edge>
<edge source="PDF_03_2016_Result_2611395328384755538" target="Gene_GAG">
  <data key="d8">MENTIONS</data>
  <data key="d9">At least 85 genes derived from the gag gene of LTR retrotransposons have been identified in the human genome.</data>
</edge>
<edge source="PDF_03_2016_Result_6182808461083643693" target="Gene_GAG">
  <data key="d8">MENTIONS</data>
  <data key="d9">Strikingly, all Mart genes carry a protein-coding region that is derived from the gag region of the ancestral Sushi retrotransposon.</data>
</edge>
<edge source="PDF_03_2016_Result_-6260615307188953613" target="Protein_GAG">
  <data key="d8">MENTIONS</data>
  <data key="d9">However, only four Mart proteins have conserved the nucleic acid-binding zinc finger from the original Gag nucleocapsid protein.</data>
</edge>
<edge source="PDF_03_2016_Result_2776163156402196038" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma4 (Ma4/Map1/Maop1) is a pro-apoptotic protein that can bind the pro-apoptotic Bax (Bcl2-associated X) protein and the pro-survival Bcl-2 and Bcl-X(L) proteins</data>
</edge>
<edge source="PDF_03_2016_Result_2776163156402196038" target="Protein_BCL-2">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnma4 (Ma4/Map1/Maop1) is a pro-apoptotic protein that can bind the pro-apoptotic Bax (Bcl2-associated X) protein and the pro-survival Bcl-2 and Bcl-X(L) proteins</data>
</edge>
<edge source="PDF_03_2016_Result_-6615997024763038732" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">The stimulation of death receptors induces the formation of a complex between Pnma4 and the tumour suppressor protein RASSFIA, allowing the binding of Pnma4 to Bax.</data>
</edge>
<edge source="PDF_03_2016_Result_-7904140944362345877" target="Protein_BAX">
  <data key="d8">MENTIONS</data>
  <data key="d9">Bax conformational change and induction of apoptosis in response to death receptor stimulation require interaction between RASSFIA and Pnma4</data>
</edge>
<edge source="PDF_03_2016_Result_-5484845071041109114" target="Disease_DISEASE">
  <data key="d8">MENTIONS</data>
  <data key="d9">Pnmal also promotes cell growth in human pancreatic ductal adenocarcinoma</data>
</edge>
<edge source="PDF_03_2016_Result_8665009682326536185" target="Gene_GAG">
  <data key="d8">MENTIONS</data>
  <data key="d9">As observed in other Gag-related genes, SCAN domain genes play a role in the control of cell survival, proliferation and apoptosis, therefore having a possible involvement in cancer</data>
</edge>
<edge source="PDF_03_2016_Result_-4249170324546643797" target="Protein_TP53">
  <data key="d8">MENTIONS</data>
  <data key="d9">ZNF307 suppresses the p53-p21 pathway possibly through p53 degradation</data>
</edge>
<edge source="PDF_03_2016_Result_-8149516773716739703" target="Gene_GAG">
  <data key="d8">MENTIONS</data>
  <data key="d9">Some Gag-derived proteins play a role in the defence of organisms against infections by retroviruses</data>
</edge>
<edge source="PDF_03_2016_Result_-5248946010868100813" target="Gene_GAG">
  <data key="d8">MENTIONS</data>
  <data key="d9">Fvl was formed about 7 MYA from the gag gene of an endogenous retrovirus family, MERV-L</data>
</edge>
<edge source="PDF_03_2016_Result_8943811499915257727" target="Gene_GAG">
  <data key="d8">MENTIONS</data>
  <data key="d9">Arc has been derived from the gag gene of a Gypsy-26-I_DR retrotransposon before the divergence between mammals and amphibians</data>
</edge>
<edge source="PDF_03_2016_Result_-7798959133294810114" target="Gene_GAG">
  <data key="d8">MENTIONS</data>
  <data key="d9">Among them, a gag-like gene called Ens-1/Erni is involved in the timing of neural plate emergence during embryonic development through the control of the expression of the Sox2 transcription factor</data>
</edge>
<edge source="PDF_03_2016_Result_2147677484367228702" target="Gene_GAG">
  <data key="d8">MENTIONS</data>
  <data key="d9">Compared with gag-derived genes, genes derived from integrases of retroviruses and LTR retrotransposons are not numerous in vertebrate genomes</data>
</edge>
<edge source="PDF_03_2016_Result_-2180706313580158849" target="Gene_GAG">
  <data key="d8">MENTIONS</data>
  <data key="d9">In addition to the protease domain, SASPase also shows homology with the capsid domain of Gag proteins from LTR retroelements</data>
</edge>
</graph></graphml>